Trait Ontology id	Trait Label	EFO description	EFO synonym	EFO Tree
EFO:0009827	abnormal result of diagnostic imaging	NA		abnormal result of diagnostic imaging|test result|information entity|experimental factor
EFO:0004536	total blood protein measurement	NA	serum total protein;TBP	total blood protein measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0004838	calcium measurement	NA	calcium levels	calcium measurement|measurement|information entity|experimental factor
EFO:0004696	sex hormone-binding globulin measurement	NA	SHBG levels;SHBG level	sex hormone-binding globulin measurement|glycoprotein measurement|protein measurement|measurement|information entity|experimental factor; sex hormone-binding globulin measurement|sex hormone measurement|hormone measurement|measurement|information entity|experimental factor
EFO:0004532	serum gamma-glutamyl transferase measurement	NA	GGT measurement;Gamma gluatamyl transferase levels;gamma glutamyl transferase measurement;Gamma glutamyl transpeptidase levels	serum gamma-glutamyl transferase measurement|liver enzyme measurement|measurement|information entity|experimental factor
EFO:0004195	LDL cholesterol	NA	LDL lipoproteins;High-density lipoprotein cholesterol;High-density lipoproteins;cholesterol, LDL;lipoproteins, LDL	LDL cholesterol|cholesterol|lipoprotein|protein|chemical entity|material entity|experimental factor; LDL cholesterol|cholesterol|sterol|steroid|lipid|chemical entity|material entity|experimental factor; LDL cholesterol|cholesterol|lipoprotein|protein|biological macromolecule|material entity|experimental factor
EFO:0004570	bilirubin measurement	NA	bilirubin levels	bilirubin measurement|measurement|information entity|experimental factor
CHEBI:17855	triglyceride	NA	triglycerides;Triglyceride	triglyceride|lipid|chemical entity|material entity|experimental factor
EFO:0020874	apolipoprotein B change measurement	NA		apolipoprotein B change measurement|apolipoprotein B measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; apolipoprotein B change measurement|apolipoprotein B measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor
CHEBI:16113	cholesterol	NA	CHOLESTEROL;cholest-5-en-3beta-ol;cholesterol;Cholesterol	cholesterol|lipoprotein|protein|chemical entity|material entity|experimental factor; cholesterol|lipoprotein|protein|biological macromolecule|material entity|experimental factor; cholesterol|sterol|steroid|lipid|chemical entity|material entity|experimental factor
EFO:0020690	protein-glutamine gamma-glutamyltransferase e measurement	NA		protein-glutamine gamma-glutamyltransferase e measurement|protein measurement|measurement|information entity|experimental factor
EFO:0003836	lipoprotein	NA	Circulating Lipoproteins;Lipoproteins, Circulating;Lipoproteins	lipoprotein|protein|chemical entity|material entity|experimental factor; lipoprotein|protein|biological macromolecule|material entity|experimental factor
EFO:0007806	total cholesterol change measurement	NA		total cholesterol change measurement|total cholesterol measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; total cholesterol change measurement|total cholesterol measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; total cholesterol change measurement|total cholesterol measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0000405	digestive system disease	A disease or disorder that involves the digestive system.	intestinal disease;digestive system disease or disorder;Digestive system diseases NOS (disorder);[X]Other diseases of intestines (disorder);Gastrointestinal Disease;Disorder of digestive system;Infantum, Cholera;Diseases, Digestive System;Gastrointestinal and digestive disorder;stomach or intestinal disorder;gastrointestinal system disorder;Disorder of digestive system (disorder);Other gallbladder disorders;Other diseases of the intestines and peritoneum (disorder);Other diseases of the intestines and peritoneum;System Diseases, Digestive;intestinal diseases;OTHER DISEASES OF INTESTINES AND PERITONEUM;Other disorders of intestine (disorder);git disease;gastrointestinal disorder;[X]Other specified diseases of anus and rectum (disorder);Other gallbladder disorders NOS;Gastrointestinal Disorder, Functional;Gastrointestinal Diseases;Functional Gastrointestinal Disorder;[X]Other diseases of the digestive system;[X]Other specified diseases of anus and rectum;Functional Gastrointestinal Disorders;digestive system disease;[X]Other diseases of intestines;gastrointestinal disease;GASTROINTESTINAL DIS;digestive disease;Other disorders of gallbladder;Disease, Digestive System;Disease of digestive system, NOS;[X]Other diseases of the digestive system (disorder);disorder of digestive system;disease of digestive system;Disease of digestive system (disorder);RECTAL & ANAL DIS NEC;Other gallbladder disorders NOS (disorder);DIGESTIVE SYSTEM DIS;Cholera Infantum;Digestive system diseases NOS;digestive system disorder;Other intestine disorders;disease or disorder of digestive system;GIT diseases;gastroenteropathy;Disorder, Functional Gastrointestinal;Other disorders of intestine;Other gallbladder disorders (disorder);Other intestinal disorders NOS;System Disease, Digestive;Disorders, Functional Gastrointestinal;alimentary system disease;gastrointestinal system disease;gastroenterological system disorder;Disease, Gastrointestinal;Diseases, Gastrointestinal;OTHER DISEASES OF DIGESTIVE SYSTEM;Disease of digestive system;Digestive System Diseases;gastroenterological system disease;Functional digestive disorders, not elsewhere classified;Other specified disorders of rectum and anus;POSTOP GI FUNCT DIS NEC;Other intestinal disorders NOS (disorder);Gastrointestinal Disorders, Functional;DISEASES OF THE DIGESTIVE SYSTEM	digestive system disease|disease|disposition|material property|experimental factor
EFO:0010684	malunion fracture	NA	malunion of broken bone;malunion of fracture;fracture, malunion	malunion fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; malunion fracture|bone fracture|injury|disease|disposition|material property|experimental factor
MONDO:0002959	radiculopathy	Disease involving a spinal nerve root (see spinal nerve roots) which may result from compression related to intervertebral disk displacement; spinal cord injuries; spinal diseases; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.	nerve root disorder	radiculopathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0003894	acne	An inflammatory process of the sebaceous glands which is characterized by comedones, nodules, papules and/or pustules on the skin.	acne;acne (disease);acne vulgaris;frontalis acne;acne varioliformis;Acne Vulgaris	acne|sebaceous gland disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; acne|inflammatory skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; acne|genetic disorder|disease|disposition|material property|experimental factor; acne|sebaceous gland disease|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor; acne|sebaceous gland disease|disorder of pilosebaceous unit|integumentary system disease|disease|disposition|material property|experimental factor; acne|genetic disorder|material entity|experimental factor; acne|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; acne|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
HP:0000152	Abnormality of head or neck	An abnormality of head and neck.	Head and neck abnormality;Abnormality of head or neck	Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1000760	rosacea	A chronic erythematous skin disorder that affects the face. It is characterized by the development of redness in the cheeks, nose, and/or forehead and telangiectasia. Sometimes, the erythematous changes may involve the eyelids.	Acne, erythematosa;acne, erythematosa;acne roscea;rosacea;acne rosacea;Acne roscea	rosacea|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
MONDO:0004828	lower urinary tract calculus	A urolithiasis that involves the lower urinary tract.	urolithiasis of lower urinary tract;lower urinary tract urolithiasis	lower urinary tract calculus|urolithiasis|urinary system disease|disease|disposition|material property|experimental factor
EFO:0003106	pneumonia	An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, caused by an infection in one or both of the lungs (by bacteria, viruses, fungi, or mycoplasma.). Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.	pneumonia;Pneumonitis (disorder);Pneumonia (disorder) [Ambiguous];Pneumonia NOS (disorder);Pneumonitis;pneumonia with infectious disease;Pneumonia due to other specified organisms;Pneumonia due to other specified organism;Pneumonia NOS;Pneumonia due to other specified organisms (disorder);acute pneumonia;Pneumonia (disorder);chest infection due to pneumonia	pneumonia|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; pneumonia|pneumonitis|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; pneumonia|pneumonitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0009628	abnormal result of function studies	NA		abnormal result of function studies|test result|information entity|experimental factor
EFO:0000319	cardiovascular disease	A disease involving the cardiovascular system.	Disorder of the circulatory system;PERICARDIAL DISEASE NEC;Ill-defined descriptions and complications of heart disease;Other pericardial disease NOS;Unspecified circulatory system disorder;DISEASES OF THE CIRCULATORY SYSTEM;Disorder of circulatory system;[X]Other ill-defined heart diseases;Certain sequelae of myocardial infarction, not elsewhere classified;ILL-DEFINED HRT DIS NEC;Other heart disease;Cardiovascular Disease (CVD);OTHER SEQUELAE OF MI NEC;Other forms of heart disease (disorder);Cardiovascular Disorder;cardiovascular system disease;Other sequelae of myocardial infarction, not elsewhere classified;Cardiovascular system disease;Diseases, Cardiovascular;disease of subdivision of hemolymphoid system;Cardiovascular Disorders;Disease of cardiovascular system (disorder);circulatory system disease;Disease of cardiovascular system, NOS;Other ill-defined heart diseases;Circulatory system disease NOS (disorder);disease or disorder of cardiovascular system;PAPILLARY MUSCLE DIS NEC;Disease of cardiovascular system;Circulatory system disease NOS;CVD;CIRCULATORY DISEASE NOS;Other heart disease NOS;cardiovascular disorder;ASCVD;Cardiovascular disorder, NOS;[X]Cardiovascular disease, unspecified;Other specified pericardial disease NOS (disorder);Cardiovascular Diseases;disorder of cardiovascular system;Disorder of circulatory system, NOS;Cardiovascular disease, unspecified;Cardiovascular disease, NOS;Other ill-defined heart disease NOS (disorder);Other heart disease (disorder);Disease affecting entire cardiovascular system;Other forms of heart disease;Other heart disease NOS (disorder);[X]Other forms of heart disease (disorder);Other diseases of endocardium;Other specified pericardial disease NOS;Disease affecting entire cardiovascular system (disorder);Other ill-defined heart disease;[X]Other specified diseases of pericardium;Other disorders of papillary muscle;[X]Other forms of heart disease;Other pericardial disease NOS (disorder);[X]Other ill-defined heart diseases (disorder);cardiovascular system disease or disorder;CVD, NOS;Disorder of cardiovascular system (disorder);cardiovascular disease;Other diseases of endocardium (disorder);Other ill-defined heart disease (disorder);Other ill-defined heart disease NOS;Other diseases of pericardium;[X]Cardiovascular disease, unspecified (disorder);disease of cardiovascular system;cardiovascular disease (CVD);[X]Other specified diseases of pericardium (disorder);Other diseases of pericardium (disorder);CARDIOVASC DIS;CVS disease;Disease, Cardiovascular;Disorder of cardiovascular system;Other specified diseases of pericardium	cardiovascular disease|disease|disposition|material property|experimental factor
EFO:1001395	Phlebitis	Inflammation of a vein.	phlebitis;vein inflammation;inflammation of vein	Phlebitis|vasculitis|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Phlebitis|vasculitis|material entity|experimental factor; Phlebitis|vasculitis|inflammatory disease|disease|disposition|material property|experimental factor; Phlebitis|vein disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0007149	appendicitis	Acute inflammation of the vermiform appendix.	acute appendicitis with peritoneal abscess (disorder);vermiform appendix inflammation;appendicitis;Appendicitis;inflammation of vermiform appendix;acute appendicitis with generalized peritonitis (disorder);acute appendicitis with generalized peritonitis;acute appendicitis;acute appendicitis with peritoneal abscess	appendicitis|disorder of appendix|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; appendicitis|inflammatory bowel disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; appendicitis|inflammatory bowel disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; appendicitis|inflammatory bowel disease|genetic disorder|disease|disposition|material property|experimental factor; appendicitis|cecal disorder|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; appendicitis|diverticulitis|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; appendicitis|diverticulitis|diverticular disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; appendicitis|inflammatory bowel disease|genetic disorder|material entity|experimental factor; appendicitis|diverticulitis|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0010476	dimethylglycine measurement	NA		dimethylglycine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:0006336	diastolic blood pressure	NA	DIABP;diastolic pressure	diastolic blood pressure|blood pressure|vital signs|measurement|information entity|experimental factor
EFO:1002048	kidney failure	An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.	renal insufficiency;failure, renal;renal failure syndrome;kidney failure;renal failure	kidney failure|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
CHEBI:22984	calcium atom	NA	calcium	calcium atom|atom|chemical entity|material entity|experimental factor
EFO:0004695	intraocular pressure measurement	NA		intraocular pressure measurement|eye measurement|measurement|information entity|experimental factor
EFO:0006335	systolic blood pressure	NA	SYSBP;systolic pressure	systolic blood pressure|blood pressure|vital signs|measurement|information entity|experimental factor
EFO:0002422	benign neoplasm	A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.	benign neoplasm;neoplasm (disease), benign;benign neoplasm (disease)	benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
HP:0001919	Acute kidney injury	Sudden loss of renal function, as manifested by decreased urine production, and a rise in serum creatinine or blood urea nitrogen concentration (azotemia).	Acute kidney failure;Acute renal failure	Acute kidney injury|Renal insufficiency|Abnormal renal physiology|Abnormality of the kidney|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Acute kidney injury|Renal insufficiency|Abnormal renal physiology|Abnormality of the urinary system physiology|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004312	vital capacity	NA	FVC;forced vital capacity	vital capacity|pulmonary function measurement|measurement|information entity|experimental factor
EFO:0000384	Crohn's disease	A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.	Crohn disease;Crohn Disease;Crohns Disease;Enteritis, Regional;Enteritis, Granulomatous;Ileitis, Regional;regional enteritis;Gastritis Associated with Crohn's Disease;granulomatous colitis;Ileitis, Terminal;Colitis, Granulomatous;Crohn's disease of large bowel;CROHN DIS;pediatric Crohn's disease;Ileocolitis;CROHNS DIS;Crohn's associated gastritis;Crohn's disease;Crohn's disease of colon;Gastritis Associated with Crohn Disease	Crohn's disease|inflammatory bowel disease|genetic disorder|disease|disposition|material property|experimental factor; Crohn's disease|inflammatory bowel disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; Crohn's disease|inflammatory bowel disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Crohn's disease|inflammatory bowel disease|genetic disorder|material entity|experimental factor
MONDO:0042981	aortic valve stenosis	Aortic valve stenosis (AVS) is a condition characterized by narrowing of the heart's aortic valve opening. This narrowing prevents the valve from opening fully, which obstructs blood flow from the heart into the aorta, and onward to the rest of the body. AVS can range from mild to severe. Signs and symptoms typically develop when the narrowing of the opening is severe and may include chest pain (angina) or tightness; shortness of breath or fatigue (especially during exertion); feeling faint or fainting; heart palpitations; and heart murmur. Individuals with less severe congenital AVS (present at birth) may not develop symptoms until adulthood. Individuals with severe cases may faint without warning. AVS can have several causes including abnormal development before birth (such as having 1 or 2 valve leaflets instead of 3); calcium build-up on the valve in adulthood; and rheumatic fever.	AS;aortic stenosis	aortic valve stenosis|aortic malformation|congenital anomaly of the great arteries|genetic vascular anomaly|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic malformation|congenital anomaly of the great arteries|genetic vascular anomaly|genetic disorder|material entity|experimental factor; aortic valve stenosis|aortic malformation|congenital anomaly of the great arteries|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic malformation|congenital anomaly of the great arteries|congenital heart malformation|genetic disorder|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic malformation|congenital anomaly of the great arteries|congenital heart malformation|congenital heart disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|ascending aorta anomaly|congenital anomaly of the great arteries|genetic vascular anomaly|genetic disorder|disease|disposition|material property|experimental factor; aortic valve stenosis|ascending aorta anomaly|congenital anomaly of the great arteries|genetic vascular anomaly|vascular anomaly|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|ascending aorta anomaly|congenital anomaly of the great arteries|genetic vascular anomaly|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; aortic valve stenosis|ascending aorta anomaly|congenital anomaly of the great arteries|genetic vascular anomaly|genetic disorder|material entity|experimental factor; aortic valve stenosis|aortic malformation|congenital anomaly of the great arteries|congenital heart malformation|genetic disorder|material entity|experimental factor; aortic valve stenosis|aortic malformation|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic valve disease|heart valve disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic valve disease|cardiac ventricle disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic malformation|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|congenital heart disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic malformation|congenital anomaly of the great arteries|genetic vascular anomaly|vascular anomaly|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|ascending aorta anomaly|congenital anomaly of the great arteries|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic valve disease|aortic disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|ascending aorta anomaly|congenital anomaly of the great arteries|congenital heart malformation|genetic disorder|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic malformation|congenital anomaly of the great arteries|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic malformation|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|genetic disorder|material entity|experimental factor; aortic valve stenosis|aortic malformation|aortic disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic malformation|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic malformation|congenital anomaly of the great arteries|genetic vascular anomaly|genetic disorder|disease|disposition|material property|experimental factor; aortic valve stenosis|ascending aorta anomaly|congenital anomaly of the great arteries|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; aortic valve stenosis|aortic malformation|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|genetic disorder|disease|disposition|material property|experimental factor; aortic valve stenosis|ascending aorta anomaly|congenital anomaly of the great arteries|congenital heart malformation|genetic disorder|material entity|experimental factor; aortic valve stenosis|ascending aorta anomaly|congenital anomaly of the great arteries|congenital heart malformation|congenital heart disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0000684	respiratory system disease	A non-neoplastic or neoplastic disorder that affects the respiratory system. Representative examples include pneumonia, chronic obstructive pulmonary disease, pulmonary failure, lung adenoma, lung carcinoma, and tracheal carcinoma.	disease or disorder of respiratory system;Other diseases of respiratory system NOS;[X]Respiratory conditions due to other specified external agents (disorder);respiratory disorder;Unspecified alveolar and parietoalveolar pneumonopathy;Respiratory conditions due to unspecified external agent;Lung involvement in other diseases classified elsewhere;Disorder of respiratory system (disorder);[X]Other diseases of the respiratory system;respiratory system disease;Other diseases of respiratory system, not elsewhere classified;Disease of respiratory system;Disease of respiratory system (disorder);Respiratory disease;Other alveolar and parietoalveolar pneumonopathy;Other respiratory system diseases (disorder);LUNG INVOLV IN OTH DIS;[X]Respiratory conditions due to unspecified external agent;[X]Chronic and other pulmonary manifestations due to radiation (disorder);Disease of respiratory system, NOS;respiratory system disorder;RESP SYSTEM DISEASE NOS;Respiratory conditions due to other specified external agents;DISEASES OF THE RESPIRATORY SYSTEM;Other diseases of respiratory system;Respiratory System Disorder;[X]Respiratory conditions due to other specified external agents;Respiratory conditions due to other and unspecified external agents;RESP SYSTEM DISEASE NEC;Respiratory system diseases NOS (disorder);Other diseases of respiratory system NOS (disorder);Respiratory disorder;Other respiratory system diseases;Pneumoconiosis due to other inorganic dust;Other diseases of mediastinum, not elsewhere classified;Respiratory system diseases NOS;PNEUMOCONIOSES AND OTHER LUNG DISEASES DUE TO EXTERNAL AGENTS;ALVEOL PNEUMONOPATHY NEC;disease of respiratory system;Lung involvement in conditions classified elsewhere;respiratory disease;CHR PUL MANIF D/T RADIAT;ALVEOL PNEUMONOPATHY NOS;Disorder of respiratory system;[X]Other diseases of the respiratory system (disorder);[X]Respiratory conditions due to unspecified external agent (disorder);MEDIASTINUM DISEASE NEC;Other respiratory system diseases NOS;Respiratory disorder, NOS;Chronic and other pulmonary manifestations due to radiation;Other respiratory system diseases NOS (disorder);Other diseases of trachea and bronchus, not elsewhere classified;respiratory system disease or disorder;Unspecified disease of respiratory system;RESP COND: EXT AGENT NEC;[X]Chronic and other pulmonary manifestations due to radiation;Other specified alveolar and parietoalveolar pneumonopathies;disorder of respiratory system;RESP COND: EXT AGENT NOS;INORG DUST PNEUMOCON NEC	respiratory system disease|disease|disposition|material property|experimental factor
EFO:0007204	chickenpox	A contagious childhood disorder caused by the varicella zoster virus. It is transmitted via respiratory secretions and contact with chickenpox blister contents. It presents with a vesicular skin rash, usually associated with fever, headache, and myalgias. The pruritic fluid-filled vesicles occur 10-21 days after exposure and last for 3-4 days. An additional 3-4 days of malaise follows before the affected individual feels better. An individual is contagious 1-2 days prior to the appearance of the blisters until all blisters are crusted over. Generally, healthy individuals recover without complications.	chicken pox infection;chicken pox;varicella;chickenpox;Varicella;Chickenpox	chickenpox|Varicella Zoster infection|Herpesviridae infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; chickenpox|Varicella Zoster infection|Herpesviridae infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; chickenpox|vesiculobullous skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; chickenpox|skin disorder caused by infection|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; chickenpox|skin disorder caused by infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0021009	3-methoxytyrosine measurement	NA		3-methoxytyrosine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0001065	endometriosis	The growth of functional endometrial tissue in anatomic sites outside the uterine body. It most often occurs in the pelvic organs.	Endometriosis (clinical);Endometriosis (disorder);Endometriosis (morphologic abnormality);ENDOMETRIOSIS NEC;Endometriosis of other specified sites;endometriosis (disease);endometriosis;Endometriosis NOS;Endometriosis NOS (disorder);Endometriosis, site unspecified	endometriosis|endometrial disorder|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0003911	atrial flutter	A disorder characterized by an electrocardiographic finding of an organized, regular atrial rhythm with atrial rate of 240-340 beats per minute. Multiple P waves typically appear in the inferior leads in a saw tooth-like pattern between the QRS complexes. (CDISC)	Flutters, Atrial;Atrial Flutters;Flutter, Atrial;Auricular Flutter;atrial flutter;Flutters, Auricular;Flutter, Auricular;atrial flutter (disease);Auricular Flutters	atrial flutter|atrial tachycardia|cardiac arrhythmia|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; atrial flutter|atrial tachycardia|cardiac rhythm disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
MONDO:0015300	cataract - microcornea syndrome	Cataract-microcornea syndrome is characterized by the association of congenital cataract and microcornea without any other systemic anomaly or dysmorphism.		cataract - microcornea syndrome|syndromic disease|material entity|experimental factor; cataract - microcornea syndrome|syndromic disease|disease|disposition|material property|experimental factor
HP:0012532	Chronic pain	Persistent pain, usually defined as pain that has lasted longer than 3 to 6 months.	Long-lasting pain;Chronic pain	Chronic pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Chronic pain|pain|sign or symptom|phenotype|quality|material property|experimental factor
EFO:0003892	pulmonary function measurement	NA	Lung Function Tests;TESTS PULM FUNCTION;FUNCTION TESTS PULM;Test, Respiratory Function;Tests, Respiratory Function;Respiratory Function Tests;Function Test, Respiratory;Function Test, Lung;Pulmonary Function Tests;Lung Function Test;Test, Pulmonary Function;Tests, Lung Function;Function Tests, Respiratory;PULM FUNCTION TESTS;Function Test, Pulmonary;Tests, Pulmonary Function;PULM FUNCTION TEST;Function Tests, Pulmonary;Function Tests, Lung;FUNCTION TEST PULM;TEST PULM FUNCTION;Test, Lung Function;pulmonary function test;Respiratory Function Test	pulmonary function measurement|measurement|information entity|experimental factor
HP:0011705	First degree atrioventricular block	Delay of conduction through the atrioventricular node, which is manifested as prolongation of the PR interval in the electrocardiogram (EKG). All atrial impulses reach the ventricles.		First degree atrioventricular block|Abnormality of cardiovascular system electrophysiology|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0021206	chronic non-suppurative otitis media	Chronic form of non-suppurative otitis media.	non-suppurative otitis media, chronic	chronic non-suppurative otitis media|chronic otitis media|Otitis media|middle ear disorder|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; chronic non-suppurative otitis media|chronic otitis media|Otitis media|head and neck disorder|disease|disposition|material property|experimental factor; chronic non-suppurative otitis media|non-suppurative otitis media|Otitis media|middle ear disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; chronic non-suppurative otitis media|non-suppurative otitis media|Otitis media|middle ear disorder|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; chronic non-suppurative otitis media|chronic otitis media|Otitis media|inflammatory disease|disease|disposition|material property|experimental factor; chronic non-suppurative otitis media|non-suppurative otitis media|Otitis media|inflammatory disease|disease|disposition|material property|experimental factor; chronic non-suppurative otitis media|non-suppurative otitis media|Otitis media|head and neck disorder|disease|disposition|material property|experimental factor; chronic non-suppurative otitis media|chronic otitis media|Otitis media|middle ear disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0007993	lymphocyte percentage of leukocytes	NA	lymphocyte count to total WBC count ratio;lymphocyte percentage of white cells;blood lymphocyte count to total leukocyte count ratio;lymphocyte count as percentage of total white blood cells;lymphocyte percentage	lymphocyte percentage of leukocytes|lymphocyte count|infectious disease biomarker|measurement|information entity|experimental factor; lymphocyte percentage of leukocytes|lymphocyte count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
HP:0002094	Dyspnea	Difficult or labored breathing. Dyspnea is a subjective feeling only the patient can rate, e.g., on a Borg scale.	Dyspnoea;Shortness of breath;Abnormal breathing;Difficult to breathe;Breathing difficulty;Trouble breathing;Difficulty breathing	Dyspnea|Abnormal pattern of respiration|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007805	HDL cholesterol change measurement	NA		HDL cholesterol change measurement|high density lipoprotein cholesterol measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; HDL cholesterol change measurement|high density lipoprotein cholesterol measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; HDL cholesterol change measurement|high density lipoprotein cholesterol measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007848	apolipoprotein A-IV measurement	NA	lipoprotein A-IV levels	apolipoprotein A-IV measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; apolipoprotein A-IV measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
CHEBI:16737	creatinine	NA	Creatinine;2-imino-1-methylimidazolidin-4-one;creatinine	creatinine|organic heterocyclic compound|chemical entity|material entity|experimental factor
EFO:0004584	mean platelet volume	NA		mean platelet volume|autoimmune disease biomarker|measurement|information entity|experimental factor; mean platelet volume|platelet measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0004458	C-reactive protein measurement	NA	C-reactive protein level	C-reactive protein measurement|protein measurement|measurement|information entity|experimental factor; C-reactive protein measurement|inflammatory biomarker measurement|measurement|information entity|experimental factor
EFO:0007800	body fat percentage	NA		body fat percentage|body composition measurement|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
CHEBI:27300	vitamin D	NA		vitamin D|steroid|lipid|chemical entity|material entity|experimental factor
EFO:0004541	HbA1c measurement	NA	glycated hemoglobin levels;HBA1C;glycosylated Hemoglobin A level;Glycosylated Hemoglobin Measurement;Hemoglobin A1C;glycosylated Haemoglobin A level;HbA1c levels;A1c measurement;Glycosylated Hemoglobin;A1C measurement	HbA1c measurement|glucose measurement|diabetes mellitus biomarker|measurement|information entity|experimental factor; HbA1c measurement|hemoglobin measurement|hematological measurement|measurement|information entity|experimental factor; HbA1c measurement|glycoprotein measurement|protein measurement|measurement|information entity|experimental factor; HbA1c measurement|hemoglobin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0005093	hip circumference	NA		hip circumference|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor; hip circumference|bone measurement|measurement|information entity|experimental factor
EFO:0004526	mean corpuscular volume	NA	MCV;mean cell volume	mean corpuscular volume|erythrocyte indices|erythrocyte measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0004530	triglyceride measurement	NA	triglyceride levels	triglyceride measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0020945	free cholesterol:total lipids ratio	NA	NA	free cholesterol:total lipids ratio|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0020944	cholesteryl esters:total lipids ratio	NA	NA	cholesteryl esters:total lipids ratio|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0004614	apolipoprotein A 1 measurement	Is a quantification of apolipoprotein A 1 in a sample. It is encoded in humans by the APOA1 gene and is the major protein component of high density lipoprotein (HDL) in plasma. Apolipoprotein A 1 relates to lower observational risk of coronary artery disease.	apo-AI levels;apoA-I levels;apolipoprotein A-I levels;apolipoprotein A-1 levels;apolipoprotein A1 levels	apolipoprotein A 1 measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor; apolipoprotein A 1 measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; apolipoprotein A 1 measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; apolipoprotein A 1 measurement|inflammatory biomarker measurement|measurement|information entity|experimental factor
EFO:0020946	phospholipids:total lipids ratio	NA	NA	phospholipids:total lipids ratio|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0010733	polyunsaturated fatty acid measurement	NA		polyunsaturated fatty acid measurement|fatty acid measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
CHEBI:17351	linoleic acid	NA	Linoleic acid;LINOLEIC ACID;(9Z,12Z)-octadeca-9,12-dienoic acid	linoleic acid|fatty acid|acid|chemical entity|material entity|experimental factor; linoleic acid|fatty acid|lipid|chemical entity|material entity|experimental factor
EFO:0005680	omega-6 polyunsaturated fatty acid measurement	NA		omega-6 polyunsaturated fatty acid measurement|fatty acid measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0004615	apolipoprotein B measurement	NA		apolipoprotein B measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; apolipoprotein B measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0020904	esterified cholesterol change measurement	NA	NA	esterified cholesterol change measurement|esterified cholesterol measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; esterified cholesterol change measurement|esterified cholesterol measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; esterified cholesterol change measurement|esterified cholesterol measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0020947	triglycerides:total lipids ratio	NA	NA	triglycerides:total lipids ratio|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
CHEBI:16247	phospholipid	NA	Phospholipid	phospholipid|lipid|chemical entity|material entity|experimental factor; phospholipid|phosphate|chemical entity|material entity|experimental factor
EFO:0007677	LDL peak particle diameter measurement	NA	low density lipoprotein peak particle diameter measurement	LDL peak particle diameter measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; LDL peak particle diameter measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0010226	phosphatidylcholine measurement	NA	NA	phosphatidylcholine measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; phosphatidylcholine measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
CHEBI:17636	sphingomyelin d18:1	NA	NA	sphingomyelin d18:1|phospholipid|phosphate|chemical entity|material entity|experimental factor; sphingomyelin d18:1|phospholipid|lipid|chemical entity|material entity|experimental factor
CHEBI:47775	high-density lipoprotein cholesterol	NA		high-density lipoprotein cholesterol|steroid|lipid|chemical entity|material entity|experimental factor
EFO:0001645	coronary artery disease	Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC)	CORONARY ARTERY DIS;CHD - Coronary heart disease;disease of coronary artery;Atheroscleroses, Coronary;Coronary Arterioscleroses;Artery Diseases, Coronary;coronary heart disease;disorder of coronary artery;Coronary Atherosclerosis;Coronary Artery Diseases;coronary disease;Heart Disease, Coronary;Disease, Coronary Artery;CHD;Arterioscleroses, Coronary;Coronary Diseases;Diseases, Coronary;Heart Diseases, Coronary;coronary artery disease or disorder;Diseases, Coronary Artery;coronary artery disorder;Arteriosclerosis, Coronary;Diseases, Coronary Heart;CAD;Disease, Coronary;Coronary Atheroscleroses;Coronary Heart Diseases;CORONARY DIS;CORONARY HEART DIS;Coronary Disease;coronary artery disease;disease or disorder of coronary artery;Coronary Arteriosclerosis;Disease, Coronary Heart;CHD (coronary heart disease);Atherosclerosis, Coronary;Artery Disease, Coronary;Coronary Artery Disease	coronary artery disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; coronary artery disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0004713	FEV/FEC ratio	NA	FEV1/FVC;FEV/FVC	FEV/FEC ratio|respiratory disease biomarker|measurement|information entity|experimental factor; FEV/FEC ratio|pulmonary function measurement|measurement|information entity|experimental factor
EFO:0009574	intoxication	NA		intoxication|poisoning|disease|disposition|material property|experimental factor
EFO:0008591	free cholesterol measurement	NA		free cholesterol measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; free cholesterol measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; free cholesterol measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0008317	very low density lipoprotein cholesterol measurement	NA	vLDL cholesterol measurement	very low density lipoprotein cholesterol measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0008595	intermediate density lipoprotein measurement	NA	IDL measurement	intermediate density lipoprotein measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; intermediate density lipoprotein measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; intermediate density lipoprotein measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0020905	free cholesterol change measurement	NA	NA	free cholesterol change measurement|free cholesterol measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; free cholesterol change measurement|free cholesterol measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; free cholesterol change measurement|free cholesterol measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
PR:000003918	serum albumin	NA		serum albumin|protein|biological macromolecule|material entity|experimental factor; serum albumin|protein|chemical entity|material entity|experimental factor
EFO:0004531	urate measurement	NA	urate levels	urate measurement|measurement|information entity|experimental factor
EFO:0004574	total cholesterol measurement	NA	cholesterol, total;total cholesterol levels	total cholesterol measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; total cholesterol measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; total cholesterol measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0000701	skin disease	Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.	disease or disorder of zone of skin;skin disorder;disease of zone of skin;skin and subcutaneous tissue disease;disorder of zone of skin;Skin Diseases and Manifestations;Skin Disorder;skin diseases and manifestations;zone of skin disease or disorder;Cutaneous Disorder;disorder of skin;SKIN AND SUBCUTANEOUS TISSUE DISORDERS;cutaneous disorder;zone of skin disease	skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0008594	very low density lipoprotein particle size measurement	NA	VLDL particle size measurement	very low density lipoprotein particle size measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; very low density lipoprotein particle size measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; very low density lipoprotein particle size measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0004975	Alzheimer disease	A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.	Alzheimer's disease;Alzheimer's dementia;Alzheimer dementia;Alzheimers disease;Alzheimer disease;Alzheimers dementia;presenile and senile dementia;AD	Alzheimer disease|dementia|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Alzheimer disease|dementia|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; Alzheimer disease|tauopathy|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0004611	low density lipoprotein cholesterol measurement	NA	LDL measurement	low density lipoprotein cholesterol measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; low density lipoprotein cholesterol measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; low density lipoprotein cholesterol measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor; low density lipoprotein cholesterol measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0020895	serum albumin change measurement	NA		serum albumin change measurement|serum albumin measurement|protein measurement|measurement|information entity|experimental factor
CHEBI:17234	glucose	NA	gluco-hexose;glucose;Glucose	glucose|carbohydrate|chemical entity|material entity|experimental factor
EFO:0004535	serum albumin measurement	NA	blood albumin	serum albumin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004533	alkaline phosphatase measurement	NA	AP	alkaline phosphatase measurement|liver enzyme measurement|measurement|information entity|experimental factor; alkaline phosphatase measurement|bone measurement|measurement|information entity|experimental factor; alkaline phosphatase measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004627	IGF-1 measurement	NA	Insulin-Like Growth Factor 1 levels	IGF-1 measurement|cancer biomarker measurement|measurement|information entity|experimental factor; IGF-1 measurement|hormone measurement|measurement|information entity|experimental factor; IGF-1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0005192	red blood cell distribution width	NA	RDW	red blood cell distribution width|hematological measurement|measurement|information entity|experimental factor
EFO:0004527	mean corpuscular hemoglobin	NA	MCH;mean corpuscular haemoglobin	mean corpuscular hemoglobin|erythrocyte indices|erythrocyte measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0004305	erythrocyte count	NA	red blood cell count;erythrocyte number;RBC	erythrocyte count|erythrocyte indices|erythrocyte measurement|hematological measurement|measurement|information entity|experimental factor; erythrocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0004509	hemoglobin measurement	NA	haemoglobin measurement;hemoglobin count;Hb	hemoglobin measurement|hematological measurement|measurement|information entity|experimental factor; hemoglobin measurement|protein measurement|measurement|information entity|experimental factor
EFO:1000910	dysplasia of cervix	Abnormal development of immature squamous epithelial cells of the uterine cervix, a term used to describe premalignant cytological changes in the cervical epithelium. These atypical cells do not penetrate the epithelial basement membrane.	cervical dysplasia NOS;Mild dysplasia of cervix;Dysplasia of cervix (uteri);Uterine Cervical Dysplasia;Dysplasia of cervix NOS (disorder);dysplasia of cervix;Cervix Dysplasia;cervical intraepithelial neoplasia grade 2;Dysplasia of cervix uteri (disorder);Moderate dysplasia of cervix;cervical dysplasia;Moderate squamous Dysplasia of the Cervix;Low-grade Intraepithelial Neoplasia of Cervix Uteri;cervical intraepithelial neoplasia grade 2 (disorder);cervical intraepithelial neoplasia grade 1;cervical intraepithelial neoplasia I [CIN I];cervical intraepithelial neoplasia grade 1 (disorder);Dysplasia of cervix uteri;Dysplasia of cervix (disorder)	dysplasia of cervix|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
HP:0002036	Hiatus hernia	The presence of a hernia in which the upper part of the stomach, i.e., mainly the gastric cardia protrudes through the diaphragmatic esophageal hiatus.	Hiatal hernia;Stomach hernia	Hiatus hernia|Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Hiatus hernia|Hernia|Abnormality of connective tissue|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0001068	malaria	Malaria is a serious and sometimes fatal disease caused by a parasite that commonly infects a certain type of mosquito which feeds on humans. Infection with malaria parasites may result in a wide variety of symptoms, ranging from absent or very mild symptoms to severe disease and even death. People who get malaria are typically very sick with high fevers, shaking chills, and flu-like illness. In general, malaria is a curable disease if diagnosed and treated promptly and correctly.Treatment depends on many factors including disease severity, the species of malaria parasite causing the infection and the part of the world in which the infection was acquired.	Other pernicious complications of malaria;Malaria, unspecified;Disease due to Plasmodiidae;induced malaria;Other malaria (disorder);malaria;Malarial fever;Plasmodium Infection;malaria infection;Infection, Plasmodium;Plasmodiosis;[X]Unspecified malaria (disorder);Marsh Fever;Disease due to Plasmodiidae (disorder);[X]Unspecified malaria;Unspecified malaria;Other malaria;MALARIA NOS;Malaria, NOS;Fever, Remittent;Paludism;Induced malaria (disorder);Infections, Plasmodium;Unspecified malaria (disorder);Remittent Fever;Plasmodium Infections;Fever, Marsh;Malarial fever (finding);MALARIA NEC;MALARIA COMPLICATED NEC;INFECT PLASMODIUM;Malaria (disorder);PLASMODIUM INFECT	malaria|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; malaria|vector-borne disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; malaria|digestive system infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; malaria|erythrocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; malaria|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; malaria|erythrocyte disorder|hematologic disease|material entity|experimental factor; malaria|protozoa infectious disease|parasitic infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:1001255	spontaneous abortion	NA	Abortion, spontaneous	spontaneous abortion|abortion|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0009190	Thyrotoxicosis	A hypermetabolic syndrome caused by the elevation of thyroid hormone levels in the serum. Signs and symptoms include tachycardia, palpitations, tremor, weight loss, warm weather intolerance, and moist skin. Causes include Graves disease, toxic nodular goiter, toxic thyroid nodule, and lymphocytic thyroiditis.	thyrotoxicosis	Thyrotoxicosis|Graves disease|autoimmune thyroid disease|autoimmune disorder of endocrine system|endocrine system disease|disease|disposition|material property|experimental factor; Thyrotoxicosis|Graves disease|autoimmune thyroid disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; Thyrotoxicosis|Graves disease|goiter|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor; Thyrotoxicosis|Graves disease|autoimmune thyroid disease|thyroiditis|inflammatory disease|disease|disposition|material property|experimental factor; Thyrotoxicosis|Graves disease|autoimmune thyroid disease|autoimmune disorder of endocrine system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; Thyrotoxicosis|Graves disease|toxic diffuse goiter|hyperthyroidism|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor; Thyrotoxicosis|Graves disease|autoimmune thyroid disease|thyroiditis|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
HP:0002024	Malabsorption	Impaired ability to absorb one or more nutrients from the intestine.	Intestinal malabsorption;Malabsorption	Malabsorption|Abnormal intestine morphology|Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009189	hyperthyroidism	Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves' disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.	overactive thyroid;hyperthyroidism	hyperthyroidism|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0000677	mental or behavioural disorder	A disease that has its basis in the disruption of mental process.	PSYCHOTIC DIS;Psychoses;Psychosis, Brief Reactive;disease of mental health;Mental Disorder;Psychotic Disorders;Psychoses, Brief Reactive;Brief Reactive Psychosis;Brief Reactive Psychoses;mental or behavioural disorder;Behavior Disorder;Reactive Psychoses, Brief;mental process disease;mental disorders;Psychotic Disorder;Disorders, Psychotic;Disorder, Psychotic;mental disorder;mental or behavioral disorder;disorder of mental process;Reactive Psychosis, Brief;Psychiatric Disorder	mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009622	fracture of pelvis	NA		fracture of pelvis|bone fracture|injury|disease|disposition|material property|experimental factor; fracture of pelvis|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0008031	aspartate aminotransferase, cytoplasmic measurement	NA		aspartate aminotransferase, cytoplasmic measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802260	alanine aminotransferase 1 measurement	NA		alanine aminotransferase 1 measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0005090	schizophrenia	A major psychotic disorder characterized by abnormalities in the perception or expression of reality. It affects the cognitive and psychomotor functions. Common clinical signs and symptoms include delusions, hallucinations, disorganized thinking, and retreat from reality.	schizophrenia (disease);schizophrenia-1;schizophrenia	schizophrenia|psychosis|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; schizophrenia|psychosis|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0004339	body height	NA	height	body height|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
EFO:0009805	whole body water mass	NA		whole body water mass|anthropometric measurement|measurement|information entity|experimental factor
EFO:0005409	fat body mass	NA	total body fat measurement	fat body mass|anthropometric measurement|measurement|information entity|experimental factor
CHEBI:60175	5-hydroxylysine	NA	5-hydroxylysine	5-hydroxylysine|amino acid|acid|chemical entity|material entity|experimental factor
CHEBI:16449	alanine	NA	2-aminopropanoic acid;Alanine;alanine	alanine|amino acid|acid|chemical entity|material entity|experimental factor
EFO:0004799	cholelithiasis	The presence of calculi in the gallbladder.	cholelithiasis;gallbladder disease type 4	cholelithiasis|gallbladder disease|genetic biliary tract disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; cholelithiasis|bladder disease|urinary system disease|disease|disposition|material property|experimental factor; cholelithiasis|gallbladder disease|genetic biliary tract disease|genetic disorder|material entity|experimental factor; cholelithiasis|gallbladder disease|genetic biliary tract disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; cholelithiasis|gallbladder disease|genetic biliary tract disease|genetic disorder|disease|disposition|material property|experimental factor; cholelithiasis|gallbladder disease|genetic biliary tract disease|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0003832	gallbladder disease	A disease involving the gall bladder.	disorder of gall bladder;gall bladder disease or disorder;Diseases, Gall Bladder;GALL BLADDER DIS;Disease, Gallbladder;Bladder Disease, Gall;Bladder Diseases, Gall;Gallbladder Diseases;gallbladder disorder;Diseases, Gallbladder;Gall bladder disorder;disease or disorder of gall bladder;Disease, Gall Bladder;GALLBLADDER DIS;Gallbladder Disease;gall bladder disease;disease of gall bladder;Gall Bladder Diseases	gallbladder disease|genetic biliary tract disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; gallbladder disease|genetic biliary tract disease|genetic disorder|disease|disposition|material property|experimental factor; gallbladder disease|genetic biliary tract disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; gallbladder disease|genetic biliary tract disease|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; gallbladder disease|genetic biliary tract disease|genetic disorder|material entity|experimental factor
EFO:0004210	gallstones	Solid crystalline precipitates in the biliary tract, usually formed in the gallbladder, resulting in the condition of cholelithiasis. Gallstones, derived from the bile, consist mainly of calcium, cholesterol, or bilirubin.	Gall Stones;Gall Stone;gallstones;Biliary Calculi	gallstones|gallbladder disease|genetic biliary tract disease|genetic disorder|disease|disposition|material property|experimental factor; gallstones|gallbladder disease|genetic biliary tract disease|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; gallstones|gallbladder disease|genetic biliary tract disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; gallstones|gallbladder disease|genetic biliary tract disease|genetic disorder|material entity|experimental factor; gallstones|gallbladder disease|genetic biliary tract disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:1000790	acalculous cholecystitis	Inflammation of the gallbladder in the absence of gallstones.	Acalculous Cholecystitis;cholecystitis without calculus (disorder);acalculous cholecystitis;acute cholecystitis without calculus (disorder);cholecystitis without calculus;acute cholecystitis without calculus;acute acalculous cholecystitis	acalculous cholecystitis|cholangitis|inflammatory disease|disease|disposition|material property|experimental factor; acalculous cholecystitis|cystitis|bladder disease|urinary system disease|disease|disposition|material property|experimental factor; acalculous cholecystitis|cystitis|inflammatory disease|disease|disposition|material property|experimental factor; acalculous cholecystitis|cholangitis|Non-Neoplastic Bile Duct Disorder|endocrine system disease|disease|disposition|material property|experimental factor; acalculous cholecystitis|gallbladder disease|genetic biliary tract disease|genetic disorder|material entity|experimental factor; acalculous cholecystitis|gallbladder disease|genetic biliary tract disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; acalculous cholecystitis|gallbladder disease|genetic biliary tract disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; acalculous cholecystitis|cholangitis|Non-Neoplastic Bile Duct Disorder|bile duct disorder|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; acalculous cholecystitis|gallbladder disease|genetic biliary tract disease|genetic disorder|disease|disposition|material property|experimental factor; acalculous cholecystitis|gallbladder disease|genetic biliary tract disease|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0010701	mean reticulocyte volume	NA		mean reticulocyte volume|reticulocyte measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0007986	reticulocyte count	NA		reticulocyte count|reticulocyte measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0009202	Reticulocyte Mean Corpuscular Hemoglobin Measurement	NA	CHr;reticulocyte hemoglobin content (CHr);Measurement of reticulocyte haemoglobin;reticulocyte haemoglobin measurement;High light scatter reticulocyte percentage	Reticulocyte Mean Corpuscular Hemoglobin Measurement|hemoglobin measurement|hematological measurement|measurement|information entity|experimental factor; Reticulocyte Mean Corpuscular Hemoglobin Measurement|hemoglobin measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0008315	prostate cancer	A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.	cancer of prostate gland;malignant prostate tumor;malignant tumor of prostate;malignant prostate gland neoplasm;NGP - new growth of prostate;malignant prostate neoplasm;prostatic cancer;prostate gland cancer;malignant neoplasm of prostate;malignant tumor of the prostate;malignant neoplasm of prostate gland;malignant neoplasm of the prostate	prostate cancer|male reproductive organ cancer|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; prostate cancer|male reproductive organ cancer|male reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; prostate cancer|male reproductive organ cancer|male reproductive system neoplasm|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; prostate cancer|male reproductive organ cancer|male reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; prostate cancer|prostate neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; prostate cancer|prostate neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; prostate cancer|male reproductive organ cancer|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; prostate cancer|male reproductive organ cancer|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; prostate cancer|prostate neoplasm|prostate disease|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:1000951	glossitis	Inflammation of the tongue.	Glossitis (disorder);glossitis;Glossitis;inflammation of tongue;tongue inflammation;Glossitis NOS (disorder)	glossitis|tongue disorder|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; glossitis|inflammatory disease|disease|disposition|material property|experimental factor; glossitis|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0007486	sinusitis	An acute or chronic inflammatory process affecting the mucous membranes of any sinus cavity.	sinusitis	sinusitis|inflammatory disease|disease|disposition|material property|experimental factor; sinusitis|paranasal sinus disease|skull disorder|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; sinusitis|paranasal sinus disease|head and neck disorder|disease|disposition|material property|experimental factor; sinusitis|paranasal sinus disease|respiratory system disease|disease|disposition|material property|experimental factor; sinusitis|paranasal sinus disease|nasal disorder|otorhinolaryngologic disease|disease|disposition|material property|experimental factor
EFO:0800716	X-12411 measurement	NA		X-12411 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1002025	measles	A highly contagious viral infection caused by the measles virus. Symptoms appear 8-12 days after exposure and include a rash, cough, fever and muscle pains that can last 4-7 days. Measles vaccines are available to provide prophylaxis, usually combined with mumps and rubella vaccines (MMR).	Measles morbillivirus disease or disorder;measles;Measles morbillivirus caused disease or disorder;morbilli;rubeola infection;Measles morbillivirus infectious disease	measles|Morbillivirus infectious disease|Paramyxoviridae infectious disease|Mononegavirales infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; measles|Morbillivirus infectious disease|Paramyxoviridae infectious disease|Mononegavirales infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0007383	Mumps virus infectious disease	A contagious viral infection caused by the mumps virus. Symptoms include swollen and tender parotid glands, fever, muscle aches and fatigue. Due to vaccination programs, mumps has become a rare disease.	mumps;mumps infectious disease;Mumps virus disease or disorder;Rubulavirus Infections;Mumps virus infectious disease;Mumps virus caused disease or disorder;epidemic parotitis;Rubulavirus infectious disease	Mumps virus infectious disease|Paramyxoviridae infectious disease|Mononegavirales infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Mumps virus infectious disease|Paramyxoviridae infectious disease|Mononegavirales infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:1000657	rectum cancer	A primary or metastatic malignant neoplasm that affects the rectum. Representative examples include carcinoma, lymphoma, and sarcoma.	malignant rectal tumor;rectum cancer;malignant neoplasm of rectum;malignant tumor of the rectum;rectal cancer;malignant neoplasm of the rectum;malignant rectum tumor;malignant tumor of rectum;carcinoma of rectum;malignant rectum neoplasm;carcinoma of the rectum;cancer of rectum;malignant rectal neoplasm	rectum cancer|rectal neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; rectum cancer|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; rectum cancer|rectal neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; rectum cancer|rectal neoplasm|rectal disease|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; rectum cancer|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; rectum cancer|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; rectum cancer|rectal neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; rectum cancer|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; rectum cancer|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; rectum cancer|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; rectum cancer|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; rectum cancer|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0007941	LDH-related sciatica symptom severity measurement	NA	lumbar disc herniation-related sciatica symptom severity measurement	LDH-related sciatica symptom severity measurement|measurement|information entity|experimental factor
EFO:0004617	cystatin C measurement	NA		cystatin C measurement|renal system measurement|measurement|information entity|experimental factor; cystatin C measurement|protein measurement|measurement|information entity|experimental factor
HP:0200119	Acute hepatitis	NA	Acute liver inflammation	Acute hepatitis|Hepatitis|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Acute hepatitis|Hepatitis|Abnormality of the liver|Abnormality of the abdominal organs|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:17347	testosterone	NA	testosterone;TESTOSTERONE;17beta-hydroxyandrost-4-en-3-one;Testosterone	testosterone|steroid|lipid|chemical entity|material entity|experimental factor
MONDO:0004847	senile cataract	A cataract with no obvious cause occurring in persons over 50 years old.		senile cataract|cataract|genetic disorder|material entity|experimental factor; senile cataract|cataract|lens disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; senile cataract|cataract|genetic disorder|disease|disposition|material property|experimental factor; senile cataract|cataract|lens disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor
EFO:1001134	pulmonary edema	Accumulation of fluid in the lung tissues causing disturbance of the gas exchange that may lead to respiratory failure. It is caused by direct injury to the lung parenchyma or congestive heart failure. The symptoms may appear suddenly or gradually. Suddenly appearing symptoms include difficulty breathing, feeling of suffocation, and coughing associated with frothy sputum. Gradually appearing symptoms include difficulty breathing while lying in bed, shortness of breath during activity, and weight gain (in patients with congestive heart failure).	edema, pulmonary;pulmonary oedema;pulmonary edema;Pulmonary Edema	pulmonary edema|acute respiratory failure|acute disease|disease|disposition|material property|experimental factor; pulmonary edema|acute respiratory failure|respiratory failure|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0004238	hearing loss	A partial or complete loss of hearing in one or both ears. It is classified as conductive, sensory, or central.	loss of hearing;hypoacuses;loss, hearing;hearing impairment;hearing loss;hearing loss disorder;hypoacusis	hearing loss|hearing disorder|perceptual disorders|nervous system disease|disease|disposition|material property|experimental factor; hearing loss|hearing disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0005148	type 2 diabetes mellitus	A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.	diabetes mellitus, noninsulin-dependent;adult-onset diabetes;non-insulin-dependent diabetes mellitus;type II diabetes;adult onset diabetes;diabetes mellitis type II;diabetes mellitus, noninsulin-dependent, association with;diabetes mellitis type 2;NIDDM;type II diabetes mellitus;type 2 diabetes mellitus;type 2 diabetes;insulin resistance, severe, digenic;non-insulin dependent diabetes;diabetes mellitus, non-insulin-dependent, susceptibility to;diabetes mellitus, type II;non-insulin dependent diabetes mellitus;type 2 diabetes mellitus, susceptibility to;diabetes mellitus, type 2, susceptibility to;noninsulin-dependent diabetes mellitus;diabetes mellitus, type 2;diabetes, type 2;diabetes mellitus, noninsulin-dependent, late onset;hypertension, insulin resistance-related, susceptibility to;noninsulin dependent diabetes;T2DM - type 2 diabetes mellitus;diabetes mellitus, type II, susceptibility to;type 2 diabetes mellitus non-insulin dependent;diabetes mellitus, noninsulin-dependent, susceptibility to	type 2 diabetes mellitus|diabetes mellitus|endocrine pancreas disorder|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor; type 2 diabetes mellitus|diabetes mellitus|glucose metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; type 2 diabetes mellitus|diabetes mellitus|endocrine pancreas disorder|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:1001060	neovascular glaucoma	Neovascular glaucoma is the most common type of secondary glaucoma, usually caused by diabetic retinopathy, central retinal vein occlusion and carotid artery obstruction but sometimes by trauma, uvietis or ocular tumors, and characterized by severe eye pain, synechial angle glaucoma, high intraocular pressure and leading to loss of vision.	Glaucoma, Neovascular;neovascular glaucoma;Neovascular glaucoma;secondary angle-closure glaucoma with rubeosis;Neovascular glaucoma (disorder)	neovascular glaucoma|material entity|experimental factor; neovascular glaucoma|glaucoma|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; neovascular glaucoma|glaucoma|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0009734	unspecified juvenile idiopathic arthritis	Unspecified juvenile idiopathic arthritis is a rare, pediatric, rheumatologic disease, a subtype of juvenile idiopathic arthritis (JIA) characterized by arthritis of an unknown cause that persists for at least 6 weeks, and does not fulfill the criteria for any of the other JIA subtypes, or fulfills criteria for more than one of the other subtypes.	unspecified juvenile idiopathic arthritis;unspecified JIA	unspecified juvenile idiopathic arthritis|juvenile idiopathic arthritis|arthritis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; unspecified juvenile idiopathic arthritis|juvenile idiopathic arthritis|arthritis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; unspecified juvenile idiopathic arthritis|juvenile idiopathic arthritis|arthritis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; unspecified juvenile idiopathic arthritis|juvenile idiopathic arthritis|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; unspecified juvenile idiopathic arthritis|juvenile idiopathic arthritis|idiopathic disease|disease|disposition|material property|experimental factor; unspecified juvenile idiopathic arthritis|juvenile idiopathic arthritis|arthritis|inflammatory disease|disease|disposition|material property|experimental factor; unspecified juvenile idiopathic arthritis|juvenile idiopathic arthritis|chronic disease|disease|disposition|material property|experimental factor; unspecified juvenile idiopathic arthritis|juvenile idiopathic arthritis|idiopathic disease|material entity|experimental factor; unspecified juvenile idiopathic arthritis|juvenile idiopathic arthritis|arthritis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor
HP:0000103	Polyuria	An increased rate of urine production.	Increased urine output	Polyuria|Abnormal urine output|Abnormal renal physiology|Abnormality of the kidney|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Polyuria|Abnormal urine output|Abnormal renal physiology|Abnormality of the urinary system physiology|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1000362	Malignant Pleural Neoplasm	A primary or metastatic malignant neoplasm affecting the pleura. A representative example of primary malignant pleural neoplasm is the malignant pleural mesothelioma. A representative example of metastatic malignant neoplasm to the pleura is metastatic carcinoma that has spread to the pleura from another anatomic site.	malignant tumor of the pleura;cancer of the pleura;malignant pleural tumor;malignant neoplasm of the pleura;pleural cancer;malignant neoplasm of pleura;malignant pleura neoplasm;malignant tumor of pleura;malignant pleural neoplasm;cancer of pleura;pleura cancer	Malignant Pleural Neoplasm|thoracic cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Malignant Pleural Neoplasm|thoracic cancer|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Malignant Pleural Neoplasm|respiratory system cancer|respiratory system disease|disease|disposition|material property|experimental factor; Malignant Pleural Neoplasm|pleural neoplasm|respiratory system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Malignant Pleural Neoplasm|pleural neoplasm|respiratory system neoplasm|respiratory system disease|disease|disposition|material property|experimental factor; Malignant Pleural Neoplasm|pleural neoplasm|pleural disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; Malignant Pleural Neoplasm|respiratory system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:1000018	bladder disease	A disease involving the urinary bladder.	urinary bladder disease;disease or disorder of urinary bladder;bladder disease;urinary bladder disease or disorder;disorder of urinary bladder;urinary bladder disorder;bladder disorder;disease of urinary bladder	bladder disease|urinary system disease|disease|disposition|material property|experimental factor
HP:0025328	Antepartum hemorrhage	NA	Antepartum haemorrhage;Prepartum haemorrhage;Prepartum hemorrhage	Antepartum hemorrhage|Abnormality of blood circulation|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Antepartum hemorrhage|hemorrhage|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Antepartum hemorrhage|Abnormal bleeding|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0800047	3-methylglutaconate measurement	NA		3-methylglutaconate measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:26020	phosphate	NA	phosphates	phosphate|chemical entity|material entity|experimental factor
EFO:0006803	vasculitis	Vasculitis represents a clinically heterogenous group of diseases of multifactorial etiology characterized by inflammation of either large-sized vessels (large-vessel vasculitis, e.g. Giant-cell arteritis and Takayasu arteritis), medium-sized vessels (medium-vessel vasculitis e.g. polyarteritis nodosa and Kawasaki disease), or small-sized vessels (small-vessel vasculitis, e.g. granulomatosis with polyangiitis, microscopic polyangiitis, immunoglobulin A vasculitis, and cutaneous leukocytoclastic angiitis). Vasculitis occurs at any age, may be acute or chronic, and manifests with general symptoms such as fever, weight loss and fatigue, as well as more specific clinical signs depending on the type of vessels and organs affected. The degree of severity is variable, ranging from life or sight threatening disease (e.g. BehC'et disease) to relatively minor skin disease.	vasculitis	vasculitis|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; vasculitis|inflammatory disease|disease|disposition|material property|experimental factor; vasculitis|material entity|experimental factor
MONDO:0044983	benign lipomatous neoplasm	A benign mesenchymal neoplasm composed of adipose (fatty) tissue. The most common representative of this category is the lipoma.	benign lipomatous neoplasm;benign neoplasm of adipose tissue;benign adipose tissue neoplasm;adipose tissue benign connective and soft tissue neoplasm;benign connective and soft tissue neoplasm of adipose tissue;benign neoplasm of the adipose tissue;benign adipose tissue tumor;benign tumor of the adipose tissue;benign lipomatous tumor	benign lipomatous neoplasm|tumor of adipose tissue|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign lipomatous neoplasm|tumor of adipose tissue|mesenchymal cell neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign lipomatous neoplasm|benign connective and soft tissue neoplasm|connective and soft tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign lipomatous neoplasm|tumor of adipose tissue|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; benign lipomatous neoplasm|benign connective and soft tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; benign lipomatous neoplasm|benign connective and soft tissue neoplasm|musculoskeletal system benign neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign lipomatous neoplasm|benign connective and soft tissue neoplasm|musculoskeletal system benign neoplasm|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0000318	cardiomyopathy	A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.	[X]Cardiomyopathy in other diseases classified elsewhere (disorder);Cardiomyopathies;CARDIOMYOPATHIES SECOND;[X]Cardiomyopathy in other diseases classified elsewhere;Cardiomyopathy, Primary;cardiomyopathy;Cardiomyopathy, NOS;Cardiomyopathy (disorder);PRIM CARDIOMYOPATHY NEC;Cardiomyopathy NOS;Primary Cardiomyopathy;Cardiomyopathy NOS (disorder);Other primary cardiomyopathy NOS;Other primary cardiomyopathies;Other primary cardiomyopathies (disorder);Primary Cardiomyopathies;Other primary cardiomyopathy NOS (disorder);Cardiomyopathies, Secondary;Cardiomyopathies, Primary;Secondary Cardiomyopathy;CARDIOMYOPATH IN OTH DIS;Secondary Cardiomyopathies;Cardiomyopathy in other diseases classified elsewhere;Cardiomyopathy, Secondary	cardiomyopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; cardiomyopathy|material entity|experimental factor; cardiomyopathy|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
GO:0070527	platelet aggregation	NA		platelet aggregation|biological process|process|experimental factor
MONDO:0001134	essential hypertension	Hypertension that presents without an identifiable cause.	idiopathic hypertension;primary hypertension	essential hypertension|hypertensive disorder|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; essential hypertension|hypertension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
MONDO:0001085	interstitial nephritis	Inflammation of the renal tubules and supporting tissues of the kidney.	Tubulointerstitial nephritis;renal tubulo-interstitial disease	interstitial nephritis|nephritis|inflammatory disease|disease|disposition|material property|experimental factor; interstitial nephritis|nephritis|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:0009450	conjunctivitis	Inflammation of the conjunctiva of the eye.	pink eye;conjunctiva inflammation;conjunctivitis (disease);conjunctivitis;inflammation of conjunctiva	conjunctivitis|inflammatory disease|disease|disposition|material property|experimental factor; conjunctivitis|Conjunctival Disorder|eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; conjunctivitis|Conjunctival Disorder|eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor
HP:0001373	Joint dislocation	Displacement or malalignment of joints.	Joint dislocations;Joint dislocation	Joint dislocation|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004274	gout	A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.	gout;gouty arthropathy;gouty arthritis;articular gout	gout|metabolic disease|disease|disposition|material property|experimental factor; gout|arthritis|inflammatory disease|disease|disposition|material property|experimental factor; gout|arthritis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; gout|arthritis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; gout|arthritis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; gout|arthritis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
HP:0031678	Atherosclerotic lesion	A lesion associated with atherosclerosis, a multifactorial and multipart progressive disease manifested by the focal development within the arterial wall of lesions, that ranges from teh development of a fatty streak, plaque progression, and plaque disruption. Atherosclerotic lesions demonstrate consistent morphological characteristics, which indicate that each type may stabilize temporarily or permanently and that progression to the next type may require an additional stimulus.		Atherosclerotic lesion|Abnormality of cardiovascular system morphology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Atherosclerotic lesion|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005917	generalised epilepsy	A chronic condition characterised by recurrent generalised seizures.	generalized epilepsy;EIG;generalised epilepsy;idiopathic generalized epilepsy;epilepsy, idiopathic generalized	generalised epilepsy|genetic disorder|material entity|experimental factor; generalised epilepsy|idiopathic disease|material entity|experimental factor; generalised epilepsy|epilepsy|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; generalised epilepsy|idiopathic disease|disease|disposition|material property|experimental factor; generalised epilepsy|genetic disorder|disease|disposition|material property|experimental factor
MONDO:0002280	anemia	A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.	anemia;anaemia;anemia (disease)	anemia|hematologic disease|material entity|experimental factor; anemia|hematologic disease|disease|disposition|material property|experimental factor
MONDO:0001498	varicocele	A condition characterized by the dilated tortuous veins of the spermatic cord with a marked left-sided predominance. Adverse effect on male fertility occurs when varicocele leads to an increased scrotal (and testicular) temperature and reduced testicular volume.	varicose disease of scrotum;scrotum varicose disease;scrotal varices	varicocele|pelvic varices|varicose disease|vein disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; varicocele|scrotal disorder|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:1001435	tenosynovitis	Inflammation of the synovial lining of a tendon sheath. Causes include trauma, tendon stress, bacterial disease (gonorrhea, tuberculosis), rheumatic disease, and gout. Common sites are the hand, wrist, shoulder capsule, hip capsule, hamstring muscles, and Achilles tendon. The tendon sheaths become inflamed and painful, and accumulate fluid. Joint mobility is usually reduced.	Tenosynovitides;inflammation of tendon sheath;tenosynovitis;Inflammation of tendon sheath;tendon sheath inflammation	tenosynovitis|tendinitis|Tendinopathy|connective tissue disease|disease|disposition|material property|experimental factor; tenosynovitis|tendinitis|Tendinopathy|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; tenosynovitis|tendon sheath disorder|Tendinopathy|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; tenosynovitis|tendinitis|myositis|immune system disease|disease|disposition|material property|experimental factor; tenosynovitis|tendinitis|myositis|myopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; tenosynovitis|tendinitis|myositis|inflammatory disease|disease|disposition|material property|experimental factor; tenosynovitis|tendon sheath disorder|Tendinopathy|connective tissue disease|disease|disposition|material property|experimental factor; tenosynovitis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
MONDO:0002319	phosphorus metabolism disease	A metabolic disorder that affects the phosphate homeostasis.	disorder of phosphorus metabolism;phosphorus metabolic disorder;phosphorus metabolism disorder;phosphorus disorder	phosphorus metabolism disease|mineral metabolism disease|metabolic disease|disease|disposition|material property|experimental factor
EFO:0009637	pleural effusion	NA		pleural effusion|sign or symptom|phenotype|quality|material property|experimental factor
EFO:0002503	cardiac hypertrophy	NA	cardiomegaly;enlarged heart;myocardial hypertrophy;heart hypertrophy	cardiac hypertrophy|hypertrophy|phenotype|quality|material property|experimental factor
EFO:0008406	susceptibility to plantar warts measurement	NA		susceptibility to plantar warts measurement|infectious disease biomarker|measurement|information entity|experimental factor; susceptibility to plantar warts measurement|susceptibility to infectious disease measurement|measurement|information entity|experimental factor
EFO:0003907	deep vein thrombosis	NA	Deep-Vein Thrombosis;Thrombosis, Deep-Vein;Vein Thrombosis, Deep;Deep Venous Thromboses;Deep-Venous Thromboses;Thromboses, Deep Vein;Thrombosis, Deep Venous;Deep-Vein Thromboses;Thrombosis, Deep-Venous;Deep Vein Thromboses;Thromboses, Deep Venous;DVT;Thromboses, Deep-Venous;Deep-Venous Thrombosis;Thromboses, Deep-Vein;Venous Thrombosis, Deep;Thrombosis, Deep Vein;Vein Thromboses, Deep;Deep Venous Thrombosis;Venous Thromboses, Deep	deep vein thrombosis|Venous thrombosis|Abnormal thrombosis|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001019	lip cancer	A primary or metastatic malignant neoplasm involving the lip.	malignant tumor of the Lip;malignant neoplasm of lip, unspecified;lip cancer;malignant neoplasm of lower lip, buccal aspect;malignant neoplasm of lip, inner aspect;malignant neoplasm of the Lip;malignant neoplasm of commissure of lip;malignant tumor of lower labial mucosa;malignant neoplasm of other sites of lip;malignant neoplasm of lip, unspecified, vermilion border;malignant neoplasm of lip, vermilion border;malignant neoplasm of lower lip, oral aspect;malignant Lip tumor;malignant tumour of lip;malignant neoplasm of labial commissure of lip;cancer of lip;malignant neoplasm of lower lip, mucosa;malignant tumor of Lip;malignant neoplasm of lip, unspecified, inner aspect;malignant neoplasm of vermilion border of lip;malignant neoplasm of lip, external;malignant Lip neoplasm;malignant lip neoplasm;malignant neoplasm of external Lip, not specified as upper or lower;malignant neoplasm of oral aspect of lip, not specified whether upper or lower;malignant tumor of commissure of lip;malignant neoplasm of lip;malignant tumor of labial mucosa;malignant neoplasm of lower lip, inner aspect;malignant tumour of labial commissure;malignant neoplasm of Lip	lip cancer|lip neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lip cancer|oral cavity cancer|head and neck malignant neoplasia|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lip cancer|integumentary system cancer|integumentary system disease|disease|disposition|material property|experimental factor; lip cancer|lip neoplasm|lip disorder|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; lip cancer|oral cavity cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; lip cancer|integumentary system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lip cancer|oral cavity cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lip cancer|lip neoplasm|lip disorder|integumentary system disease|disease|disposition|material property|experimental factor; lip cancer|oral cavity cancer|mouth neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lip cancer|oral cavity cancer|head and neck malignant neoplasia|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lip cancer|oral cavity cancer|mouth neoplasm|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lip cancer|oral cavity cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lip cancer|lip neoplasm|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; lip cancer|oral cavity cancer|mouth neoplasm|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; lip cancer|oral cavity cancer|mouth neoplasm|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; lip cancer|lip neoplasm|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lip cancer|oral cavity cancer|head and neck malignant neoplasia|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0004247	mood disorder	A cognitive disorder a disturbance in which the person's mood is hypothesized to be the main underlying feature.	mood disorder;mood disorders;affective disorders;major mood disorders	mood disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; mood disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:1000807	anterior cerebral artery infarction	Necrosis occurring in the anterior cerebral artery system, including branches such as Heubner's artery. These arteries supply blood to the medial and superior parts of the cerebral hemisphere, Infarction in the anterior cerebral artery usually results in sensory and motor impairment in the lower body.	Infarction, Anterior Cerebral Artery;anterior cerebral artery infarction	anterior cerebral artery infarction|cerebral infarction|brain infarction|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; anterior cerebral artery infarction|cerebral infarction|brain infarction|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; anterior cerebral artery infarction|cerebral infarction|brain infarction|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0002977	autoimmune disorder of the nervous system	A disorder characterized by the degeneration of the nervous system due to autoimmunity. Representative examples include multiple sclerosis, Guillain-Barre syndrome, and myasthenia gravis.	nervous system autoimmune disease;immune diseases, nervous system;autoimmune diseases, nervous system;autoimmune disorders of the nervous system;autoimmune nervous system diseases;autoimmune diseases, neurologic;nervous system immune diseases;autoimmune disease, neurologic;neurologic autoimmune disease;nervous system immune disorders;neurologic autoimmune diseases;autoimmune nervous system disorder;nervous system autoimmune diseases;diseases, neurologic autoimmune;disease, neurologic autoimmune;autoimmune disease of nervous system;immune disorders, nervous system;autoimmune disorders, nervous system;nervous system hypersensitivity reaction type II disease	autoimmune disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; autoimmune disorder of the nervous system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor
EFO:0009492	cardiac arrest	NA	circulatory arrest;cardiopulmonary arrest	cardiac arrest|cardiac arrhythmia|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:1001491	abortion	NA	loss of pregnancy	abortion|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0005938	congenital left-sided heart lesions	Serious heritable structural anomalies of the left side of the heart, including hypoplastic left heart syndrome, aortic valve stenosis, coarctation of the aorta, mitral valve anomalies and bicuspid aortic valve, that are present from birth.	LVOTD;congenital left-sided heart lesions;left ventricular obstructive tract defect;congential LSLs	congenital left-sided heart lesions|congenital heart malformation|congenital heart disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; congenital left-sided heart lesions|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; congenital left-sided heart lesions|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|cardiovascular disease|disease|disposition|material property|experimental factor; congenital left-sided heart lesions|congenital heart malformation|genetic disorder|disease|disposition|material property|experimental factor; congenital left-sided heart lesions|congenital heart malformation|genetic disorder|material entity|experimental factor
EFO:0000676	psoriasis	An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.	PUSTULAR PSORIASIS OF PALMS SOLES;Other and unspecified pityriasis;Psoriasis and similar disorders NOS;Psoriasis and similar disorders NOS (disorder);PUSTULOSIS OF PALMS SOLES;Psoriasis and similar disorders;psoriasis;PSORIAS RELATED DIS NEC;Other psoriasis and similar disorders;Other psoriasis and similar disorders (disorder);Other psoriasis and similar disorders excluding psoriatic arthropathy;Psoriases;OTHER PSORIASIS;Pustular Psoriasis of Palms and Soles;Pustulosis of Palms and Soles;Palmoplantaris Pustulosis;Psoriasis and similar disorders (disorder);PITYRIASIS NEC & NOS;Pustulosis Palmaris et Plantaris;Psoriasis and similar disorders (navigational concept)	psoriasis|inflammatory skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; psoriasis|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; psoriasis|genetic disorder|material entity|experimental factor; psoriasis|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; psoriasis|genetic disorder|disease|disposition|material property|experimental factor; psoriasis|immune system disease|disease|disposition|material property|experimental factor
HP:0001075	Atrophic scars	Scars that form a depression compared to the level of the surrounding skin because of damage to the collagen, fat or other tissues below the skin.	Sunken or indented skin due to damage;Thin, atrophic scars	Atrophic scars|Scarring|Abnormality of connective tissue|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Atrophic scars|Abnormality of skin morphology|Abnormality of the skin|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009816	perineal laceration during delivery	NA	perineal tear	perineal laceration during delivery|injury|disease|disposition|material property|experimental factor
HP:0012227	Urethral stricture	Narrowing of the urethra associated with inflammation or scar tissue.		Urethral stricture|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Urethral stricture|Abnormality of the genital system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:17992	sucrose	NA	sucrose;SUCROSE;beta-D-fructofuranosyl alpha-D-glucopyranoside;Sucrose	sucrose|carbohydrate|chemical entity|material entity|experimental factor
EFO:0005556	Gilbert syndrome	An autosomal recessive inherited disorder characterized by unconjugated hyperbilirubinemia, resulting in harmless intermittent jaundice.	constitutional hyperbilirubinemia;familial cholemia;Gilbert Disease;Gilbert's disease;Gilbert's syndrome;Gilbert syndrome;Gilbert-Meulengracht syndrome;Gilbert disease;hereditary nonhemolytic jaundice;hyperbilirubinemia type 1;Constitutional hyperbilirubinemia	Gilbert syndrome|hereditary hyperbilirubinemia|inborn disorder of bilirubin metabolism|inborn disorder of porphyrin metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor; Gilbert syndrome|hereditary hyperbilirubinemia|inborn disorder of bilirubin metabolism|bilirubin metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; Gilbert syndrome|hereditary hyperbilirubinemia|inborn disorder of bilirubin metabolism|inborn disorder of porphyrin metabolism|porphyrin metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; Gilbert syndrome|syndromic disease|material entity|experimental factor; Gilbert syndrome|hereditary hyperbilirubinemia|inborn disorder of bilirubin metabolism|inborn disorder of porphyrin metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; Gilbert syndrome|syndromic disease|disease|disposition|material property|experimental factor; Gilbert syndrome|hereditary hyperbilirubinemia|inborn disorder of bilirubin metabolism|inborn disorder of porphyrin metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor
MONDO:0019338	sarcoidosis	Sarcoidosis is a multisystemic disorder of unknown cause characterized by the formation of immune granulomas in involved organs.	Boeck's sarcoidosis;sarcoid;besnier-Boeck-Schaumann syndrome;sarcoidosis;Besnier-Boeck-Schaumann disease;Darier-Roussy sarcoid;Boeck sarcoid;Boeck's sarcoid;lymphogranulomatosis	sarcoidosis|granulomatous autoinflammatory syndrome|autoinflammatory syndrome|syndromic disease|material entity|experimental factor; sarcoidosis|granulomatous autoinflammatory syndrome|autoinflammatory syndrome|syndromic disease|disease|disposition|material property|experimental factor; sarcoidosis|granulomatous autoinflammatory syndrome|autoinflammatory syndrome|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; sarcoidosis|granulomatous autoinflammatory syndrome|autoinflammatory syndrome|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor
EFO:0005649	spondylolysis	A defect in the pars interarticularis of a vertebral bone.	spondylolysis;spondylolysis (disease)	spondylolysis|disease of bone structure|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; spondylolysis|vertebral disorder|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0000537	hypertension	Persistently high systemic arterial blood pressure. Based on multiple readings (blood pressure determination), hypertension is currently defined as when systolic pressure is consistently greater than 140 mm Hg or when diastolic pressure is consistently 90 mm Hg or more.	hypertensive disease;blood pressure, increased;blood pressure, high;HTN;vascular hypertensive disorder;Blood Pressures, High;hypertensive disorder;(hypertensive disease) or (hypertension);[X]Hypertensive diseases;Hypertensive disease NOS (disorder);high blood pressure;increased blood pressure;HTN - hypertension;hyperpiesia;High Blood Pressure;[X]Hypertensive diseases (disorder);High blood pressure (& [essential hypertension]);Blood Pressure, High;Hypertensive disease (disorder);hypertensive disease NOS;hypertension NOS;SURG COMP - HYPERTENSION;HYPERTENSIVE DISEASE;High Blood Pressures;pressure, high blood	hypertension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0003860	pancreatic neoplasm	A benign or malignant neoplasm involving the pancreas.	Pancreas Neoplasms;Neoplasms, Pancreatic;Neoplasm, Pancreatic;pancreatic tumor;PANCREATIC NEOPL;Neoplasms, Pancreas;PANCREAS NEOPL;neoplasm of the pancreas;neoplasm of pancreas;pancreatic cancer;Pancreatic Neoplasms;tumor of pancreas;Pancreas Neoplasm;pancreatic neoplasm;NEOPL PANCREATIC;pancreas neoplasm;pancreas neoplasm (disease);tumor of the pancreas;pancreas tumor;Neoplasm, Pancreas	pancreatic neoplasm|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor; pancreatic neoplasm|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor; pancreatic neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0004630	factor VIII measurement	NA	factor VIII levels	factor VIII measurement|hematological measurement|measurement|information entity|experimental factor; factor VIII measurement|coagulation factor measurement|measurement|information entity|experimental factor; factor VIII measurement|protein measurement|measurement|information entity|experimental factor
EFO:0000612	myocardial infarction	Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.	Infarcts, Myocardial;MYOCARDIAL INFARCTION, (MI);Myocardial Infarcts;Heart attack, NOS;myocardial infarction;myocardial infarct;Myocardial Infarctions;MI, MYOCARDIAL INFARCTION;MI;heart attack;Cardiac infarction;Myocardial infarction (disorder);Infarct, Myocardial;Attack - heart;infarction (MI), myocardial;Infarction of heart, NOS;Myocardial infarction, NOS;Myocardial Infarct;INFARCTION (MI), MYOCARDIAL;Infarction, Myocardial;myocardial infarction (disease);MI - Myocardial infarction;myocardial infarction, (MI);Myocardial infarction NOS;Infarction of heart;Infarctions, Myocardial;MI, myocardial infarction;Cardiac infarction, NOS	myocardial infarction|myocardial disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0006832	disposition index measurement	NA	insulin disposition index measurement	disposition index measurement|insulin measurement|protein measurement|measurement|information entity|experimental factor; disposition index measurement|insulin measurement|diabetes mellitus biomarker|measurement|information entity|experimental factor; disposition index measurement|insulin measurement|hormone measurement|measurement|information entity|experimental factor
EFO:0001073	obesity	A disorder involving an excessive amount of body fat.	Adiposity;Obesity [Ambiguous];Obesity NOS;Obese;Adiposis;obesity;Overweight and obesity;obesity disorder;obesity disease;Obesity (disorder);Obese (finding);Obesity, unspecified	obesity|overnutrition|nutritional disorder|metabolic disease|disease|disposition|material property|experimental factor
MONDO:0001187	urinary bladder cancer	A primary or metastatic malignant neoplasm involving the bladder.	urinary bladder malignant tumor;malignant neoplasm of urinary bladder;malignant neoplasm of bladder;urinary bladder cancer;malignant bladder tumor;malignant neoplasm, bladder;malignant neoplasm of the urinary bladder;malignant neoplasm, urinary bladder;urinary bladder malignant neoplasm;malignant urinary bladder neoplasm;malignant neoplasm of the bladder;malignant tumor, urinary bladder;malignant urinary bladder tumor;bladder cancer, somatic;malignant tumor of the urinary bladder;malignant bladder neoplasm;malignant tumor of bladder;malignant tumor of the bladder;malignant tumor of urinary bladder;cancer of urinary bladder	urinary bladder cancer|Malignant Urinary System Neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; urinary bladder cancer|bladder tumor|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; urinary bladder cancer|Malignant Urinary System Neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; urinary bladder cancer|Malignant Urinary System Neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; urinary bladder cancer|bladder tumor|bladder disease|urinary system disease|disease|disposition|material property|experimental factor; urinary bladder cancer|bladder tumor|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor
EFO:0000266	aortic stenosis	NA	AS;Aortic Valve Stenoses;Valve Stenoses, Aortic;Aortic valve stenosis, NOS;AS - Aortic stenosis;Stenosis, Aortic;Aortic valve stenosis (disorder);Stenoses, Aortic Valve;Stenoses, Aortic;Valve Stenosis, Aortic;Aortic Valve Stenosis;Stenosed aortic valve;Stenosis, Aortic Valve	aortic stenosis|aortic valve disease|aortic disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic stenosis|aortic valve disease|heart valve disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic stenosis|aortic valve disease|cardiac ventricle disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0003763	cerebrovascular disorder	A disorder resulting from inadequate blood flow in the vessels that supply the brain. Representative examples include cerebrovascular ischemia, cerebral embolism, and cerebral infarction.	cerebrovascular disorder;Vascular Disorders, Brain;CEREBROVASCULAR DIS;Brain Vascular Disorders;Vascular Disorder, Intracranial;Occlusions, Cerebrovascular;Brain Vascular Disorder;Cerebrovascular Occlusion;Intracranial Vascular Disorder;Insufficiencies, Cerebrovascular;Cerebrovascular Insufficiency;Intracranial Vascular Diseases;INTRACRANIAL VASCULAR DIS;Insufficiency, Cerebrovascular;cerebrovascular disease;Vascular Diseases, Intracranial;Vascular Disorder, Brain;Intracranial Vascular Disorders;Cerebrovascular Disorders;Intracranial Vascular Disease;Vascular Disease, Intracranial;Cerebrovascular Insufficiencies;Vascular Disorders, Intracranial;VASCULAR DIS INTRACRANIAL;BRAIN VASCULAR DIS;Cerebrovascular Disease;Occlusion, Cerebrovascular;Cerebrovascular Occlusions	cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor
EFO:0004842	eosinophil count	NA	blood eosinophil count	eosinophil count|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:1000726	lichen planus	A chronic, recurrent, pruritic inflammatory disorder of unknown etiology that affects the skin and mucus membranes. It presents with rashes and papules that tend to resolve spontaneously. It may be associated with hepatitis C. Certain drugs that contain arsenic or bismuth are associated with reactions mimicking lichen planus.	lichen planus;lichen ruber planus;Lichen, ruber planus;lichen, ruber planus	lichen planus|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; lichen planus|lichen disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; lichen planus|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0007984	platelet component distribution width	NA	PCDW;Platelet Component Distribution Width Measurement;Platelet distribution width	platelet component distribution width|platelet measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0009188	Red cell distribution width	NA	RDW-SD;Erythrocyte Distribution Width Measurement;Red cell distribution width (RDW) blood test;RCDW;RDW-CV;Red blood cell erythrocyte distribution width;RDW	Red cell distribution width|hemoglobin measurement|protein measurement|measurement|information entity|experimental factor; Red cell distribution width|hemoglobin measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0009888	trauma complication	NA	complication of trauma	trauma complication|complication|disease|disposition|material property|experimental factor
HP:0003419	Low back pain	NA	Lower back pain;LBP	Low back pain|Back pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Low back pain|Back pain|pain|sign or symptom|phenotype|quality|material property|experimental factor; Low back pain|Back pain|Abnormality of the vertebral column|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000464	emphysema	A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.	emphysema, pulmonary;Pulmonary Emphysema;EMPHYSEMA, PULMONARY;emphysema;pulmonary emphysema	emphysema|chronic obstructive pulmonary disease|tracheal disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; emphysema|chronic obstructive pulmonary disease|chronic lung disease|chronic disease|disease|disposition|material property|experimental factor; emphysema|chronic obstructive pulmonary disease|tracheal disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; emphysema|chronic obstructive pulmonary disease|chronic lung disease|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
CHEBI:27266	valine	NA	valine	valine|amino acid|acid|chemical entity|material entity|experimental factor
EFO:0004587	lymphocyte count	NA	lymphocyte counts	lymphocyte count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor; lymphocyte count|infectious disease biomarker|measurement|information entity|experimental factor
EFO:0007985	platelet crit	NA	plateletcrit (PCT);PCT;platelet crit (PCT);plateletcrit	platelet crit|platelet measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0004309	platelet count	NA	blood platelet number	platelet count|platelet measurement|hematological measurement|measurement|information entity|experimental factor; platelet count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0007328	influenza	An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.	orthomyxoviridae infectious disease;orthomyxoviridae caused disease or disorder;Influenza with other manifestations NOS (disorder);Influenza with non-respiratory manifestation (disorder);Influenza with other manifestations (disorder);orthomyxoviridae disease or disorder;influenza infection;influenza virus infection;Influenza with other manifestations;influenza with non-respiratory manifestation;flu;influenza;Influenza, Human	influenza|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; influenza|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; influenza|respiratory system disease|disease|disposition|material property|experimental factor; influenza|viral respiratory tract infection|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; influenza|viral respiratory tract infection|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; influenza|viral respiratory tract infection|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
CHEBI:15428	glycine	NA	GLYCINE;glycine;aminoacetic acid;Glycine	glycine|amino acid|acid|chemical entity|material entity|experimental factor
EFO:0800233	hexanoylglycine measurement	NA		hexanoylglycine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800576	4-methylhexanoylglutamine measurement	NA		4-methylhexanoylglutamine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0021655	N,N-Dimethylglycine measurement	NA		N,N-Dimethylglycine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0021042	octanoylcarnitine measurement	NA		octanoylcarnitine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0021040	hexanoylcarnitine measurement	NA		hexanoylcarnitine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800262	hexanoylglutamine measurement	NA		hexanoylglutamine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0000763	viral disease	Any disease caused by a virus.	viral infection;Viruses caused disease or disorder;Viruses infection;viral disorder;virus infection;viral disease;Viruses infectious disease;viral infectious disease;infection, viral;Viruses disease or disorder	viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0004340	body mass index	NA	BMI;Quetelet's Index	body mass index|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
EFO:0009289	left ventricular mass	NA	LV mass	left ventricular mass|heart function measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
EFO:0009819	comparative body size at age 10, self-reported	NA		comparative body size at age 10, self-reported|self-reported trait|quality|material property|experimental factor
EFO:0011011	sitting height measurement	NA		sitting height measurement|anthropometric measurement|measurement|information entity|experimental factor
EFO:0004314	forced expiratory volume	NA	FEV1;FEVt;timed vital capacity	forced expiratory volume|respiratory disease biomarker|measurement|information entity|experimental factor; forced expiratory volume|pulmonary function measurement|measurement|information entity|experimental factor
EFO:0007777	base metabolic rate measurement	NA	BMR measurement;basal metabolic rate measurement	base metabolic rate measurement|metabolic rate measurement|measurement|information entity|experimental factor
EFO:0004338	body weight	NA	weight	body weight|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
MONDO:0017760	disorder of other vitamins and cofactors metabolism and transport	NA		disorder of other vitamins and cofactors metabolism and transport|disorder of vitamin and non-protein cofactor absorption and transport|disorder of metabolite absorption and transport|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; disorder of other vitamins and cofactors metabolism and transport|disorder of vitamin and non-protein cofactor absorption and transport|disorder of metabolite absorption and transport|inborn errors of metabolism|genetic disorder|material entity|experimental factor; disorder of other vitamins and cofactors metabolism and transport|disorder of vitamin and non-protein cofactor absorption and transport|disorder of metabolite absorption and transport|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor
EFO:0009549	female reproductive system disease	A disease involving the female reproductive system.	disorder of female genital system;disorder of female reproductive system;female reproductive system disorder;disease or disorder of female reproductive system;female reproductive disease;female reproductive system disease or disorder;female reproductive system disease;disease of female reproductive system	female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0003931	bone fracture	Breaks in bones.	fracture(s);fracture of bone;Fracture, Bone;Bone Fractures;Bone, Broken;Bones, Broken;Broken Bones;bone fracture;Broken Bone;Fractures, Bone;fracture	bone fracture|injury|disease|disposition|material property|experimental factor; bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:1001272	bacterial pneumonia	Acute infection of the lung parenchyma caused by bacteria (e.g., Streptococcus pneumoniae, Haemophilus influenzae, Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila). Signs and symptoms include productive cough, fever, chills, shortness of breath, and chest pain.	Bacteria pneumonia;pneumonia due to other gram-negative bacteria;bacterial pneumonia;Pneumonia, Bacterial;Bacteria caused pneumonia;gram-negative pneumonia	bacterial pneumonia|pneumonia|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; bacterial pneumonia|pneumonia|pneumonitis|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; bacterial pneumonia|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; bacterial pneumonia|pneumonia|pneumonitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0009515	wrist fracture	NA		wrist fracture|upper extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor; wrist fracture|upper extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0009514	upper extremity fracture	NA	fracture of upper limb	upper extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor; upper extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
HP:0011868	Sciatica	Pain in the lower back and hip radiating in the distribution of the sciatic nerve.		Sciatica|Back pain|pain|sign or symptom|phenotype|quality|material property|experimental factor; Sciatica|Back pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Sciatica|Back pain|Abnormality of the vertebral column|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004269	cardiac arrhythmia	NA	cardiac arrhythmias;arrhythmia;arrythmia;arrhythmias, cardiac	cardiac arrhythmia|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
HP:0001298	Encephalopathy	Encephalopathy is a term that means brain disease, damage, or malfunction. In general, encephalopathy is manifested by an altered mental state.		Encephalopathy|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001413	Respiratory Syncytial Virus Infection	Infection with the respiratory syncytial virus, an RNA virus of the genus Pneumovirus, in the family Paramyxoviridae, which is characterized by the formation of syncytia in tissue culture. It causes minor respiratory infection with rhinitis and cough in adults, but is capable of causing severe bronchitis and bronchopneumonia in young children.	Human respiratory syncytial virus infection;respiratory syncytial virus infection;RSV infection;respiratory syncytial virus infectious disease	Respiratory Syncytial Virus Infection|Mononegavirales infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Respiratory Syncytial Virus Infection|viral respiratory tract infection|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Respiratory Syncytial Virus Infection|viral respiratory tract infection|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Respiratory Syncytial Virus Infection|Mononegavirales infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Respiratory Syncytial Virus Infection|viral respiratory tract infection|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
HP:0001259	Coma	Complete absence of wakefulness and content of conscience, which manifests itself as a lack of response to any kind of external stimuli.	Coma	Coma|Reduced consciousness/confusion|Abnormality of higher mental function|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009686	respiratory failure	The significant impairment of gas exchange within the lungs resulting in hypoxia, hypercarbia, or both, to the extent that organ tissue perfusion is severely compromised. Causes include chronic obstructive pulmonary disease, asthma, emphysema, acute respiratory distress syndrome, pneumonia, pulmonary edema, pneumothorax, and congestive heart failure. Treatment requires intubation and mechanical ventilation until the time the lungs recover sufficient function.	respiratory failure;failure, respiratory;respiratory insufficiency/failure	respiratory failure|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0008561	diaphragmatic hernia	NA		diaphragmatic hernia|Hernia|Abnormality of connective tissue|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007503	suppurative otitis media	Inflammation of the middle ear with purulent discharge.	Suppurative and unspecified otitis media;Unspecified suppurative otitis media;Suppurative otitis media;Purulent otitis media NOS (disorder);Purulent otitis media (disorder);suppurative otitis media;Suppurative otitis media &/or ([left] or [right]) &/or purulent otitis media;otitis media with effusion - purulent;Otitis media with effusion - purulent;Suppurative and unspecified otitis media (disorder);Suppurative otitis med.;Purulent otitis media NOS;Otitis Media, Suppurative;purulent otitis media	suppurative otitis media|Otitis media|inflammatory disease|disease|disposition|material property|experimental factor; suppurative otitis media|Otitis media|middle ear disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; suppurative otitis media|Otitis media|middle ear disorder|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; suppurative otitis media|Otitis media|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0000400	diabetes mellitus	A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.	diabetes mellitus (disease);Diabetes mellitus, NOS;diabetes;diabetes mellitus;Diabetes;Diabetes NOS;Diabetes mellitus (disorder);DM - Diabetes mellitus;DM	diabetes mellitus|glucose metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; diabetes mellitus|endocrine pancreas disorder|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor; diabetes mellitus|endocrine pancreas disorder|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0009759	Chronic Obstructive Asthma	NA		Chronic Obstructive Asthma|asthma|bronchial disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0003944	tibia fracture	Traumatic or pathological injury to the tibia in which the continuity of the bone is broken.	Tibial Fracture;Fractures, Tibial;tibia bone fracture;Fracture, Tibial;tibia fracture;bone fracture of tibia;Tibial Fractures	tibia fracture|lower extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor; tibia fracture|lower extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
CHEBI:27468	5,6-dihydrothymine	NA	5,6-dihydrothymine;5,6-Dihydrothymine;5-methyldihydropyrimidine-2,4(1H,3H)-dione	5,6-dihydrothymine|organic heterocyclic compound|chemical entity|material entity|experimental factor
MONDO:0002253	spondylosis	A degenerative spinal disease that can involve any part of the vertebra, the intervertebral disk, and the surrounding soft tissue.	lumbar spondylosis with myelopathy;spondylosis with myelopathy;spondylogenic compression of lumbar spinal cord;thoracic or lumbar spondylosis with myelopathy;lumbosacral spondylosis without myelopathy;spondylogenic compression of thoracic spinal cord	spondylosis|disease of bone structure|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0000555	irritable bowel syndrome	Irritable bowel syndrome (IBS) is a chronic functional condition of the lower gastrointestinal (GI) tract characterised by abdominal pain or discomfort and disordered bowel habit (diarrhoea, constipation, or fluctuation between the two).	Functional bowel disease;Irritable colon (disorder);Colitides, Mucous;IBS;Spastic colitis;irritable bowel syndrome;irritable colon;spastic colon;Irritable Colon;Colon, Irritable;Syndrome, Irritable Bowel;mucus colitis;IC - Irritable colon;Syndromes, Irritable Bowel;Irritable bowel - IBS;Spastic colon;Colitis, Mucous;Psychogenic IBS;Mucous colitis;Irritable colon syndrome;Irritable bowel;Irritable Bowel Syndromes;Colon spasm;IBS - Irritable bowel syndrome;Adaptive colitis;[X]Psychogenic IBS;Mucous Colitides;IBD;Nervous colitis;Membranous colitis;Irritable colon - Irritable bowel syndrome	irritable bowel syndrome|syndromic disease|disease|disposition|material property|experimental factor; irritable bowel syndrome|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; irritable bowel syndrome|syndromic disease|material entity|experimental factor
EFO:0004833	neutrophil count	NA	blood neutrophil count	neutrophil count|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
Orphanet:846	Alpha-thalassemia	NA		
EFO:0005091	monocyte count	NA		monocyte count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0009620	rib fracture	NA		rib fracture|bone fracture|injury|disease|disposition|material property|experimental factor; rib fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0000685	rheumatoid arthritis	A chronic, systemic autoimmune disorder characterized by inflammation in the synovial membranes and articular surfaces. It manifests primarily as a symmetric, erosive polyarthritis that spares the axial skeleton and is typically associated with the presence in the serum of rheumatoid factor.	Rheumatoid arthritis NOS;autoimmune arthritis;atrophic arthritis;arthritis, rheumatoid;rheumatoid arthritis, progression of;Arthritis or polyarthritis, rheumatic;Rheumatic gout;Proliferative arthritis;Rheumatoid disease;RA;Arthritis, Rheumatoid;Rheumatoid arthritis NOS (disorder);atrophic Arthritis;RA - Rheumatoid arthritis;RhA - Rheumatoid arthritis;Chronic rheumatic arthritis;rheumatoid arthritis;Rheumatoid arthritis (disorder);arthritis or polyarthritis, rheumatic	rheumatoid arthritis|arthritis|inflammatory disease|disease|disposition|material property|experimental factor; rheumatoid arthritis|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; rheumatoid arthritis|arthritis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; rheumatoid arthritis|autoimmune disorder of musculoskeletal system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; rheumatoid arthritis|arthritis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; rheumatoid arthritis|arthritis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; rheumatoid arthritis|autoimmune disorder of musculoskeletal system|musculoskeletal system disease|disease|disposition|material property|experimental factor; rheumatoid arthritis|arthritis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0004528	mean corpuscular hemoglobin concentration	NA	Corpuscular Hemoglobin Concentration Mean;CHCM;MCHC;Erythrocyte Corpuscular Hemoglobin Concentration Mean;mean corpuscular haemoglobin concentration;Corpuscular HGB Concentration Mean	mean corpuscular hemoglobin concentration|hemoglobin measurement|hematological measurement|measurement|information entity|experimental factor; mean corpuscular hemoglobin concentration|hemoglobin measurement|protein measurement|measurement|information entity|experimental factor; mean corpuscular hemoglobin concentration|erythrocyte indices|erythrocyte measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0007990	neutrophil percentage of leukocytes	NA	blood neutrophil count to total leukocyte count ratio;neutrophil percentage of white cells;neutrophil count as percentage of total white blood cells;neutrophil percentage;neutrophil count to total WBC count ratio	neutrophil percentage of leukocytes|neutrophil count|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
MONDO:0002039	cognitive disorder	A disease affects cognitive processes.	cognitive disorder;cognitive disease	cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0002471	bursitis	Inflammation or irritation of a synovial bursa, the fibrous sac that acts as a cushion between moving structures of bones, muscles, tendons or skin.	inflammation of synovial bursa;synovial bursa inflammation	bursitis|synovial bursa disorder|synovium disorder|musculoskeletal system disease|disease|disposition|material property|experimental factor; bursitis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; bursitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:1000831	bacterial meningitis	Inflammation of the membranes surrounding the brain and spinal cord due to a bacterial infection.	Bacteria infectious meningitis;bacterial meningitis;Meningitis, Bacterial;Bacteria caused infectious meningitis	bacterial meningitis|infectious meningitis|central nervous system infection|infectious disorder of the nervous system|material entity|experimental factor; bacterial meningitis|infectious meningitis|central nervous system infection|infectious disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; bacterial meningitis|infectious meningitis|meningitis|encephalomyelitis|inflammatory disease|disease|disposition|material property|experimental factor; bacterial meningitis|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; bacterial meningitis|infectious meningitis|meningitis|encephalomyelitis|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; bacterial meningitis|infectious meningitis|central nervous system infection|infectious disorder of the nervous system|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; bacterial meningitis|infectious meningitis|central nervous system infection|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009521	dislocation	NA		dislocation|injury|disease|disposition|material property|experimental factor
HP:0002140	Ischemic stroke	Acute ischemic stroke (AIS) is defined by the sudden loss of blood flow to an area of the brain with the resulting loss of neurologic function. It is caused by thrombosis or embolism that occludes a cerebral vessel supplying a specific area of the brain. During a vessel occlusion, there is a core area where damage to the brain is irreversible and an area of penumbra where the brain has lost function owing to decreased blood flow but is not irreversibly injured.	Ischaemic stroke	Ischemic stroke|Cerebral ischemia|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Ischemic stroke|Cerebral ischemia|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Ischemic stroke|Cerebral ischemia|ischemia|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Ischemic stroke|Abnormal cerebral vascular morphology|Abnormality of cardiovascular system morphology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Ischemic stroke|Abnormal cerebral vascular morphology|Abnormality of brain morphology|Morphological central nervous system abnormality|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Ischemic stroke|Abnormal cerebral vascular morphology|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0021039	decanoylcarnitine measurement	NA		decanoylcarnitine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009560	otitis externa	Inflammation of the anatomical structures of the outer ear and ear canal secondary to an infectious process. Bacterial etiology is most common, but fungal infection is also possible. Symptoms include erythema, edema, and pain.	external Ear infection;infectious otitis externa;outer Ear infection;otitis externa;swimmer's Ear;swimmer's ear	otitis externa|ear infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; otitis externa|external ear disease|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; otitis externa|external ear disease|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; otitis externa|post-infectious disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; otitis externa|ear infection|inflammatory disease|disease|disposition|material property|experimental factor; otitis externa|ear infection|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor
MONDO:0044919	malignant renal pelvis neoplasm	A primary or metastatic malignant neoplasm that affects the renal pelvis.	malignant renal pelvis neoplasm;malignant tumor of the renal pelvis;malignant neoplasm of the renal pelvis;renal pelvis cancer;malignant neoplasm of renal pelvis;malignant tumor of renal pelvis;malignant renal pelvis tumor;cancer of renal pelvis	malignant renal pelvis neoplasm|kidney cancer|kidney neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant renal pelvis neoplasm|kidney cancer|Malignant Urinary System Neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant renal pelvis neoplasm|renal pelvis neoplasm|kidney neoplasm|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; malignant renal pelvis neoplasm|kidney cancer|kidney neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; malignant renal pelvis neoplasm|renal pelvis neoplasm|kidney neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant renal pelvis neoplasm|kidney cancer|kidney neoplasm|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; malignant renal pelvis neoplasm|kidney cancer|Malignant Urinary System Neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; malignant renal pelvis neoplasm|renal pelvis neoplasm|kidney neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; malignant renal pelvis neoplasm|kidney cancer|Malignant Urinary System Neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0008573	alcoholic liver disease	A disorder caused by damage to the liver parenchyma due to alcohol consumption. It may present with an acute onset or follow a chronic course, leading to cirrhosis.	Alcoholic Liver Diseases;alcoholic liver diseases;alcoholic liver disease	alcoholic liver disease|alcohol-induced disorders|alcohol-related disorders|substance-related disorder|psychiatric disorder|disease|disposition|material property|experimental factor; alcoholic liver disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; alcoholic liver disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor
HP:0012514	Lower limb pain	An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the leg.	Lower limb pain;Leg pain	Lower limb pain|Limb pain|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Lower limb pain|Limb pain|pain|sign or symptom|phenotype|quality|material property|experimental factor; Lower limb pain|Limb pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0012234	Agranulocytosis	Marked decrease in the number of granulocytes.		Agranulocytosis|Granulocytopenia|Abnormal leukocyte morphology|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Agranulocytosis|Granulocytopenia|Abnormal leukocyte morphology|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0002679	cerebral infarction	An ischemic condition of the brain, producing a persistent focal neurological deficit in the area of distribution of the cerebral arteries.	telencephalon brain infarction;cerebral, infarction;infarction, cerebral;cerebral infarction;cerebral infarct;CVA - cerebral infarction;cerebral ischemia;brain infarction of telencephalon	cerebral infarction|brain infarction|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; cerebral infarction|brain infarction|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; cerebral infarction|brain infarction|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0800033	N-acetyl-aspartyl-glutamate (NAAG) measurement	NA		N-acetyl-aspartyl-glutamate (NAAG) measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:16199	urea	NA	Urea;UREA;urea	urea|chemical entity|material entity|experimental factor
EFO:0001408	cervical neck region	NA		cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; cervical neck region|vertebral column structure|postcranial axial skeleton|skeleton|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor
MONDO:0000904	complex cortical dysplasia with other brain malformations	NA	cortical dysplasia, complex, with other brain malformations;CDCBM;complex cortical dysplasia with other brain malformations	complex cortical dysplasia with other brain malformations|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; complex cortical dysplasia with other brain malformations|genetic disorder|disease|disposition|material property|experimental factor; complex cortical dysplasia with other brain malformations|genetic disorder|material entity|experimental factor; complex cortical dysplasia with other brain malformations|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:1001463	gastroenteritis	An inflammatory disorder that affects the upper and lower gastrointestinal tract. Most commonly, this is attributed to viruses; however bacteria, parasites or adverse reactions can also be the culprit. Symptoms include acute diarrhea and vomiting.	cholera morbus;gastroenteritis;inflammation of intestine;intestine inflammation	gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
HP:0001399	Hepatic failure	NA	Liver failure	Hepatic failure|Decreased liver function|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004825	temperament and character inventory	NA		temperament and character inventory|measurement|information entity|experimental factor
MONDO:0005180	Parkinson disease	A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.	Parkinson's disease;paralysis agitans;Parkinson disease	Parkinson disease|synucleinopathy|proteostasis deficiencies|metabolic disease|disease|disposition|material property|experimental factor; Parkinson disease|synucleinopathy|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Parkinson disease|parkinsonian disorder|basal ganglia disease|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Parkinson disease|inherited neurodegenerative disorder|genetic disorder|disease|disposition|material property|experimental factor; Parkinson disease|inherited neurodegenerative disorder|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Parkinson disease|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; Parkinson disease|inborn errors of metabolism|genetic disorder|material entity|experimental factor; Parkinson disease|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; Parkinson disease|inherited neurodegenerative disorder|genetic disorder|material entity|experimental factor
EFO:0003897	stomach neoplasm	A benign or malignant neoplasm involving the stomach.	Neoplasms, Stomach;Stomach Cancer;stomach tumor;gastric neoplasm;Gastric Cancer;Cancers, Stomach;Stomach Neoplasms;Neoplasm, Stomach;Neoplasm, Gastric;STOMACH NEOPL;neoplasm of stomach;neoplasm of the stomach;Gastric Cancers;Cancers, Gastric;NEOPL GASTRIC;stomach neoplasm (disease);Gastric Neoplasm;tumor of stomach;Neoplasms, Gastric;Cancer, Stomach;Gastric Neoplasms;Stomach Cancers;Cancer, Gastric;gastric tumor;Cancer of Stomach;stomach neoplasm;NEOPL STOMACH;tumor of the stomach;Cancer of the Stomach;GASTRIC NEOPL	stomach neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; stomach neoplasm|stomach disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0007822	hair colour measurement	NA		hair colour measurement|hair morphology measurement|measurement|information entity|experimental factor
EFO:0800622	methylmalonate (MMA) measurement	NA		methylmalonate (MMA) measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:132938	ethylmalonate	NA		ethylmalonate|chemical entity|material entity|experimental factor
HP:0001891	Iron deficiency anemia	NA	Iron deficiency anaemia;Iron-deficiency anemia;Iron-deficiency anaemia;Ferropenic	Iron deficiency anemia|Anemia of inadequate production|anemia (phenotype)|Abnormal erythrocyte morphology|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0800175	quinolinate measurement	NA		quinolinate measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0001537	Umbilical hernia	Protrusion of abdominal contents through a defect in the abdominal wall musculature around the umbilicus. Skin and subcutaneous tissue overlie the defect.	Umbilical hernias	Umbilical hernia|Hernia of the abdominal wall|Hernia|Abnormality of connective tissue|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Umbilical hernia|Hernia of the abdominal wall|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0004907	alopecia	Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.	hair loss;loss Of hair;alopecia	alopecia|hair anomaly|epidermal appendage anomaly|material entity|experimental factor; alopecia|hair anomaly|disorder of pilosebaceous unit|integumentary system disease|disease|disposition|material property|experimental factor; alopecia|hair anomaly|epidermal appendage anomaly|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor; alopecia|hair anomaly|epidermal appendage anomaly|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0007987	granulocyte count	NA	blood granulocyte count	granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:1000678	cholesteatoma of middle ear	A non-neoplastic lesion characterized by the proliferation of keratinizing squamous epithelium in the middle ear that results in the accumulation of keratin and cells. It is usually caused by repeated infections. If left untreated, it may increase in size and destroy the adjacent delicate bones of the middle ear.	cholesteatoma of middle ear;Epidermosis of middle ear;cholesteatoma, middle ear;middle ear cholesteatoma;Epidermosis of ear;cholesteatoma of the middle ear;unspecified cholesteatoma (morphologic abnormality);middle ear cholesteatoma (disease);Cholesteatoma of the middle ear;cholesteatoma of middle ear and mastoid;cholesteatoma (disease) of middle ear;Cholesteatoma of middle ear and mastoid;cholesteatoma of middle ear and/or mastoid	cholesteatoma of middle ear|cholesteatoma|keratosis|keratinization disease|integumentary system disease|disease|disposition|material property|experimental factor; cholesteatoma of middle ear|cholesteatoma|keratosis|keratinization disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; cholesteatoma of middle ear|cholesteatoma|keratosis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; cholesteatoma of middle ear|middle ear disorder|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; cholesteatoma of middle ear|middle ear disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor
CHEBI:30089	acetate	NA	acetate	acetate|chemical entity|material entity|experimental factor
EFO:0010112	acetate measurement	NA		acetate measurement|ketone body measurement|measurement|information entity|experimental factor
EFO:1000062	lactose intolerance	NA	LM - lactose malabsorption;lactose intolerance;lactose intolerance (disease)	lactose intolerance|malabsorption syndrome|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; lactose intolerance|inborn carbohydrate metabolic disorder|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; lactose intolerance|inborn carbohydrate metabolic disorder|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; lactose intolerance|inborn carbohydrate metabolic disorder|carbohydrate metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; lactose intolerance|inborn carbohydrate metabolic disorder|inborn errors of metabolism|genetic disorder|material entity|experimental factor; lactose intolerance|nutritional disorder|metabolic disease|disease|disposition|material property|experimental factor
EFO:0009470	soft tissue disease	NA		soft tissue disease|disease|disposition|material property|experimental factor
EFO:0001663	prostate carcinoma	A carcinoma that arises from epithelial cells of the prostate gland.	prostate gland carcinoma;prostate carcinoma;carcinoma of the prostate;carcinoma of prostate gland;carcinoma of prostate	prostate carcinoma|prostate cancer|male reproductive organ cancer|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; prostate carcinoma|prostate cancer|male reproductive organ cancer|male reproductive system neoplasm|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; prostate carcinoma|prostate cancer|male reproductive organ cancer|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; prostate carcinoma|prostate cancer|male reproductive organ cancer|male reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; prostate carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; prostate carcinoma|prostate cancer|male reproductive organ cancer|male reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; prostate carcinoma|prostate cancer|prostate neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; prostate carcinoma|prostate cancer|male reproductive organ cancer|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; prostate carcinoma|prostate cancer|prostate neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; prostate carcinoma|prostate cancer|prostate neoplasm|prostate disease|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; prostate carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
CHEBI:35366	fatty acid	NA	fatty acids;Fatty acid	fatty acid|lipid|chemical entity|material entity|experimental factor; fatty acid|acid|chemical entity|material entity|experimental factor
EFO:0001075	ovarian carcinoma	A malignant neoplasm originating from the surface ovarian epithelium. It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women. It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups. Adenocarcinomas constitute the vast majority of ovarian carcinomas. The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type. The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver. Lung and pleura are the most common sites of extra-abdominal spread. The primary form of therapy is surgical. The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms. --2002	carcinoma of the ovary;EOS;epithelial ovarian cancer;ovarian carcinoma;ovary carcinoma;ovarian cancer;carcinoma of ovary;ovarian epithelial cancer	ovarian carcinoma|malignant epithelial tumor of ovary|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian epithelial tumor|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; ovarian carcinoma|malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:1001176	sensorineural hearing loss	Hearing loss in which the root cause lies in the inner ear or sensory organ (cochlea and associated structures) or the vestibulocochlear nerve (cranial nerve VIII).	Sensorineural Deafness;sensorineural deafness;central hearing loss;Hearing Loss, Central;Sensory hearing loss;High Frequency Hearing Loss;Perceptive deafness [diagnos];Perceptive hearing loss or deafness;sensorineural hearing loss;Perceptive hearing loss;SNHL;sensorineural hearing loss disorder;high-frequency hearing loss;High frequency deafness	sensorineural hearing loss|hearing loss|hearing disorder|perceptual disorders|nervous system disease|disease|disposition|material property|experimental factor; sensorineural hearing loss|hearing loss|hearing disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0044001	hearing loss, mixed conductive-sensorineural	Hearing loss characterized by a combination of conductive and sensorineural hearing loss. It is caused by problems in both the inner ear and middle or outer ear.	mixed conductive and sensorineural deafness;mixed conductive and sensorineural hearing loss;mixed hearing loss	hearing loss, mixed conductive-sensorineural|hearing loss|hearing disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; hearing loss, mixed conductive-sensorineural|hearing loss|hearing disorder|perceptual disorders|nervous system disease|disease|disposition|material property|experimental factor
EFO:0007355	male reproductive organ cancer	A primary or metastatic malignant neoplasm involving the male reproductive system. Representative examples include prostate carcinoma, penile carcinoma, testicular seminoma, and testicular embryonal carcinoma.	male reproductive organ cancer;malignant neoplasm of male genital organ;male genital cancer;malignant tumor of male genital organ;malignant tumor of male reproductive system;malignant tumor of Male reproductive system;malignant Male reproductive system neoplasm;malignant neoplasm of Male reproductive system;malignant tumor of the Male reproductive system;malignant neoplasm of male genital organ or tract;malignant neoplasm of male genital organs;malignant neoplasm of male reproductive organ;malignant male reproductive organ neoplasm;malignant neoplasm of the Male reproductive system;malignant Male reproductive system tumor;cancer of male reproductive organ;malignant neoplasm of male genital organ, site unspecified	male reproductive organ cancer|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; male reproductive organ cancer|male reproductive system neoplasm|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; male reproductive organ cancer|male reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; male reproductive organ cancer|male reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; male reproductive organ cancer|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; male reproductive organ cancer|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0009103	theory of mind measurement	NA		theory of mind measurement|psychological measurement|brain measurement|measurement|information entity|experimental factor
EFO:0009011	Arteritis	An inflammatory process affecting an artery.	arteritis;inflammation of artery;artery inflammation	Arteritis|vasculitis|inflammatory disease|disease|disposition|material property|experimental factor; Arteritis|vasculitis|material entity|experimental factor; Arteritis|vasculitis|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Arteritis|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
CHEBI:133514	2-hydroxyoctanoate	NA	2-hydroxyoctanoate	2-hydroxyoctanoate|lipid|chemical entity|material entity|experimental factor
MONDO:0002050	depressive disorder	A melancholy feeling of sadness and despair.	depression;mental depression	depressive disorder|mood disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; depressive disorder|mood disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0007706	manic or hypomanic episode	NA		manic or hypomanic episode|Behavioral abnormality|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000407	dilated cardiomyopathy	Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure.	DCM;Cardiomyopathy, Dilated, CMD1A;Congestive cardiomyopathy (disorder);Cardiomyopathies, Familial Idiopathic;COCM - Congestive cardiomyopathy;Primary dilated cardiomyopathy;Familial Idiopathic Cardiomyopathy;Cardiomyopathy, Dilated, LMNA;Congestive dilated cardiomyopathy;Dilated Cardiomyopathies;Idiopathic Cardiomyopathies, Familial;Cardiomyopathy, Dilated;Cardiomyopathy, Familial Idiopathic;Cardiomyopathy, Dilated, with Conduction Deffect1;CCM - Congestive cardiomyopathy;Cardiomyopathies, Congestive;dilated cardiomyopathy;primary dilated cardiomyopathy (disorder);Idiopathic Cardiomyopathy, Familial;Familial Idiopathic Cardiomyopathies;Cardiomyopathy, Congestive;Cardiomyopathies, Dilated;DCM - Dilated cardiomyopathy;Congestive Cardiomyopathies;Congestive cardiomyopathy	dilated cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; dilated cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; dilated cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|material entity|experimental factor
EFO:1001418	Salmonella Infections	NA		Salmonella Infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
MONDO:0005041	glaucoma	Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.	glaucoma;glaucoma (disease)	glaucoma|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; glaucoma|eye disease|disorder of visual system|disease|disposition|material property|experimental factor
EFO:0000466	endometrioid carcinoma	An adenocarcinoma characterized by the presence of malignant glandular epithelial cells resembling endometrial cells. It can arise from the uterine body, ovary, fallopian tube, cervix, vagina, and uterine ligament.	endometrioid carcinoma of female reproductive system;endometrioid adenocarcinoma;endometrioid carcinoma;female reproductive endometrioid carcinoma;endometrioid carcinoma of the female reproductive system	endometrioid carcinoma|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrioid carcinoma|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrioid carcinoma|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrioid carcinoma|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrioid carcinoma|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrioid carcinoma|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; endometrioid carcinoma|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; endometrioid carcinoma|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrioid carcinoma|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor
MONDO:0004979	asthma	A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors resulting in recurring periods of wheezing (a whistling sound while breathing), chest tightness, shortness of breath, mucus production and coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, exercise, stress, reflux disease, medications, foods and emotional anxiety.	chronic obstructive asthma with status asthmaticus;bronchial hyperreactivity;chronic obstructive asthma	asthma|bronchial disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0005189	respiratory quotient	NA		respiratory quotient|metabolic rate measurement|measurement|information entity|experimental factor
HP:0000975	Hyperhidrosis	Abnormal excessive perspiration (sweating) despite the lack of appropriate stimuli like hot and humid weather.	Increased sweating;Sweating, increased;Sweating;Diaphoresis;Excessive sweating;Profuse sweating;Sweating profusely	Hyperhidrosis|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0041161	endometrial hyperplasia	A proliferation of the endometrial cells resulting in glandular enlargement and budding. The proliferation may or may not be associated with atypia of the endometrial cells. When the hyperplastic changes are excessive, there is formation of complex epithelial structures (complex endometrial hyperplasia).	hyperplasia of the endometrium;endometrial hyperplasia;hyperplasia of endometrium	endometrial hyperplasia|endometrial disorder|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0007788	BMI-adjusted waist-hip ratio	NA		BMI-adjusted waist-hip ratio|waist-hip ratio|body ratio measurement|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
EFO:0004344	birth weight	NA	birthweight	birth weight|body weight|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
EFO:0003756	autism spectrum disorder	A spectrum of developmental disorders that includes autism, and Asperger syndrome. Signs and symptoms include poor communication skills, defective social interactions, and repetitive behaviors.	autism spectrum disease;Spectrum Disorders, Autism;Pervasive Child Development Disorders;Pervasive Development Disorder;Child Development Disorders, Pervasive;Autism Spectrum Disorders;Disorders, Pervasive Development;pervasive developmental disorders;pervasive developmental disorder - not otherwise specified;Disorders, Autism Spectrum;Development Disorder, Pervasive;Spectrum Disorder, Autism;autism spectrum disorder;autistic spectrum disorder;Disorder, Autism Spectrum;CHILD DEVELOPMENT DIS PERVASIVE;Pervasive Development Disorders;Disorder, Pervasive Development;PERVASIVE CHILD DEVELOPMENT DIS;Development Disorders, Pervasive	autism spectrum disorder|pervasive developmental disorder|complex neurodevelopmental disorder|Neurodevelopmental disorder|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; autism spectrum disorder|pervasive developmental disorder|developmental disorder of mental health|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; autism spectrum disorder|pervasive developmental disorder|developmental disorder of mental health|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:0005407	psychosis	An abnormal condition of the mind that involves a loss of contact with reality. People experiencing psychosis may exhibit personality changes and thought disorder. Depending on its severity, this may be accompanied by unusual or bizarre behavior, as well as difficulty with social interaction and impairment in carrying out daily life activities.	psychosis;psychotic disorder	psychosis|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; psychosis|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:0003895	epistaxis	NA	Nose Bleed;Bleedings, Nasal;Nasal Bleedings;Nosebleed;Bleeding, Nasal;Nose Bleeds;Nasal Bleeding	epistaxis|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; epistaxis|hemorrhage|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0001576	telangiectasis	Local dilatation of small vessels resulting in red discoloration of the skin or mucous membranes.	telangiectasia	telangiectasis|peripheral vascular disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; telangiectasis|vascular ectasia|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
MP:0001914	hemorrhage	NA	haemorrhage;bleeding	hemorrhage|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003914	atherosclerosis	Build-up of fatty material and calcium deposition in the arterial wall resulting in partial or complete occlusion of the arterial lumen.	Atheroscleroses;atherosclerosis of artery;atherosclerosis;atherosclerotic cardiovascular disease;Atherogenesis	atherosclerosis|arteriosclerosis disorder|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; atherosclerosis|arteriosclerosis|arterial occlusive disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0800017	N-acetylglutamine measurement	NA		N-acetylglutamine measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:45441	N-acetyl-L-serine	NA	N-acetylserine	N-acetyl-L-serine|chemical entity|material entity|experimental factor
EFO:0800005	N-acetylglutamate measurement	NA		N-acetylglutamate measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:40410	N-acetylglycine	NA	N-acetylglycine;(acetylamino)acetic acid	N-acetylglycine|chemical entity|material entity|experimental factor
CHEBI:17786	N-acetyl-L-leucine	NA	N-Acetyl-L-leucine;N-acetyl-L-leucine;(2S)-2-(acetylamino)-4-methylpentanoic acid;N-acetylleucine	N-acetyl-L-leucine|chemical entity|material entity|experimental factor
EFO:0021427	N-acetylmethionine measurement	Quantification of N-acetylmethionine levels in a sample.		N-acetylmethionine measurement|methionine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:0800117	N-acetylvaline measurement	NA		N-acetylvaline measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800556	2-butenoylglycine measurement	NA		2-butenoylglycine measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:84056	N-acetylisoleucine	NA	N-acetylisoleucine	N-acetylisoleucine|chemical entity|material entity|experimental factor
EFO:0800020	N-acetylthreonine measurement	NA		N-acetylthreonine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1001189	spermatocele	A benign testicular cyst that is located in the epididymis, and which contains serous fluid, lymphocytes, spermatozoa, and debris.	Spermatocele (disorder);Spermatocele;spermatocele	spermatocele|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
HP:0001094	Iridocyclitis	A type of anterior uveitis, in which there is Inflammation of the iris and the ciliary body.		Iridocyclitis|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Iridocyclitis|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0006862	Meniere disease	A disease of the inner ear (labyrinth) that is characterized by fluctuating sensorineural hearing loss; tinnitus; episodic vertigo; and aural fullness. It is the most common form of endolymphatic hydrops.	Mnire's vertigo;Meniere disease;Meniere's disease;otogenic vertigo	Meniere disease|endolymphatic hydrops|peripheral vertigo|vestibular disease|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; Meniere disease|head and neck disorder|disease|disposition|material property|experimental factor; Meniere disease|endolymphatic hydrops|peripheral vertigo|vestibular disease|inner ear disease|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; Meniere disease|genetic otorhinolaryngologic disease|genetic disorder|disease|disposition|material property|experimental factor; Meniere disease|inherited auditory system disease|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; Meniere disease|genetic otorhinolaryngologic disease|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; Meniere disease|inherited auditory system disease|genetic disorder|material entity|experimental factor; Meniere disease|endolymphatic hydrops|peripheral vertigo|vestibular disease|perceptual disorders|nervous system disease|disease|disposition|material property|experimental factor; Meniere disease|endolymphatic hydrops|peripheral vertigo|vestibular disease|inner ear disease|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; Meniere disease|genetic otorhinolaryngologic disease|genetic disorder|material entity|experimental factor; Meniere disease|inherited auditory system disease|genetic disorder|disease|disposition|material property|experimental factor
EFO:0001379	endocrine system disease	A disease involving the endocrine system.	Endocrine Diseases;Unspecified endocrine disorder;endocrine system disease;Endocrine disturbance NOS;disease of endocrine system;Endocrine System Disorder;Hormone disturbance;Hormone disturbance NOS;endocrine system disorder;Endocrine disturbance;endocrine system disease or disorder;thyroid or other glandular disorders;endocrine disease;Disorder of endocrine system;endocrine disorder;ENDOCRINE DISORDERS;disorder of endocrine system;ENDOCRINE SYSTEM DIS;Disease of endocrine gland;Endocrine Diseases and Manifestations;Hormone disorders;ENDOCRINE DIS;Endocrine disorder NOS (disorder);Disease, Endocrine;Endocrine disturbance NOS (disorder);Disease, Endocrine System;Disorder of endocrine gland;Endocrinopathy, NOS;Endocrinopathy;Hormone abnormality (finding);System Disease, Endocrine;Disorder of endocrine system (disorder);Endocrine disease;disease or disorder of endocrine system;Endocrine disorder;Diseases of Endocrine System;Hormone abnormality;Endocrine gland disease NOS;ENDOCRINE DISORDER NOS;Endocrine gland disease NOS (disorder);Diseases, Endocrine;DIS ENDOCRINE SYSTEM;Endocrine System Diseases;endocrinopathy;System Diseases, Endocrine;Diseases, Endocrine System	endocrine system disease|disease|disposition|material property|experimental factor
EFO:1001067	nutritional deficiency disease	A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories. (From Dorland, 27th ed; Stedman, 25th ed)	malnutrition;nutritional deficiency disease;malnourished	nutritional deficiency disease|nutritional disorder|metabolic disease|disease|disposition|material property|experimental factor
EFO:0000729	ulcerative colitis	An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.	Other ulcerative colitis (disorder);ulcerative colitis (disorder);UC;UC - ulcerative colitis;Ulcerative colitis, unspecified;Left-sided ulcerative colitis;ulcerative colitis;Left-sided ulcerative (chronic) colitis;ULCERATVE COLITIS UNSPCF;colitis ulcerative;ulcerative colitis (disease);Other ulcerative colitis;Colitis, Ulcerative	ulcerative colitis|colitis|inflammatory bowel disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; ulcerative colitis|colitis|inflammatory bowel disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; ulcerative colitis|colitis|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; ulcerative colitis|colitis|inflammatory bowel disease|genetic disorder|disease|disposition|material property|experimental factor; ulcerative colitis|colitis|inflammatory bowel disease|genetic disorder|material entity|experimental factor; ulcerative colitis|colitis|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; ulcerative colitis|colitis|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
MONDO:0008903	lung cancer	A malignant neoplasm involving the lung.	adenocarcinoma of lung, somatic;malignant lung neoplasm;malignant lung tumor;malignant neoplasm of lung;nonsmall cell lung cancer, somatic;nonsmall cell lung cancer, susceptibility to, autosomal dominant, somatic mutation;adenocarcinoma of lung, response to tyrosine kinase inhibitor in, autosomal dominant, somatic mutation;lung cancer, protection against, autosomal dominant, somatic mutation;nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, autosomal dominant, somatic mutation;lung cancer;lung cancer, somatic;malignant tumor of the lung;malignant tumor of lung;malignant neoplasm of the lung;lung cancer, resistance to, autosomal dominant, somatic mutation;lung cancer, susceptibility to, autosomal dominant, somatic mutation;cancer of lung	lung cancer|lung neoplasm|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; lung cancer|lung neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lung cancer|lung neoplasm|respiratory system neoplasm|respiratory system disease|disease|disposition|material property|experimental factor; lung cancer|respiratory system cancer|respiratory system disease|disease|disposition|material property|experimental factor; lung cancer|respiratory system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lung cancer|lung neoplasm|respiratory system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lung cancer|thoracic cancer|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lung cancer|thoracic cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0003780	Behcet's syndrome	A chronic, relapsing, multisystemic vasculitis characterized by mucocutaneous lesions, as well as articular, vascular, ocular and central nervous system manifestations.	Morbus Behet's syndrome;Behcet syndrome;Behet disease;Bechet syndrome;Behcet disease;Behet's syndrome (disorder);silk road disease;Behcet's syndrome;Behet's syndrome;Triple-Symptom Complex;BEHCET DIS;Behet syndrome;Behet's syndrome;Adamantiades-Behcet disease;Behcet's disease;Behet-Adamantiades syndrome;Behcet Disease;Behcets Syndrome;triple symptom complex	Behcet's syndrome|epilepsy|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Behcet's syndrome|skin vascular disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; Behcet's syndrome|syndromic disease|disease|disposition|material property|experimental factor; Behcet's syndrome|syndromic disease|material entity|experimental factor; Behcet's syndrome|skin vascular disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Behcet's syndrome|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; Behcet's syndrome|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor
EFO:1000908	duodenal obstruction	NA	Duodenal Obstruction	duodenal obstruction|Gastrointestinal obstruction|Functional abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0002757	Recurrent fractures	The repeated occurrence of bone fractures (implying an abnormally increased tendency for fracture).	Increased fractures;Varying degree of multiple fractures;Multiple fractures;Recurrent fractures;Multiple spontaneous fractures;Frequent fractures;Increased fracture rate	Recurrent fractures|Increased susceptibility to fractures|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0020982	encounter with health service for adjustment and management of implanted device	NA		encounter with health service for adjustment and management of implanted device|encounter with health service|event|process|experimental factor
EFO:0008582	thrombin activatable fibrinolysis inhibitor activation peptide measurement	NA	carboxypeptidase B2 measurement;TAFI activation peptide levels;TAFI-AP levels	thrombin activatable fibrinolysis inhibitor activation peptide measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor; thrombin activatable fibrinolysis inhibitor activation peptide measurement|coagulation factor measurement|measurement|information entity|experimental factor; thrombin activatable fibrinolysis inhibitor activation peptide measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0003777	heart disease	A disease involving the heart and/or pericardium.	Cardiac Disease;heart disorder;heart/pericardial trouble;heart/pericardial disease;Cardiac Diseases;Diseases, Heart;disorder of heart/pericardium;heart trouble;Diseases, Cardiac;HEART DIS;Disease, Heart;disease or disorder of heart;heart disease;heart/pericardial disorder;disorder of heart;Heart Diseases;heart disease or disorder;Disease, Cardiac;CARDIAC DIS;heart/pericardial disease or disorder;disease of heart;cardiac disease	heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0004255	nephrotic syndrome	A collection of symptoms that include severe edema, proteinuria, and hypoalbuminemia; it is indicative of renal dysfunction.	syndromes, nephrotic;nephrotic syndrome;nephrotic syndromes;syndrome, nephrotic;nephrotic syndrome (acquired)	nephrotic syndrome|syndromic disease|disease|disposition|material property|experimental factor; nephrotic syndrome|nephrosis|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; nephrotic syndrome|syndromic disease|material entity|experimental factor
MONDO:0004567	ileus	Decrease in peristalsis in the absence of a mechanical bowel obstruction.	ileus of intestine	ileus|intestinal obstruction|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0000713	subarachnoid hemorrhage	Intracranial hemorrhage into the subarachnoid space.	Hemorrhages, Intracranial Subarachnoid;Hemorrhage, Aneurysmal Subarachnoid;SAH (Subarachnoid Hemorrhage);Subarachnoid Hemorrhages, Intracranial;Aneurysmal Subarachnoid Hemorrhages;Spontaneous Subarachnoid Hemorrhage;Subarachnoid Hemorrhage, Aneurysmal;Subarachnoid Hemorrhage, Spontaneous;SAH - Subarachnoid hemorrhage;Hemorrhage, Spontaneous Subarachnoid;Hemorrhages, Aneurysmal Subarachnoid;Subarachnoid Hemorrhage, Intracranial;Hemorrhages, Spontaneous Subarachnoid;Hemorrhage, Perinatal Subarachnoid;Spontaneous Subarachnoid Hemorrhages;Intracranial Subarachnoid Hemorrhage;Subarachnoid Hemorrhages, Spontaneous;Subarachnoid Hemorrhages;Subarachnoid haemorrhage NOS;Subarachnoid hemorrhage NOS (disorder);subarachnoid hemorrhage;SAH;Subarachnoid Hemorrhages, Perinatal;Subarachnoid Hemorrhages, Aneurysmal;Subarachnoid aneurysmal hemorrhage;Perinatal Subarachnoid Hemorrhages;Subarachnoid haemorrhage;SAH - Subarachnoid haemorrhage;SAHs (Subarachnoid Hemorrhage);Perinatal Subarachnoid Hemorrhage;Subarachnoid hemorrhage NOS;Aneurysmal Subarachnoid Hemorrhage;Hemorrhages, Subarachnoid;Hemorrhage, Intracranial Subarachnoid;Hemorrhage, Subarachnoid;Hemorrhages, Perinatal Subarachnoid;Intracranial Subarachnoid Hemorrhages;subarachnoid hemorrhage (disease);Subarachnoid Hemorrhage, Perinatal;Subarachnoid hemorrhage (disorder)	subarachnoid hemorrhage|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; subarachnoid hemorrhage|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; subarachnoid hemorrhage|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor
HP:0004348	Abnormality of bone mineral density	This term applies to all changes in bone mineral density which (depending on severity) can be seen on x-rays as a change in density and or structure of the bone. Changes may affect all bones of the organism, just certain bones or only parts of bones and include decreased mineralisation as may be seen in osteoporosis or increased mineralisation and or ossification as in osteopetrosis, exostoses or any kind of atopic calicfications of different origin and distribution. The overall amount of mineralization of the bone-organ can be measured as the amount of matter per cubic centimeter of bones, usually measured by densitometry of the lumbar spine or hip. The measurements are usually reported as g/cm3 or as a Z-score (the number of standard deviations above or below the mean for the patient's age and sex). Note that measurement with this method does not reflect local changes in other bones, and as such might not be correct with regard the hole bone-organ.	Abnormality of bone mineralisation and ossification	Abnormality of bone mineral density|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000474	epilepsy	A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions.	Epileptic attack;Other forms of epilepsy and recurrent seizures;Epilepsy (disorder);Generalized seizure (finding);Other forms of epilepsy NOS;Epileptic seizure (finding);Epilectic attack, NOS;Other forms of epilepsy;EF - Epileptic fit;[X]Other epilepsy;Generalized seizure;Epileptic seizures, NOS;EPILEP NOS W/O INTR EPIL;EP - Epilepsy;Generalised convulsion;Epilepsy and recurrent seizures;Epilepsy NOS;Epileptic seizures;Generalised fit;Epileptic convulsions, NOS;Other forms of epilepsy (disorder);Epileptic attack, NOS;Other forms of epilepsy NOS (disorder);Generalised seizure;Generalized fit;Epileptic fits, NOS;EPILEPSY NOS W INTR EPIL;Generalized convulsion;Epileptic;Epileptic disorder, NOS;Epileptic fit;Epilepsy, unspecified, with intractable epilepsy;seizure disorder;Seizure disorder (disorder);EPILEPSY NEC W INTR EPIL;Epileptic Seizure;Epileptic fits;epilepsy;Other forms of epilepsy, with intractable epilepsy;Epilepsy, unspecified, without mention of intractable epilepsy;Seizure disorder;Other forms of epilepsy, without mention of intractable epilepsy;Epilepsy, unspecified;[X]Other epilepsy (disorder);EPILEP NEC W/O INTR EPIL;Epileptic convulsions;Epilepsy NOS (disorder);Epileptic disorder;Epilepsy, NOS	epilepsy|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0005773	retinal detachment	An eye emergency condition which may lead to blindness if left untreated. It is characterized by the separation of the inner retina layers from the underlying pigment epithelium. Causes include trauma, advanced diabetes mellitus, high myopia, and choroid tumors. Symptoms include sudden appearance of floaters, sudden light flushes, and blurred vision.	retinal detachment;detached retina;retina, detached	retinal detachment|genetic disorder|material entity|experimental factor; retinal detachment|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; retinal detachment|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; retinal detachment|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; retinal detachment|genetic disorder|disease|disposition|material property|experimental factor
EFO:0000465	endocarditis	Inflammation of the endocardium.	Endocarditis, NOS;endocarditis;acute endocarditis, unspecified;Endocarditis, Infective;Endocarditis (disorder);acute Endocarditis;endocarditis (disease);Endocarditis NOS;endocardium inflammation;Infective Endocarditides;acute endocarditis NOS (disorder);acute endocarditis (disorder);non-infective endocarditis;Endocarditides;Endocarditides, Infective;inflammation of endocardium;Infective Endocarditis	endocarditis|endocardium disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; endocarditis|inflammation of heart layer|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; endocarditis|inflammation of heart layer|inflammatory disease|disease|disposition|material property|experimental factor
MONDO:0002312	opportunistic mycosis	A mycosis that arises from infection in an immunologically compromised host.	opportunistic mycoses	opportunistic mycosis|material entity|experimental factor; opportunistic mycosis|fungal infectious disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0007940	chronic venous insufficiency	NA		chronic venous insufficiency|Abnormal venous morphology|Abnormality of cardiovascular system morphology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; chronic venous insufficiency|Abnormal venous morphology|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1000720	keratosis	A skin disorder consisting of hypertrophy of the stratum corneum of the skin.	keratosis;keratoderma	keratosis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; keratosis|keratinization disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; keratosis|keratinization disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0000373	congestive heart failure	Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.	cardiac failure, congestive;CHF - Congestive heart failure;Cardiac Failure;Cardiac Failure Congestive;Myocardial Failure;failure, congestive heart;Heart Decompensation;CCF - Congestive cardiac failure;Congestive heart failure, unspecified;congestive heart disease;Congestive cardiac failure;Decompensation, Heart;weak heart;CHF NOS;CHF;Congetive cardiac failure;Congestive heart failure (disorder);heart failure, congestive;Heart Failure, Congestive;FAILURE, CONGESTIVE HEART;congestive heart failure;Congestive heart disease	congestive heart failure|heart failure|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0003144	heart failure	Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction.	Weak heart;heart failure;cardiac dysfunction;cardiac insufficiency;Heart: [weak] or [failure NOS];Heart failure (disorder);cardiac failure;Heart failure NOS;insufficiency, Cardiac;Heart failure NOS (disorder);failure, heart;Heart failure, unspecified	heart failure|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0010451	aconitate measurement	NA		aconitate measurement|carboxylic acid anion measurement|organic anion measurement|measurement|information entity|experimental factor
EFO:0007236	diffuse idiopathic skeletal hyperostosis	This syndrome is characterized by the association of ankylosing vertebral hyperostosis with hyperkeratosis of the soles and palms.	Hyperostosis, Diffuse Idiopathic Skeletal;Forestier's disease;disseminated idiopathic skeletal hyperostosis;DISH;diffuse idiopathic skeletal hyperostosis;Ankylosing vertebral hyperostosis;Disseminated idiopathic skeletal hyperostosis (disorder);ankylosing vertebral hyperostosis;dish	diffuse idiopathic skeletal hyperostosis|dysostosis of genetic origin|dysostosis|bone development disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; diffuse idiopathic skeletal hyperostosis|hyperostosis|bone remodeling disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; diffuse idiopathic skeletal hyperostosis|idiopathic disease|material entity|experimental factor; diffuse idiopathic skeletal hyperostosis|dysostosis of genetic origin|genetic disorder|disease|disposition|material property|experimental factor; diffuse idiopathic skeletal hyperostosis|dysostosis of genetic origin|dysostosis|material entity|experimental factor; diffuse idiopathic skeletal hyperostosis|dysostosis of genetic origin|dysostosis|bone development disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; diffuse idiopathic skeletal hyperostosis|dysostosis of genetic origin|genetic disorder|material entity|experimental factor; diffuse idiopathic skeletal hyperostosis|idiopathic disease|disease|disposition|material property|experimental factor
MONDO:0000916	intestinal infectious disease	An infectious disease involving a pathogenic inflammatory response in the intestinal mucosa.	bacterial enteritis	intestinal infectious disease|digestive system infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; intestinal infectious disease|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; intestinal infectious disease|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor
CHEBI:17268	myo-inositol	NA	myo-Inositol;myo-inositol	myo-inositol|chemical entity|material entity|experimental factor
EFO:0004342	waist circumference	NA		waist circumference|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
MONDO:0000468	third-degree atrioventricular block	A disorder characterized by an electrocardiographic finding of complete failure of atrial electrical impulse conduction to the ventricles. This is manifested on the ECG by disassociation of atrial and ventricular rhythms. The atrial rate must be faster than the ventricular rate. (CDISC)	complete AV block;non-congenital complete atrioventricular block;atrioventricular block complete;complete heart block;third degree atrioventricular block;third degree AV block;complete atrioventricular block;atrioventricular block, third degree;AV block third degree	third-degree atrioventricular block|atrioventricular block|atrioventricular dissociation|genetic disorder|material entity|experimental factor; third-degree atrioventricular block|atrioventricular block|heart conduction disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; third-degree atrioventricular block|atrioventricular block|atrioventricular dissociation|genetic disorder|disease|disposition|material property|experimental factor; third-degree atrioventricular block|genetic cardiac rhythm disease|cardiac rhythm disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; third-degree atrioventricular block|genetic cardiac rhythm disease|genetic disorder|disease|disposition|material property|experimental factor; third-degree atrioventricular block|genetic cardiac rhythm disease|genetic disorder|material entity|experimental factor
EFO:0003854	postmenopausal osteoporosis	Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.	Osteoporosis, Postmenopausal;Bone Loss, Postmenopausal;Postmenopausal Osteoporoses;postmenopausal osteoporosis;Osteoporosis, Post Menopausal;Osteoporosis, Post-Menopausal;Bone Losses, Postmenopausal;Osteoporoses, Postmenopausal;Post-Menopausal Osteoporosis;Perimenopausal Bone Loss;Perimenopausal Bone Losses;Bone Losses, Perimenopausal;Postmenopausal Bone Loss;Postmenopausal Bone Losses;Post-Menopausal Osteoporoses;Osteoporoses, Post-Menopausal;Bone Loss, Perimenopausal	postmenopausal osteoporosis|osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|skeletal dysplasia|genetic disorder|material entity|experimental factor; postmenopausal osteoporosis|osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|osteogenesis imperfecta|osteochondrodysplasia|bone development disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; postmenopausal osteoporosis|osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|skeletal dysplasia|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; postmenopausal osteoporosis|osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|skeletal dysplasia|genetic disorder|disease|disposition|material property|experimental factor; postmenopausal osteoporosis|osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|osteogenesis imperfecta|osteochondrodysplasia|bone development disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; postmenopausal osteoporosis|osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|osteogenesis imperfecta|genetic disorder|material entity|experimental factor; postmenopausal osteoporosis|osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|osteogenesis imperfecta|genetic disorder|disease|disposition|material property|experimental factor; postmenopausal osteoporosis|osteoporosis|bone resorption disease|bone remodeling disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0010339	FVC change measurement	NA	forced vital capacity change meaurement	FVC change measurement|pulmonary function measurement|measurement|information entity|experimental factor; FVC change measurement|respiratory disease biomarker|measurement|information entity|experimental factor
EFO:0002609	juvenile idiopathic arthritis	Juvenile idiopathic arthritis (JIA) is the term used to describe a group of inflammatory articular disorders of unknown cause that begin before the age of 16 and last over 6 weeks. The term juvenile idiopathic arthritis was chosen to signify the absence of any known mechanism underlying the disorder and to highlight the necessity of excluding other types of arthritis occurring in well defined diseases (in particular arthritis occurring in association with infectious, inflammatory and haematooncologic diseases).	Juvenile idiopathic arthritis (disorder);Juvenile rheumatoid arthritis (disorder);juvenile idiopathic arthritis;Juvenile chronic arthritis (disorder);arthritis, juvenile rheumatoid;JIA;Juvenile rheumatoid a.;Juvenile Rheumatoid Arthritis;chronic childhood arthritis;juvenile rheumatoid arthritis;rheumatoid arthritis, systemic juvenile, susceptibility to;breast myoepithelial carcinoma;Juvenile rheumatoid arthritis NOS (disorder);Juvenile idiopathic arthritis;Juvenile seropositive polyarthritis;Juvenile rheumatoid arthritis, NOS;juvenile arthritis;Arthritis (juvenile idiopathic)	juvenile idiopathic arthritis|idiopathic disease|material entity|experimental factor; juvenile idiopathic arthritis|chronic disease|disease|disposition|material property|experimental factor; juvenile idiopathic arthritis|arthritis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; juvenile idiopathic arthritis|arthritis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; juvenile idiopathic arthritis|arthritis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; juvenile idiopathic arthritis|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; juvenile idiopathic arthritis|idiopathic disease|disease|disposition|material property|experimental factor; juvenile idiopathic arthritis|arthritis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; juvenile idiopathic arthritis|arthritis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0004705	hypothyroidism	Abnormally low levels of thyroid hormone.	thyroid insufficiency;underactive thyroid;hypothyroidism;thyroid deficiency	hypothyroidism|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0003035	cellulitis	Inflammation of the dermis and subcutaneous tissues caused by a bacterial infection. Symptoms include erythema, edema, and pain to the affected area.	Other cellulitis and abscess;cellulitis;cellulitis (disease)	cellulitis|skin disease caused by bacterial infection|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; cellulitis|skin disease caused by bacterial infection|skin disorder caused by infection|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; cellulitis|skin disease caused by bacterial infection|skin disorder caused by infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; cellulitis|vesiculobullous skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
Orphanet:79161	Disorder of carbohydrate metabolism	NA		
HP:0032190	Abnormal meniscus morphology	Abnormal structure of the meniscus of the knee, two crescent shape fibrocartilaginous pads that disperse the weight of the body and reduce friction of the knee joint during movement.		Abnormal meniscus morphology|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Abnormal meniscus morphology|Abnormality of the lower limb|Abnormality of limbs|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0001859	algoneurodystrophy	NA		algoneurodystrophy|complex regional pain syndrome|chronic pain syndrome|neurological pain disorder|nervous system disease|disease|disposition|material property|experimental factor; algoneurodystrophy|complex regional pain syndrome|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0005055	QRS duration	NA	QRS interval	QRS duration|temporal measurement|measurement|information entity|experimental factor; QRS duration|electrocardiography|heart function measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
MONDO:0003182	anterior horn disorder	Anterior horn disease is one of a number of medical disorders affecting the anterior horn of the spinal cord. Anterior horn diseases include spinal muscular atrophy, poliomyelitis and amyotrophic lateral sclerosis.	ventral horn of spinal cord disease;disease or disorder of ventral horn of spinal cord;disease of ventral horn of spinal cord;ventral horn of spinal cord disease or disorder;disorder of ventral horn of spinal cord	anterior horn disorder|spinal cord disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009959	diverticular disease	NA		diverticular disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0005763	pulse pressure measurement	NA		pulse pressure measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
EFO:0008560	female infertility	Diminished or absent ability of a female to achieve conception.	female infertility;female reproductive system infertility disorder;female reproductive system infertility;infertility disorder of female reproductive system	female infertility|infertility|reproductive system disease|disease|disposition|material property|experimental factor; female infertility|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
HP:0100790	Hernia	NA		Hernia|Abnormality of connective tissue|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0000023	Inguinal hernia	Protrusion of the contents of the abdominal cavity through the inguinal canal.		Inguinal hernia|Hernia of the abdominal wall|Hernia|Abnormality of connective tissue|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Inguinal hernia|Hernia of the abdominal wall|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0001343	impaired renal function disease	Any disease in which the causes of the disease is a perturbation of the kidney leading to its dysfunction.	renal dysfunction	impaired renal function disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:1000999	joint disease	Any disorder of the joints.	ankylosis of joint of forearm;Joint ankylosis of the ankle and/or foot;arthropathy;disorder, Joint;ankylosis of joint of ankle and/or foot;skeletal joint disease or disorder;joint disorder;skeletal joint disease;ankylosis of joint of lower leg;Joint disorder;ankylosis of joint of upper arm;disorder of skeletal joint;ankylosis of joint of hand;disorder, joint;disease of skeletal joint;disease or disorder of skeletal joint	joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
MONDO:0002907	intracranial thrombosis	Formation or presence of a blood clot (thrombus) in a blood vessel within the skull. Intracranial thrombosis can lead to thrombotic occlusions and brain infarction. The majority of the thrombotic occlusions are associated with atherosclerosis.	cerebral thrombosis	intracranial thrombosis|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; intracranial thrombosis|thrombotic disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; intracranial thrombosis|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; intracranial thrombosis|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0000778	anthrax infection	An infection caused by Bacillus anthracis bacteria. It may affect the lungs, gastrointestinal tract, or skin. Patients with lung infection present with fever, headaches, cough, chest pain and shortness of breath. Patients with gastrointestinal infection present with nausea, vomiting and bloody diarrhea. Patients with skin infection develop blisters and ulcers.	anthrax infection;Anthrax (disorder);Anthrax, unspecified;anthrax;Other specified anthrax manifestations (disorder);anthrax disease;Infection due to Bacillus anthracis;Anthrax NOS (disorder);Bacillus anthracis disease or disorder;Bacillus anthracis caused disease or disorder;Charbon;OTHER ANTHRAX MANIFEST;[X]Anthrax, unspecified;[X]Anthrax, unspecified (disorder);Anthrax NOS;Other specified manifestations of anthrax;Other specified anthrax manifestations;Milzbrand;Splenic fever;Bacillus anthracis infectious disease	anthrax infection|primary Bacillaceae infectious disease|gram-positive bacterial infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; anthrax infection|primary bacterial infectious disease|material entity|experimental factor; anthrax infection|primary bacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:1000991	intracranial embolism	Blocking of a blood vessel in the skull by an embolus which can be a blood clot (thrombus) or other undissolved material in the blood stream. Most emboli are of cardiac origin and are associated with heart diseases. Other non-cardiac sources of emboli are usually associated with vascular diseases.	Cerebral embolism with cerebral infarction;cerebral embolism with cerebral infarction;cerebral embolism;intracranial embolism;Intracranial Embolism	intracranial embolism|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; intracranial embolism|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; intracranial embolism|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
MONDO:0020354	coloboma of choroid and retina	Coloboma of choroid and retina is a rare, genetic developmental defect during embryogenesis characterized by the partial absence of retinal pigment epithelium and choroid, most frequently located in the inferonasal quadrant. Patients usually present reduced vision and have an increased risk for retinal detachment. Other ocular anomalies (e.g. coloboma of iris, microcornea, nystagmus, strabismus, microphthalmos) are usually associated, however it may also be isolated.		coloboma of choroid and retina|coloboma, ocular, autosomal dominant|coloboma|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; coloboma of choroid and retina|coloboma, ocular, autosomal dominant|coloboma|eye disease|disorder of visual system|disease|disposition|material property|experimental factor
HP:0100633	Esophagitis	Inflammation of the esophagus.	Oesophagitis;Inflammation of the oesophagus;Inflammation of the esophagus	Esophagitis|Gastrointestinal inflammation|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Esophagitis|esophageal disease|upper digestive tract disorder|disease|disposition|material property|experimental factor; Esophagitis|esophageal disease|digestive system disease|disease|disposition|material property|experimental factor; Esophagitis|Abnormal esophagus morphology|Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Esophagitis|Gastrointestinal inflammation|Functional abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007406	oral candidiasis	Infection of the mucosal lining of the mouth with the fungus Candida albicans.	candidiasis of mouth;thrush (disorder);Thrush, oral;Candidiasis of mouth;Candidiasis of mouth (disorder);Candidiasis, Oral;oral candidiasis;oral moniliasis;mouth candidiasis;thrush, oral;Oral moniliasis;thrush	oral candidiasis|candidiasis|opportunistic mycosis|fungal infectious disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; oral candidiasis|candidiasis|opportunistic mycosis|material entity|experimental factor; oral candidiasis|mouth disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0004718	vascular dementia	A degenerative vascular disorder affecting the brain. It is caused by the blockage of the blood supply to the brain. It is manifested with decline of memory and cognitive functions.	vascular dementia;Vascular Dementias;Dementias, Vascular;Arteriosclerotic Dementias	vascular dementia|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; vascular dementia|dementia|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; vascular dementia|dementia|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; vascular dementia|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; vascular dementia|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009570	tympanic membrane disease	A disease involving the tympanic membrane.	disease or disorder of tympanic membrane;disease of tympanic membrane;tympanic membrane disorder;tympanic membrane disease;tympanic membrane disease or disorder;disorder of tympanic membrane	tympanic membrane disease|middle ear disorder|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; tympanic membrane disease|middle ear disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0000631	bone benign neoplasm	A neoplasm that arises from the bone or articular cartilage and does not invade adjacent tissues or metastasize to other anatomic sites.	benign neoplasm of bone;benign tumor of bone;benign neoplasm of the bone;benign tumor of the bone;benign osseous tumor;bone tissue benign neoplasm;benign bone neoplasm;benign osseous neoplasm;benign bone tumor	bone benign neoplasm|bone neoplasm|material entity|experimental factor; bone benign neoplasm|bone neoplasm|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; bone benign neoplasm|bone neoplasm|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bone benign neoplasm|bone neoplasm|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; bone benign neoplasm|benign connective and soft tissue neoplasm|musculoskeletal system benign neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bone benign neoplasm|benign connective and soft tissue neoplasm|connective and soft tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bone benign neoplasm|benign connective and soft tissue neoplasm|musculoskeletal system benign neoplasm|musculoskeletal system disease|disease|disposition|material property|experimental factor; bone benign neoplasm|benign connective and soft tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor
EFO:0004273	scoliosis	A congenital or acquired spinal deformity characterized by lateral curvature of the spine.	scoliosis	scoliosis|disease of bone structure|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:1000989	intestinal volvulus	NA	intestinal volvulus (disorder);Twist of intestine, bowel, or colon;Volvulus;Intestinal Volvulus;Volvulus NOS (disorder);Volvulus (& [torsion of bowel])	intestinal volvulus|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; intestinal volvulus|Gastrointestinal obstruction|Functional abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0001422	cirrhosis of liver	A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.	Liver Fibrosis;Liver Cirrhoses;Fibrosis, Liver;Cirrhosis, Hepatic;Cirrhosis of liver without mention of alcohol;CL - Cirrhosis of liver;Liver Fibroses;Fibroses, Liver;Cirrhoses, Liver;Cirrhosis, Liver;Hepatic Cirrhoses;Cirrhosis of liver NOS (disorder);Cirrhosis of liver NOS;Hepatic cirrhosis, NOS;cirrhosis;Cirrhosis of liver, NOS;cirrhosis of liver;Hepatic cirrhosis;liver cirrhosis;Cirrhosis of liver (disorder);Cirrhoses, Hepatic	cirrhosis of liver|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; cirrhosis of liver|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; cirrhosis of liver|fibrosis|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0002258	pharyngitis	Inflammation of the throat most often caused by viral and bacterial infections. Other causes include allergens, chemical substances, and trauma.	Sore throat;inflamed throat;throat inflammation;inflammation of throat	pharyngitis|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; pharyngitis|inflammatory disease|disease|disposition|material property|experimental factor
HP:0004755	Supraventricular tachycardia	Supraventricular tachycardia (SVT) is an abnormally increased heart rate (over 100 beats per minute at rest) with origin above the level of the ventricles.	Supraventricular tachyarrhythmia;SVT	Supraventricular tachycardia|Tachycardia|Ventricular arrhythmia|Abnormality of cardiovascular system electrophysiology|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Supraventricular tachycardia|cardiac arrhythmia|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:1000088	Appendix Adenocarcinoma	A carcinoma that arises from glandular epithelial cells of the vermiform appendix.	appendix adenocarcinoma;adenocarcinoma of the appendix;appendiceal adenocarcinoma;vermiform appendix adenocarcinoma;adenocarcinoma of appendix	Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|cecal neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|appendiceal neoplasm|cecal neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|appendiceal neoplasm|cecal neoplasm|cecal disorder|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|cecal neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|Digestive System Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|epithelial tumor of colon|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|cecal neoplasm|cecal disorder|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|epithelial tumor of colon|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|epithelial tumor of colon|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|cecal neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|Digestive System Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|appendiceal neoplasm|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|appendiceal neoplasm|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|appendiceal neoplasm|cecal neoplasm|cecal disorder|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|appendiceal neoplasm|cecal neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|appendiceal neoplasm|disorder of appendix|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|appendiceal neoplasm|disorder of appendix|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|appendiceal neoplasm|cecal neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|epithelial tumor of colon|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|appendiceal neoplasm|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|epithelial tumor of colon|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|appendiceal neoplasm|cecal neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|material entity|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|cecal neoplasm|cecal disorder|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|cecal neoplasm|cecal disorder|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|epithelial tumor of the appendix|appendiceal neoplasm|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|Digestive System Carcinoma|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|colon adenocarcinoma|colorectal adenocarcinoma|colorectal carcinoma|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|cecum adenocarcinoma|cecum carcinoma|colon carcinoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|appendix cancer|cecum cancer|malignant colon neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Appendix Adenocarcinoma|appendix carcinoma|cecum carcinoma|colon carcinoma|colorectal carcinoma|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:1001223	ulcerative proctosigmoiditis	Inflammation of the rectum and the distal portion of the colon.	ulcerative (chronic) proctosigmoiditis;Proctocolitis;chronic ulcerative rectosigmoiditis (disorder);Proctosigmoiditis (disorder);ulcerative proctosigmoiditis;proctosigmoiditis	ulcerative proctosigmoiditis|inflammatory bowel disease|genetic disorder|disease|disposition|material property|experimental factor; ulcerative proctosigmoiditis|inflammatory bowel disease|genetic disorder|material entity|experimental factor; ulcerative proctosigmoiditis|inflammatory bowel disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; ulcerative proctosigmoiditis|inflammatory bowel disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
MONDO:0005277	migraine disorder	A common, severe type of vascular headache often associated with increased sympathetic activity, resulting in nausea, vomiting, and light sensitivity.	migraine variant;migraine headache;migraine with or without aura;migraine;migraine disorder	migraine disorder|hypnic headache|material entity|experimental factor; migraine disorder|hypnic headache|headache disorder|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; migraine disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; migraine disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; migraine disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; migraine disorder|hypnic headache|headache disorder|neurological pain disorder|nervous system disease|disease|disposition|material property|experimental factor
EFO:1001449	Vertebrobasilar insufficiency	Localized or diffuse reduction in blood flow through the vertebrobasilar arterial system, which supplies the brain stem; cerebellum; occipital lobe; medial temporal lobe; and thalamus. Characteristic clinical features include syncope; lightheadedness; visual disturbances; and vertigo. brain stem infarctions or other brain infarction may be associated.	vertebrobasilar insufficiency;vertebrobasilar arterial insufficiency;vertebrobasilar artery syndrome;vertebro-basilar insufficiency	Vertebrobasilar insufficiency|brain infarction|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; Vertebrobasilar insufficiency|vascular insufficiency disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Vertebrobasilar insufficiency|brain infarction|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Vertebrobasilar insufficiency|brain infarction|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0001060	celiac disease	An autoimmune genetic disorder with an unknown pattern of inheritance that primarily affects the digestive tract. It is caused by intolerance to dietary gluten. Consumption of gluten protein triggers an immune response which damages small intestinal villi and prevents adequate absorption of nutrients. Clinical signs include abdominal cramping, diarrhea or constipation and weight loss. If untreated, the clinical course may progress to malnutrition, anemia, osteoporosis and an increased risk of intestinal malignancies. However, the prognosis is favorable with successful avoidance of gluten in the diet.	Enteropathies, Gluten;Enteropathy, Gluten-Sensitive;idiopathic steatorrhea;Enteropathy, Gluten;celiac disease;gluten intolerance;Coeliac rickets;Gluten-responsive sprue;Gluten-Induced Enteropathy;Sprue, Celiac;Gluten Sensitive Enteropathy;Coeliac disease [Ambiguous];CD - Coeliac disease;GSE - Gluten-sensitive enteropathy;Gluten-induced enteropathy syndrome;CD - Celiac disease;Gluten-Sensitive Enteropathy;Celiac disease NOS (disorder);Non-tropical sprue;Celiac disease NOS;Celiac Sprue;Celiac disease (disorder);Sprue;Celiac syndrome;Wheat-sensitive enteropathy;Celiac rickets;Sprue, Nontropical;Celiac rickets (disorder);Enteropathies, Gluten-Sensitive;CELIAC DIS;CS - Coeliac sprue;Idiopathic steatorrhoea;Idiopathic steatorrhea;gluten-induced enteropathy;Gluten Enteropathies;Gluten-Sensitive Enteropathies;coeliac disease;Coeliac syndrome;CS - Celiac sprue;Gluten enteropathy;Non Tropical Sprue;Steatorrhoea - idiopathic;Nontropical Sprue;Coeliac disease;celiac sprue;Coeliac disease NOS;non tropical sprue;Disease, Celiac;Coeliac sprue	celiac disease|genetic disorder|material entity|experimental factor; celiac disease|autoimmune disorder of gastrointestinal tract|digestive system disease|disease|disposition|material property|experimental factor; celiac disease|malabsorption syndrome|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; celiac disease|small intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; celiac disease|genetic disorder|disease|disposition|material property|experimental factor; celiac disease|autoimmune disorder of gastrointestinal tract|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor
EFO:0009616	finger fracture	NA		finger fracture|upper extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor; finger fracture|upper extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
HP:0004401	Meconium ileus	Obstruction of the intestine due to abnormally thick meconium.	Meconium ileus in neonates	Meconium ileus|Gastrointestinal obstruction|Functional abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Meconium ileus|Gastrointestinal dysmotility|Abnormal gastrointestinal motility|Functional abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Meconium ileus|Abnormal intestine morphology|Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004607	duodenal ulcer	An ulcer in the duodenal wall.	duodenal ulcer;duodenal ulcer (disease);curling's ulcers;stress Ulcer;curling Ulcer	duodenal ulcer|peptic ulcer disease|ulcer disease|injury|disease|disposition|material property|experimental factor; duodenal ulcer|peptic ulcer disease|digestive system disease|disease|disposition|material property|experimental factor; duodenal ulcer|duodenal disorder|small intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
HP:0032408	Breast mass	A breast lump is any discrete mass in a breast noticed by the patient, significant other, or physician.	Breast lump	Breast mass|Abnormality of the breast|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0001069	nutritional disorder	Any condition related to a disturbance between proper intake and utilization of nourishment.	nutritional disorder;Nutritional disease;Nutritional Disorders;Disorder of nutrition;Nutritional disorder (disorder);Nutritional disorder, NOS;Nutrition disorder;NUTRITION DIS;Nutritional disease, NOS;Malnutrition;nutrition disease;NUTRITIONAL DIS;Nutrition Disorders	nutritional disorder|metabolic disease|disease|disposition|material property|experimental factor
MONDO:0002462	glomerulonephritis	A renal disorder characterized by damage in the glomeruli. It may be acute or chronic, focal or diffuse, and it may lead to renal failure. Causes include autoimmune disorders, infections, diabetes, and malignancies.	glomerulonephritis;glomerulonephritis (disease);renal glomerulus nephritis;nephritis of renal glomerulus;glomerular nephritis	glomerulonephritis|nephritis|inflammatory disease|disease|disposition|material property|experimental factor; glomerulonephritis|nephritis|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; glomerulonephritis|glomerular disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; glomerulonephritis|glomerular disease|material entity|experimental factor
MONDO:0004917	internal hordeolum	A hordeolum that results from infection of a meibomian gland.	internal hordeolum;tarsal gland hordeolum;hordeolum of tarsal gland	internal hordeolum|hordeolum|eye infectious disorder|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; internal hordeolum|hordeolum|skin disease caused by bacterial infection|skin disorder caused by infection|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; internal hordeolum|sebaceous gland disease|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor; internal hordeolum|hordeolum|Staphylococcus aureus infection|staphylococcal skin infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; internal hordeolum|sebaceous gland disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; internal hordeolum|hordeolum|blepharitis|eyelid disease|eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; internal hordeolum|hordeolum|eye infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; internal hordeolum|hordeolum|skin disease caused by bacterial infection|skin disorder caused by infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; internal hordeolum|sebaceous gland disease|disorder of pilosebaceous unit|integumentary system disease|disease|disposition|material property|experimental factor; internal hordeolum|hordeolum|blepharitis|eyelid disease|eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; internal hordeolum|hordeolum|eye infectious disorder|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; internal hordeolum|hordeolum|blepharitis|inflammatory disease|disease|disposition|material property|experimental factor; internal hordeolum|hordeolum|skin disease caused by bacterial infection|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
MONDO:0003890	infiltrating bladder urothelial carcinoma	An invasive transitional cell carcinoma that arises from the urinary bladder urothelium.	invasive bladder urothelial carcinoma;infiltrating transitional cell carcinoma of the urinary bladder;infiltrating bladder urothelial carcinoma;invasive transitional cell carcinoma of the urinary bladder;invasive bladder transitional cell carcinoma	infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urinary bladder carcinoma|urinary bladder cancer|bladder tumor|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urinary bladder carcinoma|urinary bladder cancer|Malignant Urinary System Neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urinary bladder carcinoma|urinary bladder cancer|bladder tumor|bladder disease|urinary system disease|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urothelial carcinoma|urothelial neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|infiltrating urothelial carcinoma|urothelial neoplasm|transitional cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urinary bladder carcinoma|urinary bladder cancer|bladder tumor|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|infiltrating urothelial carcinoma|Malignant Urinary System Neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urinary bladder carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urothelial carcinoma|Malignant Urinary System Neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|infiltrating urothelial carcinoma|invasive carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urothelial carcinoma|Transitional Cell Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|infiltrating urothelial carcinoma|Malignant Urinary System Neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urothelial carcinoma|Malignant Urinary System Neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urinary bladder carcinoma|urinary bladder cancer|Malignant Urinary System Neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|infiltrating urothelial carcinoma|Malignant Urinary System Neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urothelial carcinoma|urothelial neoplasm|transitional cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urinary bladder carcinoma|urinary bladder cancer|Malignant Urinary System Neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|infiltrating urothelial carcinoma|urothelial neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|infiltrating urothelial carcinoma|urothelial neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urothelial carcinoma|urothelial neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urinary bladder carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urothelial carcinoma|Malignant Urinary System Neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|infiltrating urothelial carcinoma|invasive carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; infiltrating bladder urothelial carcinoma|bladder transitional cell carcinoma|urothelial carcinoma|Transitional Cell Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0003869	breast neoplasm	A benign or malignant neoplasm of the breast parenchyma. It can originate from the ducts, lobules or the breast adipose tissue. Breast neoplasms are much more common in females than males.	Breast Tumors;neoplasm of breast;Mammary Neoplasm, Human;NEOPL BREAST;Neoplasm, Human Mammary;Human Mammary Neoplasms;Human Mammary Neoplasm;BREAST NEOPL;Tumors, Breast;breast neoplasm;Neoplasms, Breast;Breast Neoplasms;Neoplasm, Breast;neoplasm of the breast;Neoplasms, Human Mammary;Tumor, Breast;Breast Tumor;neoplasm, breast;tumor of the breast;breast neoplasm (disease);breast tumor;Mammary Neoplasms, Human;tumor of breast	breast neoplasm|integumentary system disease|disease|disposition|material property|experimental factor; breast neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast neoplasm|breast disease|disease|disposition|material property|experimental factor
HP:0000072	Hydroureter	The distention of the ureter with urine.	Swelling of ureter;Dilated ureter;Megaureter;Wide ureter;Ureteral dilatation	Hydroureter|Abnormality of the ureter|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0002239	Gastrointestinal hemorrhage	Hemorrhage affecting the gastrointestinal tract.	GI hemorrhage;Gastrointestinal bleeding;GI haemorrhage;Gastrointestinal haemorrhage	Gastrointestinal hemorrhage|Abnormality of blood circulation|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Gastrointestinal hemorrhage|Abnormal bleeding|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Gastrointestinal hemorrhage|hemorrhage|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Gastrointestinal hemorrhage|Functional abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:18186	tyrosine	NA	Tyrosine;tyrosine	tyrosine|amino acid|acid|chemical entity|material entity|experimental factor
HP:0002938	Lumbar hyperlordosis	An abnormal accentuation of the inward curvature of the spine in the lumbar region.	Excessive inward curvature of lower spine;Prominent lumbar lordosis;Exaggerated lumbar lordosis;Lumbar lordosis;Increased lumbar lordosis	Lumbar hyperlordosis|Abnormality of the vertebral column|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009511	abnormal PAP smear	NA	abnormal smear (cervix);abnormal PAP test	abnormal PAP smear|test result|information entity|experimental factor
MONDO:0007079	alcohol dependence	Physical and psychological dependence on alcohol.	alcohol dependence;alcohol dependence, susceptibility to;alcoholism	alcohol dependence|drug dependence|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; alcohol dependence|alcohol-related disorders|substance-related disorder|psychiatric disorder|disease|disposition|material property|experimental factor; alcohol dependence|drug dependence|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; alcohol dependence|drug dependence|substance dependence|substance-related disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:0003770	diabetic retinopathy	A chronic, pathological complication associated with diabetes mellitus, where retinal damages are incurred due to microaneurysms in the vasculature of the retina, progressively leading to abnormal blood vessel growth, and swelling and leaking of fluid from blood vessels, resulting in vision loss or blindness.	diabetic retinopathy;retinal abnormality - diabetes-related;Retinopathies, Diabetic;Diabetic Retinopathies;Retinopathy, Diabetic	diabetic retinopathy|metabolic disease|disease|disposition|material property|experimental factor; diabetic retinopathy|retinal vascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; diabetic retinopathy|retinal vascular disorder|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; diabetic retinopathy|diabetic eye disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; diabetic retinopathy|retinal vascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; diabetic retinopathy|retinal vascular disorder|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; diabetic retinopathy|diabetic eye disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; diabetic retinopathy|retinal vascular disorder|ocular vascular disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; diabetic retinopathy|retinal vascular disorder|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; diabetic retinopathy|retinal vascular disorder|ocular vascular disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; diabetic retinopathy|retinal vascular disorder|ocular vascular disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0004502	adiponectin measurement	NA	adiponectin levels	adiponectin measurement|hormone measurement|measurement|information entity|experimental factor; adiponectin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0000540	immune system disease	A disorder resulting from an abnormality in the immune system.	[X]Disorder involving the immune mechanism, unspecified (disorder);immune disorder;Immunodeficiency and Immunosuppression Disorders;Other specified disorders involving the immune mechanism;IMMUNE MECHANISM DIS NOS;immune system disease or disorder;Disorder of the immune mechanism NOS (disorder);immune system disorder;Unspecified disorder of immune mechanism;[X]Disorder involving the immune mechanism, unspecified;Other specified disorders of the immune mechanism;disease of immune system;IMMUNE MECHANISM DIS NEC;autoimmune diseases;disease or disorder of immune system;Immune System and Related Disorders;Immunodeficiency with predominant T-cell defect, unspecified;Other specified disorders of the immune mechanism (disorder);Other deficiency of cell-mediated immunity;DEFIC CELL IMMUNITY NOS;immune disease;disorder of immune system;AUTOIMMUNE DISEASE NEC;Deficiency of cell-mediated immunity;Disorder of the immune mechanism NOS;Autoimmune disease, not elsewhere classified;IMMUNDEF T-CELL DEF NOS;Disorders involving the immune mechanism;immune dysfunction	immune system disease|disease|disposition|material property|experimental factor
HP:0011848	Abdominal colic	NA		Abdominal colic|Abdominal pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Abdominal colic|Abdominal pain|Abdominal symptom|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Abdominal colic|Abdominal pain|pain|sign or symptom|phenotype|quality|material property|experimental factor
EFO:0005769	calcium metabolic disease	Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.	Calcium Metabolism Disorders;calcium metabolic disorder;calcium metabolism disorder;disorder of calcium metabolism;calcium metabolism disease;calcium metabolic disease	calcium metabolic disease|mineral metabolism disease|metabolic disease|disease|disposition|material property|experimental factor
EFO:0009556	mineral metabolism disease	NA	mineral metabolism disease;disorder of mineral metabolism;disease of mineral metabolism	mineral metabolism disease|metabolic disease|disease|disposition|material property|experimental factor
EFO:0003948	gastroesophageal reflux disease	A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.	Esophageal Reflux;Gastro-Esophageal Reflux;Gastro oesophageal Reflux;GERD - gastro-esophageal reflux disease;gastro-esophageal reflux;Reflux, Gastro-Esophageal;Gastroesophageal Reflux;Reflux, Gastroesophageal;gastroesophageal reflux disease;acid reflux;gastroesophageal reflux;Gastresophageal reflux;reflux;GERD;GASTROESOPHAGEAL REFLUX DIS;Reflux, Gastro-oesophageal;Gastro-oesophageal Reflux;Gastro Esophageal Reflux	gastroesophageal reflux disease|stomach disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; gastroesophageal reflux disease|esophageal disease|digestive system disease|disease|disposition|material property|experimental factor; gastroesophageal reflux disease|esophageal disease|upper digestive tract disorder|disease|disposition|material property|experimental factor; gastroesophageal reflux disease|genetic disorder|material entity|experimental factor; gastroesophageal reflux disease|genetic disorder|disease|disposition|material property|experimental factor
EFO:0007405	optic neuritis	Optic neuritis is inflammation of the optic nerve, the nerve that carries the visual signal from the eye to the brain.The conditionmay cause sudden, reduced vision in the affected eye(s). While the cause of optic neuritis is unknown, it has been associated with autoimmune diseases, infections, multiple sclerosis, drug toxicity and deficiency of vitamin B-12. Vision often returns to normal within 2-3 weeks without treatment. In some cases, corticosteroids are given to speed recovery. If known, the underlying cause should be treated.	Optic Neuritis;optic neuritis	optic neuritis|encephalomyelitis|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; optic neuritis|optic nerve disorder|disorder of visual system|disease|disposition|material property|experimental factor; optic neuritis|encephalomyelitis|inflammatory disease|disease|disposition|material property|experimental factor; optic neuritis|optic nerve disorder|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; optic neuritis|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; optic neuritis|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; optic neuritis|optic nerve disorder|cranial nerve neuropathy|nervous system disease|disease|disposition|material property|experimental factor
EFO:0001380	hypopituitarism	A condition of diminution or cessation of secretion of one or more hormones from the anterior pituitary gland. This may result from surgical or radiation ablation, non-secretory pituitary neoplasms, metastatic tumors, infarction, pituitary apoplexy, infiltrative or granulomatous processes, and other conditions.	Anterior Pituitary Hyposecretion Syndrome;Simmond's Disease;Pituitary hypofunction;Hypopituitarism, NOS;SIMMONDS DIS;Hypopituitarism (disorder);pituitary hormone deficiency;Simmonds' Disease;Hypopituitarism NOS (disorder);Postpartum Pituitary Insufficiency;Hyposecretion, Adenohypophyseal;Deficient secretion of one OR more pituitary hormones;HYPOSECRET ADENOHYPOPHYSEAL;Adenohypophyseal Hyposecretion;Hypopituitarism NOS;Hyposecretion Syndrome, Anterior Pituitary;Simmonds Disease;Postpartum Hypopituitarism;Hypopituitarism, Postpartum;Insufficiency, Pituitary;ANTERIOR PITUITARY HYPOSECRET SYNDROME;Pituitary insufficiency, NOS;Pituitary Insufficiency, Postpartum;Disease, Simmonds;Hypopituitarism: [NOS] or [Sheehan's syndrome] or [Simmond's disease] or [Panhypopituitarism];Pituitary insufficiency;hypopituitarism;pituitary insufficiency;Pituitary failure;HYPOSECRET SYNDROME ANTERIOR PITUITARY;ADENOHYPOPHYSEAL HYPOSECRET	hypopituitarism|pituitary gland disease|neuroendocrine disorder|nervous system disease|disease|disposition|material property|experimental factor; hypopituitarism|pituitary gland disease|neuroendocrine disorder|endocrine system disease|disease|disposition|material property|experimental factor; hypopituitarism|pituitary gland disease|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0010681	ileostomy	NA	ileostomy operation;ileostomy procedure	ileostomy|digestive system surgery|medical procedure|experimental process|planned process|process|experimental factor
MONDO:0001858	Tietze syndrome	Idiopathic painful nonsuppurative swellings of one or more costal cartilages, especially of the second rib. The anterior chest pain may mimic that of coronary artery disease.	costochondral junction syndrome;costochondral joint syndromic disease;Tietze's syndrome;Costochondritis;Costalchondritis;Tietze syndrome;Tietze's disease;syndromic disease of costochondral joint;slipping rib syndrome	Tietze syndrome|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; Tietze syndrome|syndromic disease|material entity|experimental factor; Tietze syndrome|syndromic disease|disease|disposition|material property|experimental factor
EFO:0007261	epiglottitis	Inflammation of the epiglottis.	acute epiglottitis with obstruction (disorder);Epiglottitis (disorder);epiglottitis;acute epiglottitis and supraglottitis;Epiglottitis;mucosa of epiglottis inflammation;acute epiglottitis without obstruction;acute epiglottitis without obstruction (disorder);acute epiglottitis (disorder);supraglottitis;inflammation of mucosa of epiglottis;acute epiglottitis NOS (disorder);acute epiglottitis without mention of obstruction;acute epiglottitis with obstruction;acute epiglottitis	epiglottitis|disorder of pharynx|respiratory system disease|disease|disposition|material property|experimental factor; epiglottitis|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; epiglottitis|inflammatory disease|disease|disposition|material property|experimental factor; epiglottitis|disorder of pharynx|otorhinolaryngologic disease|disease|disposition|material property|experimental factor
MONDO:0002635	periodontal disorder	An inflammatory process of the gingival tissues and/or periodontal membrane of the teeth, resulting in an abnormally deep gingival sulcus, possibly producing periodontal pockets and loss of alveolar bone support.	periodontal disorder;disease or disorder of periodontium;disorder of periodontium;periodontium disorder;periodontal disease;periodontium disease or disorder;disease of supporting structures of teeth;disease of periodontium;periodontium disease	periodontal disorder|tooth disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; periodontal disorder|tooth disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:1000034	indeterminate colitis	It describes patients in whom a diagnosis of ulcerative colitis or Crohn's disease cannot be made based on standard clinical testing, including colonoscopy, imaging, laboratory tests, and biopsy.	colitis of indeterminate type;indeterminate colitis	indeterminate colitis|colitis|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; indeterminate colitis|colitis|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; indeterminate colitis|colitis|inflammatory bowel disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; indeterminate colitis|colitis|inflammatory bowel disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; indeterminate colitis|colitis|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; indeterminate colitis|colitis|inflammatory bowel disease|genetic disorder|disease|disposition|material property|experimental factor; indeterminate colitis|colitis|inflammatory bowel disease|genetic disorder|material entity|experimental factor
EFO:0004259	osteonecrosis	A none disease characterized by death of bone tissue due to a lack of blood supply.	bone necrosis;avascular necrosis of bone;ischemic bone disease;aseptic necrosis;osteonecrosis;aseptic necrosis of bone	osteonecrosis|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteonecrosis|material entity|experimental factor
MONDO:0018076	tuberculosis	A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial infection, latent or dormant infection, and recrudescent or adult-type TB. Ninety to 95% of primary TB infections may go unrecognized. Histopathologically, tissue lesions consist of granulomas which usually undergo central caseation necrosis. Local symptoms of TB vary according to the part affected; acute symptoms include hectic fever, sweats, and emaciation; serious complications include granulomatous erosion of pulmonary bronchi associated with hemoptysis. If untreated, progressive TB may be associated with a high degree of mortality. This infection is frequently observed in immunocompromised individuals with AIDS or a history of illicit IV drug use.	tuberculosis disease	tuberculosis|primary bacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; tuberculosis|mycobacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; tuberculosis|primary bacterial infectious disease|material entity|experimental factor
EFO:0004326	heart rate	NA	pulse rate;cardiac chronotropy	heart rate|heart function measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor; heart rate|vital signs|measurement|information entity|experimental factor
EFO:1000833	balanitis	An infectious or non-infectious inflammatory process that affects the glans penis. Symptoms include redness and pain of the glans penis and foreskin and discharge.	Balanitis [Ambiguous];inflammation of glans penis;glans penis inflammation;Balanitis (disorder);balanitis;Balanitis	balanitis|inflammatory disease|disease|disposition|material property|experimental factor; balanitis|penile disorder|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0800781	X-17438 measurement	NA		X-17438 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009454	gastric ulcer	An ulcerated lesion in the mucosal surface of the stomach. It may progress to involve the deeper layers of the gastric wall.	peptic ulcer disease of stomach;gastric ulcer (disease);gastric ulcer;stomach peptic ulcer;stomach peptic ulcer disease	gastric ulcer|peptic ulcer disease|ulcer disease|injury|disease|disposition|material property|experimental factor; gastric ulcer|peptic ulcer disease|digestive system disease|disease|disposition|material property|experimental factor; gastric ulcer|stomach disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; gastric ulcer|Peptic ulcer|Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0001493	chronic pulmonary heart disease	Heart disease which occurs as a result of a primary pulmonary disease. Cor pulmonale most often manifests as right ventricular hypertrophy; it can also lead to right ventricular failure.		chronic pulmonary heart disease|cor pulmonale|congestive heart failure|heart failure|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0007167	Bell's palsy	Partial or complete paralysis of the facial muscles of one side of a person's face. It is caused by damage to the seventh cranial nerve. It is usually temporary but it may recur.	palsy of facial nerve;Bell's (facial) palsy;Bell Palsy;facial nerve paralysis;facial nerve palsy;nerve paralysis, Facial;paralysis Of Facial nerve;Bell's palsy;Bell palsy	Bell's palsy|facial nerve disease|cranial nerve neuropathy|nervous system disease|disease|disposition|material property|experimental factor; Bell's palsy|facial paralysis|palsy|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Bell's palsy|cranial nerve palsy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Bell's palsy|facial nerve disease|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Bell's palsy|cranial nerve palsy|cranial nerve neuropathy|nervous system disease|disease|disposition|material property|experimental factor
EFO:0004280	movement disorder	Neurological conditions resulting in abnormal voluntary or involuntary movement, which may impact the speed, fluency, quality and ease of movement.	tardive dyskinesia;movement disorders;movement disorder;movement disease	movement disorder|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009557	mitral valve disease	A disease involving the mitral valve.	disease of mitral valve;disease or disorder of mitral valve;mitral valve disease or disorder;mitral valve disorder;mitral valve disease;mitral RH valve dis.;chronic rheumatic mitral valve;disorder of mitral valve	mitral valve disease|heart valve disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0005319	contact dermatitis	An inflammatory skin condition caused by direct contact between the skin and either an irritating substance or an allergen.	contact dermatitis/eczema;dermatitis, venenata;contact dermatitis;dermatitis venenata	contact dermatitis|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; contact dermatitis|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; contact dermatitis|allergic disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor
EFO:1001904	oral mucositis	NA	oral mucosal injury;oral mucosa irritation;stomatitis;oral mucosal damage;inflammation of the mouth;oral cavity mucosal damage;oral mucosal lesions	oral mucositis|mucositis|inflammation|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009453	hemiplegia	Severe or complete loss of motor function on one side of the body. This condition is usually caused by brain diseases that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, brain stem lesions; cervical spinal cord diseases; peripheral nervous system diseases; and other conditions may manifest as hemiplegia. The term hemiparesis (see paresis) refers to mild to moderate weakness involving one side of the body.	postnatal infantile hemiplegia;infantile hemiplegia;hemiplegia	hemiplegia|palsy|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:1001986	connective tissue disease	A disease involving the connective tissue.	disease of connective tissues;connective tissue diseases;Connective Tissue Disorders;connective tissue disease or disorder;disease, connective tissue;connective tissue disorder;tissue disease, connective;primary disorder of connective tissue;Connective Tissue Disorder;disease or disorder of connective tissue;disease of connective tissue;disorder of connective tissue;connective tissue disorders;connective tissue disease	connective tissue disease|disease|disposition|material property|experimental factor
EFO:0007128	actinomycosis	Actinomycosis is a chronic bacterial infection that commonly affects the face and neck. It is usually caused by an anaerobic bacteria called Actinomyces israelii. Actinomyces are normal inhabitants of the mouth, gastrointestinal tract, and female genital tract, and do not cause an infection unless there is a break in the skin or mucosa. The infection usually occurs in the face and neck, but can sometimes occur in the chest, abdomen, pelvis, or other areas of the body. The infection is not contagious.	actinomycotic madura foot;Actinomycotic mycetoma of foot;Actinomycotic mycetema;Actinomyces infection;actinomycosis;actinomycotic infection;Actinomycosis;Actinomycotic madura foot (disorder);actinomycotic mycetema;actinomycotic mycetoma of foot;Madura foot due to Actinomadura;Madura foot due to Actinomadura (disorder)	actinomycosis|material entity|experimental factor; actinomycosis|primary Actinomycetales infectious disease|anaerobic bacteria infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; actinomycosis|primary Actinomycetales infectious disease|gram-positive bacterial infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; actinomycosis|commensal bacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
MONDO:0021682	viral sexually transmitted disease	Viral diseases which are potentially transmitted or propagated by sexual conduct.	viral sexually transmitted disease	viral sexually transmitted disease|sexually transmitted disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; viral sexually transmitted disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; viral sexually transmitted disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0800069	N-formylanthranilic acid measurement	NA		N-formylanthranilic acid measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800884	X-24455 measurement	NA		X-24455 measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0008419	Intervertebral disc degeneration	The presence of degenerative changes of intervertebral disk.	Degenerative intervertebral disk;Degeneration of intervertebral discs;Degenerative disc disease;Degenerative intervertebral disc;Degeneration of intervertebral disks	Intervertebral disc degeneration|Abnormality of the vertebral column|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0016259	carcinosarcoma of the corpus uteri	An aggressive malignant mixed epithelial and mesenchymal tumor that arises from the uterine corpus. It usually affects elderly postmenopausal women and presents with vaginal bleeding. It is characterized by the presence of a malignant epithelial component that is usually glandular and a sarcomatous component.	carcinosarcoma of uterine body;uterine malignant mixed mesodermal neoplasm;carcinosarcoma of uterus;uterine corpus malignant mixed Mllerian neoplasm;carcinosarcoma of corpus uteri;malignant mixed mesodermal tumor of uterine corpus;uterine mixed Mllerian sarcoma;mixed Mullerian cancer of corpus uteri;mixed Mllerian sarcoma of uterus;uterine corpus malignant mixed mesodermal neoplasm;malignant mixed mesodermal tumor of uterus;malignant mixed mesodermal tumor of the uterus;uterine corpus malignant mixed Mullerian neoplasm;corpus uteri malignant mixed mesodermal tumor;carcinosarcoma of the uterine corpus;uterine mixed Mullerian sarcoma;carcinosarcoma of the uterine body;uterine corpus malignant mixed Mullerian tumor;uterine body malignant mixed mesodermal neoplasm;carcinosarcoma of the corpus uteri;uterine corpus carcinosarcoma;mixed Mullerian sarcoma of uterus;malignant mixed mesodermal tumor of uterine body;mixed Mullerian sarcoma of the uterus;malignant mixed mesodermal neoplasm of the uterine body;uterine body carcinosarcoma;malignant mixed mesodermal tumor of the uterine corpus;mixed Mllerian cancer of corpus uteri;malignant mixed Mllerian tumor of the corpus uteri;malignant mixed mesodermal neoplasm of uterus;uterine body malignant mixed mesodermal tumor;malignant mixed mesodermal tumor of the uterine body;uterine corpus malignant mixed Mllerian tumor;uterine corpus malignant mixed mesodermal (Mllerian) tumor;body of uterus carcinosarcoma;malignant mixed mesodermal neoplasm of the uterus;uterine corpus malignant mixed mesodermal tumor;malignant mixed mesodermal neoplasm of the uterine corpus;uterine malignant mixed mesodermal tumor;carcinosarcoma of uterine corpus;uterine corpus malignant mixed mesodermal (Mullerian) tumor;malignant mixed mesodermal neoplasm of uterine body;mixed Mllerian sarcoma of the uterus;malignant mixed Mullerian tumor of the corpus uteri;malignant mixed mesodermal neoplasm of uterine corpus	carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|uterine cancer|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|Malignant Mixed Neoplasm|mixed neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|uterine cancer|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|carcinosarcoma|Malignant Mixed Neoplasm|mixed neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|Malignant Mixed Neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus mixed epithelial and mesenchymal neoplasm|corpus uteri neoplasm|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus mixed epithelial and mesenchymal neoplasm|corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|uterine cancer|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|carcinosarcoma|Malignant Mixed Neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus mixed epithelial and mesenchymal neoplasm|corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus mixed epithelial and mesenchymal neoplasm|mixed neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|uterine cancer|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|corpus uteri neoplasm|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus mixed epithelial and mesenchymal neoplasm|corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|Uterine Carcinosarcoma|uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinosarcoma of the corpus uteri|uterine body mixed cancer|uterine corpus cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0000706	spondyloarthropathy	A group of inflammatory rheumatic diseases associated with arthritis and enthesitis, and often involving the axial skeleton. The most common form of spondyloarthritis is ankylosing spondylitis. Other forms include axial spondyloarthritis, peripheral spondyloarthritis, reactive arthritis, psoriatic arthritis/spondylitis and enteropathic arthritis/spondylitis.	Spondylarthrosis NOS;Disorder of joint of spine;Spondarthropathy;SPONDYLOS NOS W/O MYELOP;Unspecified joint disorder of other specified sites;JOINT DIS NOS-OTH JT;Spondylarthrosis;OA - Osteoarthritis of spine;Spondylarthropathy;spondyloarthritis;Spondylosis;Disorder of joint of spine (disorder);spondarthropathy;Spondylarthrosis, NOS;Osteoarthritis of spine;spondyloarthropathy;Spondylosis (disorder);spondylarthrosis;Spondylarthropathies;Spondyloarthropathy (disorder);OA - Osteoarthritis of the spine;seronegative spondyloarthropathy;Spondylosis, NOS;Spondylosis of unspecified site without mention of myelopathy	spondyloarthropathy|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; spondyloarthropathy|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; spondyloarthropathy|immune system disease|disease|disposition|material property|experimental factor; spondyloarthropathy|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
HP:0000938	Osteopenia	Osteopenia is a term to define bone density that is not normal but also not as low as osteoporosis. By definition from the World Health Organization osteopenia is defined by bone densitometry as a T score -1 to -2.5.	Generalised osteopenia;Generalized osteopenia;Osteopaenia	Osteopenia|Reduced bone mineral density|Abnormality of bone mineral density|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009520	contraception	NA	contraceptive management	contraception|medical procedure|experimental process|planned process|process|experimental factor
EFO:0004308	leukocyte count	NA	WBC;white cell count;white blood cell count	leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
HP:0011706	Second degree atrioventricular block	An intermittent atrioventricular block with failure of some atrial impulses to conduct to the ventricles, i.e., some but not all atrial impulses are conducted through the atrioventricular node and trigger ventricular contraction.		Second degree atrioventricular block|Abnormality of cardiovascular system electrophysiology|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0100309	Subdural hemorrhage	Hemorrhage occurring between the dura mater and the arachnoid mater.	Subdural haematoma;Subdural haemorrhage;Subdural hematoma	Subdural hemorrhage|intracranial hemorrhage|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; Subdural hemorrhage|Abnormality of blood circulation|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Subdural hemorrhage|intracranial hemorrhage|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Subdural hemorrhage|Abnormal cerebral vascular morphology|Abnormality of brain morphology|Morphological central nervous system abnormality|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Subdural hemorrhage|Abnormal bleeding|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Subdural hemorrhage|intracranial hemorrhage|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Subdural hemorrhage|Abnormal cerebral vascular morphology|Abnormality of cardiovascular system morphology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Subdural hemorrhage|Abnormal cerebral vascular morphology|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003833	brain neoplasm	A neoplasm (disease) that involves the brain.	Neoplasms, Intracranial;brain neoplasms;neoplasm of brain;Brain Tumor;Tumor, Brain;Neoplasm, Brain;brain neoplasm (disease);tumor of the Brain;NEOPL INTRACRANIAL;Tumors, Brain;Brain Neoplasms;Recurrent Brain Tumor;Brain Tumors, Recurrent;neoplasm of the brain;Brain Tumors;brain neoplasm;Neoplasms, Brain;Recurrent Brain Tumors;Neoplasm, Intracranial;Intracranial Neoplasms;Intracranial Neoplasm;NEOPL BRAIN;brain tumor;tumor of brain;INTRACRANIAL NEOPL;PRIMARY BRAIN NEOPL;Brain Tumor, Recurrent	brain neoplasm|Central Nervous System Neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; brain neoplasm|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; brain neoplasm|Central Nervous System Neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; brain neoplasm|Central Nervous System Neoplasm|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0018309	Hirschsprung disease	Hirschsprung disease (HSCR) is a congenital intestinal motility disorder that is characterized by signs of intestinal obstruction due to the presence of an aganglionic segment of variable extent in the terminal part of the colon.	Hirschsprung disease susceptibility;aganglionic megacolon;Hirschsprung's disease;congenital megacolon;congenital intestinal aganglionosis;pelvirectal achalasia;Hirschsprung disease;HSCR	Hirschsprung disease|genetic disorder|material entity|experimental factor; Hirschsprung disease|intestinal motility disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Hirschsprung disease|neurocristopathy|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; Hirschsprung disease|genetic disorder|disease|disposition|material property|experimental factor
EFO:0021250	X-11537 measurement	NA		X-11537 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1000049	pulmonary tuberculosis	A bacterial infection that affects the lungs and is caused by Mycobacterium tuberculosis. Most patients with tuberculosis do not have symptoms (latent tuberculosis) and are not contagious. When signs and symptoms occur (active tuberculosis), patients become contagious. The signs and symptoms include chronic cough with blood-tinged sputum, night sweats, fever, fatigue, and weight loss.	lung TB;PTB;Tuberculosis, Pulmonary;pulmonary tuberculosis;pulmonary TB;lung tuberculosis	pulmonary tuberculosis|tuberculosis|mycobacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; pulmonary tuberculosis|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; pulmonary tuberculosis|tuberculosis|primary bacterial infectious disease|material entity|experimental factor; pulmonary tuberculosis|tuberculosis|primary bacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
HP:0000016	Urinary retention	Inability to completely empty the urinary bladder during the process of urination.	Increased post-void residual urine volume	Urinary retention|Abnormality of the bladder|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000771	bacterial disease	An acute infectious disorder that is caused by gram positive or gram negative bacteria; representative examples include pneumococcal, streptococcal, salmonella, and meningeal infections.	bacterial infection;Bacteria infectious disease;Bacteria caused disease or disorder;bacterial disorder;infection, bacterial;Bacteria disease or disorder;bacterial disease;bacterial infectious disease	bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:1001866	ventral hernia	NA	hernia of anterior abdominal wall;Hernia, Ventral	ventral hernia|Hernia of the abdominal wall|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; ventral hernia|Hernia of the abdominal wall|Hernia|Abnormality of connective tissue|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0006925	lipoprotein A measurement	NA	Lp(a) measurement	lipoprotein A measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; lipoprotein A measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0005755	rheumatic disease	Inflammatory and degenerative diseases of connective tissue structures, such as arthritis.	rheumatic disease;rheumatologic disorder;rheumatism;rheumatic disorder	rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0003865	kidney neoplasm	A benign or malignant neoplasm affecting the kidney. Representative examples of benign renal neoplasms include fibroma, lipoma, oncocytoma, and juxtaglomerular cell tumor. Representative examples of malignant renal neoplasms include renal cell carcinoma, renal pelvis carcinoma, Wilms tumor, rhabdoid tumor, sarcoma, and lymphoma.	Cancer of Kidney;KIDNEY NEOPL;Cancer, Kidney;tumor of the kidney;Cancer of the Kidney;kidney neoplasm;Cancers, Renal;Cancers, Kidney;Renal Neoplasm;neoplasm of kidney;neoplasm of the kidney;Cancer, Renal;Neoplasm, Kidney;renal tumors;Kidney Cancer;tumor of kidney;Kidney Cancers;Neoplasms, Kidney;Renal Cancer;renal neoplasm;kidney neoplasm (disease);RENAL NEOPL;Kidney Neoplasms;Neoplasms, Renal;renal tumor;Renal Neoplasms;NEOPL KIDNEY;Neoplasm, Renal;kidney tumor;Renal Cancers	kidney neoplasm|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; kidney neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; kidney neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
CHEBI:35418	N-acetylneuraminate	NA	5-acetamido-3,5-dideoxy-D-galacto-non-2-ulopyranosonate;N-acetylneuraminate	N-acetylneuraminate|chemical entity|material entity|experimental factor
MONDO:0002246	perichondritis of auricle	An otitis externa involving infection of the tissue surrounding the cartilage of the earlobe (pinna), ear canal, or both. It may be caused by injury, burns, insect bites, ear piercing, or a boil on the ear. The common bacterial causative agent is Pseudomonas aeruginosa. Symptoms include redness, pain, fever, swelling of the earlobe and pus accumulation between the cartilage and the layer of connective tissue around it.	perichondritis and chondritis of pinna;perichondritis of pinna, unspecified;perichondritis of pinna	perichondritis of auricle|otitis externa|ear infection|inflammatory disease|disease|disposition|material property|experimental factor; perichondritis of auricle|otitis externa|ear infection|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; perichondritis of auricle|otitis externa|external ear disease|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; perichondritis of auricle|otitis externa|external ear disease|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; perichondritis of auricle|otitis externa|ear infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; perichondritis of auricle|otitis externa|post-infectious disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
HP:0001082	Cholecystitis	The presence of inflammatory changes in the gallbladder.	Gallbladder inflammation	Cholecystitis|Abnormal gallbladder physiology|Abnormality of the liver|Abnormality of the abdominal organs|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0002974	cervical cancer	A primary or metastatic malignant neoplasm involving the cervix.	uterine cervix cancer;cervix uteri cancer;malignant neoplasm of cervix uteri;malignant tumor of the cervix;malignant cervix uteri neoplasm;malignant tumor of cervix uteri;cervix cancer;malignant cervical tumor;malignant tumor of cervix;malignant neoplasm of the cervix uteri;malignant cervix tumor;malignant neoplasm of uterine cervix;malignant neoplasm of the cervix;malignant cervical neoplasm;malignant cervix uteri tumor;cervical cancer, somatic;malignant tumor of the cervix uteri;malignant tumor of uterine cervix;malignant uterine cervix neoplasm;malignant cervix neoplasm;malignant neoplasm of the uterine cervix;malignant uterine cervix tumor;cancer of uterine cervix;malignant neoplasm of cervix;malignant tumor of the uterine cervix	cervical cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cervical cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cervical cancer|uterine cancer|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; cervical cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cervical cancer|uterine cervix neoplasm|cervix disorder|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; cervical cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; cervical cancer|uterine cervix neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; cervical cancer|uterine cervix neoplasm|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; cervical cancer|uterine cervix neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cervical cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; cervical cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cervical cancer|uterine cervix neoplasm|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; cervical cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; cervical cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; cervical cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0005089	whole-brain volume	NA		whole-brain volume|brain volume measurement|brain measurement|measurement|information entity|experimental factor; whole-brain volume|brain volume measurement|nervous system measurement|measurement|information entity|experimental factor
MONDO:0001515	corneal degeneration	NA		corneal degeneration|corneal disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; corneal degeneration|corneal disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0007704	depressive episode measurement	NA		depressive episode measurement|mental or behavioural disorder biomarker|measurement|information entity|experimental factor
EFO:0009615	ankle fracture	NA		ankle fracture|lower extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ankle fracture|lower extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor
EFO:0000275	atrial fibrillation	A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)	Fibrillations, Auricular;Atrial Fibrillations;Atrial fibrillation (disorder);AFib;AF - Atrial fibrillation;Fibrillation, Auricular;atrial fibrillation;A-fib;AF;Auricular Fibrillation;Fibrillations, Atrial;atrial fibrillation (disease);Auricular Fibrillations;Fibrillation, Atrial	atrial fibrillation|cardiac rhythm disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; atrial fibrillation|cardiac arrhythmia|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0009270	heel bone mineral density	NA		heel bone mineral density|bone density|bone fracture related measurement|bone measurement|measurement|information entity|experimental factor
MONDO:0000890	Zika virus congenital syndrome	A congenital birth syndrome that arises from materal Zika infection.	congenital Zika virus infection;congenital Zika syndrome;ZIKV congenital infection	Zika virus congenital syndrome|post-infectious syndrome|syndromic disease|disease|disposition|material property|experimental factor; Zika virus congenital syndrome|vector-borne disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Zika virus congenital syndrome|post-viral disorder|post-infectious disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Zika virus congenital syndrome|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Zika virus congenital syndrome|post-viral disorder|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Zika virus congenital syndrome|post-infectious syndrome|syndromic disease|material entity|experimental factor; Zika virus congenital syndrome|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Zika virus congenital syndrome|post-infectious syndrome|post-infectious disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0000341	chronic obstructive pulmonary disease	A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.	COAD - Chronic obstructive airways disease;chronic obstructive airway disease;Chronic airway obstruction;PULMONARY DISEASE (COPD), CHRONIC OBSTRUCTIVE;CAL - Chronic airflow limitation;obstructive lung disease, chronic;Dops;Chronic obstructive lung disease, NOS;Airflow Obstruction, Chronic;Chronic obstructive pulmonary disease finding;Pulmonary Disease, Chronic Obstructive;pulmonary disease (COPD), chronic obstructive;Chronic Airflow Obstructions;Chronic Obstructive Lung Disease;chronic obstructive airways disease;COPD NOS;OBSTRUCTIVE PULMONARY DISEASE (COPD), CHRONIC;CHRONIC OBSTRUCTIVE PULM DIS;COLD - Chronic obstructive lung disease;Chronic airway disease;PULM DIS CHRONIC OBSTRUCTIVE;Chronic Obstructive Pulmonary Disease (COPD);chronic obstructive lung disease [Ambiguous];chronic airway obstruction, not elsewhere classified;COLD (chronic obstructive lung disease);Chronic obstructive pulmonary disease finding (finding);cold;DISEASE (COPD), CHRONIC OBSTRUCTIVE;cold (chronic obstructive lung disease);chronic obstructive airways disease NOS;COPD;Chronic irreversible airway obstruction;CHRONIC OBSTRUCTIVE PULMONARY DISEASE, (COPD);COPD, chronic obstructive pulmonary disease;Chronic Airflow Obstruction;CAO - Chronic airflow obstruction;chronic obstructive pulmonary disease, (COPD);chronic obstructive lung disease (disorder);chronic obstructive airways disease NOS (disorder);obstructive pulmonary disease (COPD), chronic;Chronic Obstructive Airways Disease;chronic obstructive pulmonary disease (COPD);COPD - Chronic obstructive pulmonary disease;Chronic airflow limitation;COAD;CHRONIC OBSTRUCTIVE LUNG DIS;chronic airway obstruction, NEC in ICD9CM_2006;COLD;chronic obstructive pulmonary disease and allied conditions;Airflow Obstructions, Chronic;chronic obstructive pulmonary disease;COPD, CHRONIC OBSTRUCTIVE PULMONARY DISEASE;CHRONIC OBSTRUCTIVE AIRWAY DIS;chronic obstructive lung disease;disease (COPD), chronic obstructive;CAFL - Chronic airflow limitation;Chronic obstructive lung disease, NEC;Chronic obstructive pulmonary disease NOS	chronic obstructive pulmonary disease|tracheal disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; chronic obstructive pulmonary disease|tracheal disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; chronic obstructive pulmonary disease|chronic lung disease|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; chronic obstructive pulmonary disease|chronic lung disease|chronic disease|disease|disposition|material property|experimental factor
HP:0000989	Pruritus	Pruritus is an itch or a sensation that makes a person want to scratch. This term refers to an abnormally increased disposition to experience pruritus.	Itching;Itchy skin;Skin itching	Pruritus|Abnormality of the skin|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:17089	glycoprotein	NA	Glycoprotein;glycoproteins	glycoprotein|protein|biological macromolecule|material entity|experimental factor; glycoprotein|protein|chemical entity|material entity|experimental factor
EFO:0003835	anal neoplasm	A benign or malignant neoplasm that affects the anal canal or anal margin. Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma.	ANUS NEOPL;tumor of anus;anus neoplasm (disease);Neoplasm, Anal;ANAL NEOPL;neoplasm of anus;neoplasm of the anus;anus neoplasm;Anus Neoplasms;anal tumor;Neoplasms, Anus;Neoplasms, Anal;anal neoplasm;anal tumors;Anus Neoplasm;NEOPL ANAL;anus tumor;Neoplasm, Anus;Anal Neoplasms;NEOPL ANUS;anal neoplasms, benign and malignant;tumor of the anus	anal neoplasm|anus disease|rectal disease|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; anal neoplasm|rectal neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; anal neoplasm|rectal neoplasm|rectal disease|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; anal neoplasm|rectal neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; anal neoplasm|rectal neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0009536	blepharitis	Inflammation of the eyelids near the eyelashes.	eyelid inflammation;blepharitis;inflammation of eyelid	blepharitis|inflammatory disease|disease|disposition|material property|experimental factor; blepharitis|eyelid disease|eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; blepharitis|eyelid disease|eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor
HP:0030766	Ear pain	Pain in the ear can be a consequence of otologic disease (primary or otogenic otalgia), or can arise from pathologic processes and structures other than the ear (secondary or referred otalgia).	Otalgia;Pain in the ear;Ear pain	Ear pain|pain|sign or symptom|phenotype|quality|material property|experimental factor; Ear pain|Abnormality of the ear|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Ear pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0006834	septic shock	NA		septic shock|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:24898	isoleucine	NA	isoleucine	isoleucine|amino acid|acid|chemical entity|material entity|experimental factor
HP:0001915	Aplastic anemia	Aplastic anemia is defined as pancytopenia with a hypocellular marrow.	Aplastic anaemia	Aplastic anemia|anemia (phenotype)|Abnormal erythrocyte morphology|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Aplastic anemia|Pancytopenia|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001489	skin and soft tissue Staphylococcus aureus infection	NA	SSTI	skin and soft tissue Staphylococcus aureus infection|Staphylococcus aureus infection|staphylococcal skin infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
HP:0100607	Dysmenorrhea	Pain during menstruation that interferes with daily activities.	Painful menstruation	Dysmenorrhea|Abnormality of the genital system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0016581	conotruncal heart malformations	Conotruncal heart malformations are a group of congenital cardiac outflow tract anomalies that include such defects as tetralogy of Fallot, pulmonary atresia with ventricular septal defect, double-outlet right ventricle (DORV), double-outlet left ventricle, truncus arteriosus and transposition of the great arteries (TGA), among others. This group of defects is frequently found in patients with 22q11.2 deletion syndrome. A deletion of chromosome 22q11.2 has equally been associated in a subset of patients with various types of isolated non-syndromic conotruncal heart malformations (with the exception of DORV and TGA where this is very uncommon).	conotruncal heart malformations;Taussig-Bing syndrome or defect;conotruncal heart malformations, variable	conotruncal heart malformations|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|genetic disorder|material entity|experimental factor; conotruncal heart malformations|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; conotruncal heart malformations|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|genetic disorder|disease|disposition|material property|experimental factor; conotruncal heart malformations|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|cardiovascular disease|disease|disposition|material property|experimental factor; conotruncal heart malformations|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|congenital heart disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0006927	severe aplastic anemia	NA	SAA	severe aplastic anemia|Aplastic anemia|anemia (phenotype)|Abnormal erythrocyte morphology|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor; severe aplastic anemia|Aplastic anemia|Pancytopenia|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0007263	cardiac rhythm disease	Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.	arrhythmia	cardiac rhythm disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0030063	copy number assessment	Result of genomic copy number assessment of a genomic element or region.	genomic copy number assessment;copy number variation analysis	copy number assessment|information entity|experimental factor
EFO:0000551	intracranial hemorrhage	NA	Hemorrhages, Posterior Fossa;Intracranial hemorrhage, NOS;Brain Hemorrhages;Intracranial haemorrhage NOS;Intracranial haemorrhage;Posterior Fossa Hemorrhage;Posterior Fossa Hemorrhages;HEMORRHAGE INTRACRANIAL;Hemorrhages, Brain;Hemorrhage, Intracranial;Hemorrhage, Brain;Intracranial Hemorrhages;Hemorrhages, Intracranial;Intracranial Hemorrhage;Unspecified intracranial hemorrhage;Hemorrhage, Posterior Fossa;Intracranial hemorrhage (disorder);Brain Hemorrhage;intracranial hemorrhage NOS (disorder);INTRACRANIAL HEMORR NOS	intracranial hemorrhage|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; intracranial hemorrhage|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; intracranial hemorrhage|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0009636	cesarean section	NA	caesarean section	cesarean section|medical procedure|experimental process|planned process|process|experimental factor
EFO:0003923	bone density	NA	aBMD;Density, Bone Mineral;Bone Mineral Densities;BMD;Bone Densities;Bone Mineral Density;Density, Bone;areal bone mineral density	bone density|bone fracture related measurement|bone measurement|measurement|information entity|experimental factor
MONDO:0021108	meningitis	A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord.	meningitis;meninx inflammation;meningitis (disease);inflammation of meninx	meningitis|encephalomyelitis|inflammatory disease|disease|disposition|material property|experimental factor; meningitis|encephalomyelitis|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0007989	monocyte percentage of leukocytes	NA	monocyte count as percentage of total white blood cells;monocyte percentage of white cells;blood monocyte count to total leukocyte count ratio;monocyte count to total WBC count ratio;monocyte percentage	monocyte percentage of leukocytes|monocyte count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0000337	chronic gastritis	Inflammation of the stomach that is chronic in nature.	Gastritis (disorder);Other specified gastritis NOS (disorder);Idiopathic erosive/hemorrhagic gastritis (disorder);Other specified gastritis (disorder);chronic gastritis;Chronic gastritis NOS (disorder);Other specified gastritis;gastritis (disease), chronic;Chronic gastritis NOS;Chronic gastritis (disorder);Hemorrhagic Gastritis;Gastritis unspecified (disorder);Other specified gastritis, without mention of hemorrhage;Chronic gastritis, NOS;Erosive gastropathy (disorder);gastritis;GASTRITIS HEMORRHAGIC;Gastritis [Ambiguous];chronic gastritis (disease);Erosive Gastritis;CG - Chronic gastritis	chronic gastritis|chronic disease|disease|disposition|material property|experimental factor; chronic gastritis|gastritis|inflammatory disease|disease|disposition|material property|experimental factor; chronic gastritis|gastritis|stomach disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
MONDO:0002076	pneumothorax	Abnormal presence of air in the pleural cavity.	pneumothorax;pneumothorax (disease)	pneumothorax|pleural disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
HP:0001962	Palpitations	A sensation that the heart is pounding or racing, which is a non-specific sign but may be a manifestation of arrhythmia.	Missed heart beat;Heart palpitations;Skipped heart beat;Palpitations	Palpitations|Abnormality of cardiovascular system electrophysiology|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005539	adrenal gland disease	A disease involving the adrenal gland.	adrenal gland disorder;adrenal gland diseases;disorder of adrenal gland;adrenal gland disease or disorder;disease or disorder of adrenal gland;adrenal gland disease;disease of adrenal gland;adrenal gland disorders	adrenal gland disease|endocrine system disease|disease|disposition|material property|experimental factor
MONDO:0002423	rectosigmoid junction neoplasm	A benign or malignant neoplasm that affects the rectosigmoid region. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Rectosigmoid adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms.	rectosigmoid tumor;rectosigmoid neoplasm;rectosigmoid junction neoplasm (disease);tumor of rectosigmoid junction;neoplasm of rectosigmoid junction;rectosigmoid junction tumor;neoplasm of the rectosigmoid junction;tumor of the rectosigmoid junction	rectosigmoid junction neoplasm|sigmoid neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; rectosigmoid junction neoplasm|sigmoid neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; rectosigmoid junction neoplasm|sigmoid neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; rectosigmoid junction neoplasm|sigmoid neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0006823	total trans-18:1 fatty acid measurement	NA	NA	total trans-18:1 fatty acid measurement|trans fatty acid measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor; total trans-18:1 fatty acid measurement|trans fatty acid measurement|fatty acid measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:1000786	osteoarthritis, hip	Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion.	Coxarthrosis;Osteoarthritis Of Hip;Osteoarthritis Of Hips;hip osteoarthritis;Coxarthroses;osteoarthritis, hip;Hip Osteoarthritides;Hip Osteoarthritis;Osteoarthritides, Hip;osteoarthritis of the hip	osteoarthritis, hip|osteoarthritis|arthritis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteoarthritis, hip|osteoarthritis|arthritis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteoarthritis, hip|osteoarthritis|arthritis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteoarthritis, hip|osteoarthritis|arthritis|inflammatory disease|disease|disposition|material property|experimental factor; osteoarthritis, hip|osteoarthritis|arthritis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor
MONDO:0001658	nontoxic goiter	Sporadic enlargement of the thyroid gland that is not associated with changes in thyroid function or malignancy.	nontoxic goiter;non-toxic goiter;goiter, non-toxic;non-toxic goitre;goitre, non-toxic;non-toxic simple goitre;Nodule-thyroid, non tox;euthyroid goiter	nontoxic goiter|goiter|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
HP:0005180	Tricuspid regurgitation	Failure of the tricuspid valve to close sufficiently upon contraction of the right ventricle, causing blood to regurgitate (flow backward) into the right atrium.	Tricuspid valve regurgitation;Tricuspid insufficiency	Tricuspid regurgitation|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001407	Puerperal Infection	An infection occurring in puerperium, the period of 6-8 weeks after giving birth.	puerperal infection	Puerperal Infection|puerperal disorder|obstetric disorder|disease|disposition|material property|experimental factor; Puerperal Infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
MONDO:0002175	degeneration of macula and posterior pole	NA	degeneration of macula or posterior pole;degeneration of macula and posterior pole of retina	degeneration of macula and posterior pole|macular degeneration|retinal degeneration|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; degeneration of macula and posterior pole|macular degeneration|retinal degeneration|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; degeneration of macula and posterior pole|macular degeneration|retinal degeneration|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
HP:0000486	Strabismus	A misalignment of the eyes so that the visual axes deviate from bifoveal fixation. The classification of strabismus may be based on a number of features including the relative position of the eyes, whether the deviation is latent or manifest, intermittent or constant, concomitant or otherwise and according to the age of onset and the relevance of any associated refractive error.	Squint eyes;Squint;Cross-eyed	Strabismus|Abnormal conjugate eye movement|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005252	orthostatic hypotension	Sudden fall of the blood pressure of at least 20/10 mm Hg when a person stands up.	orthostatic hypotension;postural hypotension;orthostatic hypotension (disease)	orthostatic hypotension|hypotension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0003913	angina pectoris	NA	Stenocardias;stable angina;angina;Angor Pectoris;Stenocardia	angina pectoris|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:35391	aspartate(1-)	NA	hydrogen aspartate;aspartate(1-)	aspartate(1-)|chemical entity|material entity|experimental factor
EFO:0007214	common cold	An inflammatory process affecting the nasal mucosa, usually caused by viruses (e.g., rhinovirus, adenovirus, parainfluenza virus, and coronavirus). It is characterized by chills, headaches, mucopurulent nasal discharge, coughing, and facial pain.	acute nasopharyngitis;acute Nasopharyngitis;Acute viral rhinopharyngitis;nasopharyngitis, acute;acute viral rhinopharyngitis;nasopharyngitis - acute;acute nasopharyngitis [common cold];rhino-sinusitis;acute coryza;acute rhinitis;Nasopharyngitis - acute;Common Cold;Nasopharyngitis, acute;common cold	common cold|nasopharyngitis|nasopharyngeal disorder|disorder of pharynx|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; common cold|nasopharyngitis|inflammatory disease|disease|disposition|material property|experimental factor; common cold|nasopharyngitis|nasopharyngeal disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; common cold|nasopharyngitis|nasopharyngeal disorder|disorder of pharynx|respiratory system disease|disease|disposition|material property|experimental factor; common cold|material entity|experimental factor
HP:0000360	Tinnitus	Tinnitus is an auditory perception that can be described as the experience of sound, in the ear or in the head, in the absence of external acoustic stimulation.	Ringing in ears;Ringing in the ears	Tinnitus|Hearing abnormality|Abnormality of the ear|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009767	glycine measurement	NA		glycine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:0004212	Keloid	An irregularly shaped, elevated mark on the skin caused by deposits of excessive amounts of collagen during wound healing. It extends beyond the original boundaries of the wound and may enlarge progressively.	keloid;keloids	Keloid|reactive cutaneous fibrous lesion|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0004213	otosclerosis	Formation of spongy bone in the labyrinth capsule which can progress toward the stapes (stapedial fixation) or anteriorly toward the cochlea leading to conductive, sensorineural, or mixed hearing loss. Several genes are associated with familial otosclerosis with varied clinical signs.	otosclerosis;otosclerosis (disease);otospongiosis	otosclerosis|inherited auditory system disease|genetic disorder|material entity|experimental factor; otosclerosis|inner ear disease|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; otosclerosis|inherited auditory system disease|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; otosclerosis|genetic otorhinolaryngologic disease|genetic disorder|disease|disposition|material property|experimental factor; otosclerosis|inner ear disease|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; otosclerosis|inherited auditory system disease|genetic disorder|disease|disposition|material property|experimental factor; otosclerosis|genetic otorhinolaryngologic disease|genetic disorder|material entity|experimental factor; otosclerosis|genetic otorhinolaryngologic disease|otorhinolaryngologic disease|disease|disposition|material property|experimental factor
HP:0002107	Pneumothorax	Accumulation of air in the pleural cavity leading to a partially or completely collapsed lung.	Collapsed lung	Pneumothorax|Abnormal lung morphology|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003959	cleft lip	NA	Harelips;Lip, Cleft;Cleft Lips;Harelip;Lips, Cleft	cleft lip|Oral cleft|Abnormality of the mouth|Abnormality of the face|Abnormality of the head|Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:11805	3-hydroxyisobutyrate	NA	3-Hydroxyisobutyrate;3-hydroxy-2-methylpropanoate	3-hydroxyisobutyrate|chemical entity|material entity|experimental factor
EFO:0003964	hip fracture	Traumatic or pathological injury to the hip in which the continuity of either the femoral head, femoral neck, intertrochanteric or subtrochanteric regions is broken. Symptoms include pain in the hip or groin, bruising and swelling in and around the hip area. The injured hip is turned outward and the leg appears shorter on that side.	Fractures, Hip;Fractures, Subtrochanteric;Trochanteric Fractures;Fractures, Intertrochanteric;Intertrochanteric Fractures;hip fracture;Subtrochanteric Fractures;Hip Fractures;Fractures, Trochanteric	hip fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; hip fracture|bone fracture|injury|disease|disposition|material property|experimental factor
EFO:0000182	hepatocellular carcinoma	A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.	hepatocellular cancer, somatic;hepatocellular carcinoma;carcinoma, hepatocellular, malignant;hepatocellular cancer;liver and intrahepatic bile duct carcinoma;carcinoma of liver cells;cancer, hepatocellular;carcinoma of liver;hepatoma;liver cell cancer (hepatocellular carcinoma);primary carcinoma of liver cells;hepatocellular carcinoma, somatic;carcinoma of the liver cells;hepatoblastoma, somatic;liver cell carcinoma;primary carcinoma of the liver cells;hepatocellular adenocarcinoma;hepatocellular carcinoma, childhood type, somatic;liver carcinoma;HCC	hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hepatocellular carcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
HP:0004398	Peptic ulcer	The term peptic ulcer refers to acid peptic injury of the digestive tract, resulting in mucosal break reaching the submucosa. Peptic ulcers are usually located in the stomach or proximal duodenum, but they can also be found in the oesophagus or Meckel's diverticulum. Infection with Helicobacter pylori and the use of non steroidal antiinflammatory drugs (NSAIDs) or aspirin are the main risk factors of both gastric and duodenal peptic ulcers.	Sore in the lining of gastrointestinal tract	Peptic ulcer|Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0007254	breast cancer	A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males.	malignant breast neoplasm;malignant tumor of the breast;BC;malignant neoplasm of the breast;malignant neoplasm of breast;malignant breast tumor;malignant tumor of breast;breast cancer;mammary cancer;cancer of breast	breast cancer|thoracic cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast cancer|breast neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast cancer|breast neoplasm|integumentary system disease|disease|disposition|material property|experimental factor; breast cancer|thoracic cancer|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast cancer|breast neoplasm|breast disease|disease|disposition|material property|experimental factor
EFO:0000389	cutaneous melanoma	A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.	melanoma of the skin;skin, melanoma;zone of skin melanoma (disease);malignant neck melanoma;malignant melanoma of skin;malignant cutaneous melanoma;malignant melanoma of skin of lower limb;malignant melanoma of skin of upper limb;cutaneous (skin) melanoma;malignant melanoma of skin of trunk except scrotum;cutaneous melanoma;malignant lower limb melanoma;malignant trunk melanoma;melanoma of skin;malignant scalp melanoma;malignant lip melanoma;cutaneous melanoma (disease);malignant upper limb melanoma;malignant melanoma (of skin), stage unspecified;malignant melanoma of ear and/or external auricular canal;malignant ear melanoma;skin melanoma;malignant melanoma of skin stage unspecified;melanoma (disease) of zone of skin;zone of skin melanoma	cutaneous melanoma|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; cutaneous melanoma|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cutaneous melanoma|melanoma|neuroendocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; cutaneous melanoma|melanoma|melanocytic neoplasm|neurocristopathy|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; cutaneous melanoma|skin cancer|integumentary system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cutaneous melanoma|melanoma|melanocytic neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cutaneous melanoma|melanocytic skin neoplasm|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; cutaneous melanoma|melanocytic skin neoplasm|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cutaneous melanoma|skin cancer|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; cutaneous melanoma|melanocytic skin neoplasm|melanocytic neoplasm|neurocristopathy|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; cutaneous melanoma|skin cancer|integumentary system cancer|integumentary system disease|disease|disposition|material property|experimental factor; cutaneous melanoma|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cutaneous melanoma|melanoma|neuroendocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cutaneous melanoma|melanocytic skin neoplasm|melanocytic neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cutaneous melanoma|skin cancer|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0021063	malignant colon neoplasm	A primary or metastatic malignant neoplasm that affects the colon. Representative examples include carcinoma, lymphoma, and sarcoma.	colon cancer;malignant colonic tumor;malignant colon tumor;malignant tumor of the colon;malignant neoplasm of colon;malignant colonic neoplasm;cancer of colon;colon tumor, malignant;malignant neoplasm of the colon;malignant colon neoplasm;colon neoplasm, malignant;malignant tumor of colon	malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant colon neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant colon neoplasm|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0009523	fecal incontinence	NA	faecal incontinence	fecal incontinence|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
MONDO:0002026	candidiasis	Infection with the organism Candida.	Candida infection;Candidosis;thrush;Candida <Debaryomycetaceae> infection	candidiasis|opportunistic mycosis|fungal infectious disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; candidiasis|opportunistic mycosis|material entity|experimental factor
EFO:0008615	Cystic Kidney Disease	A congenital or acquired kidney disorder characterized by the presence of renal cysts.	cystic kidney disease;cystic renal disease;Cystic Renal Diseases;kidney cyst;Cystic Kidney Diseases;Kidney, Cystic;renal cyst	Cystic Kidney Disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:1001092	patellofemoral pain syndrome	A syndrome characterized by retropatellar or peripatellar pain resulting from physical and biochemical changes in the patellofemoral joint. The pain is most prominent when ascending or descending stairs, squatting, or sitting with flexed knees. There is a lack of consensus on the etiology and treatment. The syndrome is often confused with (or accompanied by) chondromalacia patellae, the latter describing a pathological condition of the cartilage and not a syndrome.	patellofemoral stress syndrome;patellofemoral pain syndrome;Patellofemoral Pain Syndrome	patellofemoral pain syndrome|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
GO:0036273	response to statin	NA		response to statin|response to drug|response to stimulus|biological process|process|experimental factor
EFO:0000217	gastritis	Inflammation of the stomach.	acute haemorrhagic gastritis;Erosive Gastritis;GASTRITIS HEMORRHAGIC;Gastritis;stomach inflammation;acute hemorrhagic gastritis [dup] (disorder);Other specified gastritis;acute gastritis without mention of hemorrhage;gastritis;acute gastritis, with hemorrhage;erosive gastritis;Gastric catarrh;acute gastritis, without mention of hemorrhage;Other specified gastritis (disorder);erosive gastropathy;acute gastric mucosal erosion (disorder);Idiopathic erosive/hemorrhagic gastritis (disorder);Hemorrhagic Gastritis;acute gastritis (disorder);Other specified gastritis NOS (disorder);acute gastric mucosal erosion;Gastritis (disorder);inflammation of stomach;Other specified gastritis, with hemorrhage;acute gastritis with hemorrhage;active gastritis;Gastritis unspecified;acute gastritis;Gastritis [Ambiguous];Gastritis, NOS;acute hemorrhagic gastritis (disorder);Gastritis unspecified (disorder);Erosive gastropathy (disorder);Gastritides;gastritis (disease);Other specified gastritis, without mention of hemorrhage	gastritis|stomach disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; gastritis|inflammatory disease|disease|disposition|material property|experimental factor
HP:0001634	Mitral valve prolapse	One or both of the leaflets (cusps) of the mitral valve bulges back into the left atrium upon contraction of the left ventricle.		Mitral valve prolapse|Abnormal heart morphology|Abnormality of cardiovascular system morphology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Mitral valve prolapse|mitral valve disease|heart valve disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0005531	urticaria	A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.	hives;urticaria (disease);urticaria	urticaria|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; urticaria|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0800707	X-12125 measurement	NA		X-12125 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0007991	eosinophil percentage of leukocytes	NA	eosinophil count as percentage of total white blood cells;eosinophil count to total WBC count ratio;eosinophil percentage of white cells;blood eosinophil count to total leukocyte count ratio;eosinophil percentage	eosinophil percentage of leukocytes|eosinophil count|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
MONDO:0018174	hereditary glaucoma	Hereditary glaucoma is a clinically diverse group of rare eye disorders with genetic predisposition characterized by elevated intraocular pressure (IOP) and glaucomatous changes of the optic nerve head, leading to field defects, visual loss and blindness. Hereditary glaucoma can be sub-classified as primary (congenital glaucoma, juvenile glaucoma) or secondary according to the presence or absence of systemic or other ocular anomalies (iridogoniodysgenesis, Stickler syndrome, Coats syndrome). The clinical presentation is variable and is based on age, severity of glaucoma, presence of ocular abnormalities and development of secondary IOP related abnormalities.	hereditary glaucoma (disease)	hereditary glaucoma|genetic disorder|disease|disposition|material property|experimental factor; hereditary glaucoma|glaucoma|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; hereditary glaucoma|genetic disorder|material entity|experimental factor; hereditary glaucoma|glaucoma|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0000553	invasive lobular carcinoma	An infiltrating lobular adenocarcinoma of the breast. The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma. The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures.	classic invasive lobular carcinoma;invasive lobular carcinoma of the breast;infiltrating lobular carcinoma of breast;infiltrating lobular adenocarcinoma;invasive lobular carcinoma;infiltrating lobular breast carcinoma;invasive lobular breast carcinoma;invasive lobular adenocarcinoma;invasive lobular carcinoma of breast;invasive lobular carcinoma, classic type;infiltrating lobular carcinoma of the breast;lobular carcinoma	invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|breast carcinoma|breast cancer|breast neoplasm|integumentary system disease|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|breast carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|integumentary system cancer|integumentary system disease|disease|disposition|material property|experimental factor; invasive lobular carcinoma|Invasive Breast Carcinoma|invasive carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|Invasive Breast Carcinoma|breast carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|Invasive Breast Carcinoma|breast carcinoma|breast cancer|breast neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|breast carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|integumentary system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|Invasive Breast Carcinoma|breast carcinoma|breast cancer|breast neoplasm|breast disease|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|Invasive Breast Carcinoma|breast carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|breast carcinoma|breast cancer|thoracic cancer|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|Invasive Breast Carcinoma|invasive carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|Invasive Breast Carcinoma|breast carcinoma|breast cancer|thoracic cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|Invasive Breast Carcinoma|breast carcinoma|breast cancer|breast neoplasm|integumentary system disease|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|breast carcinoma|breast cancer|breast neoplasm|breast disease|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|breast carcinoma|breast cancer|breast neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|Invasive Breast Carcinoma|breast carcinoma|breast cancer|thoracic cancer|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; invasive lobular carcinoma|lobular breast carcinoma|breast adenocarcinoma|breast carcinoma|breast cancer|thoracic cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
CHEBI:36711	phosphoethanolamine	NA		phosphoethanolamine|phosphate|chemical entity|material entity|experimental factor
EFO:0800617	choline phosphate measurement	NA		choline phosphate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0010488	glycerol-3-phosphate measurement	NA		glycerol-3-phosphate measurement|phosphate measurement|measurement|information entity|experimental factor; glycerol-3-phosphate measurement|glycerol measurement|measurement|information entity|experimental factor
EFO:0800152	3-phosphoglycerate measurement	NA		3-phosphoglycerate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0005688	NHDL cholesterol	NA	non-high density lipoprotein cholesterol	NHDL cholesterol|cholesterol|lipoprotein|protein|biological macromolecule|material entity|experimental factor; NHDL cholesterol|cholesterol|lipoprotein|protein|chemical entity|material entity|experimental factor; NHDL cholesterol|cholesterol|sterol|steroid|lipid|chemical entity|material entity|experimental factor
MONDO:0018906	follicular lymphoma	Follicular lymphoma is a form of non-Hodgkin lymphoma characterized by a proliferation of B cells whose nodular structure of follicular architecture is preserved.	follicle center lymphoma;follicular centre cell lymphoma;lymphoma, follicular, malignant;follicular non-Hodgkin's lymphoma;follicular non-Hodgkin lymphoma;lymphoma, follicular centre cell	follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|immune system disease|disease|disposition|material property|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|immune system disease|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|hematologic disease|material entity|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|hematologic disease|material entity|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; follicular lymphoma|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; follicular lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor
HP:0011079	Impacted tooth	A tooth that has not erupted because of local impediments (overcrowding or fibrous gum overgrowth).	Impacted tooth;Retained tooth	Impacted tooth|Abnormality of the dentition|Abnormality of the mouth|Abnormality of the face|Abnormality of the head|Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0003418	Back pain	NA	Back pain	Back pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Back pain|pain|sign or symptom|phenotype|quality|material property|experimental factor; Back pain|Abnormality of the vertebral column|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0100130	adult acute respiratory distress syndrome	A very severe form of acute pulmonary failure secondary to capillary permeability impairment. The symptoms include dyspnea, hypotension and multivisceral failure. The disease is characterized by bilateral pulmonary infiltrates and severe hypoxemia due to increased alveolar-capillary permeability. The severity depends on the degree of alveolar epithelial injury, with a mortality rate of 30-50%.	adult respiratory distress syndrome, ARDS;respiratory distress syndrome, adult;adult RDS;adult ARDS;adult acute respiratory distress syndrome;adult respiratory distress syndrome	adult acute respiratory distress syndrome|acute respiratory distress syndrome|primary interstitial lung disease specific to adulthood|interstitial lung disease specific to adulthood|interstitial lung disease|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; adult acute respiratory distress syndrome|acute respiratory distress syndrome|syndromic disease|disease|disposition|material property|experimental factor; adult acute respiratory distress syndrome|acute respiratory distress syndrome|syndromic disease|material entity|experimental factor; adult acute respiratory distress syndrome|acute respiratory distress syndrome|acute respiratory failure|respiratory failure|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; adult acute respiratory distress syndrome|acute respiratory distress syndrome|acute respiratory failure|acute disease|disease|disposition|material property|experimental factor
HP:0000083	Renal insufficiency	A reduction in the level of performance of the kidneys in areas of function comprising the concentration of urine, removal of wastes, the maintenance of electrolyte balance, homeostasis of blood pressure, and calcium metabolism.	Renal failure in adulthood;Renal failure	Renal insufficiency|Abnormal renal physiology|Abnormality of the kidney|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Renal insufficiency|Abnormal renal physiology|Abnormality of the urinary system physiology|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0003441	dystonic disorder	A movement disorder characterized by sustained or intermittent muscle contractions, resulting in abnormal movements and/or postures.	dystonic disease;dystonic disorder;dystonia	dystonic disorder|movement disorder|nervous system disease|disease|disposition|material property|experimental factor
EFO:0800649	glucuronide of C19H28O4 (2) measurement	NA		glucuronide of C19H28O4 (2) measurement|metabolite measurement|measurement|information entity|experimental factor
MONDO:0004670	lupus erythematosus	An autoimmune, connective tissue chronic inflammatory disorder affecting the skin, joints, kidneys, lungs, heart, and the peripheral blood cells. It is more commonly seen in women than men. Variants include discoid and systemic lupus erythematosus.	lupus;lupus erythematosus	lupus erythematosus|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; lupus erythematosus|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; lupus erythematosus|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor
HP:0032072	Popliteal synovial cyst	A fluid-filled mass that is a distention of a preexisting bursa in the popliteal fossa, most commonly the gastrocnemio-semimembranosus bursa. This bursa is unique in that it communicates with the knee joint, unlike other periarticular bursae, via an opening in the joint capsule posterior to the medial femoral condyle.	Baker's cyst	Popliteal synovial cyst|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Popliteal synovial cyst|Abnormality of the lower limb|Abnormality of limbs|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0004700	parotid gland cancer	A primary or metastatic malignant neoplasm involving the parotid gland. Representative examples include carcinoma, malignant mixed tumor, and non-Hodgkin lymphoma.	cancer of the parotid gland;malignant tumor of parotid gland;malignant neoplasm of parotid;parotid gland cancer;malignant parotid tumor;malignant neoplasm of the parotid;malignant parotid gland tumor;malignant neoplasm of the parotid gland;malignant tumor of parotid;parotid cancer;malignant tumor of the parotid;cancer of the parotid;cancer of parotid gland;malignant neoplasm of parotid gland;malignant tumor of the parotid gland;cancer of parotid;malignant parotid gland neoplasm;malignant parotid neoplasm	parotid gland cancer|major salivary gland cancer|salivary gland cancer|Mixed Tumor of the Salivary Gland|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|oral cavity cancer|mouth neoplasm|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; parotid gland cancer|parotid neoplasm|neoplasm of major salivary gland|Mixed Tumor of the Salivary Gland|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|Mixed Tumor of the Salivary Gland|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|neoplasm of major salivary gland|Mixed Tumor of the Salivary Gland|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|oral cavity cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; parotid gland cancer|parotid neoplasm|neoplasm of major salivary gland|Mixed Tumor of the Salivary Gland|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|parotid neoplasm|parotid disease|salivary gland disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|Mixed Tumor of the Salivary Gland|salivary gland neoplasm|salivary gland disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|neoplasm of major salivary gland|Mixed Tumor of the Salivary Gland|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|oral cavity cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|neoplasm of major salivary gland|Mixed Tumor of the Salivary Gland|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|oral cavity cancer|mouth neoplasm|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|oral cavity cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|oral cavity cancer|head and neck malignant neoplasia|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|parotid neoplasm|neoplasm of major salivary gland|Mixed Tumor of the Salivary Gland|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|neoplasm of major salivary gland|Mixed Tumor of the Salivary Gland|salivary gland neoplasm|salivary gland disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; parotid gland cancer|parotid neoplasm|neoplasm of major salivary gland|Mixed Tumor of the Salivary Gland|salivary gland neoplasm|salivary gland disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|oral cavity cancer|mouth neoplasm|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|oral cavity cancer|head and neck malignant neoplasia|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|oral cavity cancer|head and neck malignant neoplasia|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|oral cavity cancer|mouth neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; parotid gland cancer|major salivary gland cancer|salivary gland cancer|Mixed Tumor of the Salivary Gland|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:1001792	femoral neck fracture	NA	Femoral Neck Fractures;fracture of neck of femur	femoral neck fracture|lower extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; femoral neck fracture|lower extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor
EFO:0008553	femur fracture	NA	Fracture of Femur	femur fracture|lower extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor; femur fracture|lower extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
HP:0002039	Anorexia	A lack or loss of appetite for food (as a medical condition).	Anorexia	Anorexia|Abdominal symptom|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004143	carpal tunnel syndrome	Entrapment of the median nerve in the wrist that is characterized by numbness, tingling and painful movement.	carpal tunnel syndrome;carpal tunnel median neuropathy;CTS - carpal tunnel syndrome;median nerve entrapment	carpal tunnel syndrome|genetic peripheral neuropathy|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; carpal tunnel syndrome|nerve compression syndrome|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; carpal tunnel syndrome|genetic peripheral neuropathy|genetic disorder|material entity|experimental factor; carpal tunnel syndrome|genetic peripheral neuropathy|genetic disorder|disease|disposition|material property|experimental factor; carpal tunnel syndrome|nerve compression syndrome|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; carpal tunnel syndrome|genetic peripheral neuropathy|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
CHEBI:36005	docosahexaenoic acid	NA	docosahexaenoic acid	docosahexaenoic acid|fatty acid|lipid|chemical entity|material entity|experimental factor; docosahexaenoic acid|fatty acid|acid|chemical entity|material entity|experimental factor
EFO:0008507	interstitial cystitis	A rare chronic debilitating urogenital disease characterized by urinary frequency, urgency, and pelvic pain.	interstitial cystitis;interstitial cystitis, chronic;chronic interstitial cystitis;interstitial cystitis/bladder pain syndrome;ulcerative cystitis;interstitial cystitis/painful bladder syndrome;bladder pain syndrome;painful bladder syndrome;IC/PBS;IC/BPS	interstitial cystitis|connective tissue disease|disease|disposition|material property|experimental factor; interstitial cystitis|chronic cystitis|cystitis|inflammatory disease|disease|disposition|material property|experimental factor; interstitial cystitis|chronic cystitis|cystitis|bladder disease|urinary system disease|disease|disposition|material property|experimental factor; interstitial cystitis|material entity|experimental factor; interstitial cystitis|chronic cystitis|chronic disease|disease|disposition|material property|experimental factor
EFO:0010815	remnant cholesterol measurement	NA		remnant cholesterol measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; remnant cholesterol measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0004639	phospholipid measurement	NA	plasma phospholipid levels	phospholipid measurement|phosphate measurement|measurement|information entity|experimental factor; phospholipid measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0005110	fatty acid measurement	NA		fatty acid measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
MONDO:0016471	pachyonychia congenita	Pachyonychia congenita (PC) is a rare genodermatosis predominantly featuring painful palmoplantar keratoderma, thickened nails, cysts and whitish oral mucosa.	PC;pachyonychia congenita, Jadassohn-Lewandowsky type;Jackson-Lawler type pachyonychia congenita;Jadassohn-Lewandowsky syndrome	pachyonychia congenita|focal palmoplantar keratoderma|hereditary palmoplantar keratoderma|genetic disorder|material entity|experimental factor; pachyonychia congenita|focal palmoplantar keratoderma|hereditary palmoplantar keratoderma|epidermal disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; pachyonychia congenita|focal palmoplantar keratoderma|hereditary palmoplantar keratoderma|epidermal disease|material entity|experimental factor; pachyonychia congenita|focal palmoplantar keratoderma|hereditary palmoplantar keratoderma|genetic disorder|disease|disposition|material property|experimental factor; pachyonychia congenita|focal palmoplantar keratoderma|hereditary palmoplantar keratoderma|palmoplantar keratosis|keratosis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; pachyonychia congenita|focal palmoplantar keratoderma|hereditary palmoplantar keratoderma|palmoplantar keratosis|keratosis|keratinization disease|integumentary system disease|disease|disposition|material property|experimental factor; pachyonychia congenita|focal palmoplantar keratoderma|hereditary palmoplantar keratoderma|palmoplantar keratosis|keratosis|keratinization disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor
MONDO:0004565	intestinal obstruction	Blockage of the normal flow of the intestinal contents within the bowel.	bowel obstruction	intestinal obstruction|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:1000391	Nasal Cavity Polyp	A soft and painless polypoid mass that arises from the mucosa in the nasal cavity. It is usually the result of an inflammatory process. It may recur following surgical resection.	polyp of nasal cavity;nasal cavity polyp;nasal polyp;polyp of the nasal cavity	Nasal Cavity Polyp|nasal cavity disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; Nasal Cavity Polyp|polyp|cancer or benign tumor|disease|disposition|material property|experimental factor; Nasal Cavity Polyp|nasal cavity disorder|nasal disorder|otorhinolaryngologic disease|disease|disposition|material property|experimental factor
EFO:0020857	very low density lipoprotein cholesterol change measurement	NA		very low density lipoprotein cholesterol change measurement|very low density lipoprotein cholesterol measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0010067	corneal resistance factor	NA		corneal resistance factor|eye measurement|measurement|information entity|experimental factor
HP:0012735	Cough	A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation.	Cough;Coughing	Cough|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009002	splenic disease	A disease involving the spleen.	splenic disorder;disease of spleen;spleen disease or disorder;diseases of spleen;spleen diseases;disease or disorder of spleen;disorder of spleen;spleen disorder;spleen disease;splenic disease;Dyssplenism	splenic disease|digestive system disease|disease|disposition|material property|experimental factor; splenic disease|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor; splenic disease|hematologic disease|material entity|experimental factor; splenic disease|hematologic disease|disease|disposition|material property|experimental factor
EFO:0000508	genetic disorder	A disease that is caused by genetic modifications where those modifications are inherited from a parent's genome.	inherited genetic disease;hereditary diseases;genetic disease;Mendelian disease;hereditary disease or disorder;molecular disease;hereditary disease;inherited disease	genetic disorder|material entity|experimental factor; genetic disorder|disease|disposition|material property|experimental factor
EFO:0002431	tumour of cranial and spinal nerves	A benign or malignant neoplasm arising from a peripheral nerve or the perineural sheaths.	tumor of the peripheral nervous system;neoplasm of the peripheral nervous system;Peripheral Nervous System Tumor;neoplasm of PNS;Tumors, Peripheral Nerve;Peripheral Nerve Neoplasms, Benign;PERIPHERAL NERVE NEOPL BENIGN;peripheral nerve tumor;Neoplasm of PNS;Neoplasm of Peripheral Nerve;Neoplasm of Peripheral Nervous System;Peripheral Nerve Neoplasms;Neoplasm of the Peripheral Nervous System;Tumor of Peripheral Nervous System;peripheral nerve neoplasm;Peripheral Nervous System Malignant Neoplasms;PNS tumor;Tumor of the Peripheral Nerve;peripheral nervous system tumor;tumor of the PNS;Peripheral Nervous System Benign Neoplasms;PNS Tumor;Nerve Neoplasms, Peripheral;neoplasm of peripheral nerve;Peripheral Nerve Tumor;peripheral nervous system cancer;tumor of PNS;Peripheral Nerve Neoplasms, Malignant;Peripheral Nerve Neoplasm;Neoplasms, Peripheral Nervous System;PNS neoplasm;Tumor of the PNS;PERIPHERAL NERVE NEOPL MALIGNANT;PNS MALIGNANT NEOPL;neoplasm of the peripheral nerve;Peripheral Nerve Neoplastic Infiltration;peripheral nervous system neoplasm;neoplasm of peripheral nervous system;neoplasms, PNS;Peripheral Nervous System Neoplasm;Neoplasms, PNS;Nerve Tumor, Peripheral;Neoplasms, Peripheral Nerve;PNS BENIGN NEOPL;Neoplasm, Peripheral Nerve;Tumor of PNS;neoplasms, peripheral nervous system;Peripheral Nerve Tumors;PNS Neoplasms;Peripheral Nervous System Neoplasms;tumor of peripheral nerve;Tumor, Peripheral Nerve;PERIPHERAL NERVE NEOPL INFILTRATION;Tumor of the Peripheral Nervous System;Tumor of Peripheral Nerve;PNS Neoplasm;PERIPHERAL NERVE NEOPL;peripheral nervous system neoplasm (disease);Neoplasm of the PNS;tumor of the peripheral nerve;PNS neoplasms;Nerve Neoplasm, Peripheral;tumor of peripheral nervous system;neoplasm of the PNS;Nerve Tumors, Peripheral;PNS NEOPL;Neoplasm of the Peripheral Nerve	tumour of cranial and spinal nerves|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; tumour of cranial and spinal nerves|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; tumour of cranial and spinal nerves|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009545	esophageal varices	Abnormally dilated veins of the esophagus.	esophageal varices in disease classified elsewhere, with bleeding;esophageal varices with bleeding in disease EC;varicose disease of esophagus;esophageal varices without mention of bleeding;esophageal varix;esophageal varices without bleeding;esophagus varicose disease;esophageal varices;esophageal varices with bleeding	esophageal varices|esophageal disease|upper digestive tract disorder|disease|disposition|material property|experimental factor; esophageal varices|esophageal disease|digestive system disease|disease|disposition|material property|experimental factor; esophageal varices|varicose disease|vein disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0005411	schizoaffective disorder	A disorder in which the individual suffers from both symptoms that qualify as schizophrenia and symptoms that qualify as a mood disorder (e.g., depression or bipolar disorder) for a substantial portion (but not all) of the active period of the illness; for the remainder of the active period of the illness, the individual suffers from delusions or hallucinations in the absence of prominent mood symptoms.	schizoaffective disorder	schizoaffective disorder|psychosis|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; schizoaffective disorder|psychosis|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009432	fibroblastic disorder	NA	fibroblastic disease	fibroblastic disorder|connective tissue disease|disease|disposition|material property|experimental factor
MONDO:0001847	nuclear senile cataract	A senile cataract that involves the lens nucleus.	senile cataract of lens nucleus;lens nucleus senile cataract;Senile nuclear cataract;Senile nuclear sclerosis	nuclear senile cataract|senile cataract|cataract|genetic disorder|disease|disposition|material property|experimental factor; nuclear senile cataract|senile cataract|cataract|lens disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; nuclear senile cataract|senile cataract|cataract|genetic disorder|material entity|experimental factor; nuclear senile cataract|nuclear cataract|cataract|genetic disorder|material entity|experimental factor; nuclear senile cataract|nuclear cataract|cataract|lens disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; nuclear senile cataract|nuclear cataract|cataract|lens disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; nuclear senile cataract|nuclear cataract|cataract|genetic disorder|disease|disposition|material property|experimental factor; nuclear senile cataract|senile cataract|cataract|lens disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0010114	citrate measurement	NA		citrate measurement|measurement|information entity|experimental factor
EFO:1001179	sialadenitis	Sialadenitis is an infection of the salivary glands. It is usually caused by a virus or bacteria. The parotid (in front ofthe ear) and submandibular (under the chin) glands are most commonly affected. Sialadenitis may be associated with pain, tenderness, redness, and gradual, localized swelling of the affected area. Sialadenitis most commonly affects the elderly and chronically ill especially those with dry mouth or who are dehydrated, but can also affected people of any age including newborn babies. Diagnosis is usually made by clinical exam but a CT scan, MRI scan or ultrasound may be done if the doctor suspects an abscess or to look for stones. Treatment may include an antibiotic (if bacterial), warm compresses, increasing fluid intake and good oral hygiene. Most salivary gland infections go away on their own or are cured with treatment. Complications are not common.	Irradiation-Induced Sialadenitis;sialadenitis;Adenitis, Salivary Gland;Sialitis;Salivary Gland Inflammation;Sialadenitis;Chronic Sialadenitis;sialoadenitis;sialitis;lymphadenitis (disease) of saliva-secreting gland;saliva-secreting gland lymphadenitis (disease);Sialoadenitis	sialadenitis|lymphadenitis|inflammatory disease|disease|disposition|material property|experimental factor; sialadenitis|salivary gland disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; sialadenitis|lymphadenitis|lymph node disorder|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor
EFO:0021261	X-11795 measurement	NA		X-11795 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009909	stage 5 chronic kidney disease	NA	End stage renal failure;chronic renal failure;End-stage renal failure;End stage renal disease;end-stage renal disease	stage 5 chronic kidney disease|chronic kidney disease|chronic disease|disease|disposition|material property|experimental factor; stage 5 chronic kidney disease|chronic kidney disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
MONDO:0004857	tendinitis	Inflammation of a tendon, usually resulting from an overuse injury. It is characterized by swelling of the tendon, tenderness around the inflamed tendon, and pain while moving the affected area of the body.	inflammation of tendon;tendonitis;tendon inflammation	tendinitis|Tendinopathy|connective tissue disease|disease|disposition|material property|experimental factor; tendinitis|myositis|immune system disease|disease|disposition|material property|experimental factor; tendinitis|myositis|myopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; tendinitis|myositis|inflammatory disease|disease|disposition|material property|experimental factor; tendinitis|Tendinopathy|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0003852	developmental disability	Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)	Developmental Delay Disorders;Disability, Developmental;DEVELOPMENTAL DELAY DIS;Development Deviations, Child;Developmental Disabilities;Deviation, Child Development;CHILD DEVELOPMENT DIS SPECIFIC;Child Development Disorder;Developmental Delay Disorder;developmental disability;Child Development Deviations;Child Development Deviation;Development Disorder, Child;Child Development Disorders;Development Disorders, Child;DEVELOPMENT DIS CHILD;Disabilities, Developmental;CHILD DEVELOPMENT DIS;Development Deviation, Child;Child Development Disorders, Specific	developmental disability|nervous system disease|disease|disposition|material property|experimental factor
EFO:0003875	peripheral vascular disease	Any disorder affecting blood flow through the veins or arteries outside of the heart.	Vascular Diseases, Peripheral;Disease, Peripheral Vascular;Peripheral Angiopathy;PERIPHERAL VASCULAR DIS;VASCULAR DIS PERIPHERAL;peripheral vascular disease;Angiopathies, Peripheral;peripheral vascular disorder;disease, peripheral vascular;Peripheral Vascular Diseases;Diseases, Peripheral Vascular;vascular disease, peripheral;Angiopathy, Peripheral;Vascular Disease, Peripheral;arterial occlusive disease;Peripheral Angiopathies;DIS PERIPHERAL VASCULAR	peripheral vascular disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
HP:0010992	Stress urinary incontinence	Involuntary urine leakage synchronous with exertion, or actions such as sneezing, or coughing.		Stress urinary incontinence|Urinary incontinence|Abnormality of the bladder|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Stress urinary incontinence|Urinary incontinence|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004303	vital signs	NA		vital signs|measurement|information entity|experimental factor
EFO:1000023	chronic cystitis	Recurrent infections of the urinary bladder.	chronic cystitis;cystitis, chronic;Other chronic cystitis	chronic cystitis|cystitis|inflammatory disease|disease|disposition|material property|experimental factor; chronic cystitis|chronic disease|disease|disposition|material property|experimental factor; chronic cystitis|cystitis|bladder disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:0003025	acute megakaryoblastic leukaemia	Acute megakaryoblastic leukemia (AMKL) is a form of acute myeloid leukemia (AML) that occurs predominantly in childhood and particularly in children with Down syndrome (DS-AMKL). Nonspecific symptoms may be irritability, weakness, and dizziness while specific symptoms include pallor, fever, mucocutaneous bleeding, hepatosplenomegaly, neurological manifestations and rarely lymphadenopathy. Acute panmyelosis with myelofibrosis may also be associated with AMKL. In contrast to DS-AMKL (around 80 % survival), non-DS-AMKL is an AML subgroup associated with poor prognosis.	acute megakaryoblastic leukemia;megakaryocytic myelosis;leukemia, megakaryocytic, malignant;acute megakaryoblastic leukaemia, FAB M7;acute megakaryocytic leukemia;AMKL;acute myeloid leukemia M7;FAB M7;AML M7;acute megakaryocytic leukemias;acute megakaryoblastic leukaemia;thrombocytic leukaemia;acute megakaryoblastic leukemia (FAB type M7);acute megakaryoblastic leukemia, FAB M7;acute M7 myeloid leukemia	acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|chronic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|musculoskeletal system cancer|musculoskeletal system disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|acute disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|immune system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|musculoskeletal system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|immune system cancer|immune system disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute megakaryoblastic leukaemia|acute myeloid leukemia by FAB classification|acute myeloid leukemia|myeloid leukemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor
MONDO:0000728	ptosis	The drooping of the upper eyelid.	ptosis (disease);ptosis;eyelid ptosis;blepharoptosis;drooping eyelid	ptosis|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; ptosis|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
MONDO:0021142	acquired rippling muscle disease	The acquired form of RMD. Although RMD most often is reported with autosomal dominant inheritance, some sporadic cases are found, and an association with other diseases such as myasthenia gravis has also been reported.	acquired rippling muscle disease;sporadic rippling muscle disease	acquired rippling muscle disease|material entity|experimental factor; acquired rippling muscle disease|rippling muscle disease|myopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:1000481	Plantar Fibromatosis	A superficial fibromatosis arising from soft tissue of the plantar regions. It is characterized by the presence of spindle-shaped fibroblasts, hypercellularity, and an infiltrative growth pattern.	plantar fibromatosis;plantar part of pes superficial fibromatosis;superficial fibromatosis of plantar part of pes;plantar part of pes superficial Fibromatosis;Dupuytren's contracture of foot;superficial Fibromatosis of plantar part of pes;Ledderhose's disease;Lederhose disease	Plantar Fibromatosis|Superficial Fibromatosis|fibromatosis|Fibroblastic Neoplasm|mesenchymal cell neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Plantar Fibromatosis|Superficial Fibromatosis|fibromatosis|Fibroblastic Neoplasm|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; Plantar Fibromatosis|Superficial Fibromatosis|fibromatosis|Fibroblastic Neoplasm|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0009446	asphyxia	NA		asphyxia|hypoxia|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0002647	Aortic dissection	Aortic dissection refers to a tear in the intimal layer of the aorta causing a separation between the intima and the medial layers of the aorta.	Tear in inner wall of large artery that carries blood away from heart	Aortic dissection|Abnormal aortic morphology|Abnormality of cardiovascular system morphology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Aortic dissection|Abnormal aortic morphology|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0019280	hypertrichosis	Excessive hair growth anywhere on the body.	hypertrichosis;hypertrichosis (disease)	hypertrichosis|disorder of pilosebaceous unit|integumentary system disease|disease|disposition|material property|experimental factor
MONDO:0002516	digestive system cancer	A primary or metastatic malignant neoplasm involving any part of the digestive system.	digestive system cancer;malignant digestive system neoplasm;malignant gastrointestinal system neoplasm;gastrointestinal system cancer;malignant neoplasm of digestive system;cancer of digestive system;malignant gastrointestinal neoplasm;gastrointestinal tract cancer	digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0007466	retroperitoneal cancer	A primary or metastatic malignant neoplasm involving the retroperitoneum. The vast majority of cases are carcinomas, lymphomas, or sarcomas.	tumor of retroperitoneum;retroperitoneal neoplasm;malignant retroperitoneal space neoplasm;malignant retroperitoneal neoplasm;malignant neoplasm of retroperitoneum and peritoneum;cancer of retroperitoneal space;retroperitoneal cancer;neoplasm of the retroperitoneum;malignant neoplasm of retroperitoneal space;malignant tumor of peritoneum and retroperitoneum;retroperitoneal space cancer;neoplasm of retroperitoneum	retroperitoneal cancer|retroperitoneal neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; retroperitoneal cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
CHEBI:28300	glutamine	NA	Glutamine;glutamine	glutamine|amino acid|acid|chemical entity|material entity|experimental factor
MONDO:0037747	spinal injury	A injury that involves the vertebral column.	vertebral column injury;injury of vertebral column	spinal injury|injury|disease|disposition|material property|experimental factor; spinal injury|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
MONDO:0004985	bipolar disorder	A disorder of the brain that causes unusual shifts in mood, energy, activity levels and the ability to carry out day-to-day tasks. Often these moods range and shift from periods of elation and energized behavior to those of hopelessness and depression.	manic-depression;bipolar disorder;major affective disorder	bipolar disorder|mood disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; bipolar disorder|mood disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0020012	indolelactate measurement	Quantification of indolelactate levels in a sample.		indolelactate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0008577	Juvenile Osteochondrosis	NA		Juvenile Osteochondrosis|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
CHEBI:25722	orotidine	NA		orotidine|organic heterocyclic compound|chemical entity|material entity|experimental factor
HP:0000651	Diplopia	Diplopia is a condition in which a single object is perceived as two images, it is also known as double vision.	Double vision	Diplopia|Abnormality of vision|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0021254	corpus uteri neoplasm	A neoplasm (disease) that involves the body of uterus.	neoplasm of the uterine corpus;tumor of uterine body;uterine corpus neoplasm;neoplasm of corpus uteri;neoplasm of the uterine body;neoplasm of uterine corpus;tumor of the uterine corpus;corpus uteri tumor;body of uterus tumor;neoplasm of the corpus uteri;tumor of uterine corpus;uterine body neoplasm;uterine body tumor;body of uterus neoplasm;body of uterus neoplasm (disease);neoplasm of uterine body;uterine corpus tumor;neoplasm of the body of uterus;tumor of the corpus uteri;tumor of body of uterus;tumor of the uterine body;tumor of corpus uteri;neoplasm of body of uterus	corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; corpus uteri neoplasm|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0008568	Sleep Disorder	A change from the patient's baseline sleeping pattern, in the hours slept and/or an alteration/dysfunction in the stages of sleep.	parasomnia;disturbances, sleep;Sleep Disturbance;sleep disturbances;Sleep Disorders;sleep disturbance;Sleep Disturbances;Disturbances, Sleep;sleep disorder	Sleep Disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; Sleep Disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0005669	intracerebral hemorrhage	Bleeding into one or both cerebral hemispheres including the basal ganglia and the cerebral cortex. It is often associated with hypertension and craniocerebral trauma.	intracerebral hemorrhage;stroke, hemorrhagic	intracerebral hemorrhage|intracranial hemorrhage|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; intracerebral hemorrhage|intracranial hemorrhage|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; intracerebral hemorrhage|intracranial hemorrhage|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor
EFO:0004994	lumbar disc degeneration	Any disease of a degenerative nature that affects the intervertebral disc.	intervertebral Disc degenerative disorder;intervertebral disc disease;vertebral Disc degenerative disease;degenerative disc disorder;intervertebral Disc degenerative disease;intervertebral disc degeneration;intervertebral Disc Degeneration;intervertebral disk degenerative disorder;IDD;intervertebral disc degenerative disorder;degenerative disc disease;vertebral Disc degenerative disorder;degenerative disorder of intervertebral disk;vertebral disc disease	lumbar disc degeneration|vertebral joint disease|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; lumbar disc degeneration|vertebral joint disease|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; lumbar disc degeneration|genetic disorder|material entity|experimental factor; lumbar disc degeneration|genetic disorder|disease|disposition|material property|experimental factor
EFO:0004262	panic disorder	An anxiety disorder characterized by multiple unexpected panic attacks with persistent concern of recurring attacks. Panic disorder may or may not be accompanied by agoraphobia.	panic attack;panic disorder;panic syndrome;panic disorder syndrome;panic attacks;panic anxiety syndrome	panic disorder|anxiety disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; panic disorder|anxiety disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
HP:0012115	Hepatitis	Inflammation of the liver.	Liver inflammation	Hepatitis|Abnormality of the liver|Abnormality of the abdominal organs|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Hepatitis|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007525	tricuspid valve stenosis	Narrowing or stricture of the tricuspid orifice of the heart.	Tricuspid valve stenosis (disorder);Tricuspid Valve Stenosis;tricuspid valve stenosis;tricuspid stenosis;Tricuspid stenosis	tricuspid valve stenosis|tricuspid valve disease|heart valve disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; tricuspid valve stenosis|aortic valve disease|cardiac ventricle disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; tricuspid valve stenosis|aortic valve disease|aortic disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; tricuspid valve stenosis|aortic valve disease|heart valve disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
MONDO:0001370	pericardial effusion	Fluid collection within the pericardial sac, usually due to inflammation.	fluid, pericardial;pericardial fluid;pericardial effusion (disease);pericardial effusion	pericardial effusion|pericardium disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0800754	X-15666 measurement	NA		X-15666 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1001896	lateral epicondylitis	NA	archer's elbow;hockey elbow;tennis elbow;lateral humeral epicondylitis;golfer's elbow;lateral epicondylalgia	lateral epicondylitis|epicondylitis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; lateral epicondylitis|epicondylitis|inflammatory disease|disease|disposition|material property|experimental factor; lateral epicondylitis|epicondylitis|Tendinopathy|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; lateral epicondylitis|epicondylitis|Tendinopathy|connective tissue disease|disease|disposition|material property|experimental factor
MONDO:0005129	cataract	Partial or complete opacity of the crystalline lens of one or both eyes that decreases visual acuity and eventually results in blindness. Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Sternberg Diagnostic Surgical Pathology, 3rd ed.)	cataract;cataract (disease);opacity of the lens	cataract|genetic disorder|material entity|experimental factor; cataract|genetic disorder|disease|disposition|material property|experimental factor; cataract|lens disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; cataract|lens disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:1000627	thyroid disease	A disease involving the thyroid gland.	disease of thyroid gland;thyroid gland disease or disorder;thyroid gland disorder;disease or disorder of thyroid gland;thyroid gland disorders;thyroid gland diseases;Thyroiditis;thyroid gland disease;thyroid disease;disorder of thyroid gland	thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0009519	device complication	NA		device complication|complication|disease|disposition|material property|experimental factor
EFO:0008546	poisoning	A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent.	poisoning	poisoning|disease|disposition|material property|experimental factor
MONDO:0021118	intestinal neoplasm	A benign or malignant neoplasm involving the small or large intestine.	tumor of intestine;tumor of the intestines;neoplasm of intestinal tract;neoplasm of the intestines;intestinal tumors;intestine neoplasm (disease);neoplasm of intestines;intestine growth;intestine tumor;intestinal neoplasms;intestinal neoplasm;intestinal tumor;neoplasm of intestine;tumor of intestines;intestine neoplasm	intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:1000652	acute pancreatitis	An acute inflammatory process that leads to necrosis of the pancreatic parenchyma. Signs and symptoms include severe abdominal pain, nausea, vomiting, diarrhea, fever, and shock. Causes include alcohol consumption, presence of gallstones, trauma, and drugs.	pancreatitis necrotizing;acute pancreatitis;acute pancreatitis (disorder) [ambiguous];acute necrotizing pancreatitis;acute pancreatic necrosis;pancreatitis, acute	acute pancreatitis|pancreatitis|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor; acute pancreatitis|pancreatitis|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor; acute pancreatitis|acute disease|disease|disposition|material property|experimental factor; acute pancreatitis|pancreatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0005058	tyrosine measurement	NA		tyrosine measurement|measurement|information entity|experimental factor
HP:0001611	Nasal speech	A type of speech characterized by the presence of an abnormally increased nasal airflow during speech.	Nasal voice;Hypernasal voice;Hypernasal speech;Nasal speech	Nasal speech|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0008620	Polycystic Kidney Disease	A usually autosomal dominant and less frequently autosomal recessive genetic disorder characterized by the presence of numerous cysts in the kidneys leading to end-stage renal failure. The autosomal dominant trait is associated with abnormalities on the short arm of chromosome 16. Symptoms in patients with the autosomal dominant trait usually appear at middle age and include abdominal pain, hematuria, and high blood pressure. Patients may develop brain aneurysms and liver cysts. Patients with the autosomal recessive trait present with progressive renal failure early in life and symptoms resulting from hepatic fibrosis. The autosomal recessive trait is associated with abnormalities of chromosome 6. Polycystic kidney disease may also result as a side effect in patients on renal dialysis.	polycystic kidney disease;fibrocystic renal disease;Fibrocystic Renal Disease;PKD - polycystic kidney disease;PKD - Polycystic Kidney Disease	Polycystic Kidney Disease|familial cystic renal disease|genetic disorder|disease|disposition|material property|experimental factor; Polycystic Kidney Disease|familial cystic renal disease|genetic disorder|material entity|experimental factor; Polycystic Kidney Disease|familial cystic renal disease|Cystic Kidney Disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:0003898	ankylosing spondylitis	An autoimmune chronic inflammatory disorder characterized by inflammation in the vertebral joints of the spine and sacroiliac joints. It predominantly affects young males. Patients present with stiffness and pain in the spine.	Spondylarthritis Ankylopoietica;Ankylosing Spondylarthritides;Ankylosing Spondyloarthritides;Bechterew's Disease;Bekhterev's disease;Bechterew Disease;Spondylarthritis, Ankylosing;Marie-Strumpell disease;Marie-Struempell Disease;Spondylitis, Rheumatoid;Ankylosing Spondylarthritis;ankylosing spondylarthritis;Bekhterev syndrome;Marie Struempell Disease;Spondylitis, Ankylosing;BECHTEREW DIS;Rheumatoid Spondylitis;Bechterews Disease;ankylosing spondylitis;BECHTEREWS DIS;Spondylarthritides, Ankylosing;Spondyloarthritis, Ankylosing;Spondyloarthritides, Ankylosing;Ankylosing Spondyloarthritis;MARIE STRUEMPELL DIS	ankylosing spondylitis|vertebral joint disease|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|vertebral joint disease|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|spondyloarthropathy|immune system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|rheumatoid arthritis|arthritis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|spondyloarthropathy|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|spondyloarthropathy|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|spondylitis|inflammatory disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|rheumatoid arthritis|arthritis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|rheumatoid arthritis|arthritis|inflammatory disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|rheumatoid arthritis|autoimmune disorder of musculoskeletal system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|rheumatoid arthritis|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|spondyloarthropathy|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|rheumatoid arthritis|arthritis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|spondylitis|vertebral disorder|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|rheumatoid arthritis|autoimmune disorder of musculoskeletal system|musculoskeletal system disease|disease|disposition|material property|experimental factor; ankylosing spondylitis|rheumatoid arthritis|arthritis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor
EFO:0000616	neoplasm	A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.	neoplasia;neoplastic growth;neoplasm (disease);tumor disease;disease of cellular proliferation;neoplasm;neoplastic disease;tumor	neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0001941	blindness (disorder)	The lack of vision. It is caused by neurological or physiological factors.	visual impairment;vision loss;vision impairment	blindness (disorder)|vision disorder|perceptual disorders|nervous system disease|disease|disposition|material property|experimental factor; blindness (disorder)|vision disorder|disorder of visual system|disease|disposition|material property|experimental factor
MONDO:0001434	inflammatory spondylopathy	NA	inflammatory spondylopathies in disease EC	inflammatory spondylopathy|spondylitis|vertebral disorder|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; inflammatory spondylopathy|spondylitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0000756	melanoma	A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.	malignant melanoma;melanoma;melanoma (disease);Naevocarcinoma;melanoma, malignant	melanoma|melanocytic neoplasm|neurocristopathy|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; melanoma|melanocytic neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; melanoma|neuroendocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; melanoma|neuroendocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0021366	X-14208--phenylalanylserine measurement	NA		X-14208--phenylalanylserine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0004196	viral human hepatitis infection	An acute or chronic inflammation of the liver parenchyma caused by viruses. Representative examples include hepatitis A, B, and C, cytomegalovirus hepatitis, and herpes simplex hepatitis.	viral Hepatitis;Viruses caused hepatitis;human viral hepatitis;Viruses hepatitis;hepatitis, viral, human;viral hepatitis;Hepatitis viral;viral human hepatitis	viral human hepatitis infection|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; viral human hepatitis infection|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; viral human hepatitis infection|digestive system infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; viral human hepatitis infection|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; viral human hepatitis infection|inflammatory disease|disease|disposition|material property|experimental factor; viral human hepatitis infection|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0003764	transient ischemic attack	A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.	Attacks, Transient Ischemic;Transient cerebral ischaemia NOS;transient cerebral ischaemia;Transient Cerebral Ischemias;TIAs (Transient Ischemic Attack);Transient Ischemic Attack, Anterior Circulation;transient cerebral ischemia (disorder) [ambiguous];transient ischemic attack;Transient cerebral ischemia (disorder) [Ambiguous];Ischemia, Transient Cerebral;Transient cerebral ischaemia;Anterior Circulation Transient Ischemic Attack;Crescendo Transient Ischemic Attacks;Transient Ischemic Attack, Brainstem;Posterior Circulation Transient Ischemic Attack;Transient Ischemic Attacks;Brainstem Ischemias, Transient;Carotid Circulation Transient Ischemic Attack;Transient Cerebral Ischemia;Ischemic Attack, Transient;Transient ischemic attacks (disorder);ischemic attack, transient;Brain Stem Transient Ischemic Attack;Brainstem Transient Ischemic Attack;Transient Ischemic Attack, Brain Stem;transient ischemic attack (disease);transient ischemic attacks;TIA (Transient Ischemic Attack);Brain Stem Ischemia, Transient;Brainstem Ischemia, Transient;Brain TIA;Transient Ischemic Attack, Carotid Circulation;Ischemia, Transient Brainstem;TIA;Transient Ischemic Attack, Vertebrobasilar Circulation;Transient Brainstem Ischemia;TIA, Brain;Cerebral Ischemias, Transient;Vertebrobasilar Circulation Transient Ischemic Attack;TIA - transient ischaemic attack;Transient Ischemic Attacks, Crescendo;attack, transient ischemic;Transient Ischemic Attack, Posterior Circulation;Ischemias, Transient Cerebral;Attack, Transient Ischemic;Ischemias, Transient Brainstem;Cerebral Ischemia, Transient;Ischemic Attacks, Transient;TIA - Transient ischaemic attack	transient ischemic attack|brain ischemia|ischemic disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; transient ischemic attack|brain ischemia|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; transient ischemic attack|brain ischemia|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; transient ischemic attack|brain ischemia|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor
EFO:1001454	amnesia	NA	Amnestic syndrome;Amnestic State;Amnesia-Memory Loss	amnesia|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; amnesia|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:0009525	foreign body	NA		foreign body|injury|disease|disposition|material property|experimental factor
EFO:0009555	male reproductive system disease	A disease involving the male reproductive system.	disorder of Male reproductive system;male reproductive disease;Male reproductive system disorder;disease of male reproductive system;male reproductive system disease or disorder;disease or disorder of male reproductive system;male reproductive system disorder;Male reproductive system disease;male reproductive system disease;disorder of male reproductive system	male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
MONDO:0021462	benign neoplasm of rectum	A benign neoplasm that involves the rectum.	benign rectal tumors;benign rectal tumor;benign rectal neoplasms;rectum benign neoplasm;rectal tumors, benign;rectal neoplasms, benign;benign tumor of the rectum;benign rectal neoplasm;benign tumor of rectum;benign neoplasm of the rectum	benign neoplasm of rectum|rectal neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; benign neoplasm of rectum|rectal neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign neoplasm of rectum|benign neoplasm of large intestine|intestinal benign neoplasm|benign digestive system neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign neoplasm of rectum|benign neoplasm of large intestine|intestinal benign neoplasm|benign digestive system neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign neoplasm of rectum|benign neoplasm of large intestine|intestinal benign neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; benign neoplasm of rectum|benign neoplasm of large intestine|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; benign neoplasm of rectum|rectal neoplasm|rectal disease|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; benign neoplasm of rectum|benign neoplasm of large intestine|intestinal benign neoplasm|benign digestive system neoplasm|digestive system disease|disease|disposition|material property|experimental factor; benign neoplasm of rectum|benign neoplasm of large intestine|intestinal benign neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign neoplasm of rectum|rectal neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
MONDO:0021449	benign neoplasm of stomach	A benign neoplasm that involves the stomach.	stomach tumors, benign;benign gastric tumor;benign tumors of the stomach;benign stomach tumors;benign tumor of the stomach;benign tumor of stomach;gastric neoplasms, benign;benign tumors of stomach;benign gastric tumors;gastric tumors, benign;benign gastric neoplasm;stomach benign neoplasm;benign neoplasm of the stomach;benign stomach neoplasms;stomach neoplasms, benign	benign neoplasm of stomach|benign digestive system neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign neoplasm of stomach|benign digestive system neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign neoplasm of stomach|stomach neoplasm|stomach disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; benign neoplasm of stomach|stomach neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign neoplasm of stomach|benign digestive system neoplasm|digestive system disease|disease|disposition|material property|experimental factor
EFO:1000107	Benign Brain Neoplasm	A benign neoplasm that involves the brain.	benign brain tumor;benign tumor of brain;brain benign neoplasm;benign neoplasm of the brain;benign tumor of the brain;benign neoplasm of brain;benign brain neoplasm;brain neoplasms, benign	Benign Brain Neoplasm|central nervous system organ benign neoplasm|nervous system benign neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; Benign Brain Neoplasm|brain neoplasm|Central Nervous System Neoplasm|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Benign Brain Neoplasm|central nervous system organ benign neoplasm|Central Nervous System Neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Benign Brain Neoplasm|brain neoplasm|Central Nervous System Neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; Benign Brain Neoplasm|brain neoplasm|Central Nervous System Neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Benign Brain Neoplasm|central nervous system organ benign neoplasm|Central Nervous System Neoplasm|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Benign Brain Neoplasm|central nervous system organ benign neoplasm|nervous system benign neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Benign Brain Neoplasm|brain neoplasm|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Benign Brain Neoplasm|central nervous system organ benign neoplasm|nervous system benign neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Benign Brain Neoplasm|central nervous system organ benign neoplasm|Central Nervous System Neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0002278	benign colon neoplasm	A non-metastasizing neoplasm arising from the wall of the colon.	benign neoplasm of the colon;colon benign neoplasm;benign tumor of the colon;benign colon neoplasm;colonic Mass;benign colon tumor;benign tumor of colon;benign neoplasm of colon;benign colonic tumor;benign colonic neoplasm	benign colon neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; benign colon neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; benign colon neoplasm|benign neoplasm of large intestine|intestinal benign neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign colon neoplasm|benign neoplasm of large intestine|intestinal benign neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; benign colon neoplasm|benign neoplasm of large intestine|intestinal benign neoplasm|benign digestive system neoplasm|digestive system disease|disease|disposition|material property|experimental factor; benign colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign colon neoplasm|benign neoplasm of large intestine|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; benign colon neoplasm|benign neoplasm of large intestine|intestinal benign neoplasm|benign digestive system neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; benign colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; benign colon neoplasm|benign neoplasm of large intestine|intestinal benign neoplasm|benign digestive system neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0000493	family history	NA	FamilyHistory	family history|clinical history|information entity|experimental factor
MONDO:0000527	colon adenoma	An adenoma that arises from the colon. The group of colonic adenomas includes tubular, villous, and tubulovillous adenomas, traditional serrated adenomas, sessile serrated adenomas/polyps, and familial adenomatous polyposis.	adenoma of the colon;colonic adenoma;colon adenoma;adenoma of colon	colon adenoma|colorectal adenoma|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; colon adenoma|colorectal adenoma|Digestive System Adenoma|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; colon adenoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; colon adenoma|colorectal adenoma|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; colon adenoma|epithelial tumor of colon|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; colon adenoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; colon adenoma|epithelial tumor of colon|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; colon adenoma|colorectal adenoma|Digestive System Adenoma|digestive system disease|disease|disposition|material property|experimental factor; colon adenoma|epithelial tumor of colon|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; colon adenoma|colorectal adenoma|Digestive System Adenoma|adenoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; colon adenoma|colorectal adenoma|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0005842	colorectal cancer	A primary or metastatic malignant neoplasm that affects the colon or rectum. Representative examples include carcinoma, lymphoma, and sarcoma.	malignant tumor of large bowel;colorectal cancer;colon cancer, somatic;colorectal cancer, susceptibility to, autosomal dominant, somatic mutation;malignant neoplasm of the large intestine;malignant large intestine neoplasm;colorectum cancer;malignant neoplasm of large intestine;malignant large bowel tumor;malignant tumor of large intestine;cancer of large intestine;malignant colorectal tumor;malignant tumor of the large bowel;malignant tumor of the large intestine;colorectal cancer, somatic;cancer of colorectum;cancer of large bowel;malignant neoplasm of the large bowel;malignant large bowel neoplasm;colon cancer, advanced, somatic;malignant colorectal neoplasm;colorectal cancer with chromosomal instability, somatic;colorectal cancer, autosomal dominant, somatic mutation;cancer of the large bowel;malignant neoplasm of colorectum;malignant large intestine tumor;malignant colorectum neoplasm;malignant neoplasm of large bowel	colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0001421	liver disease	A disease involving the liver.	Liver disorder in pregnancy NOS (disorder);Liver disorder in pregnancy, with delivery;Liver disorder in pregnancy;Liver Disorder;[X]Diseases of the liver;disease of liver [Ambiguous];Disease, Liver;hepatic disease;Hepatopathy;[X]Diseases of the liver (disorder);Liver Dysfunction;LD - Liver disease;Disorder of liver;liver disorder;LIVER DIS;liver disease;Liver disorder in pregnancy (disorder);disorder of liver;Liver disorder in pregnancy - delivered (disorder);Liver and Intrahepatic Bile Duct Disorder;Diseases, Liver;liver disease or disorder;disease of the liver (disorder);Dysfunctions, Liver;liver disorder antepartum;Liver disorder in pregnancy unspecified (disorder);disease of liver;Liver disorder NOS;Liver disorder NOS (disorder);Dysfunction, Liver;liver disorder in pregnancy - delivered;Unspecified disorder of liver;Disease of liver;disease or disorder of liver;disorder of liver (disorder);Liver disorder in pregnancy, unspecified as to episode of care;liver and intrahepatic bile duct disorder;Liver Dysfunctions;hepatic disorder;Liver Diseases	liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; liver disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0008588	peritonitis	Inflammation of the peritoneum due to infection by bacteria or fungi. Causes include liver disease, perforation of the gastrointestinal tract or biliary tract, and peritoneal dialysis. Patients usually present with abdominal pain and tenderness, fever, chills, and nausea and vomiting. It is an emergency medical condition that requires prompt medical attention and treatment.	primary bacterial peritonitis;acute generalized peritonitis;retractile mesenteritis;peritonitis;peritoneum inflammation;inflammation of peritoneum	peritonitis|disease of peritoneum|digestive system disease|disease|disposition|material property|experimental factor; peritonitis|serositis|inflammatory disease|disease|disposition|material property|experimental factor
MONDO:0000956	small intestine cancer	A primary or metastatic malignant neoplasm involving the small intestine.	malignant small intestinal neoplasm;malignant neoplasm of small intestine;malignant tumor of the small intestine;small intestine cancer;malignant tumor of the small bowel;malignant tumor of small bowel;malignant neoplasm of the small intestine;malignant small bowel neoplasm;malignant small bowel tumor;malignant neoplasm of small bowel;malignant tumor of small intestine;cancer of small intestine;malignant small intestine tumor;malignant neoplasm of the small bowel;malignant small intestine neoplasm	small intestine cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; small intestine cancer|small intestine neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; small intestine cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; small intestine cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; small intestine cancer|small intestine neoplasm|small intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; small intestine cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; small intestine cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; small intestine cancer|small intestine neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0020925	angina unstable	NA		angina unstable|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001268	Aortic Rupture	NA		Aortic Rupture|aortic disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
MONDO:0018630	hereditary nonpolyposis colon cancer	Hereditary nonpolyposis colon cancer (HNPCC) is a cancer-predisposing condition characterized by the development of colorectal cancer not associated with colorectal polyposis, endometrial cancer, and various other cancers (such as malignant epithelial tumor of ovary, gastric, biliary tract, small bowel, and urinary tract cancer) that are frequently diagnosed at an early age.	HNPCC;colorectal cancer, hereditary nonpolyposis;hereditary nonpolyposis colon cancer;familial nonpolyposis colorectal cancer;Hereditary nonpolyposis colorectal cancer (HNPCC);hereditary nonpolyposis colorectal cancer;familial nonpolyposis colon cancer	hereditary nonpolyposis colon cancer|familial colorectal cancer|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|inherited digestive cancer-predisposing syndrome|hereditary neoplastic syndrome|neoplastic syndrome|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|inherited digestive cancer-predisposing syndrome|hereditary neoplastic syndrome|neoplastic syndrome|syndromic disease|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|inherited digestive cancer-predisposing syndrome|hereditary neoplastic syndrome|genetic disorder|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|familial colorectal cancer|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|inherited digestive cancer-predisposing syndrome|hereditary neoplastic syndrome|genetic disorder|material entity|experimental factor; hereditary nonpolyposis colon cancer|familial colorectal cancer|inherited digestive tract tumor|genetic disorder|material entity|experimental factor; hereditary nonpolyposis colon cancer|familial colorectal cancer|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|familial colorectal cancer|inherited digestive tract tumor|genetic disorder|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|familial colorectal cancer|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|inherited digestive cancer-predisposing syndrome|hereditary neoplastic syndrome|neoplastic syndrome|syndromic disease|material entity|experimental factor; hereditary nonpolyposis colon cancer|familial colorectal cancer|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|familial colorectal cancer|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|familial colorectal cancer|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|familial colorectal cancer|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hereditary nonpolyposis colon cancer|familial colorectal cancer|inherited digestive tract tumor|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:1000502	Rectal Hyperplastic Polyp	A serrated polypoid lesion that arises in the rectum. It rarely produces symptoms. This group includes goblet cell rich, mucin poor, and microvesicular hyperplastic polyps.	rectal MP;rectal metaplastic polyp;rectal Hp;hyperplastic polyp of the rectum;hyperplastic polyp of rectum;rectal hyperplastic polyp	Rectal Hyperplastic Polyp|polyp of rectum|rectal disease|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Rectal Hyperplastic Polyp|polyp of rectum|polyp of large intestine|polyp|cancer or benign tumor|disease|disposition|material property|experimental factor; Rectal Hyperplastic Polyp|polyp of rectum|polyp of large intestine|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0001423	encephalomyelitis	Inflammation of the brain and the spinal cord.	encephalitis &/or myelitis;encephalitis and/or myelitis;Encephalitis/myelitis NOS (disorder);encephalitis;Inflammatory Encephalomyelitis;Myeloencephalitides;MYELOENCEPH;central nervous system inflammation;Encephalomyelitis NOS;INFLAMM ENCEPH;inflammation of central nervous system;Encephalitis &/or myelitis;Encephalomyelitis NOS (disorder);Myeloencephalitis;Encephalitis/myelitis NOS;Encephalomyelitis (disorder);encephalomyelitis;ENCEPH INFLAMM;Encephalomyelitis, Inflammatory;Encephalomyelitis, NOS	encephalomyelitis|inflammatory disease|disease|disposition|material property|experimental factor; encephalomyelitis|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0006509	Varicella Zoster infection	A highly contagious viral infection caused by the varicella zoster virus. Clinically, it may be manifested as shingles or chicken pox.	varicella zoster infection;Varicella-zoster Virus infection	Varicella Zoster infection|Herpesviridae infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Varicella Zoster infection|Herpesviridae infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
MONDO:0001627	dementia	Loss of intellectual abilities interfering with an individual's social and occupational functions. Causes include Alzheimer's disease, brain injuries, brain tumors, and vascular disorders.	dementia (disease);dementia	dementia|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; dementia|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009479	throat disease	NA	throat or larynx disorder;throat disorder	throat disease|head and neck disorder|disease|disposition|material property|experimental factor
CHEBI:37054	3-hydroxybutyrate	NA	3-hydroxybutanoate	3-hydroxybutyrate|lipid|chemical entity|material entity|experimental factor
CHEBI:13705	acetoacetate	NA	acetoacetate;Acetoacetate;3-oxobutanoate	acetoacetate|lipid|chemical entity|material entity|experimental factor
EFO:0010732	omega-6:omega-3 polyunsaturated fatty acid ratio	NA	NA	omega-6:omega-3 polyunsaturated fatty acid ratio|fatty acid measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
CHEBI:9150	simvastatin	NA	(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate;Simvastatin	simvastatin|lipid|chemical entity|material entity|experimental factor; simvastatin|organic heterocyclic compound|chemical entity|material entity|experimental factor
HP:0003124	Hypercholesterolemia	An increased concentration of cholesterol in the blood.	Elevated serum cholesterol;Increased total cholesterol;Elevated total cholesterol	Hypercholesterolemia|Abnormal circulating lipid concentration|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:39548	atorvastatin	NA	Atorvastatin;(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-4-phenyl-2-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid	atorvastatin|organic heterocyclic compound|chemical entity|material entity|experimental factor
EFO:0000589	metabolic disease	A congenital disorder (due to inherited enzyme abnormality) or acquired (due to failure of a metabolically important organ) disorder resulting from an abnormal metabolic process.	MD - Metabolic disorders;metabolic disorder;Metabolic disorders;disorder of metabolic process;metabolism disorder;Generalised metabolic disorder;disease of metabolism;DIS METAB;Metabolic Disorder;metabolic disease;Disorder of metabolism NOS (disorder);METAB DIS;Generalized metabolic disorder;METABOLISM DISORDER NOS;Unspecified disorder of metabolism;Disease, Metabolic;Disorder of metabolism NOS;Metabolic Diseases;Thesaurismoses;Metabolic disease, NOS;Metabolic disorder, NOS;Diseases, Metabolic;Metabolic disease (disorder);Thesaurismosis;metabolic process disease;Generalized metabolic disorder (disorder)	metabolic disease|disease|disposition|material property|experimental factor
EFO:0004631	vitamin D measurement	NA		vitamin D measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; vitamin D measurement|vitamin measurement|measurement|information entity|experimental factor
CHEBI:39026	low-density lipoprotein	NA		low-density lipoprotein|protein|chemical entity|material entity|experimental factor; low-density lipoprotein|protein|biological macromolecule|material entity|experimental factor
NCBITaxon:12721	Human immunodeficiency virus	NA	HIV;AIDS virus	Human immunodeficiency virus|Virus|organism|material entity|experimental factor
EFO:0000764	HIV infection	An infection caused by the human immunodeficiency virus.	Infection, HIV;[X]Unspecified human immunodeficiency virus [HIV] disease;Infections, HTLV-III-LAV;HTLV WIII LAV INFECTIONS;[X]Human immunodeficiency virus disease;HTLV III INFECT;Infections, HIV;HTLV-III Infection;Human immunodeficiency virus disease (disorder);Human immunodeficiency virus infectious disease;Human immunodeficiency virus infection (disorder);Infections, HTLV-III;T Lymphotropic Virus Type III Infections, Human;HTLV III Infections;HTLV-III-LAV Infection;HTLV-III Infections;[X]Human immunodeficiency virus disease (disorder);HIV;HIV infectious disease;Unspecified human immunodeficiency virus [HIV] disease (disorder);HIV - Human immunodeficiency virus infection;[X]Unspecified human immunodeficiency virus [HIV] disease (disorder);HTLV III LAV Infections;HUMAN IMMUNO VIRUS DIS;LYMPHOTROPIC VIRUS TYPE III INFECTIONS HUMAN T;HTLV III LAV INFECT;HIV Infections;Human immunodeficiency virus infection;Human immunodeficiency virus [HIV] disease;Infection, HTLV-III;HTLV-III-LAV Infections;HTLV WIII INFECTIONS;HUMAN IMMUNOdeficiency VIRUS [HIV] INFECTION;HIV Infection;Infection, HTLV-III-LAV;Human immunodeficiency virus disease or disorder;T-Lymphotropic Virus Type III Infections, Human;Human immunodeficiency virus infection, NOS;human immunodeficiency virus;Human immunodeficiency virus disease;Human immunodeficiency virus caused disease or disorder;HIV INFECT;HIV infection;T LYMPHOTROPIC VIRUS TYPE III INFECT HUMAN	HIV infection|viral sexually transmitted disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; HIV infection|viral sexually transmitted disease|sexually transmitted disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; HIV infection|Lentivirus Infections|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; HIV infection|viral sexually transmitted disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; HIV infection|Lentivirus Infections|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0010116	choline measurement	NA		choline measurement|measurement|information entity|experimental factor
EFO:0003882	osteoporosis	A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).	Bone Loss, Age Related;Osteoporoses, Age-Related;Osteoporosis, Post Traumatic;Osteoporosis, Senile;Age-Related Bone Loss;Osteoporosis, Age-Related;Age Related Osteoporosis;osteoporosis, postmenopausal;Post-Traumatic Osteoporosis;BONE LOSS AGE RELAT;osteoporosis;osteoporosis, postmenopausal, susceptibility;Bone Losses, Age-Related;Osteoporoses, Senile;AGE RELAT OSTEOPOROSIS;Bone Loss, Age-Related;osteoporosis, susceptibility to;Osteoporosis, Age Related;Senile Osteoporoses;Post-Traumatic Osteoporoses;Age-Related Bone Losses;bone mineral density variation QTL, osteoporosis;Osteoporosis, Post-Traumatic;Age-Related Osteoporosis;Age-Related Osteoporoses;OSTEOPOROSIS AGE RELAT;Senile Osteoporosis;Osteoporoses	osteoporosis|bone resorption disease|bone remodeling disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|osteogenesis imperfecta|osteochondrodysplasia|bone development disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|osteogenesis imperfecta|genetic disorder|disease|disposition|material property|experimental factor; osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|skeletal dysplasia|genetic disorder|material entity|experimental factor; osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|skeletal dysplasia|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|osteogenesis imperfecta|genetic disorder|material entity|experimental factor; osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|osteogenesis imperfecta|osteochondrodysplasia|bone development disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; osteoporosis|osteogenesis imperfecta and a reduction of bone mineral density.|skeletal dysplasia|genetic disorder|disease|disposition|material property|experimental factor
EFO:1001870	late-onset Alzheimers disease	NA	Senile Dementia, Alzheimer Type;late-onset Alzheimer's;Alzheimer Senile Dementia;Alzheimer Type Senile Dementia	late-onset Alzheimers disease|Alzheimer disease|tauopathy|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; late-onset Alzheimers disease|Alzheimer disease|dementia|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; late-onset Alzheimers disease|Alzheimer disease|dementia|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:0002950	pregnancy	NA	PREGN;Gestation;Pregnancies	pregnancy|reproductive process|biological process|process|experimental factor
EFO:0006807	linoleic acid measurement	NA		linoleic acid measurement|omega-6 polyunsaturated fatty acid measurement|fatty acid measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:1001513	liver neoplasm	NA	NEOPL LIVER;Hepatic Cancers;Cancers, hepatic;Neoplasm, liver;liver Cancers;Cancers, liver;liver Cancer;Hepatic Neoplasms;Cancer of liver;Cancer, liver;Cancer, hepatic;Cancer of the liver;Neoplasm, hepatic;LIVER NEOPL;Hepatic Cancer	liver neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; liver neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; liver neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0009569	trigeminal nerve disease	A disease involving the trigeminal nerve.	disease or disorder of trigeminal nerve;disease of trigeminal nerve;trigeminal nerve disease;trigeminal nerve disease or disorder;trigeminal nerve disorder;disorder of trigeminal nerve	trigeminal nerve disease|cranial nerve neuropathy|nervous system disease|disease|disposition|material property|experimental factor; trigeminal nerve disease|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0800347	2-hydroxydecanoate measurement	NA		2-hydroxydecanoate measurement|metabolite measurement|measurement|information entity|experimental factor
MONDO:0001583	diabetic polyneuropathy	NA	diabetes mellitus with polyneuropathy;polyneuropathy in diabetes	diabetic polyneuropathy|diabetic neuropathy|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; diabetic polyneuropathy|diabetic neuropathy|autonomic nervous system disease|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; diabetic polyneuropathy|diabetic neuropathy|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; diabetic polyneuropathy|diabetic neuropathy|autonomic nervous system disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009322	proliferative diabetic retinopathy	Advanced retinopathy due to diabetes mellitus characterized by the formation of new vessels in the retina. The new vessels are abnormal and fragile. If hemorrhage occurs due to the vascular fragility, there is increased risk of vision loss or blindness.	PDR;proliferative diabetic retinopathy	proliferative diabetic retinopathy|diabetic retinopathy|metabolic disease|disease|disposition|material property|experimental factor; proliferative diabetic retinopathy|diabetic retinopathy|retinal vascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; proliferative diabetic retinopathy|diabetic retinopathy|retinal vascular disorder|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; proliferative diabetic retinopathy|diabetic retinopathy|retinal vascular disorder|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; proliferative diabetic retinopathy|diabetic retinopathy|retinal vascular disorder|ocular vascular disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; proliferative diabetic retinopathy|diabetic retinopathy|retinal vascular disorder|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; proliferative diabetic retinopathy|diabetic retinopathy|retinal vascular disorder|ocular vascular disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; proliferative diabetic retinopathy|diabetic retinopathy|diabetic eye disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; proliferative diabetic retinopathy|diabetic retinopathy|diabetic eye disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; proliferative diabetic retinopathy|diabetic retinopathy|retinal vascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; proliferative diabetic retinopathy|diabetic retinopathy|retinal vascular disorder|ocular vascular disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0009253	Immature Reticulocyte Fraction Measurement	NA	Immature Reticulocyte Fraction;IRF;Measurement of Immature Reticulocyte Fraction	Immature Reticulocyte Fraction Measurement|Blood Cell Count Ratio Measurement|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0008205	left ventricular structural measurement	NA		left ventricular structural measurement|cardiovascular measurement|measurement|information entity|experimental factor
EFO:0001067	parasitic infection	A successful invasion of a host by an organism that uses the host for food and shelter.	Parasitosis, NOS;parasitic eye infectious disease;Disease caused by parasite, NOS;Parasite infestation, NOS;disease caused by parasite;intestinal parasitism (disorder);Parasitic skin infestation (disorder);parasitic liver infectious disease;parasitic infestation of orbit;Disease caused by parasite;Parasitic infection of lung;Infestation;Disease caused by parasite (disorder);parasitic gastrointestinal disorder;Parasitosis;parasitic infection;parasitemia;central nervous system parasitic infectious disease;Parasitic endophthalmitis NOS (disorder);Infestation, NOS;intestinal parasitism NOS (disorder);Ectoparasitic disease;psorospermiasis;Parasite infestation;parasitic intestinal infectious disease;PARASITIC DIS;Parasitic infestation of orbit (disorder);Parasitism, NOS;Parasitic endophthalmitis NOS;intestinal parasitism, unspecified;Parasitic Diseases;Disease, Parasitic;Parasitic disease;parasitic liver disorder;Diseases, Parasitic;parasitic infectious disease;parasitic lung infectious disease;Parasitic infection, NOS;parasitic skin disorder;parasitic animal;parasitic skin infectious disease;Parasitism;Parasitic eye infection (disorder);parasitic eye infection;Parasitic infectious disease of the central nervous system (disorder);intestinal parasitism, unspecified (disorder);skin Infestation NOS;parasitic disease;animal parasitic infectious disease;Parasitic infection of skin;Psorospermiasis (disorder);Parasitic disease, NOS;parasitic endophthalmitis;Parasitic endophthalmitis (disorder);Parasitic infectious disease, NOS;parasitic pregnancy complication	parasitic infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:1001160	rheumatic fever	A post-bacterial multisystem inflammatory disease occurring as a post-infectious, nonsuppurative sequela of untreated streptococcus pyogenes (Group A streptococcus [GAS]) pharyngitis, and mainly occurs in individuals aged 5 to 15 years. The most common presenting signs are fever, migratory polyarthritis and carditis.	RHF - rheumatic fever;rheumatic fever;ACUTE RHEUMATIC FEVER;RhF - Rheumatic fever;acute rheumatic fever;Rheumatic Fever;ARF	rheumatic fever|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; rheumatic fever|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; rheumatic fever|post-bacterial disorder|post-infectious disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
HP:0001788	Premature rupture of membranes	Premature rupture of membranes (PROM) is a condition which occurs in pregnancy when the amniotic sac ruptures more than an hour before the onset of labor.		Premature rupture of membranes|Abnormal delivery|Abnormality of prenatal development or birth|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0011412	Ventouse delivery	Delivery of newborn by means of a ventouse, a vacuum device used to assist the delivery of a baby when the second stage of labour has not progressed adequately.	Vacuum-assisted vaginal delivery;Vacuum extraction	Ventouse delivery|Abnormal delivery|Abnormality of prenatal development or birth|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MPATH:579	ulcer	Loss of epithelium and the basement membrane (full thickness). Cf Erosion.		ulcer|pathological entity|material entity|experimental factor
EFO:0006941	grip strength measurement	NA		grip strength measurement|anthropometric measurement|measurement|information entity|experimental factor
EFO:0009538	chronic inflammatory demyelinating polyneuropathy	A form of Guillain-Barre syndrome (GBS) that occurs in persons or families with a genetic predisposition to the acute or chronic forms of GBS. Note that GBS is considered to be a complex multifactorial disorder with both genetic and environmental factors, and families with clear Mendelian inheritance have been rarely reported: a mutation in the PMP22 gene (601097) on chromosome 17 was identified in a single family with the acute (AIDP) and chronic (CIDP) forms of inflammatory demyelinating polyneuropathy.	CIDP;AIDP;chronic inflammatory demyelinating polyneuropathy;Guillain-Barre syndrome, familial;neuropathy, inflammatory demyelinating;polyneuropathy, inflammatory demyelinating, acute;chronic inflammatory demyelinating polyradiculoneuropathy	chronic inflammatory demyelinating polyneuropathy|Guillain-Barre syndrome|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; chronic inflammatory demyelinating polyneuropathy|polyradiculoneuropathy|polyneuropathy|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; chronic inflammatory demyelinating polyneuropathy|Guillain-Barre syndrome|autoimmune disorder of peripheral nervous system|autoimmune disorder of the nervous system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; chronic inflammatory demyelinating polyneuropathy|polyradiculoneuropathy|polyneuropathy|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; chronic inflammatory demyelinating polyneuropathy|polyradiculoneuropathy|demyelinating disease|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; chronic inflammatory demyelinating polyneuropathy|Guillain-Barre syndrome|autoimmune disorder of peripheral nervous system|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; chronic inflammatory demyelinating polyneuropathy|chronic disease|disease|disposition|material property|experimental factor; chronic inflammatory demyelinating polyneuropathy|Guillain-Barre syndrome|syndromic disease|disease|disposition|material property|experimental factor; chronic inflammatory demyelinating polyneuropathy|Guillain-Barre syndrome|syndromic disease|material entity|experimental factor; chronic inflammatory demyelinating polyneuropathy|Guillain-Barre syndrome|autoimmune disorder of peripheral nervous system|autoimmune disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; chronic inflammatory demyelinating polyneuropathy|polyradiculoneuropathy|demyelinating disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor
EFO:0007420	paratyphoid fever	A condition resembling typhoid fever that is caused by infection by Salmonella enterica serovar Parathyphi.	Paratyphoid A fever (disorder);Paratyphoid Fever A;paratyphoid fever;Paratyphoid fever B;paratyphoid b;Paratyphoid fever C;paratyphoid c;Paratyphoid Fever B;paratyphoid a;Paratyphoid Fever;Paratyphoid C fever (disorder);Paratyphoid;Paratyphoid Fever C;Paratyphoid fever A;Paratyphoid B fever (disorder)	paratyphoid fever|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; paratyphoid fever|salmonellosis|primary bacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; paratyphoid fever|salmonellosis|primary bacterial infectious disease|material entity|experimental factor
EFO:0005628	proctitis	An inflammatory process affecting the anus. It is usually caused by sexually transmitted infectious agents and/or inflammatory bowel disease.	proctitis;inflammation of anus;anus inflammation;rectitis	proctitis|inflammatory bowel disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; proctitis|inflammatory bowel disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; proctitis|inflammatory bowel disease|genetic disorder|material entity|experimental factor; proctitis|anus disease|rectal disease|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; proctitis|inflammatory disease|disease|disposition|material property|experimental factor; proctitis|inflammatory bowel disease|genetic disorder|disease|disposition|material property|experimental factor
EFO:0003769	endocrine neoplasm	A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. Representative examples include pituitary gland adenoma, pituitary gland carcinoma, thyroid gland carcinoma, carcinoid tumor, and neuroendocrine carcinoma.	Cancer, Endocrine;endocrine gland neoplasm;Endocrine Gland Neoplasms;ENDOCRINE GLAND NEOPL;Endocrine Gland Carcinoma;endocrine system neoplasm;endocrine neoplasm;endocrine system tumor;Carcinoma of Endocrine Gland;Endocrine Cancer;Cancer, Endocrine Gland;Neoplasms, Endocrine Gland;NEOPL ENDOCRINE GLAND;Endocrine Cancers;Cancers, Endocrine;Endocrine Gland Neoplasm;tumor of endocrine gland;Cancer of the Endocrine Gland;Carcinoma, Endocrine Gland;endocrine gland tumor;Endocrine Gland Cancer;Cancer of Endocrine Gland;endocrine tumor;neoplasm of endocrine gland;endocrine gland neoplasm (disease);Neoplasm, Endocrine Gland	endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0020984	skin sensitization	NA	skin sensitisation	skin sensitization|inflammatory skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
MONDO:0002181	exostosis	Non-neoplastic overgrowth of bone.	bony outgrowth;bone osteophyte;osteophyte;bone spur;exostosis	exostosis|hyperostosis|bone remodeling disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0009659	aneurysm	NA		aneurysm|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0007490	spinal stenosis	Narrowing of the spinal canal.	Spinal Stenosis;spinal stenosis;lumbar spinal stenosis;Spinal stenosis of lumbar region;cervical spinal stenosis	spinal stenosis|disease of bone structure|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; spinal stenosis|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:1002026	rubella	A viral infection caused by the rubella virus. It is initially manifested with flu-like symptoms that last one or two days, followed by the development of a characteristic red rash which lasts from one to five days. The rash first appears in the neck and face. It subsequently spreads to the rest of the body.	Rubella virus caused disease or disorder;three-Day Measles;rubella;three-day measles;Rubella virus disease or disorder;german measles;Rubella infection;Rubella virus infectious disease;German measles	rubella|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; rubella|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0000618	nervous system disease	A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.	disease of nervous system;disorder of nervous system;neurologic disorder;disease or disorder of nervous system;neurological disorder;nervous system disorder;nervous system disease or disorder;neurological problem;neurological disease;neurologic disease;nervous system disease	nervous system disease|disease|disposition|material property|experimental factor
HP:0000505	Visual impairment	Visual impairment (or vision impairment) is vision loss (of a person) to such a degree as to qualify as an additional support need through a significant limitation of visual capability resulting from either disease, trauma, or congenital or degenerative conditions that cannot be corrected by conventional means, such as refractive correction, medication, or surgery.	Impaired vision;Loss of eyesight;Poor vision;Visual impairment	Visual impairment|Abnormality of vision|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0002791	Hypoventilation	A reduction in the amount of air transported into the pulmonary alveoli by breathing, leading to hypercapnia (increase in the partial pressure of carbon dioxide).	Under breathing;Alveolar hypoventilation;Slow breathing	Hypoventilation|Abnormal pattern of respiration|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005952	non-Hodgkins lymphoma	Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.	non-Hodgkin lymphoma;non-Hodgkins lymphoma;non-Hodgkin's lymphoma;non-Hodgkin's lymphoma (NHL);NHL	non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor
EFO:1000764	seborrheic dermatitis	A chronic, inflammatory skin disorder that affects the scalp, central face and skin folds; it is characterized by scaling and itching.	seborrhea;seborrheic dermatitis (disease);skin seborrheic;Seborrhoeic dermatitis;seborrhoeic eczema;seborrheic dermatitis;seborrhoea;cradle Cap;seborrheic eczema;Seborrhoeic eczema	seborrheic dermatitis|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; seborrheic dermatitis|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0009532	autonomic nervous system disease	A disease involving the autonomic nervous system.	disease or disorder of autonomic nervous system;disorder of peripheral autonomic nervous system;autonomic nervous system disease or disorder;disorder of autonomic nervous system;autonomic nervous system disease;autonomic nervous disease;disorder of the autonomic nervous system;dysautonomia;autonomic nervous system disorder;disease of autonomic nervous system	autonomic nervous system disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; autonomic nervous system disease|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0004766	subcutaneous adipose tissue measurement	NA		subcutaneous adipose tissue measurement|adipose tissue measurement|anthropometric measurement|measurement|information entity|experimental factor
MONDO:0004678	dermatophytosis	A common fungal infection of the stratum corneum of the skin, hair, or nails by a dermatophyte. It is characterized by itching, inflammation, redness of the skin, small papular vesicles, central clearing, fissures, scaling, and/or hair loss in the affected area.	skin disease, fungal;fungal skin diseases;skin diseases, fungal;fungal skin disease	dermatophytosis|tinea|skin infection|skin disorder caused by infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; dermatophytosis|tinea|skin infection|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; dermatophytosis|superficial mycosis|cutaneous mycosis|fungal infectious disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; dermatophytosis|tinea|cutaneous mycosis|material entity|experimental factor; dermatophytosis|superficial mycosis|cutaneous mycosis|material entity|experimental factor; dermatophytosis|tinea|cutaneous mycosis|fungal infectious disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; dermatophytosis|tinea|skin infection|skin disorder caused by infection|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; dermatophytosis|tinea|skin infection|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:1000718	irritant dermatitis	An inflammatory skin condition caused by direct contact between the skin and an irritating substance. It is typically manifested by erythema, mild edema, and scaling at the affected site.	irritant contact dermatitis;irritant dermatitis;primary irritant dermatitis	irritant dermatitis|contact dermatitis|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; irritant dermatitis|contact dermatitis|allergic disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; irritant dermatitis|contact dermatitis|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:1001388	Pelvic Inflammatory Disease	Pelvic inflammatory disease (PID) is an acute or chronic inflammation in the pelvic cavity. It is most commonly caused by sexually transmitted diseases, including chlamydia and gonorrhea that have ascended into the uterus, fallopian tubes, or ovaries as a result of intercourse or childbirth, or of surgical procedures, including insertion of IUDs or abortion. PID may be either symptomatic or asymptomatic. It may cause infertility and it may raise the risk of ectopic pregnancy. PID is a disease associated with HIV infection.	pelvic inflammatory disease;PID	Pelvic Inflammatory Disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; Pelvic Inflammatory Disease|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0004593	gestational diabetes	Carbohydrate intolerance first diagnosed during pregnancy.	GDM;gestational diabetes;diabetes in pregnancy;gestational diabetes mellitus;maternal gestational diabetes mellitus	gestational diabetes|diabetes mellitus|endocrine pancreas disorder|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor; gestational diabetes|pregnancy disorder|obstetric disorder|disease|disposition|material property|experimental factor; gestational diabetes|diabetes mellitus|glucose metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; gestational diabetes|diabetes mellitus|endocrine pancreas disorder|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0006922	delivery measurement	NA		delivery measurement|measurement|information entity|experimental factor
EFO:0009579	postpartum hemorrhage	NA	postpartum haemorrhage	postpartum hemorrhage|hemorrhage|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor; postpartum hemorrhage|puerperal disorder|obstetric disorder|disease|disposition|material property|experimental factor
EFO:0021784	age at initiation of smoking	NA		age at initiation of smoking|age|temporal measurement|measurement|information entity|experimental factor
EFO:0000403	diffuse large B-cell lymphoma	Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma (NHL) in adults characterized by a median age of presentation in the sixth decade of life (but also rarely occurring in adolescents and children) with the initial presentation being single or multiple rapidly growing masses (that may or may not be painful) in nodal or extranodal sites (such as thyroid, skin, breast, gastrointestinal tract, testes, bone, or brain) and that can be accompanied by symptoms of fever, night sweats and weight loss. DLBCL has an aggressive disease course, with the elderly having a poorer prognosis than younger patients, and with relapses being common.	diffuse large B-cell lymphoma;DLBCL	diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|immune system disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|immune system disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|aggressive B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; diffuse large B-cell lymphoma|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor
HP:0000093	Proteinuria	Increased levels of protein in the urine.	High urine protein levels;Protein in urine	Proteinuria|Abnormality of urine homeostasis|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Proteinuria|Abnormality of urine homeostasis|Abnormality of the urinary system physiology|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000678	pterygium	A wedge-shaped fibrovascular lesion arising from the bulbar conjunctiva and extending to the cornea. It is caused by chronic exposure to solar ultraviolet radiation, heat, and dust. It may cause severe vision loss. Studies have linked pterygium to neoplastic proliferation and suggest that it may be a stem cell disorder.	pterygium;pterygium of conjunctiva and cornea;surfer's eye	pterygium|Benign Conjunctival Neoplasm|benign neoplasm of eye|eye neoplasm|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|cornea neoplasm|eye neoplasm|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|conjunctival tumor|Conjunctival Disorder|eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|benign neoplasm of eye|eye neoplasm|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|benign neoplasm of eye|eye neoplasm|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|benign neoplasm of eye|sensory organ benign neoplasm|nervous system benign neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|cornea neoplasm|eye neoplasm|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|benign neoplasm of eye|sensory organ benign neoplasm|nervous system benign neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|cornea neoplasm|corneal disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|cornea neoplasm|corneal disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|benign neoplasm of eye|sensory organ benign neoplasm|nervous system benign neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|benign neoplasm of eye|eye neoplasm|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|benign neoplasm of eye|eye neoplasm|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|cornea neoplasm|eye neoplasm|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|conjunctival tumor|eye neoplasm|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|conjunctival tumor|eye neoplasm|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|conjunctival tumor|eye neoplasm|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|benign neoplasm of eye|eye neoplasm|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|benign neoplasm of eye|eye neoplasm|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|conjunctival tumor|Conjunctival Disorder|eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|benign neoplasm of eye|sensory organ benign neoplasm|nervous system benign neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|conjunctival tumor|material entity|experimental factor; pterygium|Benign Conjunctival Neoplasm|benign neoplasm of eye|sensory organ benign neoplasm|nervous system benign neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|benign neoplasm of eye|eye neoplasm|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; pterygium|Benign Conjunctival Neoplasm|conjunctival tumor|eye neoplasm|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|benign neoplasm of eye|sensory organ benign neoplasm|nervous system benign neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; pterygium|benign neoplasm of cornea|cornea neoplasm|eye neoplasm|eye disease|disorder of visual system|disease|disposition|material property|experimental factor
MONDO:0005098	stroke disorder	A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.	syndrome, stroke;CVA, cerebrovascular accident;CVA;cerebrovascular accident;undetermined stroke;cerebrovascular accident, (CVA);stroke syndrome;stroke	stroke disorder|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; stroke disorder|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; stroke disorder|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0001212	non-suppurative otitis media	A otitis media which involves transudation of fluid in the middle ear without pus formation.	nonsuppurative otitis media	non-suppurative otitis media|Otitis media|middle ear disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; non-suppurative otitis media|Otitis media|middle ear disorder|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; non-suppurative otitis media|Otitis media|head and neck disorder|disease|disposition|material property|experimental factor; non-suppurative otitis media|Otitis media|inflammatory disease|disease|disposition|material property|experimental factor
EFO:1001456	central nervous system infection	An infectious process that affects the brain and/or spinal cord. Representative examples include encephalitis, poliomyelitis, arachnoiditis, and meningitis.	central nervous system infectious disease;infectious disease of central nervous system;central nervous system infectious disorder;Central Nervous System Infections	central nervous system infection|infectious disorder of the nervous system|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; central nervous system infection|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; central nervous system infection|infectious disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; central nervous system infection|infectious disorder of the nervous system|material entity|experimental factor
EFO:0006343	chronic periodontitis	A chronic inflammatory process that affects the tissues that surround and support the teeth.	chronic periodontitis;Chronic periodontitis;chronic pericementitis;Chronic pericementitis (disorder);Chronic periodontitis NOS;chronic periodontitis (disorder);periodontitis, chronic;chronic periodontitis NOS (disorder)	chronic periodontitis|periodontitis|periodontal disorder|tooth disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; chronic periodontitis|chronic disease|disease|disposition|material property|experimental factor; chronic periodontitis|periodontitis|inflammatory disease|disease|disposition|material property|experimental factor; chronic periodontitis|periodontitis|head and neck disorder|disease|disposition|material property|experimental factor; chronic periodontitis|periodontitis|periodontal disorder|tooth disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor
HP:0002321	Vertigo	An abnormal sensation of spinning while the body is actually stationary.	Dizzy spell	Vertigo|Abnormality of the ear|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0001388	Joint laxity	Lack of stability of a joint.	Ligamentous laxity;Loosejointedness;Joint ligamentous laxity;Lax joints;Loose-jointedness;Joint instability;Hyperlaxity	Joint laxity|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0030148	Heart murmur	An extra or unusual sound heard during a heartbeat caused vibrations resulting from the flow of blood through the heart.	Heart murmurs;Heart murmur;Cardiac murmurs;Cardiac murmur	Heart murmur|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0003326	Myalgia	Pain in muscle.	Muscle pain;Muscle ache	Myalgia|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:17113	erythritol	NA	Erythritol;meso-erythritol;erythritol	erythritol|carbohydrate|chemical entity|material entity|experimental factor
EFO:1002028	cicatricial alopecia	NA	scarring hair loss;scarring alopecia;alopecia cicatrisata	cicatricial alopecia|Rare genetic skin disease|genetic disorder|material entity|experimental factor; cicatricial alopecia|Rare genetic skin disease|genetic disorder|disease|disposition|material property|experimental factor; cicatricial alopecia|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
HP:0009763	Limb pain	Chronic pain in the limbs with no clear focal etiology.	Limb pain	Limb pain|pain|sign or symptom|phenotype|quality|material property|experimental factor; Limb pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Limb pain|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005251	hypotension	Blood pressure that is abnormally low.	low blood pressure;hypotension;hypotension (disease);hypotensive disorder	hypotension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
MONDO:0007666	glaucoma-sleep apnea syndrome	Glaucoma-sleep apnea syndrome is characterized by sleep apnoea associated with glaucoma. It has been described in five members of a family (the mother and four of her children).		glaucoma-sleep apnea syndrome|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; glaucoma-sleep apnea syndrome|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; glaucoma-sleep apnea syndrome|syndromic disease|disease|disposition|material property|experimental factor; glaucoma-sleep apnea syndrome|syndromic disease|material entity|experimental factor
MONDO:0001592	prolapse of female genital organ	NA		prolapse of female genital organ|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
MONDO:0003193	bile duct adenocarcinoma	A carcinoma that arises from glandular epithelial cells of the bile duct	bile duct adenocarcinoma	bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|bile duct disorder|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0005771	ovarian disease	A disease involving the ovary.	ovary disease;ovary disease or disorder;disease of ovary;ovarian disorder;ovarian disease;Ovarian Disorder;disorder of ovary;disease ovarian;disease or disorder of ovary	ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0000712	stroke	A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.	stroke;Cerebrovascular Accident;Vascular Accident, Brain;Cerebrovascular Apoplexy;Cerebrovascular accident (disorder);undetermined stroke;CEREBROVASCULAR ACCIDENT, (CVA);Cerebrovascular Accidents;Cerebrovascular Accidents, Acute;CVA;Apoplexy;CVA - Cerebrovascular accident;Acute Cerebrovascular Accidents;Acute Strokes;syndrome, stroke;stroke syndrome;Cerebrovascular accident (disorder) [Ambiguous];CVA (cerebral vascular accident);SYNDROME, STROKE;Cerebrovascular Strokes;Stroke NOS (disorder);stroke disorder;Stroke/CVA - undefined;CVAs (Cerebrovascular Accident);Brain Vascular Accidents;Cerebral Stroke;Stroke, Acute;Acute Cerebrovascular Accident;Cerebrovascular Apoplexya;CVA, CEREBROVASCULAR ACCIDENT;Stroke NOS;Stroke, Cerebral;cerebrovascular accident, (CVA);Brain Vascular Accident;STROKE SYNDROME;Vascular Accidents, Brain;Strokes, Cerebral;cerebrovascular accident;Strokes, Cerebrovascular;Apoplexy, Cerebrovascular;Acute Stroke;Strokes;CVA, cerebrovascular accident;Cerebral Strokes;Strokes, Acute;CVA (Cerebrovascular Accident);ischemic stroke;CVA - Cerebrovascular accident unspecified;Cerebrovascular Stroke;Stroke and cerebrovascular accident unspecified (disorder);Stroke, Cerebrovascular;Cerebrovascular Accident, Acute;Stroke and cerebrovascular accident unspecified	stroke|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; stroke|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; stroke|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor
EFO:0000398	dermatomyositis	Dermatomyositis (DM) is a type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.	Dermatopolymyositides;dermatomyositis;Dermatomyositides, Adult Type;Polymyositis Dermatomyositis;DM;[X]Dermatopolymyositis, unspecified;Dermatomyositides;DM - Dermatomyositis;Polymyositis-Dermatomyositides;Polydermatomyositis;Polymyositis-Dermatomyositis;Dermatomyositis (disorder);Dermatomyositis, Adult Type;Adult Type Dermatomyositides;polymyositis with skin involvement;Dermatopolymyositis, unspecified (disorder);Dermatomyositis, Childhood Type;Adult Type Dermatomyositis;Wagner-Unverricht syndrome;dermatopolymyositis;[X]Dermatopolymyositis, unspecified (disorder);Dermatopolymyositis;Polymyositis with skin involvement;Dermatopolymyositis, unspecified	dermatomyositis|polymyositis|acquired idiopathic inflammatory myopathy|acquired skeletal muscle disease|material entity|experimental factor; dermatomyositis|polymyositis|acquired idiopathic inflammatory myopathy|idiopathic disease|material entity|experimental factor; dermatomyositis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; dermatomyositis|polymyositis|secondary glomerular disease|glomerular disease|material entity|experimental factor; dermatomyositis|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; dermatomyositis|polymyositis|acquired idiopathic inflammatory myopathy|idiopathic inflammatory myopathy|myositis|inflammatory disease|disease|disposition|material property|experimental factor; dermatomyositis|polymyositis|acquired idiopathic inflammatory myopathy|idiopathic inflammatory myopathy|myositis|myopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; dermatomyositis|polymyositis|acquired peripheral neuropathy|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; dermatomyositis|polymyositis|acquired peripheral neuropathy|material entity|experimental factor; dermatomyositis|polymyositis|acquired peripheral neuropathy|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; dermatomyositis|polymyositis|secondary glomerular disease|glomerular disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; dermatomyositis|polymyositis|acquired idiopathic inflammatory myopathy|idiopathic inflammatory myopathy|myositis|immune system disease|disease|disposition|material property|experimental factor; dermatomyositis|polymyositis|acquired idiopathic inflammatory myopathy|idiopathic disease|disease|disposition|material property|experimental factor; dermatomyositis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; dermatomyositis|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; dermatomyositis|polymyositis|acquired idiopathic inflammatory myopathy|acquired skeletal muscle disease|skeletal muscle disorder|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; dermatomyositis|polymyositis|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor
CHEBI:132948	pyridoxate	NA		pyridoxate|chemical entity|material entity|experimental factor
EFO:0000666	portal hypertension	Increased blood pressure in the portal venous system. It is most commonly caused by cirrhosis. Other causes include portal vein thrombosis, Budd-Chiari syndrome, and right heart failure. Complications include ascites, esophageal varices, encephalopathy, and splenomegaly.	Portal hypertension (disorder);Portal Hypertensions;Hypertension, Portal;Cruveilhier-Baumgarten Syndrome;Cruveilhier Baumgarten Syndrome;portal hypertension;Hypertensions, Portal;PHT - Portal hypertension;Syndrome, Cruveilhier-Baumgarten	portal hypertension|hepatic vascular disorder|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; portal hypertension|hepatic vascular disorder|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; portal hypertension|hepatic vascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
HP:0004872	Incisional hernia	An abdominal hernia that occurs at a site of weakness in the abdominal wall resulting from an incompletely-healed surgical wound.	Recurrent abdominal hernia	Incisional hernia|Hernia of the abdominal wall|Hernia|Abnormality of connective tissue|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Incisional hernia|Hernia of the abdominal wall|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003957	radius fracture	Traumatic or pathological injury to the radius bone in which the continuity of the bone is broken.	Fracture, Radius;Radius Fractures;Fractures, Radius;radius fracture	radius fracture|upper extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; radius fracture|upper extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor
EFO:0006510	Herpes Zoster	A common dermal and neurologic disorder caused by reactivation of the varicella-zoster virus that has remained dormant within dorsal root ganglia, often for decades, after the patient's initial exposure to the virus in the form of varicella (chickenpox). It is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area.	HZ;Zoster;herpes zoster;herpes zona;shingles;herpes Zoster;zoster	Herpes Zoster|disease arising from reactivation of latent virus|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Herpes Zoster|Varicella Zoster infection|Herpesviridae infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Herpes Zoster|Varicella Zoster infection|Herpesviridae infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Herpes Zoster|disease arising from reactivation of latent virus|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Herpes Zoster|vesiculobullous skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; Herpes Zoster|skin disorder caused by infection|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; Herpes Zoster|skin disorder caused by infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Herpes Zoster|post-viral disorder|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Herpes Zoster|post-viral disorder|post-infectious disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0003950	ulna fracture	Fractures of the larger bone of the forearm.	bone fracture of ulna;ulna fracture;Ulna Fractures;ulna bone fracture;Fractures, Ulna;Fracture, Ulna	ulna fracture|upper extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ulna fracture|upper extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor
EFO:0007499	streptococcal pneumonia	A febrile disease caused by streptococcus pneumoniae.	Streptococcus pneumoniae caused pneumonia;pneumococcal pneumonia;streptococcal pneumonia;pneumonia due to streptococcus;Pneumonia, Pneumococcal;Streptococcus pneumoniae pneumonia	streptococcal pneumonia|pneumococcal infection|streptococcal infection|gram-positive bacterial infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; streptococcal pneumonia|bacterial pneumonia|pneumonia|pneumonitis|inflammatory disease|disease|disposition|material property|experimental factor; streptococcal pneumonia|bacterial pneumonia|pneumonia|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; streptococcal pneumonia|bacterial pneumonia|pneumonia|pneumonitis|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; streptococcal pneumonia|bacterial pneumonia|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0004298	cardiovascular measurement	NA	Diagnostic Techniques, Cardiovascular;cardiovascular diagnostic technique	cardiovascular measurement|measurement|information entity|experimental factor
HP:0000952	Jaundice	Yellow pigmentation of the skin due to bilirubin, which in turn is the result of increased bilirubin concentration in the bloodstream.	Yellowing of the skin;Yellow skin;Icterus;Jaundice	Jaundice|Abnormality of the liver|Abnormality of the abdominal organs|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Jaundice|Abnormality of skin morphology|Abnormality of the skin|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0008603	pemphigus erythematosus	Pemphigus erythematosus is a rare superficial pemphigus disease characterized clinically by well-demarcated, localized, erythematous, scaly, hyperkeratotic, crusted plaques, with frequent butterfly distribution over the malar area of the face (but also commonly involving trunk and scalp, and less frequently the extremities, with a photoexposed distribution). Histologically, granular deposits along the dermal-epidermal junction, in addition to intercellular deposition in the upper epidermis, are observed.	seborrheic pemphigus;Senear-Usher syndrome;pemphigus erythematosus;seborrheic pemphigoid	pemphigus erythematosus|superficial pemphigus|autoimmune bullous skin disease|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; pemphigus erythematosus|pemphigus|autoimmune bullous skin disease|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; pemphigus erythematosus|superficial pemphigus|autoimmune bullous skin disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; pemphigus erythematosus|pemphigus|autoimmune bullous skin disease|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; pemphigus erythematosus|pemphigus|autoimmune bullous skin disease|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; pemphigus erythematosus|superficial pemphigus|autoimmune bullous skin disease|vesiculobullous skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; pemphigus erythematosus|superficial pemphigus|autoimmune bullous skin disease|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; pemphigus erythematosus|pemphigus|autoimmune bullous skin disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; pemphigus erythematosus|superficial pemphigus|autoimmune bullous skin disease|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; pemphigus erythematosus|pemphigus|autoimmune bullous skin disease|vesiculobullous skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:1001289	Cholecystitis, Acute	NA	acute cholecystitis	Cholecystitis, Acute|cystitis|bladder disease|urinary system disease|disease|disposition|material property|experimental factor; Cholecystitis, Acute|gallbladder disease|genetic biliary tract disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; Cholecystitis, Acute|gallbladder disease|genetic biliary tract disease|genetic disorder|disease|disposition|material property|experimental factor; Cholecystitis, Acute|gallbladder disease|genetic biliary tract disease|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; Cholecystitis, Acute|gallbladder disease|genetic biliary tract disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; Cholecystitis, Acute|gallbladder disease|genetic biliary tract disease|genetic disorder|material entity|experimental factor; Cholecystitis, Acute|cystitis|inflammatory disease|disease|disposition|material property|experimental factor
CHEBI:28044	phenylalanine	NA	Phenylalanine;2-amino-3-phenylpropanoic acid;phenylalanine	phenylalanine|amino acid|acid|chemical entity|material entity|experimental factor
MONDO:0005374	bone marrow neoplasm	Neoplasms that affect the bone marrow. Such neoplasms may arise in the bone marrow (e.g. myeloid leukemias) or may involve the bone marrow as secondary, metastatic tumors (e.g. metastatic carcinomas to the bone marrow).	bone marrow neoplasm (disease);neoplasm of bone marrow;bone marrow neoplasm;tumor of bone marrow;bone marrow tumor	bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor
EFO:1000025	cystitis	Inflammation of the urinary bladder.	cystitis;inflammation of urinary bladder;urinary bladder inflammation;bladder infection	cystitis|inflammatory disease|disease|disposition|material property|experimental factor; cystitis|bladder disease|urinary system disease|disease|disposition|material property|experimental factor
MONDO:0007197	bladder diverticulum	NA	diverticulum of bladder;bladder diverticulum (disease);diverticulum - bladder;bladder diverticulum	bladder diverticulum|bladder disease|urinary system disease|disease|disposition|material property|experimental factor; bladder diverticulum|genetic disorder|disease|disposition|material property|experimental factor; bladder diverticulum|genetic disorder|material entity|experimental factor
MONDO:0019724	secondary glomerular disease	Secondary glomerular diseases are conditions with glomerular pathology in which an underlying cause can be established.		secondary glomerular disease|glomerular disease|material entity|experimental factor; secondary glomerular disease|glomerular disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
HP:0000802	Impotence	Inability to develop or maintain an erection of the penis.	Difficulty getting an erection;Difficulty getting a full erection	Impotence|Abnormality of the genital system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0010461	argininosuccinate measurement	NA		argininosuccinate measurement|amino acid measurement|measurement|information entity|experimental factor
HP:0012390	Anal fissure	A small tear in the thin, moist tissue (mucosa) that lines the anus. It appears as a crack or slit in the mucous membrane of the anus.		Anal fissure|Abnormality of the anus|Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0001948	Alkalosis	Depletion of acid or accumulation base in the body fluids.		Alkalosis|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0001365	age-related macular degeneration	Age-related loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.	Senile macular retinal degeneration;Macular degeneration (senile) of retina, unspecified;age-related macular degeneration;Age-Related Macular Degenerations;Senile macular degeneration of retina;AAMD - Age related macular degeneration;Degeneration, Macular;Macular Dystrophies;Maculopathies, Age Related;Age related maculopathy;Age Related Macular Degeneration;Degeneration, Age-Related Macular;Degenerations, Age-Related Macular;AGE RELAT MACULOPATHIES;AMD - Age-related macular degeneration;MACULAR DEGENERATION NOS;Dystrophies, Macular;MACULOPATHIES AGE RELAT;Unspecified senile macular degeneration;MACULOPATHY AGE RELAT;Macular Degeneration, Age-Related;Macular Degenerations, Age-Related;Maculopathy, Age-Related;Maculopathy, Age Related;AMD;age related Maculopathies;Senile macular degeneration;Age related macular degeneration (disorder) [Ambiguous];macular degeneration, age-related;Macular Dystrophy;ARMD;Dystrophy, Macular;Age-related macular degeneration (disorder);age related maculopathy;SMD - Senile macular degeneration;ARMD - Age-related macular degeneration;AGE RELAT MACULOPATHY;Amended;Age Related Maculopathies;Degenerations, Macular;Age-Related Maculopathy;Age-Related Maculopathies;Maculopathies, Age-Related;Macular Degeneration;Macular degeneration (disorder);Macular Degenerations	age-related macular degeneration|inherited retinal dystrophy|inherited vitreous-retinal disease|genetic disorder|disease|disposition|material property|experimental factor; age-related macular degeneration|inherited retinal dystrophy|inherited vitreous-retinal disease|genetic disorder|material entity|experimental factor; age-related macular degeneration|inherited retinal dystrophy|vision disorder|perceptual disorders|nervous system disease|disease|disposition|material property|experimental factor; age-related macular degeneration|inherited retinal dystrophy|inherited vitreous-retinal disease|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; age-related macular degeneration|inherited retinal dystrophy|retinal degeneration|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; age-related macular degeneration|inherited retinal dystrophy|inherited vitreous-retinal disease|vitreous body disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; age-related macular degeneration|inherited retinal dystrophy|retinal degeneration|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; age-related macular degeneration|inherited retinal dystrophy|retinal degeneration|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; age-related macular degeneration|degeneration of macula and posterior pole|macular degeneration|retinal degeneration|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; age-related macular degeneration|inherited retinal dystrophy|inherited vitreous-retinal disease|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; age-related macular degeneration|inherited retinal dystrophy|inherited vitreous-retinal disease|vitreous body disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; age-related macular degeneration|inherited retinal dystrophy|vision disorder|disorder of visual system|disease|disposition|material property|experimental factor; age-related macular degeneration|degeneration of macula and posterior pole|macular degeneration|retinal degeneration|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; age-related macular degeneration|inherited retinal dystrophy|inherited vitreous-retinal disease|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; age-related macular degeneration|degeneration of macula and posterior pole|macular degeneration|retinal degeneration|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
HP:0002110	Bronchiectasis	Persistent abnormal dilatation of the bronchi owing to localized and irreversible destruction and widening of the large airways.	Permanent enlargement of the airways of the lungs	Bronchiectasis|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0004804	Congenital hemolytic anemia	A form of hemolytic anemia with congenital onset.	Congenital hemolytic anaemia;Congenital haemolytic anemia;Congenital haemolytic anaemia	Congenital hemolytic anemia|hemolytic anemia|normocytic anemia|anemia|hematologic disease|material entity|experimental factor; Congenital hemolytic anemia|hemolytic anemia|anemia (phenotype)|Abnormal erythrocyte morphology|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Congenital hemolytic anemia|hemolytic anemia|normocytic anemia|anemia|hematologic disease|disease|disposition|material property|experimental factor
EFO:0000565	leukemia	A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.	leukemia (disease);leukemia;leukemias, general;leukemias;blood (leukemia);leukemia, malignant;leukemia, disease	leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; leukemia|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; leukemia|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor
HP:0100806	Sepsis	Systemic inflammatory response to infection.	Infection in blood stream	Sepsis|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003768	nicotine dependence	Physical and psychological dependence on nicotine.	Tobacco Dependences;smoking;Dependence, Tobacco;nicotine addiction;Nicotine Use Disorders;TOBACCO USE DIS;Tobacco Smoking;Tobacco Use Disorder;Tobacco Use Disorders;Tobacco Smokings;Nicotine Use Disorder;Smoking, Cigarette;Cigarette Smoking;Smokings, Tobacco;Smoking, Tobacco;Dependence, Nicotine;Disorder, Nicotine Use;Tobacco-Use Disorder;nicotine dependence;NICOTINE USE DIS;Use Disorder, Nicotine;Nicotine Addiction;tobacco use disorder;Disorder, Tobacco-Use;Disorder, Tobacco Use;Tobacco Dependence	nicotine dependence|drug dependence|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; nicotine dependence|drug dependence|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; nicotine dependence|drug dependence|substance dependence|substance-related disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:0006527	smoking status measurement	NA		smoking status measurement|smoking behaviour measurement|measurement|information entity|experimental factor
Orphanet:2686	Cyclic neutropenia	NA		
EFO:0004318	smoking behavior	NA	smoking	smoking behavior|behavior|biological process|process|experimental factor
EFO:0006526	pack-years measurement	NA		pack-years measurement|smoking behaviour measurement|measurement|information entity|experimental factor
EFO:0000198	myelodysplastic syndrome	A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)	oligoblastic leukemia;MDS-U;MDS;myelodysplasia;smoldering leukemia;myelodysplastic syndrome, somatic;myelodysplastic syndrome;dysmyelopoietic syndrome;myelodysplastic neoplasm;preleukemia;MDS, unclassifiable;hematopoeitic - myelodysplastic syndrome (MDS);myelodysplastic syndromes;myelodysplastic syndrome/neoplasm;myelodysplastic syndrome, unclassifiable	myelodysplastic syndrome|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; myelodysplastic syndrome|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; myelodysplastic syndrome|neoplastic syndrome|syndromic disease|material entity|experimental factor; myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; myelodysplastic syndrome|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; myelodysplastic syndrome|neoplastic syndrome|syndromic disease|disease|disposition|material property|experimental factor; myelodysplastic syndrome|neoplastic syndrome|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor
EFO:0007541	viral pneumonia	Inflammation of the lung parenchyma that is caused by a viral infection.	Pneumonia, Viral;viral pneumonia;Viruses pneumonia;Viruses caused pneumonia	viral pneumonia|pneumonia|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; viral pneumonia|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; viral pneumonia|viral respiratory tract infection|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; viral pneumonia|pneumonia|pneumonitis|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; viral pneumonia|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; viral pneumonia|viral respiratory tract infection|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; viral pneumonia|pneumonia|pneumonitis|inflammatory disease|disease|disposition|material property|experimental factor; viral pneumonia|viral respiratory tract infection|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0005803	hematologic disease	A disease involving the hematopoietic system.	hematologic disorder;rare hematologic disease;hematologic disease;disease of the blood and blood-forming organs;blood disease;blood dyscrasia;disease of hematopoietic system;Hematologic Diseases;disorder of hematopoietic system;hematological system disease;hematological disorder;haematological system disorder;hematopoietic system disease;hematopoietic disease;hematopoietic system disease or disorder;disease or disorder of hematopoietic system;haematological system disease;hematological system disorder;blood disorder;hematological disease;hematologic and lymphocytic disorder	hematologic disease|disease|disposition|material property|experimental factor; hematologic disease|material entity|experimental factor
MONDO:0002492	acute kidney failure	Sudden and sustained deterioration of the kidney function characterized by decreased glomerular filtration rate, increased serum creatinine or oliguria.	ARF;kidney failure, acute;acute kidney injury;acute renal failure;AKI	acute kidney failure|kidney failure|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; acute kidney failure|acute disease|disease|disposition|material property|experimental factor
EFO:0020988	blood transfusion	NA		blood transfusion|medical procedure|experimental process|planned process|process|experimental factor
EFO:0009267	delirium	A disorder characterized by confusion; inattentiveness; disorientation; illusions; hallucinations; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)	delirium	delirium|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; delirium|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:1001254	noise-induced hearing loss	A condition in which a person loses the ability to hear due to exposure to high intensity sound.	noise induced hearing loss;noise-induced hearing loss;NIHL;Hearing Loss, Noise-Induced	noise-induced hearing loss|sensorineural hearing loss|hearing loss|hearing disorder|perceptual disorders|nervous system disease|disease|disposition|material property|experimental factor; noise-induced hearing loss|inherited auditory system disease|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; noise-induced hearing loss|sensorineural hearing loss|hearing loss|hearing disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; noise-induced hearing loss|inherited auditory system disease|genetic disorder|disease|disposition|material property|experimental factor; noise-induced hearing loss|inherited auditory system disease|genetic disorder|material entity|experimental factor
MONDO:0002311	retinal vascular disorder	Retinal damage resulting from diminished blood flow/oxygenation due to abnormalities of the retinal vessels. Causes include hypertension, diabetes, thrombosis, embolism, and hemorrhage.	retina circulation disorder;retinal vascular disorder	retinal vascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; retinal vascular disorder|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; retinal vascular disorder|ocular vascular disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; retinal vascular disorder|ocular vascular disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; retinal vascular disorder|ocular vascular disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; retinal vascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; retinal vascular disorder|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; retinal vascular disorder|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor
HP:0002019	Constipation	Infrequent or difficult evacuation of feces.	Costiveness;Constipation;Dyschezia	Constipation|Abdominal symptom|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004251	myeloproliferative disorder	A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)	chronic myeloproliferative neoplasm;myeloproliferative neoplasm;myeloproliferative neoplasm, chronic;myeloproliferative tumor;chronic myeloproliferative disease;MPD;CMPD, U;CMPD;MPN;myeloproliferative disorder;chronic myeloproliferative disorder	myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; myeloproliferative disorder|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor
EFO:1001228	ureterolithiasis	The presence of a calculus in the ureter of the kidney; this is most often composed of mineral salts and proteins.	ureteric stone;Ureteric calculus;Ureteric Stone;Ureteric stone (disorder);Ureterolithiasis;Ureteric stone;Ureterolithiasis (disorder);ureterolithiasis;calculus of ureter;ureteric calculus	ureterolithiasis|bladder disease|urinary system disease|disease|disposition|material property|experimental factor; ureterolithiasis|ureteral disorder|urinary system disease|disease|disposition|material property|experimental factor; ureterolithiasis|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:0004682	QT interval	NA		QT interval|temporal measurement|measurement|information entity|experimental factor; QT interval|electrocardiography|heart function measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
HP:0001541	Ascites	Accumulation of fluid in the peritoneal cavity.	Accumulation of fluid in the abdomen	Ascites|Abnormal abdomen morphology|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009660	anus disease	A non-neoplastic or neoplastic disorder that affects the anal canal or anal margin. Representative examples of non-neoplastic disorders include hemorrhoids and anal ulcer. Representative examples of neoplastic disorders include carcinoma, lymphoma, and melanoma.	anal fissure and fistula;disorder of anus;fissure in ano;disease or disorder of anus;solitary anal ulcer;anus disease or disorder;anal disorder;nontraumatic tear of anus;anus disease;Ulcer of anus;anal ulcer;disorder of anal region;anal disease;anus disorder;anal fissure;disease of anus	anus disease|rectal disease|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
HP:0010769	Pilonidal sinus	A sinus in the coccygeal region (the region of the intergluteal cleft). A pilonidal sinus often contains hair and skin debris.	Pilonidal cyst	Pilonidal sinus|Abnormality of the vertebral column|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004198	skin neoplasm	A benign or malignant tumor involving the skin. Representative examples of benign skin neoplasms include the benign melanocytic skin nevus, acanthoma, sebaceous adenoma, sweat gland adenoma, lipoma, hemangioma, fibroma, and benign fibrous histiocytoma. Representative examples of malignant skin neoplasms include basal cell carcinoma, squamous cell carcinoma, melanoma, and Kaposi sarcoma.	skin tumor;neoplasm of zone of skin;neoplasm of skin by site;zone of skin neoplasm;skin cancer;tumor of the skin;zone of skin tumor;tumor of skin;tumor of zone of skin;neoplasm of skin;zone of skin neoplasm (disease);skin neoplasm;skin neoplasms;cancer of the skin;neoplasm of the skin	skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0008207	chondromalacia patellae	Familial chondromalacia patellae is an inherited bone disorder described in 5 families in 1963 and is characterized by localized patellar pain and male-to-male transmission.	softening of articular cartilage of patella;chondromalacia of patella;patella chondromalacia;chondromalacia patellae	chondromalacia patellae|patellar dysostosis|dysostosis of genetic origin|dysostosis|bone development disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; chondromalacia patellae|patellar dysostosis|dysostosis of genetic origin|genetic disorder|disease|disposition|material property|experimental factor; chondromalacia patellae|patellar dysostosis|dysostosis of genetic origin|genetic disorder|material entity|experimental factor; chondromalacia patellae|patellar dysostosis|dysostosis of genetic origin|dysostosis|bone development disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; chondromalacia patellae|patellar dysostosis|dysostosis of genetic origin|dysostosis|material entity|experimental factor; chondromalacia patellae|patellar dysostosis|skeletal dysplasia|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; chondromalacia patellae|patellar dysostosis|skeletal dysplasia|genetic disorder|material entity|experimental factor; chondromalacia patellae|patellar dysostosis|skeletal dysplasia|genetic disorder|disease|disposition|material property|experimental factor; chondromalacia patellae|chondromalacia|articular cartilage disorder|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
Orphanet:332	Congenital intrinsic factor deficiency	NA		
EFO:0004698	insomnia	A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep.	insomnia;insomnia (disease)	insomnia|Sleep Disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; insomnia|Sleep Disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:0000228	adenocarcinoma	A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.	adenocarcinoma NOS (morphologic abnormality);adenocarcinoma;adenocarcinoma, malignant;adenocarcinomas;adenocarcinoma, no subtype (morphologic abnormality)	adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0009640	family history of cancer	NA	family history of malignant neoplasm	family history of cancer|family history|clinical history|information entity|experimental factor
EFO:0020832	tyrosine-protein kinase YES measurement	NA		tyrosine-protein kinase YES measurement|protein measurement|measurement|information entity|experimental factor
EFO:1000359	Malignant Pancreatic Neoplasm	A malignant neoplasm involving the pancreas.	malignant pancreatic neoplasm;Ca body of pancreas;pancreas cancer;malignant pancreas neoplasm;Ca tail of pancreas;pancreatic cancer;malignant neoplasm of the pancreas;malignant neoplasm of head of pancreas;malignant neoplasm of body of pancreas;cancer of pancreas;malignant neoplasm of tail of pancreas;malignant neoplasm of pancreas;Ca head of pancreas	Malignant Pancreatic Neoplasm|pancreatic neoplasm|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor; Malignant Pancreatic Neoplasm|pancreatic neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Malignant Pancreatic Neoplasm|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Malignant Pancreatic Neoplasm|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Malignant Pancreatic Neoplasm|pancreatic neoplasm|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor; Malignant Pancreatic Neoplasm|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor
EFO:1001961	intrahepatic cholangiocarcinoma	A carcinoma that arises from the intrahepatic bile duct epithelium in any site of the intrahepatic biliary tree. Grossly, the malignant lesions are solid, nodular, and grayish. Morphologically, the vast majority of cases are adenocarcinomas. Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats. Early detection is difficult and the prognosis is generally poor.	intrahepatic carcinoma of the bile duct;intrahepatic bile duct carcinoma;intrahepatic cholangiocarcinoma;intrahepatic carcinoma of bile duct;peripheral cholangiocarcinoma;intrahepatic cholangiocarcinoma (bile duct cancer);ICC;cholangiocarcinoma, intrahepatic, malignant;intrahepatic Cholangiocellular carcinoma;intrahepatic bile duct cancer (cholangiocarcinoma)	intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|bile duct neoplasm|bile duct disorder|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|carcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|bile duct disorder|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|carcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|bile duct neoplasm|bile duct disorder|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|carcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct neoplasm|bile duct neoplasm|bile duct disorder|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|carcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|carcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|carcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|extrahepatic bile duct neoplasm|bile duct neoplasm|bile duct disorder|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|carcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|biliary tract neoplasm|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|bile duct disorder|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|carcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct neoplasm|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|malignant tumor of extrahepatic bile duct|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|adenocarcinoma of liver and intrahepatic biliary tract|carcinoma of liver and intrahepatic biliary tract|Digestive System Carcinoma|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|bile duct cancer|bile duct neoplasm|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|extrahepatic bile duct carcinoma|bile duct carcinoma|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|intrahepatic bile duct cancer|bile duct cancer|biliary tract cancer|biliary tract neoplasm|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; intrahepatic cholangiocarcinoma|cholangiocarcinoma|adenocarcinoma of gallbladder and extrahepatic biliary tract|extrahepatic bile duct adenocarcinoma|bile duct adenocarcinoma|bile duct carcinoma|carcinoma of liver and intrahepatic biliary tract|liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor
MONDO:0004658	breast carcinoma in situ	A in situ carcinoma that involves the breast.	carcinoma in situ of breast;non-infiltrating breast carcinoma;non-invasive carcinoma of breast;non-invasive carcinoma of the breast;stage 0 breast carcinoma in situ;non-infiltrating carcinoma of breast;stage 0 breast cancer aJCC v6;non-infiltrating carcinoma of the breast;non-invasive breast carcinoma;stage 0 breast cancer;in situ breast cancer;breast cancer stage 0;stage 0 carcinoma of the breast;stage 0 breast cancer aJCC v7;stage 0 breast carcinoma;breast cancer in situ;breast carcinoma in situ;stage 0 breast cancer aJCC v6 and v7;breast in situ carcinoma;stage 0 carcinoma of breast;carcinoma in situ of the breast	breast carcinoma in situ|breast carcinoma|breast cancer|breast neoplasm|breast disease|disease|disposition|material property|experimental factor; breast carcinoma in situ|in situ carcinoma|precancerous condition|cancer or benign tumor|disease|disposition|material property|experimental factor; breast carcinoma in situ|in situ carcinoma|high grade malignant neoplasm|material entity|experimental factor; breast carcinoma in situ|in situ carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast carcinoma in situ|breast carcinoma|breast cancer|breast neoplasm|integumentary system disease|disease|disposition|material property|experimental factor; breast carcinoma in situ|in situ carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast carcinoma in situ|breast carcinoma|breast cancer|thoracic cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast carcinoma in situ|breast carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast carcinoma in situ|in situ carcinoma|high grade malignant neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast carcinoma in situ|breast carcinoma|breast cancer|thoracic cancer|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast carcinoma in situ|breast carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast carcinoma in situ|breast carcinoma|breast cancer|breast neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0007899	lichen sclerosus et atrophicus	A chronic inflammatory process affecting the skin. It is characterized by the presence of white, indurated plaques, epidermal atrophy, and fibrosis of the upper dermis. It usually appears in the vulva and penis.	lichen sclerosus et atrophicus	lichen sclerosus et atrophicus|genetic disorder|disease|disposition|material property|experimental factor; lichen sclerosus et atrophicus|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; lichen sclerosus et atrophicus|genetic disorder|material entity|experimental factor; lichen sclerosus et atrophicus|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0006939	cup-to-disc ratio measurement	NA		cup-to-disc ratio measurement|optic disc measurement|eye measurement|measurement|information entity|experimental factor
MONDO:0002314	chronic conjunctivitis	Conjunctivitis that is persistent and long-standing.	chronic conjunctivitis, unspecified;chronic conjunctivitis (disease);conjunctivitis (disease), chronic;chronic conjunctivitis	chronic conjunctivitis|conjunctivitis|Conjunctival Disorder|eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; chronic conjunctivitis|conjunctivitis|Conjunctival Disorder|eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; chronic conjunctivitis|conjunctivitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0000278	pancreatitis	Inflammation of the pancreas.	Pancreatitis NOS;pancreas inflammation;pancreatitis;inflammation of pancreas;Pancreatitis, NOS;Pancreatitides;Pancreatitis (disorder)	pancreatitis|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor; pancreatitis|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor; pancreatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0010119	omega-3 polyunsaturated fatty acid measurement	NA	Omega-3 fatty acid measurement	omega-3 polyunsaturated fatty acid measurement|fatty acid measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
HP:0100783	Breast aplasia	NA	Mammary gland aplasia;Congenital absence of breast;Absent breast	Breast aplasia|Abnormality of the breast|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003843	pain	NA	Burning Pain;Pains, Splitting;Physical Suffering;Radiating Pain;Pains, Burning;Sufferings, Physical;Aches;Crushing Pain;Pains, Crushing;Pains, Migratory;Radiating Pains;Physical Sufferings;Migratory Pain;Pain, Splitting;Suffering, Physical;Splitting Pain;Pain, Burning;Splitting Pains;Pains, Radiating;Pain, Crushing;Ache;Pain, Radiating;Burning Pains;Migratory Pains;Pain, Migratory;Crushing Pains	pain|sign or symptom|phenotype|quality|material property|experimental factor
EFO:0004215	anorexia nervosa	A disorder most often seen in adolescent females characterized by a refusal to maintain a minimally normal body weight, an intense fear of gaining weight, a disturbance in body image, and, in postmenarcheal females, the development of amenorrhea.	anorexia nervosa	anorexia nervosa|eating disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; anorexia nervosa|eating disorder|nutritional disorder|metabolic disease|disease|disposition|material property|experimental factor; anorexia nervosa|eating disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0005044	hypertensive disorder	Persistently high systemic arterial blood pressure. Based on multiple readings (blood pressure determination), hypertension is currently defined as when systolic pressure is consistently greater than 140 mm Hg or when diastolic pressure is consistently 90 mm Hg or more.	vascular hypertensive disorder;high blood pressure;hyperpiesia;pressure, high blood;blood pressure, high;hypertensive disease;increased blood pressure;blood pressure, increased	hypertensive disorder|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
HP:0011110	Recurrent tonsillitis	Inflammation of the tonsils that has occurred repeatedly. The definition of recurrent may vary somewhat, but the criteria used recently as a measure of severity were five or more episodes of true tonsillitis per year, symptoms recurring for at least a year, and episodes that are disabling and that prevent normal functioning. In some cases recurrent tonsillitis may be related to immunosusceptibility. Evidence exists for a genetic predisposition for recurrent tonsillitis.	Recurrent inflammation of tonsils	Recurrent tonsillitis|Recurrent infections|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Recurrent tonsillitis|Abnormality of the lymphatic system|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Recurrent tonsillitis|Abnormality of the lymphatic system|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0002012	Abnormality of the abdominal organs	An abnormality of the viscera of the abdomen.	Gastrointestinal tract defects;Abnormality of the abdominal organs	Abnormality of the abdominal organs|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000650	whooping cough	A contagious bacterial respiratory infection caused by Bordetella pertussis. It is characterized by severe and uncontrollable cough, resulting in a whooping sound during breathing following the cough.	Bordetella pertussis disease or disorder;pertussis;whooping cough;Bordetella pertussis caused disease or disorder;Bordetella pertussis infectious disease;Bordetella pertussis infection;WC - whooping cough	whooping cough|material entity|experimental factor; whooping cough|respiratory system disease|disease|disposition|material property|experimental factor; whooping cough|bordetellosis|gram-negative bacterial infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:1001908	phobic disorder	An anxiety disorder characterized by an intense, irrational fear of an object, activity, or situation. The individual seeks to avoid the object, activity, or situation. In adults, the individual recognizes that the fear is excessive or unreasonable.	phobic disorder;phobias;phobic disorders;phobia	phobic disorder|anxiety disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; phobic disorder|anxiety disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
HP:0008404	Nail dystrophy	Onychodystrophy (nail dystrophy) refers to nail changes apart from changes of the color (nail dyschromia) and involves partial or complete disruption of the various keratinous layers of the nail plate.	Poor nail formation;Dystrophic nails;Onychodystrophy	Nail dystrophy|Abnormality of the nail|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0011962	endometrial cancer	Primary or metastatic malignant neoplasm involving the endometrium (mucous membrane that lines the endometrial cavity).	endometrial Ca;malignant endometrial neoplasm;endometrial cancer, susceptibility to, autosomal dominant, somatic mutation;endometrial cancer;endometrial cancer, familial, autosomal dominant, somatic mutation;endometrial carcinoma, somatic;malignant neoplasm of endometrium;malignant endometrium neoplasm;primary malignant neoplasm of endometrium;endometrium cancer;cancer of endometrium	endometrial cancer|endometrium neoplasm|endometrial disorder|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; endometrial cancer|endometrium neoplasm|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; endometrial cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrial cancer|endometrium neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; endometrial cancer|uterine cancer|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; endometrial cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; endometrial cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrial cancer|endometrium neoplasm|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; endometrial cancer|endometrium neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrial cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; endometrial cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; endometrial cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; endometrial cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; endometrial cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrial cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0005090	basophil count	NA	blood basophil count	basophil count|inflammatory biomarker measurement|measurement|information entity|experimental factor; basophil count|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
MONDO:0024477	liver and intrahepatic bile duct neoplasm	A benign or malignant neoplasm that affects the liver parenchyma or intrahepatic bile ducts. Representative examples of benign neoplasms include hepatocellular adenoma, and bile duct adenoma. Representative examples of malignant neoplasms include hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and lymphoma.	liver and intrahepatic bile duct neoplasm;epithelial hepatic and intrahepatic bile duct neoplasm;hepatic and intrahepatic bile duct neoplasm;tumor of liver;liver tumor;neoplasm of liver;liver neoplasm (disease);liver and intrahepatic bile duct epithelial neoplasm;liver neoplasm	liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor
MONDO:0021066	urinary system neoplasm	A benign or malignant, primary or metastatic neoplasm involving the urinary system. --2003	urinary tract tumor;neoplasm of urinary tract;tumor of the urinary system;renal system neoplasm (disease);neoplasm of the urinary system;tumor of renal system;tumor of urinary tract;urinary system tumor;urinary tract neoplasm;renal system neoplasm;neoplasm of the urinary tract;neoplasm of renal system;neoplasm of urinary system;tumor of urinary system;renal system tumor;urinary system neoplasm;tumor of the urinary tract	urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor
EFO:0005937	longitudinal BMI measurement	NA	body mass index change measurement	longitudinal BMI measurement|body mass index|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
EFO:0000717	systemic scleroderma	A chronic disorder, possibly autoimmune, marked by excessive production of collagen which results in hardening and thickening of body tissues. The two types of systemic scleroderma, limited cutaneous and diffuse cutaneous are classified with focus on the extent of affected skin. A relationship exists between the extent of skin area affected and degree of internal organ/system involvement. Systemic scleroderma can manifest itself in pulmonary fibrosis, Raynaud's syndrome, digestive system telangiectasias, renal hypertension and/or pulmonary hypertension.	Scleroderma, Systemic;Scleroderma, diffuse;Scleroderma syndrome;Thibierge-Weissenbach syndrome;SSc, diffuse sclerosis;systemic scleroderma;diffuse Scleroderma;Scleroderma;SS - Systemic sclerosis;PSS (progressive systemic sclerosis);progressive systemic sclerosis;systemic sclerosis;Progressive systemic sclerosis;Scleroderma (& [systemic sclerosis]);systemic Scleroderma;Systemic sclerosis (disorder);Scleroderma, systemic;PSS - Progressive systemic sclerosis;SSc;Sclerosis, Systemic;Systemic sclerosis;diffuse sclerosis	systemic scleroderma|familial restrictive cardiomyopathy|restrictive cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|material entity|experimental factor; systemic scleroderma|scleroderma|Connective tissue disease with eye involvement|hereditary disorder of connective tissue|genetic disorder|disease|disposition|material property|experimental factor; systemic scleroderma|autoimmune cardiomyopathy|cardiomyopathy|material entity|experimental factor; systemic scleroderma|scleroderma|Connective tissue disease with eye involvement|Rare genetic eye disease|genetic disorder|material entity|experimental factor; systemic scleroderma|familial restrictive cardiomyopathy|familial cardiomyopathy|genetic disorder|disease|disposition|material property|experimental factor; systemic scleroderma|respiratory system disease|disease|disposition|material property|experimental factor; systemic scleroderma|familial restrictive cardiomyopathy|restrictive cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; systemic scleroderma|scleroderma|Connective tissue disease with eye involvement|hereditary disorder of connective tissue|genetic disorder|material entity|experimental factor; systemic scleroderma|Non-familial restrictive cardiomyopathy|restrictive cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; systemic scleroderma|scleroderma|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; systemic scleroderma|autoimmune cardiomyopathy|autoimmune disorder of musculoskeletal system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; systemic scleroderma|scleroderma|Connective tissue disease with eye involvement|hereditary disorder of connective tissue|connective tissue disease|disease|disposition|material property|experimental factor; systemic scleroderma|familial restrictive cardiomyopathy|familial cardiomyopathy|cardiomyopathy|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; systemic scleroderma|scleroderma|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; systemic scleroderma|familial restrictive cardiomyopathy|familial cardiomyopathy|cardiomyopathy|material entity|experimental factor; systemic scleroderma|autoimmune cardiomyopathy|cardiomyopathy|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; systemic scleroderma|autoimmune cardiomyopathy|cardiomyopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; systemic scleroderma|scleroderma|Connective tissue disease with eye involvement|Rare genetic eye disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; systemic scleroderma|secondary glomerular disease|glomerular disease|material entity|experimental factor; systemic scleroderma|autoimmune cardiomyopathy|autoimmune disorder of musculoskeletal system|musculoskeletal system disease|disease|disposition|material property|experimental factor; systemic scleroderma|autoimmune cardiomyopathy|autoimmune disorder of cardiovascular system|cardiovascular disease|disease|disposition|material property|experimental factor; systemic scleroderma|familial restrictive cardiomyopathy|familial cardiomyopathy|genetic disorder|material entity|experimental factor; systemic scleroderma|Non-familial restrictive cardiomyopathy|restrictive cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|material entity|experimental factor; systemic scleroderma|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; systemic scleroderma|familial restrictive cardiomyopathy|familial cardiomyopathy|cardiomyopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; systemic scleroderma|secondary glomerular disease|glomerular disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; systemic scleroderma|autoimmune cardiomyopathy|autoimmune disorder of cardiovascular system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; systemic scleroderma|scleroderma|Connective tissue disease with eye involvement|Rare genetic eye disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; systemic scleroderma|familial restrictive cardiomyopathy|restrictive cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; systemic scleroderma|Non-familial restrictive cardiomyopathy|restrictive cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; systemic scleroderma|scleroderma|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; systemic scleroderma|scleroderma|Connective tissue disease with eye involvement|Rare genetic eye disease|genetic disorder|disease|disposition|material property|experimental factor
EFO:1001875	amyloidosis	A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.	amyloidosis (disease);systemic amyloidosis;amyloidoses;amyloid disease;amyloidosis;amyloid	amyloidosis|acquired metabolic disease|metabolic disease|disease|disposition|material property|experimental factor; amyloidosis|acquired metabolic disease|material entity|experimental factor; amyloidosis|proteostasis deficiencies|metabolic disease|disease|disposition|material property|experimental factor
HP:0002829	Arthralgia	Joint pain.	Joint pain;Arthralgias	Arthralgia|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000694	severe acute respiratory syndrome	A viral respiratory infection caused by the SARS coronavirus. It is transmitted through close person-to-person contact. It is manifested with high fever, headache, dry cough and myalgias. It may progress to pneumonia and cause death.	SARS ASSOC CORONAVIRUS;Respiratory Syndrome, Acute, Severe;SARS coronavirus caused disease or disorder;severe acute respiratory syndrome;SARS-associated coronavirus;SARS coronavirus infectious disease;SARS coronavirus disease or disorder;Severe acute respiratory syndrome (disorder);SARS;acute respiratory coronavirus infection;SARS-CoV infection;Respiratory Syndrome, Severe Acute	severe acute respiratory syndrome|respiratory system disease|disease|disposition|material property|experimental factor; severe acute respiratory syndrome|acute disease|disease|disposition|material property|experimental factor; severe acute respiratory syndrome|material entity|experimental factor; severe acute respiratory syndrome|Orthocoronavirinae infectious disease|Coronaviridae infectious disease|Nidovirales infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; severe acute respiratory syndrome|Orthocoronavirinae infectious disease|Coronaviridae infectious disease|Nidovirales infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
NCBITaxon:210	Helicobacter pylori	NA	Campylobacter pylori;Campylobacter pyloridis;Helicobacter nemestrinae;Campylobacter pylori subsp. pylori	Helicobacter pylori|Bacteria|organism|material entity|experimental factor
EFO:0009003	ovarian dysfunction	The inability of the ovaries to function.	ovarian dysfunction;ovarian failure;ovarian insufficiency;ovarian hypofunction	ovarian dysfunction|ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; ovarian dysfunction|ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; ovarian dysfunction|ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
HP:0000272	Malar flattening	Underdevelopment of the malar prominence of the jugal bone (zygomatic bone in mammals), appreciated in profile, frontal view, and/or by palpation.	Depressed malar region;Decreased size of malar bone;Underdevelopment of malar bone;Zygomatic flattening;Flat cheekbone;Malar hypoplasia	Malar flattening|Abnormal zygomatic bone morphology|Abnormal facial skeleton morphology|Abnormal skull morphology|Abnormality of the head|Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Malar flattening|Abnormal zygomatic bone morphology|Abnormal facial skeleton morphology|Abnormal skull morphology|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Malar flattening|Abnormal zygomatic bone morphology|Abnormality of the face|Abnormality of the head|Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003762	vitamin D deficiency	NA	Deficiencies, Vitamin D;Deficiency, Vitamin D;DEFIC VITAMIN D;Vitamin D Deficiencies;Avitaminosis D, NOS;Vitamin D deficiency, NOS;Avitaminosis D;Vitamin D insufficiency;VITAMIN D DEFIC;Vitamin D deficiency (disorder)	vitamin D deficiency|vitamin deficiency|Abnormality of vitamin metabolism|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003778	psoriatic arthritis	Joint inflammation associated with psoriasis.	Psoriasis, Arthritic;PsA;arthritis psoriatica;Arthritis, Psoriatic;psoriatic arthritis;arthropathic psoriasis;Psoriasis Arthropathica;Arthritic Psoriasis	psoriatic arthritis|rheumatoid arthritis|arthritis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; psoriatic arthritis|rheumatoid arthritis|arthritis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; psoriatic arthritis|rheumatoid arthritis|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; psoriatic arthritis|rheumatoid arthritis|arthritis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; psoriatic arthritis|rheumatoid arthritis|arthritis|inflammatory disease|disease|disposition|material property|experimental factor; psoriatic arthritis|rheumatoid arthritis|autoimmune disorder of musculoskeletal system|musculoskeletal system disease|disease|disposition|material property|experimental factor; psoriatic arthritis|syndromic disease|disease|disposition|material property|experimental factor; psoriatic arthritis|rheumatoid arthritis|arthritis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; psoriatic arthritis|rheumatoid arthritis|autoimmune disorder of musculoskeletal system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; psoriatic arthritis|syndromic disease|material entity|experimental factor
EFO:0009286	heart relative wall thickness	NA		heart relative wall thickness|heart function measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
EFO:0004465	fasting blood glucose measurement	NA	fasting blood glucose level;fasting plasma glucose;fasting glucose-related traits	fasting blood glucose measurement|glucose measurement|diabetes mellitus biomarker|measurement|information entity|experimental factor
EFO:0010822	stenosing tenosynovitis	NA	trigger finger	stenosing tenosynovitis|tenosynovitis|tendinitis|Tendinopathy|connective tissue disease|disease|disposition|material property|experimental factor; stenosing tenosynovitis|tenosynovitis|tendinitis|myositis|immune system disease|disease|disposition|material property|experimental factor; stenosing tenosynovitis|tenosynovitis|tendon sheath disorder|Tendinopathy|connective tissue disease|disease|disposition|material property|experimental factor; stenosing tenosynovitis|tenosynovitis|tendinitis|Tendinopathy|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; stenosing tenosynovitis|tenosynovitis|tendinitis|myositis|myopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; stenosing tenosynovitis|tenosynovitis|tendon sheath disorder|Tendinopathy|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; stenosing tenosynovitis|tenosynovitis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; stenosing tenosynovitis|tenosynovitis|tendinitis|myositis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0005524	large artery stroke	Stroke caused by the blockage of blood flow in one of the large arteries feeding the brain.	large artery stroke;atherosclerotic stroke	large artery stroke|stroke|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; large artery stroke|stroke|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; large artery stroke|stroke|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; large artery stroke|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
NCBITaxon:1930	Streptomyces scabiei	NA	Oospora scabies;Streptomyces scabies;Actinomyces scabies	Streptomyces scabiei|Bacteria|organism|material entity|experimental factor
EFO:0005553	eccrine sweat gland cancer	An cancer with eccrine differentiation arising from the sweat glands.B	malignant eccrine tumor;malignant eccrine tumor of skin;eccrine sweat gland cancer;malignant eccrine sweat gland neoplasm;malignant eccrine neoplasm of the skin;malignant eccrine skin neoplasm;malignant eccrine neoplasm;malignant eccrine neoplasm of skin;cancer of eccrine sweat gland;malignant eccrine skin tumor;malignant neoplasm of eccrine sweat gland;malignant eccrine tumor of the skin	eccrine sweat gland cancer|sweat gland cancer|sweat gland neoplasm|sweat gland disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|sweat gland cancer|skin cancer|integumentary system cancer|integumentary system disease|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|eccrine sweat gland neoplasm|sweat gland neoplasm|epidermal appendage tumor|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|sweat gland cancer|skin cancer|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|sweat gland cancer|skin cancer|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|sweat gland cancer|skin cancer|integumentary system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|sweat gland cancer|sweat gland neoplasm|epidermal appendage tumor|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|eccrine sweat gland neoplasm|sweat gland neoplasm|epidermal appendage tumor|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|sweat gland cancer|sweat gland neoplasm|epidermal appendage tumor|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|eccrine sweat gland neoplasm|sweat gland neoplasm|sweat gland disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|sweat gland cancer|sweat gland neoplasm|epidermal appendage tumor|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; eccrine sweat gland cancer|eccrine sweat gland neoplasm|sweat gland neoplasm|epidermal appendage tumor|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0000284	benign prostatic hyperplasia	A non-cancerous nodular enlargement of the prostate gland. It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements. It is the most common urologic disorder in men, causing blockage of urine flow.	Adenomas, Prostatic;Benign Hyperplasia of Prostate;Nodular hyperplasia of prostate gland;Benign prostatic hyperplasia, NOS;BEP - Benign enlargement of prostate;Benign Prostatic Hyperplasia - BPH;Benign Prostate Hyperplasia;Glandular, stromal AND/OR muscular hyperplasia of prostate gland;Benign myoma of prostate;benign prostatic hyperplasia (disease);Adenoma, Prostatic;Prostatic Adenoma;Enlarged prostate - benign;Benign prostatic hyperplasia (disorder);Hyperplasia of prostate;benign hyperplasia of the prostate;benign hypertrophy of prostate NOS;Benign Hyperplasia of the Prostate;Prostatauxe;Glandular, stromal and muscular hyperplasia of prostate gland;Prostatic hypertrophy;benign hyperplasia of prostate;Benign fibroma of prostate;benign prostatic hypertrophy;benign prostatic hyperplasia;benign prostatic Hypertrophy;Prostatic Hyperplasia, Benign;Benign adenoma of prostate;Hyperplasia of prostate (disorder);Hypertrophy (benign) of prostate;Prostatic Hyperplasia;Benign enlargement of prostate, NOS;Lobular hyperplasia of prostate gland;Adenomyomatous hyperplasia of prostate gland;Prostatic Hypertrophy, Benign;Fibromuscular hyperplasia of prostate gland;Hyperplasia of prostate, NOS;benign prostate hyperplasia;Hyperplasia, Prostatic;Benign enlargement of prostate;BPH - Benign prostatic hypertrophy;Prostatic hyper -benign;Adenofibromatous hypertrophy of prostate;BPH;Adenofibromatous hypertrophy of prostate, NOS;Prostatic area hypertrophy;Hypertrophy, Benign Prostatic;Prostatic Adenomas;benign prostatic hyperplasia - BPH	benign prostatic hyperplasia|prostate disease|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; benign prostatic hyperplasia|hyperplasia|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0006788	anxiety disorder	A category of psychiatric disorders which are characterized by anxious feelings or fear often accompanied by physical symptoms associated with anxiety.	anxiety disorder;neurotic anxiety states;anxiety neurosis;anxiety neuroses;anxiety/mood disorders;mood and anxiety disorder;anxiety state;anxiety disorders;mood and anxiety disorders;chronic stress	anxiety disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; anxiety disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:0010683	localized superficial swelling, mass, or lump	NA		localized superficial swelling, mass, or lump|sign or symptom|phenotype|quality|material property|experimental factor
EFO:0007067	decubitus ulcer	NA	bed sore;pressure sore;pressure ulcer	decubitus ulcer|chronic ulcer of skin|Skin ulcer|Abnormality of skin morphology|Abnormality of the skin|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0002619	Varicose veins	Enlarged and tortuous veins.		Varicose veins|Abnormal venous morphology|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Varicose veins|Abnormal venous morphology|Abnormality of cardiovascular system morphology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
GO:0006306	DNA methylation	NA		DNA methylation|regulation of gene expression|regulation of biological process|biological process|process|experimental factor
EFO:0000668	preeclampsia	Preeclampsia is a hypertensive disorder of pregnancy that is characterized by new-onset hypertension with proteinuria presenting after 20 weeks of gestation, and depending on mild or severe forms may initially present with severe headache, visual disturbances, and hyperreflexia.	Gestational hypertension (disorder);Toxemia;Gestosis, Edema-Proteinuria-Hypertension;pregnancy associated hypertension;Toxemia of pregnancy, NOS;Proteinuria Edema Hypertension Gestosis;EPH Complex;Hypertension Edema Proteinuria Gestosis;Gestational hypertension;Proteinuria-Edema-Hypertension Gestosis;PE - Pre-eclampsia;Pre-eclamptic toxaemia;Proteinuric hypertension of pregnancy;Toxaemia NOS;pregnancy toxemia;Pregnancy Toxemia;pre-eclamptic toxaemia;EPH - Oedema, proteinuria and hypertension of pregnancy;Pre Eclampsia;EPH Toxemia;Toxemia of pregnancy (disorder);Pre-eclampsia, unspecified;Pre-eclampsia NOS;Gestosis, Hypertension-Edema-Proteinuria;Toxemia NOS;Toxemias, Pregnancy;Toxemia of Pregnancy;PREECLAMPSIA/ECLAMPSIA;Gestosis, EPH;Pregnancy-induced hypertension (disorder);toxaemia of pregnancy;hypertension of pregnancy NOS (disorder);PREGN TOXEMIAS;Toxaemia of pregnancy;EPH Gestosis;Toxemia NOS (disorder);PET - Pre-eclamptic toxemia;preeclampsia;Toxemia, EPH;Pre-eclamptic NOS;EPH Toxemias;gestational hypertension;Pre-Eclampsia;Pregnancy associated hypertension;pre-eclampsia;PET - Pre-eclamptic toxaemia;Toxemias, EPH;Edema Proteinuria Hypertension Gestosis;Gestosis, Proteinuria-Edema-Hypertension;preeclampsia/eclampsia;Hypertension-Edema-Proteinuria Gestosis;hypertension of preg.;hypertension of pregnancy NOS;Toxemia, Pregnancy;EPH - Edema, proteinuria and hypertension of pregnancy;Pre-eclampsia (disorder);Pre-eclampsia NOS (disorder);Pregnancy Toxemias;Edema-Proteinuria-Hypertension Gestosis;Toxaemia of pregnancy, NOS;hypertension induced by pregnancy;proteinuric hypertension of pregnancy;Pre-eclamptic toxemia	preeclampsia|toxemia of pregnancy|hypertension, pregnancy-induced|pregnancy disorder|obstetric disorder|disease|disposition|material property|experimental factor; preeclampsia|genetic hypertension|genetic disorder|material entity|experimental factor; preeclampsia|genetic hypertension|hypertension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; preeclampsia|genetic hypertension|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; preeclampsia|genetic hypertension|genetic disorder|disease|disposition|material property|experimental factor; preeclampsia|toxemia of pregnancy|hypertension, pregnancy-induced|hypertension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0007518	tracheitis	A tracheal disease which involves bacterial infection of the trachea often caused by Staphylococcus aureus and streptococci that follows a recent viral upper respiratory infection. The symptoms include barking croup cough, loud squeaking noise while breathing, scratchy feeling in the throat, high fever, and production of large amounts of pus-filled secretions.	Tracheitis, NOS;Tracheitis (disorder);tracheal Inflammation;acute tracheitis (disorder);Tracheitis;acute tracheitis;tracheitis;tracheal mucosa inflammation;inflammation of tracheal mucosa;chronic tracheitis;acute tracheitis NOS (disorder)	tracheitis|tracheobronchitis|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; tracheitis|tracheal disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; tracheitis|tracheal disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; tracheitis|tracheobronchitis|inflammatory disease|disease|disposition|material property|experimental factor; tracheitis|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; tracheitis|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0007450	poliomyelitis	An acute infectious disorder that affects the nervous system. It is caused by the poliovirus. The virus spreads by direct contact, and can be prevented by prophylaxis with the polio vaccine.	Polia;poliomyelitis;acute poliomyelitis;Poliomyelitis;polio	poliomyelitis|acquired motor neuron disease|motor neuron disease|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; poliomyelitis|viral infection of central nervous system|central nervous system infection|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; poliomyelitis|Myelitis|spinal cord disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; poliomyelitis|viral infection of central nervous system|central nervous system infection|infectious disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; poliomyelitis|acute disease|disease|disposition|material property|experimental factor; poliomyelitis|viral infection of central nervous system|central nervous system infection|infectious disorder of the nervous system|material entity|experimental factor; poliomyelitis|Myelitis|encephalomyelitis|inflammatory disease|disease|disposition|material property|experimental factor; poliomyelitis|Myelitis|central nervous system infection|infectious disorder of the nervous system|material entity|experimental factor; poliomyelitis|viral infection of central nervous system|central nervous system infection|infectious disorder of the nervous system|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; poliomyelitis|Myelitis|central nervous system infection|infectious disorder of the nervous system|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; poliomyelitis|poliovirus infection|Enterovirus infectious disease|Picornaviridae infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; poliomyelitis|acquired motor neuron disease|material entity|experimental factor; poliomyelitis|poliovirus infection|Enterovirus infectious disease|Picornaviridae infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; poliomyelitis|anterior horn disorder|spinal cord disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; poliomyelitis|Myelitis|encephalomyelitis|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; poliomyelitis|Myelitis|central nervous system infection|infectious disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; poliomyelitis|Myelitis|central nervous system infection|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; poliomyelitis|acquired motor neuron disease|motor neuron disease|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0003866	paranasal sinus neoplasm	A benign or malignant neoplasm that affects the paranasal sinuses. Representative examples of benign neoplasms include Schneiderian papilloma and salivary gland-type adenoma. Representative examples of malignant neoplasms include carcinoma and lymphoma.	tumor of paranasal sinus;neoplasm of the accessory sinus;paranasal sinus tumor;paranasal sinus neoplasm (disease);paranasal sinus neoplasm;tumor of accessory sinus;paranasal sinus neoplasms;tumor of the paranasal sinus;accessory sinus tumor;tumor of the accessory sinus;neoplasm of the paranasal sinus;accessory sinus neoplasm;neoplasm of accessory sinus;neoplasm of paranasal sinus	paranasal sinus neoplasm|skull neoplasm|bone neoplasm|material entity|experimental factor; paranasal sinus neoplasm|skull neoplasm|bone neoplasm|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; paranasal sinus neoplasm|paranasal sinus disease|skull disorder|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; paranasal sinus neoplasm|paranasal sinus disease|respiratory system disease|disease|disposition|material property|experimental factor; paranasal sinus neoplasm|paranasal sinus disease|head and neck disorder|disease|disposition|material property|experimental factor; paranasal sinus neoplasm|skull neoplasm|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor; paranasal sinus neoplasm|skull neoplasm|bone neoplasm|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; paranasal sinus neoplasm|skull neoplasm|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; paranasal sinus neoplasm|paranasal sinus disease|nasal disorder|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; paranasal sinus neoplasm|skull neoplasm|bone neoplasm|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; paranasal sinus neoplasm|skull neoplasm|skull disorder|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0000538	hypertrophic cardiomyopathy	A condition in which the myocardium is hypertrophied without an obvious cause. The hypertrophy is generally asymmetric and may be associated with obstruction of the ventricular outflow tract.	hypertrophic subaortic stenosis;Cardiomyopathy, Hypertrophic Obstructive;Hypertrophic Obstructive Cardiomyopathy;Asymmetric Septal Hypertrophy;HYPERTR OBSTR CARDIOMYOP;SUBVALV STENOSIS IDIOPATHIC HYPERTROPHIC;hyper. obst. cardiomyopathy;Hypertrophy, Asymmetric Septal;IHSS;obstructive hypertrophic cardiomyopathy;HCM - Hypertrophic cardiomyopathy;Idiopathic Hypertrophic Subaortic Stenosis;Obstructive cardiomyopathy;Hypertrophic Obstructive Cardiomyopathies;Septal Hypertrophies, Asymmetric;hypertrophic cardiomyopathy;Septal Hypertrophy, Asymmetric;IDIOPATHIC HYPERTROPHIC SUBVALV STENOSIS;HCM;IHSSs;Subvalvular Stenosis, Idiopathic Hypertrophic;primary hypertrophic cardiomyopathy (disorder) [Ambiguous];Cardiomyopathy, hypertrophic;Hypertrophies, Asymmetric Septal;Hypertrophic obstructive cardiomyopathy (disorder);HOCM - Hypertrophic obstructive cardiomyopathy;Hypertrophic Cardiomyopathies;SUBVALV STENOSIS;hypertrophic myocardiopathy;Hypertrophic cardiomyopathy (disorder);Cardiomyopathies, Hypertrophic Obstructive;Cardiomyopathies, Hypertrophic;Obstructive Cardiomyopathies, Hypertrophic;Primary hypertrophic cardiomyopathy;Obstructive Cardiomyopathy, Hypertrophic;Idiopathic Hypertrophic Subvalvular Stenosis;Asymmetric Septal Hypertrophies;hypertrophic obstructive cardiomyopathy	hypertrophic cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; hypertrophic cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; hypertrophic cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|material entity|experimental factor
HP:0005268	Miscarriage	A pregnancy that ends at a stage in which the fetus is incapable of surviving on its own, defined as the spontaneous loss of a fetus before the 22th week of pregnancy.	Spontaneous abortion;Early fetal demise	Miscarriage|Prenatal death|age at death|age|temporal measurement|measurement|information entity|experimental factor
EFO:0009568	tricuspid valve disease	A disease involving the tricuspid valve.	disease or disorder of tricuspid valve;tricuspid valve disorder;disease of tricuspid valve;disorder of tricuspid valve;tricuspid valve disease or disorder;tricuspid valve disease;tricuspid disease	tricuspid valve disease|heart valve disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0009546	eye adnexa disease	A disease involving the ocular adnexa.	disease or disorder of ocular adnexa;ocular adnexa disease;eye adnexa disorder;disorder of ocular adnexa;ocular adnexa disease or disorder;disease of ocular adnexa	eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0005772	neurodegenerative disease	A disorder of the central nervous system characterized by gradual and progressive loss of neural tissue and neurologic function.	brain degeneration;Neurodegenerative Diseases;neurodegenerative disorder;neurodegenerative disorders;neurodegenerative disease;central nervous system neurodegenerative disorder;degenerative disorder of central nervous system;central nervous system degenerative disorder	neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
CHEBI:25017	leucine	NA	leucine	leucine|amino acid|acid|chemical entity|material entity|experimental factor
EFO:0007540	animal viral hepatitis	NA	Viral hepatitis with hepatic coma (disorder);viral hepatitis with hepatic coma;viral hepatitis;Hepatitis, Viral, Animal;Unspecified viral hepatitis with hepatic coma	animal viral hepatitis|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; animal viral hepatitis|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0007199	central nervous system tuberculosis	A well-circumscribed mass composed of tuberculous granulation tissue that may occur in the cerebral hemispheres, cerebellum, brain stem, or perimeningeal spaces. Multiple lesions are quite common. Management of intracranial manifestations vary with lesion site. Intracranial tuberculomas may be associated with seizures, focal neurologic deficits, and intracranial hypertension. Spinal cord tuberculomas may be associated with localized or radicular pain, weakness, sensory loss, and incontinence. Tuberculomas may arise as opportunistic infections, but also occur in immunocompetent individuals.	tuberculosis of central nervous system;tuberculoma of brain;Tuberculosis, Central Nervous System;central nervous system tuberculosis;tuberculosis of meninges and central nervous system;Tuberculoma, Intracranial;Tuberculosis of meninges and central nervous system (disorder);tuberculous abscess of brain;intracranial tuberculoma	central nervous system tuberculosis|central nervous system infection|infectious disorder of the nervous system|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; central nervous system tuberculosis|extrapulmonary tuberculosis|tuberculosis|primary bacterial infectious disease|material entity|experimental factor; central nervous system tuberculosis|central nervous system infection|infectious disorder of the nervous system|material entity|experimental factor; central nervous system tuberculosis|extrapulmonary tuberculosis|tuberculosis|mycobacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; central nervous system tuberculosis|central nervous system infection|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; central nervous system tuberculosis|central nervous system infection|infectious disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; central nervous system tuberculosis|extrapulmonary tuberculosis|tuberculosis|primary bacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
HP:0030016	Dyspareunia	Recurrent or persistent genital pain associated with sexual intercourse.		Dyspareunia|Abnormality of the genital system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000783	myositis	An inflammatory disease involving a pathogenic inflammatory response in the muscle tissue.	MYALGIA AND MYOSITIS NOS;Myopathies, Inflammatory;Inflammatory myopathy;Infectious Myositides;Infectious Myositis;Myositis, Focal;inflammation of muscle tissue;Myositides, Proliferative;Myopathies, Idiopathic Inflammatory;Idiopathic Inflammatory Myopathies;Inflammatory disorder of muscle;Inflammatory Muscle Diseases;inflammatory disorder of muscle (disorder);Myopathy, Idiopathic Inflammatory;myositis;Myositis, NOS;Myositis NOS;IDIOPATHIC INFLAMM MYOPATHIES;Inflammatory disorder of muscle (disorder);Proliferative Myositis;INFLAMM MYOPATHIES IDIOPATHIC;Myositis unspecified;Proliferative Myositides;Mylagia and myositis, unspecified;Myositis, Proliferative;INFECT MYOSITIS;inflammatory disorder of muscle;Inflammatory Myopathy, Idiopathic;Myositides, Infectious;muscle tissue inflammation;Unspecified disorder of muscle, ligament, and fascia;Inflammatory Myopathies;Muscle Diseases, Inflammatory;Myositides;MUSCLE/LIGAMENT DIS NOS;MUSCLE DIS INFLAMM;Inflammatory Muscle Disease;INFLAMM MYOPATHY;MYOSITIS INFECT;Muscle Disease, Inflammatory;Myopathy, Inflammatory;Muscle inflammation;MYOPATHY INFLAMM;Myositides, Focal;Myositis unspecified (disorder);Focal Myositides;INFLAMM MUSCLE DIS;Focal Myositis;MYOPATHIES IDIOPATHIC INFLAMM;Idiopathic Inflammatory Myopathy;Inflammatory Myopathies, Idiopathic;Myositis, Infectious;Myositis (disorder)	myositis|immune system disease|disease|disposition|material property|experimental factor; myositis|myopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; myositis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:1001917	social anxiety disorder	An anxiety disorder characterized by an intense, irrational fear of one or more social or performance situations in which the individual believes that he or she will be scrutinized by others. Exposure to social situations immediately provokes an anxiety response. In adults, the social phobia is recognized as excessive or unreasonable.	SAD;social phobia;social anxiety disorder;social anxiety	social anxiety disorder|phobic disorder|anxiety disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; social anxiety disorder|phobic disorder|anxiety disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:0003943	humerus fracture	A traumatic or pathologic injury to the humerus in which the continuity of the humerus is broken.	humeral fracture;Fracture, Humeral;Humeral Fracture;Humeral Fractures;fractures, humeral;Fractures, Humeral;fracture, humeral;humerus fracture	humerus fracture|upper extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; humerus fracture|upper extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor
MONDO:0005301	multiple sclerosis	A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.		multiple sclerosis|autoimmune disorder of central nervous system|autoimmune disorder of the nervous system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; multiple sclerosis|CNS demyelinating autoimmune disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; multiple sclerosis|autoimmune disorder of central nervous system|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; multiple sclerosis|CNS demyelinating autoimmune disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; multiple sclerosis|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; multiple sclerosis|demyelinating disease|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; multiple sclerosis|autoimmune disorder of central nervous system|autoimmune disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; multiple sclerosis|demyelinating disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; multiple sclerosis|CNS demyelinating autoimmune disease|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor
MONDO:0002220	tooth hard tissue disease	NA	disorder of hard tissues of teeth	tooth hard tissue disease|tooth disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; tooth hard tissue disease|tooth disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0801071	2-methylcitrate measurement	NA		2-methylcitrate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009477	vertebral joint disease	A disease that involves the intervertebral joint.	disease or disorder of intervertebral joint;disorder of intervertebral joint;intervertebral joint disease or disorder;disc problem;vertebral joint disorder;intervertebral joint disease;disorder of joint of spine;disease of intervertebral joint	vertebral joint disease|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; vertebral joint disease|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0000699	Sjogren syndrome	An autoimmune disorder in which immune cells attack and destroy the glands that produce tears and saliva. Sjgren syndrome is also associated with rheumatic disorders such as rheumatoid arthritis or systemic lupus erythematosus. The hallmark symptoms of Sjgren syndrome are dry mouth and dry eyes. In addition, Sjogren syndrome may cause skin, nose, and vaginal dryness. It also may affect other organs of the body including the kidneys, blood vessels, lungs, liver, pancreas, and brain	xerodermosteosis;Sicca syndrome;Sjogren's syndrome (disorder);SJOGREN'S SYNDROME;primary Sjgren-Gougerot syndrome;Sjogrens Syndrome;Sjogren syndrome;syndrome, Sjogren's;Syndrome, Sicca;Syndrome, Sjogren's;Sicca (Sjogren's) syndrome;Sjogren's disease;primary Sjogren-Gougerot syndrome;Sjgren syndrome;Sjgren-Gougerot syndrome;sicca syndrome;Mikulicz disease;Sicca syndrome (disorder);Sjgren's syndrome (disorder)	Sjogren syndrome|autoimmune disorder of exocrine system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; Sjogren syndrome|syndromic disease|material entity|experimental factor; Sjogren syndrome|disorder of lacrimal gland|lacrimal apparatus disease|eyelid disease|eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; Sjogren syndrome|syndromic disease|disease|disposition|material property|experimental factor; Sjogren syndrome|salivary gland disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; Sjogren syndrome|disorder of lacrimal gland|lacrimal apparatus disease|eyelid disease|eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; Sjogren syndrome|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor
MONDO:0004359	delusional disorder	A disorder characterized by the presence of one or more nonbizarre delusions that persist for at least 1 month; the delusion(s) are not due to schizophrenia or a mood disorder, and do not impair psychosocial functioning apart from the ramifications of the delusion(s).		delusional disorder|psychosis|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; delusional disorder|psychosis|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:1000438	Palmar Fibromatosis	A superficial fibromatosis arising from the soft tissue of the palm. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern. It predominantly affects adult males.	Dupuytren contracture (disease);palmar fibromatosis;Dupuytren contracture;palmar part of manus fibromatosis	Palmar Fibromatosis|Superficial Fibromatosis|fibromatosis|Fibroblastic Neoplasm|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Palmar Fibromatosis|contracture|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; Palmar Fibromatosis|Superficial Fibromatosis|fibromatosis|Fibroblastic Neoplasm|mesenchymal cell neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Palmar Fibromatosis|Superficial Fibromatosis|fibromatosis|Fibroblastic Neoplasm|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor
EFO:0005207	congenital heart disease	A heart disease that is present at birth. Representative examples include atrial septal defect, ventricular septal defect, tetralogy of Fallot, and patent foramen ovale.	heart defect;congenital heart disease;congenital heart defects;CHD;congenital anomaly of heart;congenital heart defect;heart malformation	congenital heart disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; congenital heart disease|congenital anomaly of cardiovascular system|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; congenital heart disease|congenital anomaly of cardiovascular system|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0008533	dyspepsia	An uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach pain, bloating, heartburn, nausea, and vomiting. Causes include gastritis, gastric ulcer, gastroesophageal reflux disease, pancreatic disease, and gallbladder disease.	dyspepsia, indigestion;indigestion NOS;dyspepsia;indigestion	dyspepsia|functional gastric disease|stomach disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0000274	atopic eczema	A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.	atopic eczema;Other atopic dermatitis and related conditions;Dermatitides, Atopic;Neurodermatitis, Atopic;Neurodermatitides, Atopic;eczema;allergic;Atopic Neurodermatitis;atopic dermatitis and related conditions;Disseminated Neurodermatitides;Neurodermatitides, Disseminated;Eczema, Infantile;Disseminated Neurodermatitis;Eczema, Atopic;Atopic Neurodermatitides;Atopic dermatitis;Atopic Dermatitis;allergic dermatitis;Besnier's prurigo;Atopic dermatitis and related conditions (disorder);Neurodermatitis, Disseminated;Atopic Dermatitides;eczematous dermatitis;Atopic neurodermatitis;allergic form of dermatitis;Infantile Eczema;OTHER ATOPIC DERMATITIS;Dermatitis, Atopic	atopic eczema|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; atopic eczema|inflammatory skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; atopic eczema|genetic disorder|material entity|experimental factor; atopic eczema|allergic disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; atopic eczema|genetic disorder|disease|disposition|material property|experimental factor; atopic eczema|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0007992	basophil percentage of leukocytes	NA	blood basophil count to total leukocyte count ratio;basophil count to total WBC count ratio;basophil percentage of white cells;basophil count as percentage of total white blood cells;basophil percentage	basophil percentage of leukocytes|basophil count|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor; basophil percentage of leukocytes|basophil count|inflammatory biomarker measurement|measurement|information entity|experimental factor
EFO:1000761	scalp dermatosis	Dermotosis of scalp	Dermatosis of scalp;scalp dermatosis;dermatosis of scalp	scalp dermatosis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:1000350	Malignant Bone Neoplasm	A primary or metastatic malignant neoplasm affecting the bone or articular cartilage.	cancer of skeletal element;cancer of the bone;malignant neoplasm of bone;malignant tumor of the bone;malignant osseous tumor;bone cancer;malignant skeletal element neoplasm;malignant bone tumor;malignant osseous neoplasm;CA - bone cancer;malignant tumor of bone;malignant bone neoplasm;malignant neoplasm of the bone;malignant neoplasm of skeletal element;malignant bone tumour;skeletal element cancer;osseous cancer;cancer of bone	Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; Malignant Bone Neoplasm|bone neoplasm|material entity|experimental factor; Malignant Bone Neoplasm|musculoskeletal system cancer|musculoskeletal system disease|disease|disposition|material property|experimental factor; Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Malignant Bone Neoplasm|bone neoplasm|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; Malignant Bone Neoplasm|musculoskeletal system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0009812	secondary malignant neoplasm	A malignant neoplasm that arises from a pre-existing lower grade lesion, or as a result of a primary lesion that has spread to secondary sites, or due to a complication of a cancer treatment.	secondary cancer;secondary malignant neoplasm;secondary malignancy	secondary malignant neoplasm|secondary neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; secondary malignant neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0008496	chronic hepatitis	NA		chronic hepatitis|Hepatitis|Abnormality of the liver|Abnormality of the abdominal organs|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; chronic hepatitis|Hepatitis|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0010447	Anal fistula	An abnormal connection between the epithelialised surface of the anal canal and the perianal skin.	Fistula in ano	Anal fistula|Abnormality of the anus|Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Anal fistula|Abnormal intestine morphology|Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1000897	diabetic ketoacidosis	The metabolic condition resulted from uncontrolled diabetes mellitus, in which the shift of acid-base status of the body toward the acid side because of loss of base or retention of acids other than carbonic acid is accompanied by the accumulation of ketone bodies in body tissues and fluids.	ketosis-prone diabetes mellitus;DIABETES MELLITUS, KETOSIS-PRONE;Diabetic Ketoacidosis;diabetic ketoacidosis	diabetic ketoacidosis|diabetes mellitus|endocrine pancreas disorder|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor; diabetic ketoacidosis|diabetes mellitus|glucose metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; diabetic ketoacidosis|diabetes mellitus|endocrine pancreas disorder|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0004343	waist-hip ratio	NA		waist-hip ratio|body ratio measurement|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
MONDO:0044334	connective and soft tissue neoplasm	A benign, intermediate, or malignant neoplasm that affects the connective and soft tissue.	connective and soft tissue tumor;connective and soft tissue neoplasm;tumor of skeletal and soft tissue;neoplasm of soft tissue and skeleton;musculoskeletal and soft tissue neoplasm;neoplasm of skeletal and soft tissue;skeletal and soft tissue tumor;soft tissue and bone neoplasm;soft tissue and bone tumor;musculoskeletal and soft tissue tumor;tumor of soft tissue and skeleton;tumor of soft tissue and bone;skeletal and soft tissue neoplasm;neoplasm of soft tissue and bone	connective and soft tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0003874	flatfoot	An anatomic deformity in which the arch of the foot collapses, resulting in the entire sole of the foot coming into complete or near-complete contact with the ground.	flatfoot;Feet, Flat;Flatfeet;Flat Foot;flat Foot;fallen Arch;flat feet;Foot, Flat;Pes Planus	flatfoot|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0009717	bilateral oophorectomy	NA		bilateral oophorectomy|medical procedure|experimental process|planned process|process|experimental factor
EFO:0003881	hysterectomy	NA	Hysterectomies	hysterectomy|medical procedure|experimental process|planned process|process|experimental factor
EFO:0003893	ovarian neoplasm	A benign, borderline, or malignant neoplasm involving the ovary.	tumor of the ovary;OVARY NEOPL;ovary neoplasm (disease);ovarian tumor;ovary neoplasm;Ovary Neoplasm;Neoplasm, Ovary;ovarian neoplasm;ovarian tumors;neoplasm of ovary;neoplasm of the ovary;Ovary Neoplasms;ovary tumor;Neoplasms, Ovary;Neoplasm, Ovarian;Cancer of Ovary;OVARIAN NEOPL;Neoplasms, Ovarian;Ovarian Neoplasms;tumor of ovary;NEOPL OVARIAN	ovarian neoplasm|ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian neoplasm|ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; ovarian neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; ovarian neoplasm|ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0020978	encounter with health service for breast reconstruction following mastectomy	NA	mammoplasty	encounter with health service for breast reconstruction following mastectomy|encounter with health service|event|process|experimental factor
MONDO:0004992	cancer	A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.	cell type cancer;CA;neoplasm (disease), malignant;organ system cancer;malignant neoplastic disease;malignant Growth;malignant neoplasm (disease);neoplasm, malignant;cancer;primary cancer;malignancy;malignant tumor;malignant neoplasm	cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0020987	mastectomy	NA		mastectomy|medical procedure|experimental process|planned process|process|experimental factor
MONDO:0018364	malignant epithelial tumor of ovary	An invasive malignant tumor that originates from the surface epithelium of the ovary. It is composed of malignant epithelial cells and stroma. Representative examples include serous adenocarcinoma, mucinous adenocarcinoma, endometrioid adenocarcinoma, clear cell adenocarcinoma, and malignant Brenner tumor.	malignant ovarian surface epithelial-stromal neoplasm;ovarian malignant epithelial tumor;malignant ovarian epithelial tumor;ovarian epithelial tumor, malignant;ovarian stromal cancer;ovarian epithelial cancer;malignant ovarian surface epithelial-stromal tumor;epithelial cancer of ovary	malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian epithelial tumor|ovarian neoplasm|ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian epithelial tumor|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|ovarian cancer|ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; malignant epithelial tumor of ovary|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0009580	prophylactic surgery	NA		prophylactic surgery|medical procedure|experimental process|planned process|process|experimental factor
MONDO:0008170	ovarian cancer	A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.	ovary cancer;malignant ovarian tumor;malignant tumor of ovary;cancer of the ovary;malignant neoplasm of the ovary;malignant ovarian neoplasm;ovarian cancer;malignant tumour of ovary;malignant neoplasm of ovary;malignant tumor of the ovary;ovarian malignant tumor;ovarian cancer, somatic;malignant ovary neoplasm;cancer of ovary	ovarian cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; ovarian cancer|ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; ovarian cancer|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian cancer|ovarian neoplasm|ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; ovarian cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian cancer|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian cancer|ovarian neoplasm|ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian cancer|ovarian neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; ovarian cancer|ovarian neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; ovarian cancer|ovarian neoplasm|ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; ovarian cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor
MONDO:0021138	bone marrow cancer	Malignant neoplasms that either originate from the bone marrow (e.g. myeloid leukemias) or involve the bone marrow as secondary-metastatic tumors (e.g. metastatic carcinomas to the bone marrow). --2003	cancer of bone marrow;malignant neoplasm of bone marrow;bone marrow cancer;malignant bone marrow neoplasm;malignant bone marrow tumor	bone marrow cancer|immune system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bone marrow cancer|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; bone marrow cancer|Malignant Bone Neoplasm|musculoskeletal system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bone marrow cancer|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; bone marrow cancer|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|material entity|experimental factor; bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; bone marrow cancer|Malignant Bone Neoplasm|musculoskeletal system cancer|musculoskeletal system disease|disease|disposition|material property|experimental factor; bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; bone marrow cancer|immune system cancer|immune system disease|disease|disposition|material property|experimental factor; bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bone marrow cancer|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor
EFO:0003922	menopause	NA	Change of Life, Female	menopause|sign or symptom|phenotype|quality|material property|experimental factor
MONDO:0004379	female breast carcinoma	A carcinoma that arises from the breast in females. It is the most common malignant tumor that affects females.	female breast cancer;carcinoma of female breast;mammary carcinoma of the female breast;carcinoma of the female breast;female breast carcinoma;mammary carcinoma of female breast;breast carcinoma, female	female breast carcinoma|breast carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; female breast carcinoma|breast carcinoma|breast cancer|thoracic cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; female breast carcinoma|breast carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; female breast carcinoma|breast carcinoma|breast cancer|thoracic cancer|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; female breast carcinoma|breast carcinoma|breast cancer|breast neoplasm|breast disease|disease|disposition|material property|experimental factor; female breast carcinoma|breast carcinoma|breast cancer|breast neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; female breast carcinoma|breast carcinoma|breast cancer|breast neoplasm|integumentary system disease|disease|disposition|material property|experimental factor
EFO:1001331	Genital neoplasm, female	A primary or metastatic malignant neoplasm involving the female reproductive system. Representative examples include endometrial carcinoma, cervical carcinoma, ovarian carcinoma, uterine corpus leiomyosarcoma, adenosarcoma, malignant mixed mesodermal (mullerian) tumor, and gestational choriocarcinoma.	female reproductive organ cancer;malignant tumor of the female reproductive system;malignant female reproductive system tumor;malignant neoplasm of female genital organ;cancer of female reproductive organ;malignant neoplasm of female reproductive organ;gynecologic cancer;malignant tumor of female reproductive system;malignant gynecologic neoplasm;malignant female reproductive system neoplasm;malignant neoplasm of female reproductive system;malignant gynecologic tumor;female reproductive cancer;malignant female reproductive organ neoplasm;malignant neoplasm of the female reproductive system	Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
HP:0100523	Liver abscess	The presence of an abscess of the liver.	Hepatic abscess;Liver abscess	Liver abscess|Abnormality of the liver|Abnormality of the abdominal organs|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Liver abscess|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1000402	Normal Breast-Like Subtype of Breast Carcinoma	A biologic subset of breast carcinoma defined by high expression of many genes expressed by adipose and other non-epithelial tissues.	normal breast-like subtype of breast carcinoma;normal breast-like subtype of breast cancer	Normal Breast-Like Subtype of Breast Carcinoma|Breast Carcinoma by Gene Expression Profile|breast carcinoma|breast cancer|breast neoplasm|breast disease|disease|disposition|material property|experimental factor; Normal Breast-Like Subtype of Breast Carcinoma|Breast Carcinoma by Gene Expression Profile|breast carcinoma|breast cancer|thoracic cancer|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Normal Breast-Like Subtype of Breast Carcinoma|Breast Carcinoma by Gene Expression Profile|breast carcinoma|breast cancer|thoracic cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Normal Breast-Like Subtype of Breast Carcinoma|Breast Carcinoma by Gene Expression Profile|breast carcinoma|breast cancer|breast neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Normal Breast-Like Subtype of Breast Carcinoma|Breast Carcinoma by Gene Expression Profile|breast carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Normal Breast-Like Subtype of Breast Carcinoma|Breast Carcinoma by Gene Expression Profile|breast carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Normal Breast-Like Subtype of Breast Carcinoma|Breast Carcinoma by Gene Expression Profile|breast carcinoma|breast cancer|breast neoplasm|integumentary system disease|disease|disposition|material property|experimental factor
MONDO:0024621	serous cystadenocarcinoma	A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.	serous cystadenocarcinoma	serous cystadenocarcinoma|cystadenocarcinoma|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; serous cystadenocarcinoma|cystadenocarcinoma|cystic neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; serous cystadenocarcinoma|cystadenocarcinoma|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; serous cystadenocarcinoma|serous adenocarcinoma|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; serous cystadenocarcinoma|serous adenocarcinoma|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; serous cystadenocarcinoma|cystadenocarcinoma|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; serous cystadenocarcinoma|serous adenocarcinoma|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0004647	in situ carcinoma	A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.	carcinoma, in situ, malignant;epithelial tumor, in situ, malignant;stage 0 disease;carcinoma in situ;intraepithelial carcinoma;non-invasive carcinoma	in situ carcinoma|precancerous condition|cancer or benign tumor|disease|disposition|material property|experimental factor; in situ carcinoma|high grade malignant neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; in situ carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; in situ carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; in situ carcinoma|high grade malignant neoplasm|material entity|experimental factor
EFO:0000707	squamous cell carcinoma	A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.	squamous cell carcinoma;epidermoid carcinoma;carcinoma, squamous cell, malignant;malignant epidermoid cell neoplasm;squamous cell carcinoma (morphologic abnormality);squamous cell carcinoma NOS (morphologic abnormality);squamous cell cancer;malignant squamous cell neoplasm;epidermoid cell cancer;squamous carcinoma;malignant squamous cell tumor;malignant epidermoid cell tumor;squamous cell epithelioma;SCC	squamous cell carcinoma|squamous cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; squamous cell carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; squamous cell carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0021506	2-hydroxyglutarate measurement	NA		2-hydroxyglutarate measurement|metabolite measurement|measurement|information entity|experimental factor
MONDO:0005147	type 1 diabetes mellitus	A chronic condition characterized by minimal or absent production of insulin by the pancreas.	juvenile diabetes;type I diabetes;diabetes mellitis type I;IDDM;insulin dependent diabetes;type I diabetes mellitus;type 1 diabetes;insulin-dependent diabetes mellitus;immune mediated diabetes;diabetes mellitis type 1	type 1 diabetes mellitus|autoimmune disorder of gastrointestinal tract|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; type 1 diabetes mellitus|diabetes mellitus|glucose metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; type 1 diabetes mellitus|autoimmune disorder of endocrine system|endocrine system disease|disease|disposition|material property|experimental factor; type 1 diabetes mellitus|autoimmune disorder of endocrine system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; type 1 diabetes mellitus|diabetes mellitus|endocrine pancreas disorder|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor; type 1 diabetes mellitus|autoimmune disorder of gastrointestinal tract|digestive system disease|disease|disposition|material property|experimental factor; type 1 diabetes mellitus|diabetes mellitus|endocrine pancreas disorder|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor
HP:0002315	Headache	Cephalgia, or pain sensed in various parts of the head, not confined to the area of distribution of any nerve.	Headache;Headaches	Headache|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003878	urethritis	Inflammation of the urethra.	Urethritides;urethra inflammation;Nongonococcal urethritis;inflammation of urethra;non-gonococcal urethritis;urethritis;urethritis (disease)	urethritis|inflammatory disease|disease|disposition|material property|experimental factor; urethritis|bacterial urinary tract infection|urinary tract infection|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; urethritis|urethral disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:1000012	Rienhoff syndrome	Loeys-Dietz syndrome-5 (LDS5), also known as Rienhoff (pronounced REENhoff) syndrome, is characterized by syndromic presentation of aortic aneurysms involving the thoracic and/or abdominal aorta, with risk of dissection and rupture. Other systemic features include cleft palate, bifid uvula, mitral valve disease, skeletal overgrowth, cervical spine instability, and clubfoot deformity; however, not all clinical features occur in all patients. In contrast to other forms of LDS, no striking aortic or arterial tortuosity is present in these patients, and there is no strong evidence for early aortic dissection.	LDS5;Rienhoff syndrome;Loeys-Dietz syndrome type 5;Loeys-Dietz syndrome-5;Loeys-Dietz syndrome 5	Rienhoff syndrome|overgrowth or tall stature syndrome with skeletal involvement|skeletal dysplasia|genetic disorder|disease|disposition|material property|experimental factor; Rienhoff syndrome|overgrowth or tall stature syndrome with skeletal involvement|skeletal dysplasia|genetic disorder|material entity|experimental factor; Rienhoff syndrome|overgrowth or tall stature syndrome with skeletal involvement|skeletal dysplasia|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; Rienhoff syndrome|Loeys-Dietz syndrome|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Rienhoff syndrome|Loeys-Dietz syndrome|syndromic disease|disease|disposition|material property|experimental factor; Rienhoff syndrome|Loeys-Dietz syndrome|autosomal dominant disease|autosomal genetic disease|genetic disorder|disease|disposition|material property|experimental factor; Rienhoff syndrome|Loeys-Dietz syndrome|Marfan and Marfan-related disorder|hereditary disorder of connective tissue|genetic disorder|disease|disposition|material property|experimental factor; Rienhoff syndrome|Loeys-Dietz syndrome|autosomal dominant disease|autosomal genetic disease|genetic disorder|material entity|experimental factor; Rienhoff syndrome|Loeys-Dietz syndrome|Marfan and Marfan-related disorder|hereditary disorder of connective tissue|genetic disorder|material entity|experimental factor; Rienhoff syndrome|Loeys-Dietz syndrome|syndromic disease|material entity|experimental factor; Rienhoff syndrome|Loeys-Dietz syndrome|Marfan and Marfan-related disorder|hereditary disorder of connective tissue|connective tissue disease|disease|disposition|material property|experimental factor
EFO:1000840	bladder neck obstruction	Blockage of the opening between the bladder and the urethra resulting in the reduction or prevention of the urine flow from the bladder into the urethra.	Obstruction of bladder neck or vesicourethral orifice;obstruction of bladder neck or vesicourethral orifice;bladder neck obstruction;bladder neck obstruction (disorder);Urinary Bladder Neck Obstruction	bladder neck obstruction|bladder disease|urinary system disease|disease|disposition|material property|experimental factor
HP:0002015	Dysphagia	Difficulty in swallowing.	Swallowing difficulties;Difficulty swallowing;Poor swallowing;Swallowing difficulty	Dysphagia|Abnormal esophagus physiology|Functional abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Dysphagia|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004263	partial epilepsy	A seizure caused by a localized disorder.	epilepsies, partial;partial epilepsies;focal epilepsy;localisation-related epilepsy;partial epilepsy	partial epilepsy|epilepsy|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
HP:0011713	Left bundle branch block	A conduction block of the left branch of the bundle of His. This manifests as a generalized disturbance of QRS morphology on EKG.		Left bundle branch block|Abnormality of cardiovascular system electrophysiology|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001800	Intervertebral Disc Displacement	NA	displacement of intervertebral disc	Intervertebral Disc Displacement|vertebral joint disease|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; Intervertebral Disc Displacement|vertebral joint disease|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
CHEBI:16236	ethanol	NA	ethanol;ETHANOL;Ethanol	ethanol|chemical entity|material entity|experimental factor
EFO:0009572	uterine inflammatory disease	NA	uterine inflammatory disease;inflammatory disease of the uterus	uterine inflammatory disease|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
MONDO:0002108	thyroid cancer	A malignant neoplasm involving the thyroid gland	malignant tumor of the thyroid gland;malignant tumor of thyroid;cancer of thyroid gland;malignant thyroid neoplasm;malignant neoplasm of the thyroid;malignant thyroid gland neoplasm;malignant thyroid tumor;malignant tumour of thyroid gland;malignant neoplasm of the thyroid gland;malignant neoplasm of thyroid gland;malignant neoplasm of thyroid;thyroid gland cancer;malignant thyroid gland tumor;malignant tumor of thyroid gland;malignant tumor of the thyroid	thyroid cancer|thyroid neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; thyroid cancer|thyroid neoplasm|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor; thyroid cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; thyroid cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; thyroid cancer|thyroid neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; thyroid cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0024647	urolithiasis	Stone(s) within the urinary tract.	urinary stones;calculus;urolithiasis	urolithiasis|urinary system disease|disease|disposition|material property|experimental factor
MONDO:0017408	rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome	A very rare disorder that appears after the first year and a half of life in previously healthy children. It is characterized by rapid-onset weight gain, hypothalamic dysfunction, breathing abnormalities, and autonomic system dysregulation. The hypothalamic dysfunction manifestations include inability to maintain normal water balance, high prolactin levels, low thyroid, low cortisol, and early or late puberty. The breathing abnormalities include sleep apnea and alveolar hypoventilation, requiring ventilation support. The autonomic system dysregulation includes eye abnormalities, intestinal abnormalities, temperature dysregulation, and low heart rhythm. This disorder requires early recognition because it may lead to cardiorespiratory arrest. Up to 40% of the patients develop tumors of neural crest origin.	rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation;rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome;ROHHAD;rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation-neural tumors syndrome;ROHHAD syndrome;ROHHADNET	rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome|syndromic genetic obesity|inherited obesity|inborn errors of metabolism|genetic disorder|material entity|experimental factor; rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome|syndromic genetic obesity|syndromic disease|disease|disposition|material property|experimental factor; rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome|syndromic genetic obesity|overgrowth/obesity syndrome|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome|syndromic genetic obesity|inherited obesity|endocrine system disease|disease|disposition|material property|experimental factor; rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome|syndromic genetic obesity|inherited obesity|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome|syndromic genetic obesity|inherited obesity|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome|syndromic genetic obesity|syndromic disease|material entity|experimental factor; rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome|syndromic genetic obesity|inherited obesity|obesity|overnutrition|nutritional disorder|metabolic disease|disease|disposition|material property|experimental factor
EFO:0001378	multiple myeloma	A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)	multiple myeloma, resistance to, Somatic mutation;myeloma, plasma cell, malignant;medullary plasmacytoma;myeloid neoplasm of plasma cell;myeloma, multiple;multiple myeloma/plasma cell myeloma;plasma cell myeloma;myeloma;multiple myeloma, susceptibility to, Somatic mutation;myelomatosis;Kahler's disease;plasma cell myeloid neoplasm;multiple myeloma;Kahler disease	multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|immune system disease|disease|disposition|material property|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; multiple myeloma|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|hematologic disease|material entity|experimental factor; multiple myeloma|immune system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; multiple myeloma|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; multiple myeloma|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; multiple myeloma|plasma cell neoplasm|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; multiple myeloma|immune system cancer|immune system disease|disease|disposition|material property|experimental factor
EFO:1001173	secondary hyperparathyroidism	Overproduction of parathyroid hormone in response to influence external to the parathyroid glands.	Hyperparathyroidism, Secondary;secondary hyperparathyroidism (disease);secondary hyperparathyroidism;secondary hyperparathyroidism NOS;secondary hyperparathyroidism (disorder)	secondary hyperparathyroidism|hyperparathyroidism|parathyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
HP:0001653	Mitral regurgitation	An abnormality of the mitral valve characterized by insufficiency or incompetence of the mitral valve resulting in retrograde leaking of blood through the mitral valve upon ventricular contraction.	Mitral valve regurgitation;Mitral insufficiency;Mitral incompetence;Mitral valve insufficiency	Mitral regurgitation|Abnormal mitral valve physiology|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0100550	Tendon rupture	Breakage (tear) of a tendon.	Tendon/muscle rupture;Rupture of tendons;Ruptured tendon;Tendon rupture	Tendon rupture|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0800361	11-ketoetiocholanolone glucuronide measurement	NA		11-ketoetiocholanolone glucuronide measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:73707	gamma-Glu-Gln	NA	L-gamma-glutamyl-L-glutamine	gamma-Glu-Gln|amide|chemical entity|material entity|experimental factor
EFO:0009550	headache disorder	Various conditions with the symptom of headache. Headache disorders are classified into major groups, such as primary headache disorders (based on characteristics of their headache symptoms) and secondary headache disorders (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)	headache disorder	headache disorder|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; headache disorder|neurological pain disorder|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009657	acute pharyngitis	An acute and painful inflammatory process that affects the pharynx. It is usually caused by viruses and less often bacteria. Signs and symptoms include discomfort on swallowing, low-grade fever, headache, and earache.	pharyngitis, acute;acute pharyngitis	acute pharyngitis|pharyngitis|inflammatory disease|disease|disposition|material property|experimental factor; acute pharyngitis|acute disease|disease|disposition|material property|experimental factor; acute pharyngitis|pharyngitis|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0004992	Otitis media	Inflammation of the anatomical structures of the middle ear, which is most often caused by an infectious process. Symptoms include erythema and edema of the tympanic membrane, pain, and possibly fever.	otitis media;middle Ear Inflammation;middle ear inflammation;medial otitis;otitis media (disease);otitis Media;inflammation of middle ear;AOM	Otitis media|middle ear disorder|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; Otitis media|inflammatory disease|disease|disposition|material property|experimental factor; Otitis media|middle ear disorder|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; Otitis media|head and neck disorder|disease|disposition|material property|experimental factor
MONDO:0001674	diverticulitis of colon	Inflammation of the colonic diverticula, generally with abscess formation and subsequent perforation.	colonic diverticular disease;colon diverticulitis	diverticulitis of colon|diverticulitis|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; diverticulitis of colon|diverticulitis|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; diverticulitis of colon|diverticulitis|diverticular disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; diverticulitis of colon|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
MONDO:0004627	duodenitis	Acute or chronic inflammation of the duodenum. Causes include bacterial and viral infections and gastroesophageal reflux disease. Symptoms include vomiting and abdominal pain.	duodenitis;inflammation of duodenum;duodenum inflammation	duodenitis|enteritis|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; duodenitis|duodenal disorder|small intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; duodenitis|enteritis|small intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; duodenitis|enteritis|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0007997	granulocyte percentage of myeloid white cells	NA		granulocyte percentage of myeloid white cells|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0800026	2-methylbutyrylcarnitine (C5) measurement	NA		2-methylbutyrylcarnitine (C5) measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0002013	Vomiting	Forceful ejection of the contents of the stomach through the mouth by means of a series of involuntary spasmic contractions.	Throwing up;Vomiting;Emesis	Vomiting|Nausea and vomiting|Abdominal symptom|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001837	rectocele	NA	female rectocele;herniation of rectum into vagina	rectocele|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
MONDO:0002406	dermatitis	An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.	inflammatory skin disease;inflammation of zone of skin;zone of skin inflammation;skin inflammation;inflammation of skin;inflammation of the skin	dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
MONDO:0004822	bronchiectasis	Segmental, irreversible dilation of the bronchial tree resulting in the accumulation of secretions which leads to obstruction. The most common cause is bacterial infection.	Polynesian bronchiectasis	bronchiectasis|chronic obstructive pulmonary disease|chronic lung disease|chronic disease|disease|disposition|material property|experimental factor; bronchiectasis|chronic obstructive pulmonary disease|tracheal disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; bronchiectasis|bronchial disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; bronchiectasis|chronic obstructive pulmonary disease|chronic lung disease|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; bronchiectasis|chronic obstructive pulmonary disease|tracheal disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; bronchiectasis|genetic disorder|disease|disposition|material property|experimental factor; bronchiectasis|genetic disorder|material entity|experimental factor
HP:0100749	Chest pain	NA	Thoracic pain;Chest pain	Chest pain|pain|sign or symptom|phenotype|quality|material property|experimental factor; Chest pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0001337	Tremor	An unintentional, oscillating to-and-fro muscle movement about a joint axis.	Tremor;Tremors	Tremor|Abnormal central motor function|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Tremor|Abnormality of movement|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0002017	Nausea and vomiting	Nausea is a commonly encountered symptom that has been defined as an unpleasant painless subjective feeling that one will imminently vomit. Vomiting has been defined as the forceful expulsion of the contents of the stomach, duodenum, or jejunum through the oral cavity. While nausea and vomiting are often thought to exist on a temporal continuum, this is not always the case. There are situations when severe nausea may be present without emesis and less frequently, when emesis may be present without preceding nausea.	Nausea and vomiting	Nausea and vomiting|Abdominal symptom|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005676	Autoimmune Hepatitis	Hepatitis caused by autoantibodies. Drugs, infections, and toxins may trigger the production of the autoantibodies against the liver parenchyma.	autoimmune-like hepatitis;chronic autoimmune hepatitis;autoimmune hepatitis with centrilobular necrosis;autoimmune hepatitis;AIH;autoimmune chronic active hepatitis	Autoimmune Hepatitis|inflammatory disease|disease|disposition|material property|experimental factor; Autoimmune Hepatitis|autoimmune disorder of exocrine system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; Autoimmune Hepatitis|autoimmune disorder of endocrine system|endocrine system disease|disease|disposition|material property|experimental factor; Autoimmune Hepatitis|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; Autoimmune Hepatitis|autoimmune disorder of gastrointestinal tract|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; Autoimmune Hepatitis|autoimmune disorder of gastrointestinal tract|digestive system disease|disease|disposition|material property|experimental factor; Autoimmune Hepatitis|autoimmune disorder of endocrine system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; Autoimmune Hepatitis|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; Autoimmune Hepatitis|material entity|experimental factor; Autoimmune Hepatitis|liver disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:1001045	middle cerebral artery infarction	Necrosis occurring in the middle cerebral artery distribution system which brings blood to the entire lateral aspects of each cerebral hemisphere. Clinical signs include impaired cognition; aphasia; agraphia; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.	middle cerebral artery infarction;Infarction, Middle Cerebral Artery	middle cerebral artery infarction|cerebral infarction|brain infarction|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; middle cerebral artery infarction|cerebral arterial disease|intracranial arterial disease|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; middle cerebral artery infarction|cerebral arterial disease|intracranial arterial disease|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; middle cerebral artery infarction|cerebral arterial disease|intracranial arterial disease|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; middle cerebral artery infarction|cerebral infarction|brain infarction|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; middle cerebral artery infarction|cerebral infarction|brain infarction|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009573	high-risk pregnancy	NA	high risk pregnancy	high-risk pregnancy|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0004540	chronic fatigue syndrome	A medical condition characterized by long-term fatigue and other symptoms that limit a person's ability to carry out ordinary daily activities.	systemic exertion intolerance disease;chronic fatigue syndrome;CFS;myalgic encephalomyelitis;chronic fatigue immune dysfunction syndrome;Postviral fatigue syndrome;Myalgic Encephalomyelitis;myalgic encephalitis;myalgic encephalomeyelitis/chronic fatigue syndrome	chronic fatigue syndrome|syndromic disease|material entity|experimental factor; chronic fatigue syndrome|syndromic disease|disease|disposition|material property|experimental factor; chronic fatigue syndrome|immunodeficiency disease|genetic disorder|material entity|experimental factor; chronic fatigue syndrome|chronic disease|disease|disposition|material property|experimental factor; chronic fatigue syndrome|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; chronic fatigue syndrome|immunodeficiency disease|genetic disorder|disease|disposition|material property|experimental factor; chronic fatigue syndrome|nervous system disease|disease|disposition|material property|experimental factor; chronic fatigue syndrome|immunodeficiency disease|immune system disease|disease|disposition|material property|experimental factor
CHEBI:15361	pyruvate	NA	pyruvate;2-oxopropanoate	pyruvate|chemical entity|material entity|experimental factor
CHEBI:27570	histidine	NA	histidine;2-amino-3-(1H-imidazol-4-yl)propanoic acid;Histidine	histidine|amino acid|acid|chemical entity|material entity|experimental factor; histidine|organic heterocyclic compound|chemical entity|material entity|experimental factor
EFO:0009604	labyrinthitis	Inflammation of the inner ear. The cause is often not clear. It may be due to a virus, but it can also arise from bacterial infection, head injury, extreme stress, an allergy, or as a reaction to medication.	inflammation of internal ear;labyrinthitis;internal ear inflammation	labyrinthitis|inner ear disease|auditory system disease|sensory system disease|nervous system disease|disease|disposition|material property|experimental factor; labyrinthitis|inflammatory disease|disease|disposition|material property|experimental factor; labyrinthitis|inner ear disease|disorder of ear|otorhinolaryngologic disease|disease|disposition|material property|experimental factor
MONDO:0019254	inborn disorder of purine or pyrimidine metabolism	NA	inborn errors of purine-pyrimidine metabolism;inborn purine-pyrimidine metabolic disorder	inborn disorder of purine or pyrimidine metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; inborn disorder of purine or pyrimidine metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor; inborn disorder of purine or pyrimidine metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor
MONDO:0004514	chronic rhinitis	Chronic inflammation of the nasal cavity mucosa. It may lead to post-nasal drip resulting in chronic sore throat and chronic cough.	rhinitis - chronic;rhinitis, chronic	chronic rhinitis|rhinitis|inflammatory disease|disease|disposition|material property|experimental factor; chronic rhinitis|rhinitis|nasal cavity disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; chronic rhinitis|rhinitis|nasal cavity disorder|nasal disorder|otorhinolaryngologic disease|disease|disposition|material property|experimental factor
HP:0000572	Visual loss	Loss of visual acuity (implying that vision was better at a certain time point in life). Otherwise the term reduced visual acuity should be used (or a subclass of that).	Vision loss;Visual loss;Loss of vision	Visual loss|Visual impairment|Abnormality of vision|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0800687	phenylacetylglutamate measurement	NA		phenylacetylglutamate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1001178	shoulder impingement syndrome	Compression of the rotator cuff tendons and subacromial bursa between the humeral head and structures that make up the coracoacromial arch and the humeral tuberosities. This condition is associated with subacromial bursitis and rotator cuff (largely supraspinatus) and bicipital tendon inflammation, with or without degenerative changes in the tendon. Pain that is most severe when the arm is abducted in an arc between 40 and 120 degrees, sometimes associated with tears in the rotator cuff, is the chief symptom. (From Jablonski's Dictionary of Syndromes and Eponymic Diseases, 2d ed)	Shoulder Impingement Syndrome;Shoulder impingement syndrome (disorder) [Ambiguous];Subacromial impingement (disorder);Impingement syndrome of shoulder region (disorder);subacromial impingement;Impingement syndrome of shoulder region;shoulder impingement syndrome (disorder) [ambiguous];shoulder impingement syndrome	shoulder impingement syndrome|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:1001791	femoral hernia	NA	Hernia, Femoral	femoral hernia|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
MONDO:0005475	migraine with aura	A migraine disorder characterized by episodes that are preceded by focal neurological symptoms.	classic migraine	migraine with aura|migraine disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; migraine with aura|migraine disorder|hypnic headache|headache disorder|neurological pain disorder|nervous system disease|disease|disposition|material property|experimental factor; migraine with aura|migraine disorder|hypnic headache|material entity|experimental factor; migraine with aura|migraine disorder|hypnic headache|headache disorder|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; migraine with aura|migraine disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; migraine with aura|migraine disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0004596	cor pulmonale	Hypertrophy and dilation of the right ventricle of the heart that is caused by pulmonary hypertension. This condition is often associated with pulmonary parenchymal or vascular diseases, such as chronic obstructive pulmonary disease and pulmonary embolism.	pulmonary heart disease;cardiopulmonary disease;cor pulmonale	cor pulmonale|congestive heart failure|heart failure|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
CHEBI:11951	4-acetamidobutanoate	NA	4-acetamidobutanoate	4-acetamidobutanoate|chemical entity|material entity|experimental factor
MONDO:0000620	breast benign neoplasm	A non-metastasizing neoplasm arising from the breast parenchyma.	breast benign neoplasm;benign tumor of the breast;benign neoplasm of breast;benign breast neoplasm;benign neoplasm of the breast;benign tumor of breast;benign breast tumor	breast benign neoplasm|breast neoplasm|integumentary system disease|disease|disposition|material property|experimental factor; breast benign neoplasm|breast neoplasm|breast disease|disease|disposition|material property|experimental factor; breast benign neoplasm|thoracic benign neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast benign neoplasm|thoracic benign neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; breast benign neoplasm|breast neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0003102	osteomyelitis	An acute or chronic inflammation of the bone and its structures due to infection with pyogenic bacteria.	Osteomyelitis of upper arm (disorder);bone infection NOS, of the shoulder region (disorder);Osteomyelitis of shoulder region (disorder);osteomyelitis (disease);Unspecified osteomyelitis of the ankle and foot;Unspecified infection of bone, forearm;Osteomyelitis of hand (disorder);chronic osteomyelitis of the ankle and foot;Unspecified infection of bone, hand;chronic osteomyelitis involving pelvic region and thigh;Unspecified osteomyelitis of the forearm (disorder);Unspecified osteomyelitis of the ankle and foot (disorder);chronic osteomyelitis;Unspecified osteomyelitis of the lower leg (disorder);Unspecified osteomyelitis of the upper arm (disorder);chronic osteomyelitis involving ankle and foot;acute osteomyelitis involving pelvic region and thigh;osteomyelitis of upper arm;Unspecified infection of bone, ankle and foot;Unspecified osteomyelitis of multiple sites;osteomyelitis;osteomyelitis of lower leg;Unspecified osteomyelitis of the hand;Unspecified infection of bone of shoulder region;bone infection NOS, of the lower leg (disorder);Unspecified osteomyelitis of the shoulder region;Unspecified infection of bone, upper arm;acute osteomyelitis involving ankle and foot;osteomyelitis of ankle and foot;acute osteomyelitis of the ankle and foot (disorder);chronic osteomyelitis involving lower leg;bone infection NOS, of ankle and foot (disorder);Osteomyelitis of multiple sites (disorder);Unspecified osteomyelitis of the hand (disorder);Unspecified infection of bone, lower leg;osteomyelitis of shoulder region;Unspecified osteomyelitis involving multiple sites;acute osteomyelitis involving lower leg;osteomyelitis of hand;acute osteomyelitis of ankle and/or foot (disorder);chronic osteomyelitis involving upper arm;acute osteomyelitis involving shoulder region;Osteomyelitis of forearm (disorder);Osteomyelitis of lower leg (disorder);osteomyelitis of multiple sites;Unspecified osteomyelitis of the shoulder region (disorder);chronic osteomyelitis involving hand;bone infection NOS, of the forearm (disorder);acute osteomyelitis involving hand;chronic osteomyelitis involving multiple sites;acute osteomyelitis involving upper arm;Unspecified osteomyelitis of multiple sites (disorder);osteomyelitis of forearm;bone infection NOS, of the upper arm (disorder);chronic osteomyelitis involving shoulder region;acute osteomyelitis of the ankle and foot;chronic osteomyelitis of the ankle and foot (disorder);bone infection NOS, of multiple sites (disorder);acute osteomyelitis;acute osteomyelitis involving multiple sites;bone infection NOS, of the hand (disorder);chronic osteomyelitis of ankle and/or foot (disorder);Osteomyelitis of ankle and/or foot (disorder)	osteomyelitis|bone marrow disorder|hematologic disease|material entity|experimental factor; osteomyelitis|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; osteomyelitis|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; osteomyelitis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteomyelitis|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteomyelitis|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor
EFO:0004207	pathological myopia	NA	degenerative myopia;myopia, pathological;myopia (pathological);progressive myopia	pathological myopia|Myopia|Abnormality of refraction|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005043	cardiac troponin T measurement	NA	hs-cTnT levels;cardiac troponin T levels;cardiac troponin T level	cardiac troponin T measurement|heart function measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor; cardiac troponin T measurement|protein measurement|measurement|information entity|experimental factor
HP:0000405	Conductive hearing impairment	An abnormality of vibrational conductance of sound to the inner ear leading to impairment of sensory perception of sound.	Conduction deafness;Hearing loss, conductive;Conductive deafness;Conductive hearing loss	Conductive hearing impairment|Abnormal ear morphology|Abnormality of the ear|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Conductive hearing impairment|Hearing abnormality|Abnormality of the ear|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003819	dental caries	The decay of a tooth, in which it becomes softened, discolored, and/or porous.	CARIES DENT;WHITE SPOT DENT;dental caries of smooth surface;Dental White Spot;DENT WHITE SPOTS;caries;White Spot, Dental;Dental White Spots;Spot, White;Dental Decay;Spots, White;White Spots, Dental;Caries, Dental;dental caries pit and fissure;Decay, Dental;DENT DECAY;White Spot;White Spots;WHITE SPOTS DENT;DENT WHITE SPOT;dental caries extending into pulp;dental caries;DENT CARIES;DECAY DENT	dental caries|tooth hard tissue disease|tooth disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; dental caries|head and neck disorder|disease|disposition|material property|experimental factor; dental caries|tooth hard tissue disease|tooth disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor
MONDO:0002674	stricture or kinking of ureter	NA		stricture or kinking of ureter|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:1000418	Ovarian Endometriosis	A non-neoplastic disorder characterized by the growth of endometrial tissue in the ovaries. It results in the development of blood filled ovarian cysts (chocolate cysts), and creation of scars and adhesions.	ovarian endometriosis;endometriosis (disease) of ovary;endometriosis of ovary;ovary endometriosis (disease)	Ovarian Endometriosis|ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; Ovarian Endometriosis|endometriosis|endometrial disorder|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; Ovarian Endometriosis|ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; Ovarian Endometriosis|ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0021781	age at initiation of corrective lens use	NA		age at initiation of corrective lens use|age at initiation of treatment|age|temporal measurement|measurement|information entity|experimental factor
EFO:0007493	spondylolisthesis	A condition in which there is forward displacement of a vertebral bone over the on below it.	spondylolisthesis (disease);spondylolisthesis;Spondylolisthesis	spondylolisthesis|genetic disorder|material entity|experimental factor; spondylolisthesis|disease of bone structure|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; spondylolisthesis|genetic disorder|disease|disposition|material property|experimental factor
EFO:0005067	block	NA	batch	block|collection of material|material entity|experimental factor
EFO:1000660	acanthosis nigricans	A melanotic cutaneous lesion that develops in the axilla and other body folds. It may be idiopathic, drug-induced, or it may be associated with the presence of an endocrine disorder or malignancy.	AN;acanthosis nigricans (disease);keratosis nigricans;acanthosis nigricans;Keratosis nigricans;an - acanthosis nigricans	acanthosis nigricans|pigmentation disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; acanthosis nigricans|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; acanthosis nigricans|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0000574	lymphoma	A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.	lymphoma;malignant lymphoma;lymphoid cancer;lymphoma (Hodgkin and non-Hodgkin);lymphoma, malignant;lymphomatous;lymphoma (Hodgkin's and non-Hodgkin's)	lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor
EFO:0007705	manic episode measurement	NA		manic episode measurement|mental or behavioural disorder biomarker|measurement|information entity|experimental factor
MONDO:0016642	meningioma	A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade I tumors, and some are WHO grade II or III tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)	meningioma;intracranial meningioma;meningioma (disease)	meningioma|meningeal neoplasm|Central Nervous System Neoplasm|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; meningioma|meningeal neoplasm|Central Nervous System Neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; meningioma|meningeal neoplasm|material entity|experimental factor; meningioma|meningeal neoplasm|Central Nervous System Neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:1001336	Hammer Toe Syndrome	NA		Hammer Toe Syndrome|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
MONDO:0007245	cafe au lait spots, multiple	A cutaneous disorder characterized by the presence of several cafe-au-lait (CAL) macules without any other manifestations of neurofibromatosis or any other systemic disorder.	familial caf-au-lait spots;multiple caf-au-lait spots;multiple cafe-au-lait syndrome;multiple cafe-au-lait spots;multiple caf-au-lait syndrome;autosomal dominant caf au lait spots;NF6;cafe-au-lait spots, multiple;neurofibromatosis type 6;familial cafe-au-lait spots	cafe au lait spots, multiple|hyperpigmentation of the skin|skin pigmentation disorder|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:1001078	orchitis	Inflammation of one or both testes due to viral or bacterial infections. Signs and symptoms include enlargement or tenderness of the affected testis, inguinal lymphadenopathy, blood in the semen, and pain during urination, intercourse, or ejaculation.	testis inflammation;Inflammation of testis;orchitis (disease);orchitis;Inflammation of testis (disorder);Orchititis;testisitis;inflammation of testis;Orchitis	orchitis|testicular disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; orchitis|testicular disease|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; orchitis|inflammatory disease|disease|disposition|material property|experimental factor; orchitis|testicular disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor
EFO:1000879	corneal edema	Hazy, swollen cornea.	Corneal edema (disorder);corneal edema;CORNEAL EDEMA;cornea edema;Corneal edema, unspecified;Corneal edema NOS (disorder);Corneal Edema;Corneal oedema;Unspecified corneal edema (disorder);Corneal oedema [Ambiguous];corneal oedema	corneal edema|corneal disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; corneal edema|corneal disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0000479	essential thrombocythemia	A chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. It is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage. (WHO, 2008)	essential thrombocythemia;hemorrhagic thrombocythemia;primary thrombocythemia;essential thrombocytemia;essential thrombocythaemia;essential thrombocytosis;primary thrombocytosis	essential thrombocythemia|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; essential thrombocythemia|familial thrombocytosis|inherited blood coagulation disorder|blood coagulation disease|hematologic disease|disease|disposition|material property|experimental factor; essential thrombocythemia|myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; essential thrombocythemia|familial thrombocytosis|inherited blood coagulation disorder|genetic disorder|material entity|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; essential thrombocythemia|hereditary disorder of connective tissue|genetic disorder|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|immune system cancer|immune system disease|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; essential thrombocythemia|myeloproliferative disorder|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|musculoskeletal system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; essential thrombocythemia|myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; essential thrombocythemia|familial thrombocytosis|thrombocytosis disease|blood platelet disease|hematologic disease|material entity|experimental factor; essential thrombocythemia|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|immune system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; essential thrombocythemia|familial thrombocytosis|inherited blood coagulation disorder|blood coagulation disease|hematologic disease|material entity|experimental factor; essential thrombocythemia|familial thrombocytosis|thrombocytosis disease|blood platelet disease|hematologic disease|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; essential thrombocythemia|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|material entity|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; essential thrombocythemia|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|chronic disease|disease|disposition|material property|experimental factor; essential thrombocythemia|familial thrombocytosis|inherited blood coagulation disorder|genetic disorder|disease|disposition|material property|experimental factor; essential thrombocythemia|myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; essential thrombocythemia|hereditary disorder of connective tissue|connective tissue disease|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; essential thrombocythemia|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|musculoskeletal system cancer|musculoskeletal system disease|disease|disposition|material property|experimental factor; essential thrombocythemia|hereditary disorder of connective tissue|genetic disorder|material entity|experimental factor; essential thrombocythemia|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; essential thrombocythemia|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0800068	acisoga measurement	NA		acisoga measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0009800	Maternal diabetes	Maternal diabetes can either be a gestational, mostly type 2 diabetes, or a type 1 diabetes. Essential is the resulting maternal hyperglycemia as a non-specific teratogen, imposing the same risk of congenital malformations to pregnant women with both type 1 and type2 diabetes.	gestational diabetes;Maternal diabetes	Maternal diabetes|Abnormality of the endocrine system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Maternal diabetes|Abnormality of prenatal development or birth|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Maternal diabetes|Glucose intolerance|Abnormal glucose homeostasis|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009614	clavicle fracture	NA		clavicle fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; clavicle fracture|bone fracture|injury|disease|disposition|material property|experimental factor
MONDO:0005178	osteoarthritis	A noninflammatory degenerative joint disease occurring chiefly in older persons, characterised by degeneration of the articular cartilage, hypertrophy of bone at the margins and changes in the synovial membrane. It is accompanied by pain and stiffness, particularly after prolonged activity.	hypertrophic arthritis;degenerative joint disease;osteoarthrosis and allied disorder;degenerative arthritis;osteoarthrosis	osteoarthritis|arthritis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; osteoarthritis|arthritis|inflammatory disease|disease|disposition|material property|experimental factor; osteoarthritis|arthritis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteoarthritis|arthritis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteoarthritis|arthritis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
HP:0000964	Eczema	Eczema is a form of dermatitis. The term eczema is broadly applied to a range of persistent skin conditions and can be related to a number of underlying conditions. Manifestations of eczema can include dryness and recurring skin rashes with redness, skin edema, itching and dryness, crusting, flaking, blistering, cracking, oozing, or bleeding.	Eczema	Eczema|Inflammatory abnormality of the skin|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Eczema|Inflammatory abnormality of the skin|Abnormality of the skin|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0002052	lymphadenitis	Acute or chronic inflammation of one or more lymph nodes. It is usually caused by an infectious process.	lymph nodeitis;chronic lymphadenitis;lymphadenitis (disease);Inflammation of lymph node;acute adenitis;chronic adenitis;acute lymphadenitis;adenitis;lymphadenitis;inflammation of lymph node;lymph node inflammation	lymphadenitis|lymph node disorder|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor; lymphadenitis|inflammatory disease|disease|disposition|material property|experimental factor
HP:0100582	Nasal polyposis	Polypoidal masses arising mainly from the mucous membranes of the nose and paranasal sinuses. They are freely movable and nontender overgrowths of the mucosa that frequently accompany allergic rhinitis.	Polyposis nasi;Polyps of nose;Nasal polyps	Nasal polyposis|Abnormality of the nose|Abnormality of the face|Abnormality of the head|Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0002496	actinic keratosis	A precancerous lesion of the skin composed of atypical keratinocytes. It is characterized by the presence of thick, scaly patches of skin. Several histologic variants have been described, including atrophic, acantholytic, and hyperkeratotic variants.	actinic keratosis (disease);Senile hyperkeratosis;actinic keratosis;solar keratosis;actinic (Solar) Keratosis;actinic keratosis (morphologic abnormality);SK - solar keratosis;SK - Solar keratosis;Solar keratosis;actinic (solar) keratosis;actinic keratosis (disorder)	actinic keratosis|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; actinic keratosis|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; actinic keratosis|pre-malignant neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; actinic keratosis|pre-malignant neoplasm|precancerous condition|cancer or benign tumor|disease|disposition|material property|experimental factor
Orphanet:2543	Microphthalmia - cataract	NA		
EFO:0005924	binge eating	Recurrent episodes of over-eating.	binge eating disorder;binge eating	binge eating|eating disorder|nutritional disorder|metabolic disease|disease|disposition|material property|experimental factor; binge eating|eating disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; binge eating|eating disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:1001840	respiratory paralysis	NA	respiratory tract paralysis;paralysis, respiratory	respiratory paralysis|nervous system disease|disease|disposition|material property|experimental factor; respiratory paralysis|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0006792	Lewy body dementia	A progressive form of dementia characterized by the presence of protein deposits called Lewy bodies in the midbrain and cerebral cortex, and loss of cholinergic and dopaminergic neurons. The signs and symptoms overlap with Alzheimer and Parkinson disease.	lewy body dementia, susceptibility to;DLB;Lewy body dementia;cortical Lewy body disease;Senile dementia of the Lewy body type;dementia with Lewy bodies;Lewy body disease	Lewy body dementia|synucleinopathy|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Lewy body dementia|synucleinopathy|proteostasis deficiencies|metabolic disease|disease|disposition|material property|experimental factor; Lewy body dementia|dementia|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Lewy body dementia|dementia|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
MONDO:0019719	congenital anomaly of kidney and urinary tract	A urinary system disease characterized by structural malformations in the kidney and/or urinary tract containing vesicoureteral reflux.	congenital anomalies of kidney and urinary tract;CAKUT;renal or urinary tract malformation;congenital anomalies of the kidney and urinary tract;congenital anomaly of kidney and urinary tract	congenital anomaly of kidney and urinary tract|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; congenital anomaly of kidney and urinary tract|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; congenital anomaly of kidney and urinary tract|genetic disorder|material entity|experimental factor; congenital anomaly of kidney and urinary tract|genetic disorder|disease|disposition|material property|experimental factor
EFO:0004997	type 2 diabetes nephropathy	NA		type 2 diabetes nephropathy|diabetic nephropathy|chronic kidney disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; type 2 diabetes nephropathy|diabetic nephropathy|chronic kidney disease|chronic disease|disease|disposition|material property|experimental factor; type 2 diabetes nephropathy|diabetic nephropathy|metabolic disease|disease|disposition|material property|experimental factor
EFO:1001180	sialolithiasis	A concretion in the salivary gland.	Sialolithiasis NOS (disorder);Stone of salivary gland or duct;Sialolithiasis (disorder);Salivary Gland Calculi;Sialolith;salivary gland Stone;sialolith;Salivary gland Stone;sialolithiasis	sialolithiasis|salivary gland disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor
HP:0031456	Ectopic pregnancy	NA		Ectopic pregnancy|Abnormality of prenatal development or birth|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004266	primary ovarian insufficiency	Absent or premature cessation of ovarian function due to a pathologic process originating within the ovaries.	hypergonadotropic hypogonadism;premature ovarian failure;primary ovarian failure;hypergonadotropic hypogonadism (female);resistant ovary syndrome;primary ovarian insufficiency	primary ovarian insufficiency|ovarian dysfunction|ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; primary ovarian insufficiency|ovarian dysfunction|ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; primary ovarian insufficiency|ovarian dysfunction|ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0002920	vulva sarcoma	A malignant mesenchymal neoplasm that arises from the vulva. Representative examples include childhood botryoid-type embryonal rhabdomyosarcoma, alveolar soft part sarcoma, and leiomyosarcoma.	vulvar sarcoma;vulva sarcoma;sarcoma of vulva;mammalian vulva sarcoma;sarcoma of mammalian vulva	vulva sarcoma|soft tissue sarcoma|sarcoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; vulva sarcoma|vulva cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; vulva sarcoma|vulva cancer|vulvar neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; vulva sarcoma|vulva cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; vulva sarcoma|vulva cancer|vulvar neoplasm|vulvar disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; vulva sarcoma|vulva cancer|vulvar neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; vulva sarcoma|soft tissue sarcoma|malignant soft tissue neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; vulva sarcoma|soft tissue sarcoma|material entity|experimental factor; vulva sarcoma|vulva cancer|vulvar neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; vulva sarcoma|vulva cancer|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; vulva sarcoma|vulva cancer|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; vulva sarcoma|vulva cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; vulva sarcoma|soft tissue sarcoma|malignant soft tissue neoplasm|Soft Tissue Neoplasm|connective and soft tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; vulva sarcoma|vulva cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor
HP:0000689	Dental malocclusion	Dental malocclusion refers to an abnormality of the occlusion, or alignment, of the teeth and the way the upper and lower teeth fit together, resulting in overcrowding of teeth or in abnormal bite patterns.	Bad bite;Malocclusion;Incorrect relation between upper and lower dental arches;Bilateral crossbite malocclusion;Malalignment of upper and lower dental arches;Bilateral crossbite;Misalignment of upper and lower dental arches;Malocclusion of teeth;Occlusion anomaly	Dental malocclusion|Abnormality of the dentition|Abnormality of the mouth|Abnormality of the face|Abnormality of the head|Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001193	subacute bacterial endocarditis	Subacute inflammation of the endocardium. Streptococcus viridans is the usual etiologic agent of subacute bacterial endocarditis. The distinction between "acute" and "subacute" endocarditis has traditionally been made based on the pathogenic organism and clinical presentation.	Subacute bacterial endocarditis;Endocarditis lenta;subacute bacterial endocarditis;Subacute bacterial endocarditis (disorder);Endocarditis, Subacute Bacterial;endocarditis lenta;SBE;SBE - Subacute bacterial endocarditis;Subacute endocarditis, lenta	subacute bacterial endocarditis|infective endocarditis|endocarditis|inflammation of heart layer|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; subacute bacterial endocarditis|infective endocarditis|endocarditis|endocardium disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; subacute bacterial endocarditis|infective endocarditis|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; subacute bacterial endocarditis|infective endocarditis|endocarditis|inflammation of heart layer|inflammatory disease|disease|disposition|material property|experimental factor; subacute bacterial endocarditis|acute disease|disease|disposition|material property|experimental factor
MONDO:0002715	uterine cancer	Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.	malignant uterine neoplasm;CA - cancer of uterus;uterus cancer;cancer of uterus;malignant tumor of uterus;malignant tumor of the uterus;malignant neoplasm of the uterus;cancer of the uterus;malignant uterus neoplasm;uterine cancer;malignant uterine tumor;malignant neoplasm of uterus	uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; uterine cancer|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; uterine cancer|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; uterine cancer|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0005854	allergic rhinitis	Inflammation of the nasal mucous membranes caused by an IgE-mediated response to external allergens. The inflammation may also involve the mucous membranes of the sinuses, eyes, middle ear, and pharynx. Symptoms include sneezing, nasal congestion, rhinorrhea, and itching. It may lead to fatigue, drowsiness, and malaise thus causing impairment of the quality of life.	allergic rhinitis;pollenosis;allergic form of rhinitis;AR;atopic rhinitis	allergic rhinitis|allergic respiratory disease|allergic disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; allergic rhinitis|allergic respiratory disease|respiratory system disease|disease|disposition|material property|experimental factor; allergic rhinitis|rhinitis|nasal cavity disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; allergic rhinitis|rhinitis|nasal cavity disorder|nasal disorder|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; allergic rhinitis|rhinitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:1000640	basal ganglia cerebrovascular disease	A pathological condition caused by impaired blood flow in the basal regions of cerebral hemispheres (basal ganglia), such as infarction; hemorrhage; or ischemia in vessels of this brain region including the lateral lenticulostriate arteries. Primary clinical manifestations include involuntary movements (dyskinesias) and muscle weakness (hemiparesis).	collection of basal ganglia cerebrovascular disorder;basal ganglia cerebrovascular disorder;cerebrovascular disorder of collection of basal ganglia	basal ganglia cerebrovascular disease|basal ganglia disease|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; basal ganglia cerebrovascular disease|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; basal ganglia cerebrovascular disease|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; basal ganglia cerebrovascular disease|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0004145	myopathy	A disease of the muscle in which the muscle fibers do not function properly. This results in muscular weakness.	myopathy	myopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
MONDO:0020121	muscular dystrophy	Muscular dystrophy (MD) refers to a group of more than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement. Some forms of MD are seen in newborns, infants or children, while others have late-onset and may not appear until middle age or later. The disorders differ in terms of the distribution and extent of muscle weakness (some forms of MD also affect cardiac muscle), age of onset, rate of progression, and pattern of inheritance. The prognosis for people with MD varies according to the type and progression of the disorder. There is no specific treatment to stop or reverse any form of MD. Treatment is supportive and may include physical therapy, respiratory therapy, speech therapy, orthopedic appliances used for support, corrective orthopedic surgery, and medicationsincluding corticosteroids, anticonvulsants (seizure medications), immunosuppressants, and antibiotics. Some individuals may need assisted ventilation to treat respiratory muscle weaknessor a pacemaker for cardiac (heart)abnormalities.		muscular dystrophy|myopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; muscular dystrophy|skeletal muscle disorder|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; muscular dystrophy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor
EFO:0007191	cannabis dependence	Physical and psychological dependence on the drug cannabis.	Marijuana Dependence;marijuana abuse;cannabis abuse;cannabis dependence;Cannabis Abuse;Hashish Abuse;marijuana dependence;Cannabis Dependence;Cannabis-Related Disorder;Marihuana Abuse	cannabis dependence|drug dependence|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; cannabis dependence|drug dependence|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; cannabis dependence|drug dependence|substance dependence|substance-related disorder|psychiatric disorder|disease|disposition|material property|experimental factor
MONDO:0045044	ligament disorder	A disease or disorder that involves the ligament.	ligament disease or disorder;disorder of ligament;disease or disorder of ligament;disease of ligament	ligament disorder|musculoskeletal system disease|disease|disposition|material property|experimental factor
HP:0002105	Hemoptysis	Coughing up (expectoration) of blood or blood-streaked sputum from the larynx, trachea, bronchi, or lungs.	Coughing up blood;Haemoptysis	Hemoptysis|Abnormal sputum|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005585	shigellosis	Shigellosis is a bacterial infection leading to dysentery and is caused by Shigella, which are small, ubiquitous Gram-negative bacteria belonging to the enterobacteria family. There are four species: S. dysenteriae, S. flexneri, S. boydii and S. sonnei, all of which cause bacillary dysentery and are strictly limited to human hosts.	Shigella boydii infectious disease;bacillary dysentery;Shigella sonnei infectious disease;shigellosis;Shigella flexneri infectious disease;Shigella gastroenteritis	shigellosis|dysentery|intestinal infectious disease|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; shigellosis|dysentery|inflammatory diarrhea|diarrheal disease|digestive system disease|disease|disposition|material property|experimental factor; shigellosis|dysentery|inflammatory diarrhea|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; shigellosis|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; shigellosis|dysentery|intestinal infectious disease|digestive system infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; shigellosis|dysentery|inflammatory diarrhea|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; shigellosis|primary bacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; shigellosis|dysentery|acute diarrhea|diarrheal disease|digestive system disease|disease|disposition|material property|experimental factor; shigellosis|dysentery|acute diarrhea|acute disease|disease|disposition|material property|experimental factor; shigellosis|dysentery|intestinal infectious disease|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; shigellosis|primary bacterial infectious disease|material entity|experimental factor
EFO:0009618	foot fracture	NA		foot fracture|lower extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor; foot fracture|lower extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0005306	ventricular tachycardia	A disorder characterized by an electrocardiographic finding of three or more consecutive complexes of ventricular origin with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. (CDISC)	ventricular tachycardia	ventricular tachycardia|cardiac rhythm disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; ventricular tachycardia|cardiac arrhythmia|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0009825	sign or symptom concerning food and fluid intake	NA		sign or symptom concerning food and fluid intake|sign or symptom|phenotype|quality|material property|experimental factor
EFO:1000753	phototoxic dermatitis	Dermatitis caused or precipitated by exposure to ultraviolet sunlight, or by mediating phototoxic or photoallergic material in response to ultraviolet sunlight.	sun poisoning;photosensitiveness;photosensitisation reaction;photoallergic dermatitis;photoallergic eczema;photosensitive dermatitis;photoallergy;Photodermatitis;photosensitivity reaction;Photosensitisation reaction;phototoxic dermatitis	phototoxic dermatitis|photosensitivity disease|radiodermatitis|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; phototoxic dermatitis|irritant dermatitis|contact dermatitis|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; phototoxic dermatitis|irritant dermatitis|contact dermatitis|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; phototoxic dermatitis|photosensitivity disease|radiodermatitis|radiation-induced disorder|disease|disposition|material property|experimental factor; phototoxic dermatitis|irritant dermatitis|contact dermatitis|allergic disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; phototoxic dermatitis|photosensitivity disease|radiodermatitis|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; phototoxic dermatitis|photosensitivity disease|allergic disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor
CL:0000738	leukocyte	An achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.	white blood cell;leucocyte	leukocyte|hematopoietic cell|somatic cell|cell type|material entity|experimental factor; leukocyte|hematopoietic cell|somatic cell|cell|cellular component|material entity|experimental factor
EFO:1000601	Transitional Cell Carcinoma	A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.	carcinoma of transitional epithelial cell;urothelial cell carcinoma;transitional epithelial cell carcinoma;transitional cell carcinoma;transitional cell tumor;carcinoma of urothelial cell;transitional carcinoma;carcinoma, urothelial, malignant	Transitional Cell Carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Transitional Cell Carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
CHEBI:132917	2-isopropylmalate	NA		2-isopropylmalate|chemical entity|material entity|experimental factor
EFO:0003761	unipolar depression	NA	Disorder, Depressive;Psychosis, Involutional;Involutional Psychosis;Neurotic Depression;Depressive Symptom;Involutional Depression;Major Depressive Disorders;Symptoms, Depressive;Syndromes, Depressive;Disorder, Major Depressive;Depression, Involutional;DEPRESSIVE DIS MAJOR;Depressive Disorders;Disorders, Depressive;Endogenous Depressions;MAJOR DEPRESSIVE DIS;Endogenous Depression;Depression, Emotional;Depressive Neurosis;Symptom, Depressive;Depression, Neurotic;Depressive Symptoms;Emotional Depressions;Involutional Psychoses;Depression;Syndrome, Depressive;Unipolar Depressions;Neuroses, Depressive;DEPRESSIVE DIS;Depressions, Unipolar;Depressive Syndrome;Disorders, Major Depressive;Neurotic Depressions;Psychoses, Involutional;Depressive Disorders, Major;Neurosis, Depressive;Paraphrenia, Involutional;Depression, Unipolar;Depressions, Endogenous;Depressive Disorder;Depressions, Neurotic;Depressive Syndromes;Depressions, Emotional;Depressions;Depression, Endogenous;Depressive Neuroses;major depressive disorder;Emotional Depression;Depressive Disorder, Major	unipolar depression|mood disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; unipolar depression|mood disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:1000853	carotid artery thrombosis	Blood clot formation in any part of the carotid arteries. This may produce carotid stenosis or occlusion of the vessel, leading to transient ischemic attack; cerebral infarction; or amaurosis fugax.	carotid artery thrombosis;Carotid artery thrombosis;Carotid Artery Thrombosis;Carotid artery thrombosis (disorder)	carotid artery thrombosis|intracranial thrombosis|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; carotid artery thrombosis|carotid artery disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; carotid artery thrombosis|carotid artery disease|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; carotid artery thrombosis|intracranial thrombosis|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; carotid artery thrombosis|intracranial thrombosis|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; carotid artery thrombosis|carotid artery disease|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; carotid artery thrombosis|intracranial thrombosis|thrombotic disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; carotid artery thrombosis|carotid artery disease|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:1000039	meningeal tuberculosis	A bacterial infection of the membranes covering the brain and the spinal cord caused by Mycobacterium tuberculosis.	tubercular meningitis;TB meningitis;tuberculous meningitis;TBM;meningeal tuberculosis	meningeal tuberculosis|central nervous system tuberculosis|central nervous system infection|infectious disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; meningeal tuberculosis|central nervous system tuberculosis|central nervous system infection|infectious disorder of the nervous system|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meningeal tuberculosis|central nervous system tuberculosis|central nervous system infection|infectious disorder of the nervous system|material entity|experimental factor; meningeal tuberculosis|bacterial meningitis|infectious meningitis|central nervous system infection|infectious disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; meningeal tuberculosis|bacterial meningitis|infectious meningitis|central nervous system infection|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; meningeal tuberculosis|bacterial meningitis|infectious meningitis|meningitis|encephalomyelitis|inflammatory disease|disease|disposition|material property|experimental factor; meningeal tuberculosis|central nervous system tuberculosis|extrapulmonary tuberculosis|tuberculosis|primary bacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meningeal tuberculosis|central nervous system tuberculosis|extrapulmonary tuberculosis|tuberculosis|mycobacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meningeal tuberculosis|central nervous system tuberculosis|central nervous system infection|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; meningeal tuberculosis|tuberculous salpingitis|salpingitis|Pelvic Inflammatory Disease|inflammatory disease|disease|disposition|material property|experimental factor; meningeal tuberculosis|tuberculous salpingitis|urogenital tuberculosis|urogenital neoplasm|disease|disposition|material property|experimental factor; meningeal tuberculosis|bacterial meningitis|infectious meningitis|meningitis|encephalomyelitis|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; meningeal tuberculosis|tuberculous salpingitis|salpingitis|fallopian tube disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; meningeal tuberculosis|tuberculous salpingitis|urogenital tuberculosis|extrapulmonary tuberculosis|tuberculosis|mycobacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meningeal tuberculosis|tuberculous salpingitis|salpingitis|Pelvic Inflammatory Disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; meningeal tuberculosis|central nervous system tuberculosis|extrapulmonary tuberculosis|tuberculosis|primary bacterial infectious disease|material entity|experimental factor; meningeal tuberculosis|bacterial meningitis|infectious meningitis|central nervous system infection|infectious disorder of the nervous system|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meningeal tuberculosis|tuberculous salpingitis|urogenital tuberculosis|extrapulmonary tuberculosis|tuberculosis|primary bacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meningeal tuberculosis|bacterial meningitis|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meningeal tuberculosis|tuberculous salpingitis|urogenital tuberculosis|extrapulmonary tuberculosis|tuberculosis|primary bacterial infectious disease|material entity|experimental factor; meningeal tuberculosis|bacterial meningitis|infectious meningitis|central nervous system infection|infectious disorder of the nervous system|material entity|experimental factor
HP:0010771	Pilonidal abscess	A hair-containing cyst or sinus usually in the coccygeal region.	Sacrococcygeal fistula	Pilonidal abscess|Cutaneous abscess|Inflammatory abnormality of the skin|Abnormality of the skin|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Pilonidal abscess|Abnormality of the vertebral column|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Pilonidal abscess|Cutaneous abscess|Inflammatory abnormality of the skin|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001968	soft tissue sarcoma	A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.	connective tissue sarcoma;soft tissue sarcoma;sarcoma of the soft tissue;sarcoma of soft tissue;malignant mesenchymal tumor;non-Rhabdo. soft tissue sarcoma;malignant soft tissue tumor;soft part sarcoma	soft tissue sarcoma|sarcoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; soft tissue sarcoma|malignant soft tissue neoplasm|Soft Tissue Neoplasm|connective and soft tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; soft tissue sarcoma|malignant soft tissue neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; soft tissue sarcoma|material entity|experimental factor
EFO:1001412	renal colic	NA		renal colic|pain|sign or symptom|phenotype|quality|material property|experimental factor
MONDO:0000726	idiopathic scoliosis	A scoliosis with no known cause.		idiopathic scoliosis|scoliosis|disease of bone structure|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; idiopathic scoliosis|idiopathic disease|material entity|experimental factor; idiopathic scoliosis|idiopathic disease|disease|disposition|material property|experimental factor
EFO:0005240	rhegmatogenous retinal detachment	Retinal detachment secondary to retinal tear or break.	rhegmatogenous retinal detachment	rhegmatogenous retinal detachment|retinal detachment|genetic disorder|material entity|experimental factor; rhegmatogenous retinal detachment|retinal detachment|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; rhegmatogenous retinal detachment|retinal detachment|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; rhegmatogenous retinal detachment|retinal detachment|genetic disorder|disease|disposition|material property|experimental factor; rhegmatogenous retinal detachment|retinal detachment|retinopathy|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009484	uterine polyp	A benign protruding lesion arising either from the endometrial cavity (endometrial polyp) or the endocervix (endocervical polyp). It may occasionally recur following complete resection.	endometrial/uterine polyp;uterine polyp;polyp of uterus;polyp of the uterus;uterus polyp;polyp of corpus uteri;polyp, uterus	uterine polyp|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; uterine polyp|female genital tract polyp|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; uterine polyp|female genital tract polyp|polyp|cancer or benign tumor|disease|disposition|material property|experimental factor
HP:0031273	Shock	NA		Shock|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0016244	atypical hemolytic-uremic syndrome	Atypical hemolytic-uremic syndrome (aHUS) is a thrombotic microangiopathy characterized by mechanical hemolytic anemia, thrombocytopenia, and renal dysfunction.	atypical hemolytic uremic syndrome;D-HUS;aHUS;non-diarrhea-associated hemolytic uremic syndrome;hemolytic-uremic syndrome without diarrhea;atypical HUS	atypical hemolytic-uremic syndrome|complement deficiency|immunodeficiency disease|genetic disorder|material entity|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|familial hemolytic anemia|genetic disorder|material entity|experimental factor; atypical hemolytic-uremic syndrome|complement deficiency|immunodeficiency disease|immune system disease|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|familial hemolytic anemia|normocytic anemia|anemia|hematologic disease|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|inherited blood coagulation disorder|blood coagulation disease|hematologic disease|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|familial hemolytic anemia|genetic disorder|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|complement deficiency|immunodeficiency disease|genetic disorder|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|thrombotic microangiopathy|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|thrombotic microangiopathy|blood coagulation disease|hematologic disease|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|inherited blood coagulation disorder|genetic disorder|material entity|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|familial hemolytic anemia|normocytic anemia|anemia|hematologic disease|material entity|experimental factor; atypical hemolytic-uremic syndrome|complement deficiency|inborn error of immunity|immune deficiency disease|genetic disorder|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|inherited blood coagulation disorder|blood coagulation disease|hematologic disease|material entity|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|inherited blood coagulation disorder|genetic disorder|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|syndromic disease|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|complement deficiency|inborn error of immunity|immune deficiency disease|immune system disease|disease|disposition|material property|experimental factor; atypical hemolytic-uremic syndrome|hemolytic-uremic syndrome|thrombotic microangiopathy|blood coagulation disease|hematologic disease|material entity|experimental factor; atypical hemolytic-uremic syndrome|complement deficiency|inborn error of immunity|immune deficiency disease|genetic disorder|material entity|experimental factor; atypical hemolytic-uremic syndrome|syndromic disease|material entity|experimental factor
EFO:0021835	melanin measurement	NA		melanin measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0012219	Erythema nodosum	An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral.		Erythema nodosum|Inflammatory abnormality of the skin|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Erythema nodosum|Inflammatory abnormality of the skin|Abnormality of the skin|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000681	renal cell carcinoma	A carcinoma that arises from glandular epithelial cells of the kidney	renal cell carcinoma;hypernephroma;renal cell carcinoma (disease);RCC;kidney adenocarcinoma	renal cell carcinoma|renal carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell carcinoma|material entity|experimental factor; renal cell carcinoma|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell carcinoma|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell carcinoma|renal carcinoma|kidney cancer|Malignant Urinary System Neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell carcinoma|renal carcinoma|kidney cancer|Malignant Urinary System Neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; renal cell carcinoma|renal carcinoma|kidney cancer|Malignant Urinary System Neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell carcinoma|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell carcinoma|renal carcinoma|kidney cancer|kidney neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; renal cell carcinoma|renal carcinoma|kidney cancer|kidney neoplasm|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; renal cell carcinoma|renal carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell carcinoma|renal carcinoma|kidney cancer|kidney neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:1001494	psoriasis vulgaris	NA	plaque psoriasis	psoriasis vulgaris|psoriasis|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; psoriasis vulgaris|psoriasis|genetic disorder|material entity|experimental factor; psoriasis vulgaris|psoriasis|inflammatory skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; psoriasis vulgaris|psoriasis|genetic disorder|disease|disposition|material property|experimental factor; psoriasis vulgaris|psoriasis|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; psoriasis vulgaris|psoriasis|immune system disease|disease|disposition|material property|experimental factor
EFO:0009449	keratitis	A corneal disease that is characterized by inflammation of the cornea.	cornea inflammation;corneaitis;inflammation of cornea;keratitis	keratitis|inflammatory disease|disease|disposition|material property|experimental factor; keratitis|corneal disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; keratitis|corneal disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0008574	gangrene	NA		gangrene|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0001458	ulnar nerve lesion	A peripheral nerve lesion that involves the ulnar nerve.	lesion of ulnar nerve;peripheral nerve lesion of ulnar nerve;ulnar nerve peripheral nerve lesion	ulnar nerve lesion|ulnar neuropathy|brachial plexus neuropathy|nerve plexus disease|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; ulnar nerve lesion|ulnar neuropathy|mononeuropathy|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; ulnar nerve lesion|ulnar neuropathy|brachial plexus neuropathy|nerve plexus disease|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; ulnar nerve lesion|peripheral nerve lesion|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; ulnar nerve lesion|ulnar neuropathy|mononeuropathy|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; ulnar nerve lesion|peripheral nerve lesion|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor
EFO:0004234	erectile dysfunction	Persistent or recurrent inability to achieve or to maintain an erection during sexual activity.	male impotence;male sexual impotence;impotence;erectile dysfunction;male erectile Disorder;erectile dysfunction (disease);sexual impotence (finding);sexual impotence	erectile dysfunction|physiological sexual disorder|reproductive system disease|disease|disposition|material property|experimental factor; erectile dysfunction|penile disorder|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0002571	medical procedure	NA	Interventional;Procedure;Intervention Strategies;interventionDescription;Intervention or Procedure;Intervention;SURGICAL AND MEDICAL PROCEDURES	medical procedure|experimental process|planned process|process|experimental factor
EFO:0010117	pyruvate measurement	NA		pyruvate measurement|measurement|information entity|experimental factor
EFO:0008583	acute myocardial infarction	Necrosis of the myocardium, as a result of interruption of the blood supply to the area. It is characterized by a severe and rapid onset of symptoms that may include chest pain, often radiating to the left arm and left side of the neck, dyspnea, sweating, and palpitations.	AMI;myocardial infarction (disease), acute;acute myocardial infarction;acute myocardial infarction (disease)	acute myocardial infarction|acute disease|disease|disposition|material property|experimental factor; acute myocardial infarction|myocardial infarction|myocardial disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
HP:0001332	Dystonia	An abnormally increased muscular tone that causes fixed abnormal postures. There is a slow, intermittent twisting motion that leads to exaggerated turning and posture of the extremities and trunk.	Dystonic movements	Dystonia|Abnormality of movement|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Dystonia|Behavioral abnormality|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0600078	Achilles tendon injury	NA		Achilles tendon injury|leg injury|limb injury|injury|disease|disposition|material property|experimental factor
HP:0000726	Dementia	A loss of global cognitive ability of sufficient amount to interfere with normal social or occupational function. Dementia represents a loss of previously present cognitive abilities, generally in adults, and can affect memory, thinking, language, judgment, and behavior.	Progressive dementia;Dementia, progressive;Dementia	Dementia|Mental deterioration|Cognitive impairment|Abnormality of higher mental function|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0200134	Epileptic encephalopathy	A condition in which epileptiform abnormalities are believed to contribute to the progressive disturbance in cerebral function. Epileptic encephalaopathy is characterized by (1) electrographic EEG paroxysmal activity that is often aggressive, (2) seizures that are usually multiform and intractable, (3) cognitive, behavioral and neurological deficits that may be relentless, and (4) sometimes early death.	Convulsive encephalopathy	Epileptic encephalopathy|Encephalopathy|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0002898	skin cancer	A malignant neoplasm involving the zone of skin	malignant neoplasm of the skin;skin cancer;melanoma and non-melanoma skin cancer;malignant zone of skin neoplasm;malignant neoplasm of skin;zone of skin cancer;CA - skin cancer;malignant skin tumor;malignant tumor of skin;skin cancer, Including melanoma;skin neoplasm, malignant;malignant tumor of the skin;cancer of zone of skin;malignant neoplasm of zone of skin;malignant skin neoplasm	skin cancer|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; skin cancer|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; skin cancer|integumentary system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; skin cancer|integumentary system cancer|integumentary system disease|disease|disposition|material property|experimental factor
MONDO:0020638	superficial spreading melanoma	A type of melanoma that typically occurs in light-skinned individuals ranging in age from young adults to the elderly. Risk factors include extensive sun exposure during childhood, a family history of melanoma, and the presence of dysplastic nevi.	superficial spreading cutaneous (skin) melanoma;cutaneous superficial spreading melanoma;superficial spreading melanoma;superficial spreading malignant melanoma of the skin;superficial spreading melanoma of skin;superficial spreading malignant skin melanoma;superficial spreading melanoma of the skin;superficial spreading malignant melanoma of skin;SSM;pagetoid melanoma	superficial spreading melanoma|cutaneous melanoma|melanocytic skin neoplasm|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|skin cancer|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|melanoma|melanocytic neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|melanocytic skin neoplasm|melanocytic neoplasm|neurocristopathy|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|melanoma|melanocytic neoplasm|neurocristopathy|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|melanocytic skin neoplasm|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|skin cancer|integumentary system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|melanoma|neuroendocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|melanoma|neuroendocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|melanocytic skin neoplasm|melanocytic neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|skin cancer|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; superficial spreading melanoma|cutaneous melanoma|skin cancer|integumentary system cancer|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0020006	enterocele	NA	vaginal enterocele	enterocele|prolapse of female genital organ|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0008555	Methicillin-Resistant Staphylococcus Aureus Infection	Infections caused by a strain of Staphylococcus aureus that is non-susceptible to the action of the antibiotic, methicillin. The mechanism of resistance usually involves modification of normal or the presence of acquired penicillin binding proteins.	MRSA bacteremia;MRSA infection;Infection, MRSA;infection by MRSA;MRSA bacteremias;methicillin-resistant staphylococcus aureus infectious disease;Methicillin-resistant Staphylococcus aureus (MRSA) infection;methicillin-resistant Staphylococcus aureus (MSSA) bacteremia;MRSA	Methicillin-Resistant Staphylococcus Aureus Infection|Staphylococcus aureus infection|staphylococcal skin infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:1000802	alcoholic liver cirrhosis	A disorder of the liver characterized by the presence of fibrotic scar tissue instead of healthy liver tissue. This condition is attributed to excessive consumption of alcoholic beverages.	Portal cirrhosis (disorder);Laennec's cirrhosis;alcoholic cirrhosis of liver;Alcoholic Cirrhosis;portal cirrhosis;Portal Cirrhosis;alcoholic cirrhosis;Liver Cirrhosis, Alcoholic;Laennec's cirrhosis, alcoholic;alcoholic liver cirrhosis;Portal cirrhosis;Portal cirrhosis unspecified (disorder);Alcoholic cirrhosis of liver (disorder) [Ambiguous];Alcoholic cirrhosis of liver;Alcoholic cirrhosis of liver (disorder)	alcoholic liver cirrhosis|cirrhosis of liver|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; alcoholic liver cirrhosis|cirrhosis of liver|fibrosis|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; alcoholic liver cirrhosis|alcoholic liver disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; alcoholic liver cirrhosis|alcoholic liver disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; alcoholic liver cirrhosis|alcoholic liver disease|alcohol-induced disorders|alcohol-related disorders|substance-related disorder|psychiatric disorder|disease|disposition|material property|experimental factor; alcoholic liver cirrhosis|cirrhosis of liver|liver disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0004307	glucose tolerance test	NA		glucose tolerance test|glucose measurement|diabetes mellitus biomarker|measurement|information entity|experimental factor
EFO:1001391	Periapical Periodontitis	Inflammation of the periapical tissue. It includes general, unspecified, or acute nonsuppurative inflammation. Chronic nonsuppurative inflammation is periapical granuloma. Suppurative inflammation is periapical abscess.	apical periodontitis;periapical periodontitis	Periapical Periodontitis|periodontitis|head and neck disorder|disease|disposition|material property|experimental factor; Periapical Periodontitis|periodontitis|periodontal disorder|tooth disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; Periapical Periodontitis|periodontitis|periodontal disorder|tooth disease|mouth disease|digestive system disease|disease|disposition|material property|experimental factor; Periapical Periodontitis|periodontitis|inflammatory disease|disease|disposition|material property|experimental factor
MONDO:0001285	endometriosis of pelvic peritoneum	NA		endometriosis of pelvic peritoneum|endometriosis|endometrial disorder|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
MONDO:0004867	upper respiratory tract disorder	A disease involving the upper respiratory tract.	disease or disorder of upper respiratory tract;disorder of upper respiratory tract;disease of upper respiratory tract;upper respiratory tract disease or disorder;upper respiratory tract disease	upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0009602	prostate disease	A disease involving the prostate gland.	prostate disorder;disorder of prostate gland;disease of prostate gland;disease or disorder of prostate gland;prostate gland disease;prostate disease;prostate gland disease or disorder	prostate disease|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0000326	central nervous system cancer	A malignant neoplasm involving the central nervous system	central nervous system neoplasms, malignant;malignant CNS neoplasms;cancer of the central nervous system;malignant neoplasm of the central nervous system;central nervous system tumor;malignant neoplasm of the CNS;central nervous system tumors;cancer of the CNS;CNS malignant neoplasms;CNS neoplasms, malignant;malignant tumor of the central nervous system;central nervous system cancer;cancer of CNS;malignant tumor of the CNS;CNS cancer;malignant CNS neoplasm;malignant neoplasm of central nervous system;malignant central nervous system neoplasm;malignant tumor of central nervous system;malignant CNS tumor;malignant neoplasm of CNS;cancer of central nervous system;CNS neoplasm;malignant tumor of CNS;malignant central nervous system tumor	central nervous system cancer|Central Nervous System Neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; central nervous system cancer|Central Nervous System Neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; central nervous system cancer|nervous system cancer|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; central nervous system cancer|nervous system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; central nervous system cancer|Central Nervous System Neoplasm|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; central nervous system cancer|nervous system cancer|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009577	orthopedic nursing	NA	orthopaedic nursing;orthopaedic care	orthopedic nursing|medical procedure|experimental process|planned process|process|experimental factor
EFO:0004191	androgenetic alopecia	NA	alopecia androgenetica, male pattern baldness;male-pattern baldness;alopecia, androgenetic;alopecia, androgenic;male pattern baldness;androgenic alopecia;androgenetic alopecia;alopecia, male pattern	androgenetic alopecia|genetic alopecia|genetic epidermal appendage anomaly|epidermal appendage anomaly|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; androgenetic alopecia|Rare genetic skin disease|genetic disorder|material entity|experimental factor; androgenetic alopecia|Rare genetic skin disease|genetic disorder|disease|disposition|material property|experimental factor; androgenetic alopecia|endocrine alopecia|alopecia|hair anomaly|epidermal appendage anomaly|material entity|experimental factor; androgenetic alopecia|endocrine alopecia|alopecia|hair anomaly|epidermal appendage anomaly|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor; androgenetic alopecia|genetic alopecia|alopecia|hair anomaly|epidermal appendage anomaly|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; androgenetic alopecia|endocrine alopecia|alopecia|hair anomaly|disorder of pilosebaceous unit|integumentary system disease|disease|disposition|material property|experimental factor; androgenetic alopecia|genetic alopecia|genetic epidermal appendage anomaly|epidermal appendage anomaly|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor; androgenetic alopecia|genetic alopecia|alopecia|hair anomaly|epidermal appendage anomaly|material entity|experimental factor; androgenetic alopecia|genetic alopecia|alopecia|hair anomaly|epidermal appendage anomaly|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor; androgenetic alopecia|genetic alopecia|genetic epidermal appendage anomaly|epidermal appendage anomaly|material entity|experimental factor; androgenetic alopecia|endocrine alopecia|alopecia|hair anomaly|epidermal appendage anomaly|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; androgenetic alopecia|genetic alopecia|genetic epidermal appendage anomaly|genetic disorder|disease|disposition|material property|experimental factor; androgenetic alopecia|genetic alopecia|alopecia|hair anomaly|disorder of pilosebaceous unit|integumentary system disease|disease|disposition|material property|experimental factor; androgenetic alopecia|genetic alopecia|genetic epidermal appendage anomaly|genetic disorder|material entity|experimental factor
EFO:0004634	coagulation factor measurement	NA		coagulation factor measurement|measurement|information entity|experimental factor
EFO:1000669	allergic urticaria	A urticaria with a basis in a pathological type I hypersensitivity reaction.	allergic form of urticaria (disease);allergic form of urticaria;allergic urticaria (disease);allergic urticaria	allergic urticaria|atopic eczema|allergic disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; allergic urticaria|atopic eczema|inflammatory skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; allergic urticaria|atopic eczema|genetic disorder|disease|disposition|material property|experimental factor; allergic urticaria|atopic eczema|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; allergic urticaria|urticaria|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; allergic urticaria|atopic eczema|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; allergic urticaria|atopic eczema|genetic disorder|material entity|experimental factor; allergic urticaria|urticaria|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0009524	female genital tract fistula	NA		female genital tract fistula|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
HP:0002381	Aphasia	An acquired language impairment of some or all of the abilities to produce or comprehend speech and to read or write.	Difficulty finding words;Loss of words;Losing words	Aphasia|Neurological speech impairment|Abnormality of higher mental function|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1000826	atrophic gastritis	Atrophic gastritis that is persistent and long-standing.	Gastritides, atrophic;Gastritis, Atrophic;chronic atrophic gastritis;atrophic Gastritides;gastric atrophy;atrophic gastritis	atrophic gastritis|chronic gastritis|chronic disease|disease|disposition|material property|experimental factor; atrophic gastritis|chronic gastritis|gastritis|stomach disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; atrophic gastritis|chronic gastritis|gastritis|inflammatory disease|disease|disposition|material property|experimental factor
MONDO:0001410	postmenopausal atrophic vaginitis	Inflammation of the vagina due to thinning of the vaginal wall and decreased lubrication associated with reduced estrogen levels at menopause.	atrophic vaginitis;senile vaginitis	postmenopausal atrophic vaginitis|vaginitis|vaginal disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; postmenopausal atrophic vaginitis|vaginitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0004320	suicidal ideation	NA	suicidal thought	suicidal ideation|suicide behaviour|behavior|biological process|process|experimental factor
EFO:0003966	eye disease	A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma.	disease or disorder of eyeball of camera-type eye;eyeball of camera-type eye disease or disorder;disorder of eye;globe disease;disease of eye;eye disease;eye disorder;disease of eyeball of camera-type eye;disorder of eyeball of camera-type eye;eyeball of camera-type eye disease	eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; eye disease|disorder of visual system|disease|disposition|material property|experimental factor
EFO:0004248	male infertility	The inability of the male to effect fertilization of an ovum after a specified period of unprotected intercourse. Male sterility is permanent infertility.	sterility, male;male infertility;male reproductive system infertility disorder;infertility, male;male reproductive system infertility;infertility disorder of male reproductive system;male sterility	male infertility|infertility|reproductive system disease|disease|disposition|material property|experimental factor; male infertility|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
MONDO:0009061	cystic fibrosis	Cystic fibrosis (CF) is a genetic disorder characterized by the production of sweat with a high salt content and mucus secretions with an abnormal viscosity.	cystic fibrosis lung disease, modifier of;CF;mucoviscidosis;pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis;cystic fibrosis	cystic fibrosis|autosomal recessive disease|autosomal genetic disease|genetic disorder|material entity|experimental factor; cystic fibrosis|autosomal recessive disease|autosomal genetic disease|genetic disorder|disease|disposition|material property|experimental factor; cystic fibrosis|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0000279	azoospermia	A male infertility characterized by dirsuption of the process of sperm development from diploid cells into mature haploid spermatozoa.	Oligozoospermia;Counts, Low Sperm;spermatogenic failure;Oligospermia;Low Sperm Count;Low Sperm Counts;Azoospermia (finding);Count, Low Sperm;Sperm Counts, Low;Sperm Count, Low	azoospermia|male infertility|infertility|reproductive system disease|disease|disposition|material property|experimental factor; azoospermia|genetic disorder|material entity|experimental factor; azoospermia|male infertility|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; azoospermia|genetic disorder|disease|disposition|material property|experimental factor
EFO:1001887	epicondylitis	Inflammation of the lateral epicondyle.	archer's elbow;inflammation of ectepicondyle of humerus;medial epicondylitis;ectepicondyle of humerus inflammation;andrel epicondylitis;epicondylitis;hockey elbow;golfer's elbow;lateral epicondylitis	epicondylitis|inflammatory disease|disease|disposition|material property|experimental factor; epicondylitis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; epicondylitis|Tendinopathy|connective tissue disease|disease|disposition|material property|experimental factor; epicondylitis|Tendinopathy|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
MONDO:0001815	extrapyramidal and movement disease	NA		extrapyramidal and movement disease|movement disorder|nervous system disease|disease|disposition|material property|experimental factor
HP:0001824	Weight loss	Reduction of total body weight.	Loss of weight	Weight loss|Decreased body weight|Abnormality of body weight|Growth abnormality|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:68561	N-acetyltyrosine	NA	N-acetyltyrosine;2-(acetylamino)-3-(4-hydroxyphenyl)propanoic acid	N-acetyltyrosine|phenols|chemical entity|material entity|experimental factor
HP:0011841	Ventricular flutter	A potentially lethal cardiac arrhythmia characterized by an extremely rapid, hemodynamically unstable ventricular tachycardia (150-300 beats/min) with a large oscillating sine-wave appearance.		Ventricular flutter|Tachycardia|Ventricular arrhythmia|Abnormality of cardiovascular system electrophysiology|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000095	chronic lymphocytic leukemia	B-cell chronic lymphocytic leukemia (B-CLL) is a type of B-cell non-Hodgkin lymphoma, and the most common form of leukemia in Western countries, affecting elderly adults (mean age of 67 and 72 years) with a slight male predominance (1.7:1), and characterized by a highly variable clinical presentation that can include asymptomatic disease or non-specific B-symptoms such as unintentional weight loss, severe fatigue, fever (without evidence of infection), and night sweats as well as cervical lymphadenopathy, splenomegaly and frequent infections. Some patients can also develop autoimmune complications such as autoimmune hemolytic anemia or immune thrombocytopenia. The clinical course is extremely heterogeneous with survival ranging from a few months to several decades.	B-CLL;hematopoeitic - chronic lymphocytic leukemia (CLL);chronic lymphogenous leukemia;B-cell chronic lymphocytic leukemia;B-cell lymphocytic leukemia;chronic lymphocytic leukemia;B-cell chronic lymphoid leukemia;B-cell chronic lymphogenous leukemia;chronic B-cell lymphocytic leukemia;B cell chronic lymphocytic leukemia;BCLL;CLL;chronic lymphocytic leukemia (CLL);small lymphocytic lymphoma;B cell CLL;lymphoplasmacytic leukemia;chronic lymphatic leukemia;B-cell CLL;B cell lymphocytic leukemia	chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|precursor lymphoblastic lymphoma/leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|chronic leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|chronic leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; chronic lymphocytic leukemia|chronic leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|chronic leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|chronic leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|precursor lymphoblastic lymphoma/leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|neoplasm of immature B and T cells|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|chronic leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|neoplasm of immature B and T cells|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|immune system disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|precursor lymphoblastic lymphoma/leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|acute disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|chronic leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|neoplasm of immature B and T cells|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|chronic leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|chronic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|immune system disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|Acute Leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|chronic leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|leukocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|chronic leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; chronic lymphocytic leukemia|indolent B-cell non-Hodgkin lymphoma|B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; chronic lymphocytic leukemia|neoplasm of mature B-cells|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor
EFO:0003961	hormone replacement therapy	NA	Replacement Therapy, Hormone;Therapy, Hormone Replacement;Hormone Replacement Therapy;HORMONE REPLACE THER;REPLACE THER HORMONE;THER HORMONE REPLACE;Therapies, Hormone Replacement;Hormone Replacement Therapies;Replacement Therapies, Hormone	hormone replacement therapy|treatment|planned process|process|experimental factor
HP:0032141	Precordial pain	A type of chest pain that arises in the or under the left breast and often described as throbbing, stabbing, or burning, and lasting hours or longer. The pain may arise with or after effort, and may spread to the left arm or left side of the neck.		Precordial pain|Chest pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Precordial pain|Chest pain|pain|sign or symptom|phenotype|quality|material property|experimental factor
MONDO:0021117	lung neoplasm	A benign or malignant, primary or metastatic neoplasm involving the lungs. Representative examples of benign neoplasms include adenoma, papilloma, chondroma, and endobronchial lipoma. Representative examples of malignant neoplasms include carcinoma, carcinoid tumor, sarcoma, and lymphoma.	tumor of lung;lung neoplasms;tumor of the lung;lung neoplasm;neoplasm of lung;lung tumor;neoplasm of the lung;lung neoplasm (disease)	lung neoplasm|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; lung neoplasm|respiratory system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lung neoplasm|respiratory system neoplasm|respiratory system disease|disease|disposition|material property|experimental factor; lung neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0008590	Status Asthmaticus	An acute exacerbation of asthma, characterized by inadequate response to initial bronchodilators.	severe asthma attack;status asthmaticus;Asthma with status asthmaticus;Severe asthma attack;asthma with status asthmaticus	Status Asthmaticus|asthma|bronchial disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:1000756	pityriasis rosea	A mild, self-limited skin disorder that is most commonly seen in children and young adults. It is characterized by an initial large round spot on the chest, abdomen, or back, often referred to as a herald patch, that is usually followed within a week by a distinctive pattern of similar but smaller papules on the torso, arms, and legs. There may also be itching, especially when overheated.	Pityriasis rosea;pityriasis rosea;pityriasis rosea Gibert;Pityriasis circinata	pityriasis rosea|exanthem|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; pityriasis rosea|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; pityriasis rosea|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0003827	pulmonary embolism	The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.	Embolisms, Pulmonary;EMBOLISMS PULM;Thromboembolism, Pulmonary;PULM EMBOLISM;PULM THROMBOEMBOLISM;PULM EMBOLISMS;Pulmonary Thromboembolism;EMBOLISM PULM;Pulmonary Thromboembolisms;THROMBOEMBOLISMS PULM;Pulmonary Embolisms;Thromboembolisms, Pulmonary;pulmonary embolism;pulmonary embolism (disease);Embolism, Pulmonary;embolism, pulmonary;pulmonary artery embolism;pulmonary embolus;PULM THROMBOEMBOLISMS	pulmonary embolism|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0003818	lung disease	A disease involving the lung.	pulmonary diseases;Lung Diseases;disease or disorder of lung;Diseases, Pulmonary;Pulmonary Disease;Disease, Lung;pulmonary disease;lung disorder;Diseases, Lung;lung disorders;disorder of lung;Disease, Pulmonary;disease of lung;PULM DIS;pulmonary disorders;lung disease;DIS PULM;pulmonary disorder;Pulmonary Diseases;lung disease or disorder;LUNG DIS	lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0009505	head injury	NA		head injury|injury|disease|disposition|material property|experimental factor
EFO:0009490	nervous system injury	Traumatic injuries to the brain, cranial nerves, spinal cord, autonomic nervous system, or neuromuscular system, including iatrogenic injuries induced by surgical procedures.	injury of nervous system;nerve injury;nervous system injury;nerve trauma;neurological injury;neurological trauma	nervous system injury|injury|disease|disposition|material property|experimental factor; nervous system injury|nervous system disease|disease|disposition|material property|experimental factor
EFO:0004192	alopecia areata	Loss of scalp and body hair involving microscopically inflammatory patchy areas.	alopecia areata;circumscribed alopecia	alopecia areata|genetic alopecia|genetic epidermal appendage anomaly|epidermal appendage anomaly|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor; alopecia areata|genetic alopecia|alopecia|hair anomaly|disorder of pilosebaceous unit|integumentary system disease|disease|disposition|material property|experimental factor; alopecia areata|genetic alopecia|alopecia|hair anomaly|epidermal appendage anomaly|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; alopecia areata|Rare genetic skin disease|genetic disorder|disease|disposition|material property|experimental factor; alopecia areata|genetic alopecia|alopecia|hair anomaly|epidermal appendage anomaly|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor; alopecia areata|genetic alopecia|genetic epidermal appendage anomaly|genetic disorder|disease|disposition|material property|experimental factor; alopecia areata|Rare genetic skin disease|genetic disorder|material entity|experimental factor; alopecia areata|genetic alopecia|genetic epidermal appendage anomaly|epidermal appendage anomaly|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; alopecia areata|genetic alopecia|genetic epidermal appendage anomaly|genetic disorder|material entity|experimental factor; alopecia areata|genetic alopecia|genetic epidermal appendage anomaly|epidermal appendage anomaly|material entity|experimental factor; alopecia areata|genetic alopecia|alopecia|hair anomaly|epidermal appendage anomaly|material entity|experimental factor
HP:0002637	Cerebral ischemia	NA	Cerebrovascular ischemia;Brain ischemia;Disruption of blood oxygen supply to brain	Cerebral ischemia|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Cerebral ischemia|ischemia|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Cerebral ischemia|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0021658	vascular ectasia	NA	vascular ectasia	vascular ectasia|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:1001825	pleurisy	Inflammation of the pleura. It is usually caused by infections. Chest pain while breathing or coughing is the presenting symptom.	pleuritis;pleurisy;inflammation of pleura;pleura inflammation	pleurisy|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; pleurisy|serositis|inflammatory disease|disease|disposition|material property|experimental factor; pleurisy|pleural disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0003956	seasonal allergic rhinitis	Allergic rhinitis caused by outdoor allergens.	seasonal allergic rhinitis;Seasonal Allergic Rhinitides;Allergic Rhinitis, Seasonal;Hay Fever;Rhinitides, Seasonal Allergic;Pollinoses;Allergy, Pollen;Rhinitis, Seasonal Allergic;Pollen Allergies;Pollen Allergy;Rhinitis, Allergic, Seasonal;hay fever;Allergic Rhinitides, Seasonal;Allergies, Pollen;Fever, Hay;Hayfever;Pollinosis	seasonal allergic rhinitis|allergic rhinitis|allergic respiratory disease|allergic disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; seasonal allergic rhinitis|allergic rhinitis|rhinitis|inflammatory disease|disease|disposition|material property|experimental factor; seasonal allergic rhinitis|allergic rhinitis|rhinitis|nasal cavity disorder|nasal disorder|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; seasonal allergic rhinitis|allergic rhinitis|allergic respiratory disease|respiratory system disease|disease|disposition|material property|experimental factor; seasonal allergic rhinitis|allergic rhinitis|rhinitis|nasal cavity disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0005208	glomerular filtration rate	NA	GFR	glomerular filtration rate|renal system measurement|measurement|information entity|experimental factor
MONDO:0024664	hypertension, pregnancy-induced	A hypertensive disorder that develops during pregnancy.	hypertension-associated pregnancy disorder;pregnancy-induced hypertension;hypertension associated disorders of pregnancy	hypertension, pregnancy-induced|hypertension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; hypertension, pregnancy-induced|pregnancy disorder|obstetric disorder|disease|disposition|material property|experimental factor
EFO:0003830	prostatitis	An infectious or non-infectious inflammatory process affecting the prostate gland.	Chronic Bacterial Prostatitides;prostatitis;Acute Bacterial Prostatitides;prostate gland inflammation;Inflammatory Prostatitis, Asymptomatic;inflammation of prostate gland;prostatitis (disease);Chronic Bacterial Prostatitis;Bacterial Prostatitis, Chronic;Asymptomatic Inflammatory Prostatitis;Bacterial Prostatitis, Acute;Asymptomatic Inflammatory Prostatitides;Prostatitides;Bacterial Prostatitides, Acute;Bacterial Prostatitides, Chronic;Acute Bacterial Prostatitis;Chronic Prostatitis with Chronic Pelvic Pain Syndrome;Prostatitides, Chronic Bacterial	prostatitis|prostate disease|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; prostatitis|inflammatory disease|disease|disposition|material property|experimental factor; prostatitis|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
CHEBI:15963	ribitol	NA	ribitol;meso-ribitol;(2R,3s,4S)-pentane-1,2,3,4,5-pentol;Ribitol	ribitol|carbohydrate|chemical entity|material entity|experimental factor
EFO:0021122	N1-methyladenosine measurement	NA		N1-methyladenosine measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0012598	Abnormal urine potassium concentration	An abnormal concentration of potassium(1+) in the urine.	Abnormal urine K concentration	Abnormal urine potassium concentration|Abnormality of urine homeostasis|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Abnormal urine potassium concentration|Abnormality of urine homeostasis|Abnormality of the urinary system physiology|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1000243	Epidermal Inclusion Cyst	NA	sebaceous cyst;EIC;epidermoid cyst	Epidermal Inclusion Cyst|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; Epidermal Inclusion Cyst|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0007052	antisocial behaviour measurement	NA	adult antisocial behaviour measurement	antisocial behaviour measurement|mental or behavioural disorder biomarker|measurement|information entity|experimental factor
HP:0002840	Lymphadenitis	Inflammation of a lymph node.	Inflammation of the lymph nodes	Lymphadenitis|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Lymphadenitis|Abnormality of the lymphatic system|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Lymphadenitis|Abnormality of the lymphatic system|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0001751	cholestasis	Impairment of the bile flow caused by obstruction within the liver, or outside the liver in the bile duct system.	bile occlusion;obstruction of bile duct	cholestasis|bile duct disorder|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor
HP:0002196	Myelopathy	NA		Myelopathy|Morphological central nervous system abnormality|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0800042	S-methylmethionine measurement	NA		S-methylmethionine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009476	neck injury	NA		neck injury|injury|disease|disposition|material property|experimental factor
MONDO:0019019	osteogenesis imperfecta	Osteogenesis imperfecta (OI) comprises a heterogeneous group of genetic disorders characterized by increased bone fragility, low bone mass, and susceptibility to bone fractures with variable severity.	OI;brittle bone disease;Lobstein disease;Lobstein's syndrome;Osteopsathyrosis;glass bone disease;Vrolik's disease;Porak and Durante disease	osteogenesis imperfecta|osteochondrodysplasia|bone development disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteogenesis imperfecta|genetic disorder|disease|disposition|material property|experimental factor; osteogenesis imperfecta|genetic disorder|material entity|experimental factor; osteogenesis imperfecta|osteochondrodysplasia|bone development disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor
EFO:0004260	bone disease	Diseases of bones.	bone element disease;bone disorder;disease of bone element;disorder of bone element;bone element disease or disorder;disease or disorder of bone element	bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
MONDO:0004580	retinal degeneration	Degeneration of the retina.	retina degeneration;retina, Degeneration Of;degeneration of retina	retinal degeneration|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; retinal degeneration|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; retinal degeneration|retinopathy|nervous system disease|disease|disposition|material property|experimental factor
EFO:0005269	congenital heart malformation	A disease that has its basis in the disruption of heart development.	heart development disease;congenital heart malformation;disorder of heart development	congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; congenital heart malformation|congenital heart disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; congenital heart malformation|genetic disorder|disease|disposition|material property|experimental factor; congenital heart malformation|genetic disorder|material entity|experimental factor; congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0010967	urinary microalbumin measurement	NA		urinary microalbumin measurement|urinary metabolite measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0007778	urinary albumin to creatinine ratio	NA		urinary albumin to creatinine ratio|urinary metabolite measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009481	paranasal sinus disease	A disease involving the paranasal sinus.	paranasal sinus disorder;paranasal sinus disease;disorder of nasal sinus;disorder of paranasal sinus;disease or disorder of paranasal sinus;paranasal sinus disease or disorder;disease of paranasal sinus;sinus disorder	paranasal sinus disease|head and neck disorder|disease|disposition|material property|experimental factor; paranasal sinus disease|nasal disorder|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; paranasal sinus disease|respiratory system disease|disease|disposition|material property|experimental factor; paranasal sinus disease|skull disorder|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
HP:0000790	Hematuria	The presence of blood in the urine. Hematuria may be gross hematuria (visible to the naked eye) or microscopic hematuria (detected by dipstick or microscopic examination of the urine).	Blood in urine	Hematuria|Abnormal urine cytology|Abnormality of urine homeostasis|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Hematuria|Abnormal urine cytology|Abnormality of urine homeostasis|Abnormality of the urinary system physiology|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Hematuria|Abnormal renal physiology|Abnormality of the kidney|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Hematuria|Abnormal renal physiology|Abnormality of the urinary system physiology|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0010066	corneal hysteresis	NA		corneal hysteresis|eye measurement|measurement|information entity|experimental factor
EFO:0004253	nephrolithiasis	The presence of a calculus in the pelvis of the kidney; this is most often composed of mineral salts and proteins.	calculus of kidney and ureter;Stone - kidney/ureter;Kidney stones;Calculus, Kidney;Calculi, Renal;Renal stones;Kidney Calculi;nephrolithiasis;Calculus, Renal;Renal Calculus;kidney stones;kidney stone;Kidney Calculus;Stone, Kidney;Calculi, Kidney;Stones, Kidney;Renal Calculi;Kidney Stones;Renal calculi;renal calculi	nephrolithiasis|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; nephrolithiasis|urolithiasis|urinary system disease|disease|disposition|material property|experimental factor
EFO:0003952	fever of unknown origin	NA	Unknown Origin Fever;Unknown Origin Fevers	fever of unknown origin|sign or symptom|phenotype|quality|material property|experimental factor
EFO:0800066	6-oxopiperidine-2-carboxylate measurement	NA		6-oxopiperidine-2-carboxylate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0000280	Barrett's esophagus	Esophageal lesion lined with columnar metaplastic epithelium which is flat or villiform. Barrett epithelium is characterized by two different types of cells: goblet cells and columnar cells. The symptomatology of Barrett esophagus is that of gastro-esophageal reflux. It is the precursor of most esophageal adenocarcinomas. (WHO)	Barrett's esophagus (disorder) [Ambiguous];Barrett Syndrome;cello;Epithelium, Barrett;Barrett's ulcer of esophagus (disorder);CLE;Barrett esophagus/esophageal adenocarcinoma;(ulcerative esophagitis) or (Barrett's esophagus);ulcerative esophagitis;Barrett's esophagus;Barrett Esophagus;Esophagus, Barrett's;Barretts Esophagus;Barrett's oesophagus;Barretts syndrome;BE;columnar-lined esophagus;Barrett's Syndrome;Barrett esophagus;columnar epithelial-lined Lower esophagus;Barrett's esophagus (disorder);Barrett's esophagus with esophagitis (disorder);Barrett Epithelium;Syndrome, Barrett;Esophagus, Barrett;Barrett's esophagus with esophagitis;Barrett's ulcer of esophagus;Syndrome, Barrett's	Barrett's esophagus|esophageal disease|digestive system disease|disease|disposition|material property|experimental factor; Barrett's esophagus|esophageal disease|upper digestive tract disorder|disease|disposition|material property|experimental factor
EFO:0009489	cranial nerve palsy	Injury to any of the cranial nerves or their nuclei in the brain resulting in muscle weakness.	cranial nerve palsy;cranial nerve paralysis	cranial nerve palsy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; cranial nerve palsy|cranial nerve neuropathy|nervous system disease|disease|disposition|material property|experimental factor
EFO:0004228	drug-induced liver injury	A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to acute liver failure, caused by drugs, drug metabolites, and chemicals from the environment.	drug induced hepatotoxicity;Hepatitis, Toxic;Toxic Hepatitis;drug-induced disorder of liver;Hepatitis, Drug-Induced;Liver Injury, Drug-Induced;Drug-Induced Liver Disease;drug-induced liver injury	drug-induced liver injury|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; drug-induced liver injury|liver disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:1000050	renal leiomyoma	A leiomyoma that involves the kidney.	renal leiomyoma;leiomyoma of kidney;kidney leiomyoma	renal leiomyoma|kidney benign neoplasm|benign urinary system neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal leiomyoma|kidney benign neoplasm|benign urinary system neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; renal leiomyoma|kidney benign neoplasm|kidney neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal leiomyoma|leiomyoma|Benign Smooth Muscle Neoplasm|benign muscle neoplasm|musculoskeletal system benign neoplasm|musculoskeletal system disease|disease|disposition|material property|experimental factor; renal leiomyoma|leiomyoma|Benign Smooth Muscle Neoplasm|benign muscle neoplasm|musculoskeletal system benign neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal leiomyoma|leiomyoma|Benign Smooth Muscle Neoplasm|smooth muscle tumor|myomatous neoplasm|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; renal leiomyoma|kidney benign neoplasm|kidney neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; renal leiomyoma|leiomyoma|Benign Smooth Muscle Neoplasm|benign muscle neoplasm|myomatous neoplasm|mesenchymal cell neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal leiomyoma|leiomyoma|Benign Smooth Muscle Neoplasm|smooth muscle tumor|myomatous neoplasm|mesenchymal cell neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal leiomyoma|leiomyoma|Benign Smooth Muscle Neoplasm|benign muscle neoplasm|myomatous neoplasm|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; renal leiomyoma|kidney benign neoplasm|benign urinary system neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal leiomyoma|kidney benign neoplasm|kidney neoplasm|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:0009458	alcohol use disorder measurement	NA		alcohol use disorder measurement|mental or behavioural disorder biomarker|measurement|information entity|experimental factor
EFO:0021047	docosahexaenoate DHA; 22:6n3 measurement	NA		docosahexaenoate DHA; 22:6n3 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009314	blood coagulation disease	A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.	postpartum coagulation defect with delivery;blood coagulation disease;coagulopathy;Coagulation Disorder;Disorder, Blood Coagulation;Coagulation Disorder, Blood;postpartum coagulation defect;coagulation disorders, blood;coagulation defect;Blood Coagulation Disorder;Coagulopathy;coagulation disorder, blood;Coagulation Disorders, Blood;disorders, blood coagulation;coagulation disorder;Coagulation Defect;Disorders, Blood Coagulation;disorder, blood coagulation;blood coagulation disorder;excessive bleeding;clotting disorder	blood coagulation disease|hematologic disease|material entity|experimental factor; blood coagulation disease|hematologic disease|disease|disposition|material property|experimental factor
EFO:0009611	orbital fracture	NA		orbital fracture|Skull Fractures|bone fracture|injury|disease|disposition|material property|experimental factor; orbital fracture|Skull Fractures|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0000519	glioblastoma multiforme	The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma, IDH-mutant), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma, IDH- wildtype). (Adapted from WHO)	primary glioblastoma multiforme;glioblastoma multiforme (disease);grade IV adult astrocytic tumor;glioblastoma multiforme;spongioblastoma multiforme;grade IV astrocytic neoplasm;glioblastoma;WHO grade IV glioma;grade IV astrocytoma;grade IV astrocytic tumor;GBM (glioblastoma);glioblastoma (disease);GBM	glioblastoma multiforme|astrocytoma|astrocytic tumor|glioma|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|astrocytic tumor|glioma|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|central nervous system cancer|nervous system cancer|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; glioblastoma multiforme|astrocytoma|astrocytic tumor|glioma|neuroepithelial neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|glioma|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|central nervous system cancer|nervous system cancer|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|astrocytic tumor|glioma|neuroepithelial neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|central nervous system cancer|Central Nervous System Neoplasm|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|central nervous system cancer|Central Nervous System Neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|high grade malignant neoplasm|material entity|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|astrocytic tumor|glioma|neuroepithelial neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|glioma|neuroepithelial neoplasm|nervous system neoplasm|nervous system disease|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|central nervous system cancer|Central Nervous System Neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|glioma|neuroepithelial neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; glioblastoma multiforme|astrocytoma|astrocytic tumor|glioma|neuroepithelial neoplasm|nervous system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|central nervous system cancer|nervous system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; glioblastoma multiforme|high grade astrocytic tumor|malignant glioma|high grade malignant neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0021169	epithelioid hemangioma	A hemangioma characterized by the presence of epithelioid endothelial cells.	histiocytoid hemangioma;epithelioid hemangioma;epithelioid haemangioma	epithelioid hemangioma|hemangioma|benign blood vessel neoplasm|blood vessel neoplasm|vascular neoplasm|cardiovascular neoplasm|cardiovascular disease|disease|disposition|material property|experimental factor; epithelioid hemangioma|hemangioma|benign blood vessel neoplasm|cardiovascular organ benign neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; epithelioid hemangioma|hemangioma|benign epithelial neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; epithelioid hemangioma|hemangioma|benign blood vessel neoplasm|blood vessel neoplasm|vascular neoplasm|cardiovascular neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; epithelioid hemangioma|hemangioma|vascular anomaly|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; epithelioid hemangioma|hemangioma|benign blood vessel neoplasm|cardiovascular organ benign neoplasm|cardiovascular neoplasm|cardiovascular disease|disease|disposition|material property|experimental factor; epithelioid hemangioma|hemangioma|benign blood vessel neoplasm|blood vessel neoplasm|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; epithelioid hemangioma|hemangioma|benign blood vessel neoplasm|cardiovascular organ benign neoplasm|cardiovascular neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; epithelioid hemangioma|hemangioma|benign epithelial neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0004286	venous thromboembolism	Occlusion of the lumen of a vein by a thrombus that has migrated from a distal site via the blood stream.	VTE;venous thromboembolism	venous thromboembolism|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0009493	paroxysmal tachycardia	NA	Bouveret-Hoffmann syndrome	paroxysmal tachycardia|cardiac arrhythmia|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
MONDO:0000474	pericardium disorder	A disease involving the pericardium.	pericardium disease;disease of pericardium;disorder of pericardium;pericardium disease or disorder;disease or disorder of pericardium	pericardium disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0009469	Bartholin gland disease	NA	Bartholin's gland disease;major vestibular gland disease	Bartholin gland disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0007227	croup	Acute upper respiratory airways infection that results in the swelling of the larynx. It is usually caused by parainfluenza viruses. Signs include a characteristic barking cough and stridor.	acute Obstructive Laryngitis;acute obstructive laryngitis;croup syndrome;Croup;Croup (disorder);Croup syndrome;croup;acute laryngotracheobronchitis;Laryngotracheobronchitis	croup|acute laryngitis|acute disease|disease|disposition|material property|experimental factor; croup|acute laryngitis|laryngitis|inflammatory disease|disease|disposition|material property|experimental factor; croup|laryngotracheitis|tracheitis|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; croup|bronchitis|tracheobronchitis|inflammatory disease|disease|disposition|material property|experimental factor; croup|laryngotracheitis|laryngitis|inflammatory disease|disease|disposition|material property|experimental factor; croup|bronchitis|bronchial disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; croup|laryngotracheitis|laryngitis|laryngeal disease|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; croup|laryngotracheitis|tracheitis|tracheal disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; croup|laryngotracheitis|tracheitis|tracheobronchitis|inflammatory disease|disease|disposition|material property|experimental factor; croup|bronchitis|tracheobronchitis|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; croup|acute laryngitis|laryngitis|laryngeal disease|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; croup|laryngotracheitis|tracheitis|tracheal disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; croup|laryngotracheitis|tracheitis|tracheobronchitis|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; croup|laryngotracheitis|tracheitis|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
MONDO:0000263	laryngotracheitis	An inflammation of both larynx and trachea.		laryngotracheitis|tracheitis|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; laryngotracheitis|tracheitis|tracheobronchitis|inflammatory disease|disease|disposition|material property|experimental factor; laryngotracheitis|tracheitis|tracheal disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; laryngotracheitis|laryngitis|laryngeal disease|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; laryngotracheitis|tracheitis|tracheobronchitis|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; laryngotracheitis|tracheitis|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; laryngotracheitis|laryngitis|inflammatory disease|disease|disposition|material property|experimental factor; laryngotracheitis|tracheitis|tracheal disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0009718	peak expiratory flow	NA	PEF	peak expiratory flow|pulmonary function measurement|measurement|information entity|experimental factor; peak expiratory flow|test result|information entity|experimental factor
EFO:0005279	temporomandibular joint disorder	Any condition affecting the anatomic and functional characteristics of the temporomandibular joint.	TMD;temporomandibular joint disorder	temporomandibular joint disorder|head and neck disorder|disease|disposition|material property|experimental factor; temporomandibular joint disorder|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
CHEBI:36257	taurocholate	NA	2-[(3alpha,7alpha,12alpha-trihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate;taurocholate	taurocholate|chemical entity|material entity|experimental factor
MONDO:0002203	constipation disorder	Irregular and infrequent or difficult evacuation of the bowels.	constipation	constipation disorder|bowel dysfunction|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0007444	Plasmodium falciparum malaria	Malaria resulting from infection by Plasmodium falciparum.	Plasmodium falciparum malaria;Plasmodium falciparum malaria, unspecified (disorder);Falciparum malaria [malignant tertian];falciparum malaria;malaria fever, subtertian;malignant tertian fever (finding);falciparum malaria [malignant tertian];malignant tertian fever;Plasmodium falciparum malaria, unspecified;Falciparum malaria (disorder);Malaria fever, subtertian;Falciparum Malaria;Malaria, Falciparum	Plasmodium falciparum malaria|malaria|digestive system infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Plasmodium falciparum malaria|malaria|vector-borne disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Plasmodium falciparum malaria|malaria|protozoa infectious disease|parasitic infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Plasmodium falciparum malaria|malaria|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; Plasmodium falciparum malaria|malaria|erythrocyte disorder|hematologic disease|material entity|experimental factor; Plasmodium falciparum malaria|malaria|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; Plasmodium falciparum malaria|malaria|erythrocyte disorder|hematologic disease|disease|disposition|material property|experimental factor
EFO:0010685	menopausal or post-menopausal disease	NA	menopausal or post-menopausal disorder	menopausal or post-menopausal disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0004197	hepatitis B virus infection	A viral infection caused by the hepatitis B virus.	viral hepatitis B;hepatitis B infection;hepatitis B, chronic;Hepatitis B virus caused hepatitis;Hepatitis B infection;hepatitis B virus infection;viral Hepatitis B;Hepatitis B virus hepatitis;Hepatitis B;hepatitis type B;HBV infection	hepatitis B virus infection|viral human hepatitis infection|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; hepatitis B virus infection|Hepadnaviridae infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; hepatitis B virus infection|Hepadnaviridae infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; hepatitis B virus infection|viral human hepatitis infection|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; hepatitis B virus infection|viral human hepatitis infection|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; hepatitis B virus infection|viral human hepatitis infection|inflammatory disease|disease|disposition|material property|experimental factor; hepatitis B virus infection|viral human hepatitis infection|digestive system infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; hepatitis B virus infection|viral human hepatitis infection|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0004261	osteitis deformans	A disease of bone that initially results in the excessive resorption of bone (by osteoclasts) followed by the replacement of normal bone marrow with vascular and fibrous tissue.	Paget's disease of the bone;osseous Paget's disease;bone Paget disease;osteitis deformans;bone Paget's disease;Paget's disease of bone;Pagets disease (bone);Paget disease of bone;Paget's bone disease;Paget disease (bone);Paget's disease (bone)	osteitis deformans|hyperostosis|bone remodeling disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; osteitis deformans|genetic disorder|disease|disposition|material property|experimental factor; osteitis deformans|genetic disorder|material entity|experimental factor
EFO:0001967	medial collateral ligament	NA	Medial Collateral Ligament of the Knee	medial collateral ligament|knee joint|skeletal joint|articular system|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|ligament|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|appendage|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|hindlimb|limb|appendage|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|limb|appendage|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|hindlimb|limb|appendage|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|appendage|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|hindlimb|limb|appendage|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|hindlimb|limb|appendage|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|ligament|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|limb|appendage|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|ligament|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|hindlimb|limb|appendage|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|appendage|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|limb|appendage|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|limb|appendage|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeletal system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|appendage|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeletal system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|hindlimb|limb|appendage|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|ligament|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeletal system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeletal system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeletal system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeletal system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|limb|appendage|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|ligament|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|limb|appendage|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|hindlimb|limb|appendage|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|hindlimb|limb|appendage|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|appendage|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|limb|appendage|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeletal system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeletal system|musculoskeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|limb|appendage|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|limb|appendage|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeletal system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|hindlimb|limb|appendage|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|ligament|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|appendage|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|appendage|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|skeleton structure|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articular system|skeletal system|musculoskeletal system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|hindlimb|limb|appendage|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|limb|appendage|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|appendage|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|hindlimb|limb|appendage|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articular system|skeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|joint component|skeletal joint|articulation|articular system|skeletal system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeletal system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|hindlimb|limb|appendage|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|anatomical structure|anatomical entity|organism part|material entity|experimental factor; medial collateral ligament|knee joint|skeletal joint|articulation|articular system|skeleton structure|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|limb|appendage|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; medial collateral ligament|knee joint|knee|leg|limb|appendage|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor
HP:0011368	Epidermal thickening	Thickening of the epidermal layer of the skin.		Epidermal thickening|Thickened skin|Abnormality of skin morphology|Abnormality of the skin|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1000014	acidosis	An abnormally high acidity of the blood and other body tissues. Acidosis can be either respiratory or metabolic.	acidosis;acidosis disorder	acidosis|blood disease|hematologic disease|disease|disposition|material property|experimental factor; acidosis|disorder of acid-base balance|metabolic disease|disease|disposition|material property|experimental factor; acidosis|blood disease|hematologic disease|material entity|experimental factor
HP:0030151	Cholangitis	Inflammation of the biliary ductal system, affecting the intrahepatic or extrahepatic portions, or both.	Bile duct inflammation	Cholangitis|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Cholangitis|Abnormal biliary tract morphology|Abnormality of the liver|Abnormality of the abdominal organs|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009522	disturbance of skin sensation	NA		disturbance of skin sensation|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009765	alanine measurement	NA		alanine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:0009487	nerve compression syndrome	Any nerve disorder caused by the entrapment and compression of a nerve.	entrapment neuropathy;peripheral nerve entrapment syndrome;compression neuropathy;nerve compression syndrome;trapped nerve/compressed nerve	nerve compression syndrome|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; nerve compression syndrome|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor
EFO:0003100	peripheral neuropathy	A disorder affecting the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.	neuropathy;peripheral neuropathy;peripheral nerve disorder	peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009387	peripheral nervous system disease	A disease involving the peripheral nervous system.	PNS (peripheral nervous system) diseases;disorder of peripheral nervous system;peripheral nerve disorder;disorder of the peripheral nervous system;disease or disorder of peripheral nervous system;peripheral nervous system disorders;peripheral nervous system disorder;peripheral nervous system disease or disorder;PNS diseases;PNS disease;disease of peripheral nervous system;peripheral nervous system disease	peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0010177	lobar intracerebral hemorrhage	NA		lobar intracerebral hemorrhage|intracerebral hemorrhage|intracranial hemorrhage|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; lobar intracerebral hemorrhage|intracerebral hemorrhage|intracranial hemorrhage|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; lobar intracerebral hemorrhage|intracerebral hemorrhage|intracranial hemorrhage|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0000211	unspecified peripheral T-cell lymphoma	Aggressive nodal or extranodal mature (peripheral) T-cell lymphomas that do not belong to the better defined entities of the remainder of mature T-cell lymphomas. This category includes the following variants: lymphoepithelioid cell variant (Lennert's lymphoma), follicular variant, and T-zone variant.	peripheral T-cell lymphoma, not otherwise specified	unspecified peripheral T-cell lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; unspecified peripheral T-cell lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; unspecified peripheral T-cell lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; unspecified peripheral T-cell lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; unspecified peripheral T-cell lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; unspecified peripheral T-cell lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; unspecified peripheral T-cell lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; unspecified peripheral T-cell lymphoma|neoplasm of mature T-cells or NK-cells|T-cell and NK-cell neoplasm|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; unspecified peripheral T-cell lymphoma|neoplasm of mature T-cells or NK-cells|T-cell and NK-cell neoplasm|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; unspecified peripheral T-cell lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; unspecified peripheral T-cell lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; unspecified peripheral T-cell lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; unspecified peripheral T-cell lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; unspecified peripheral T-cell lymphoma|neoplasm of mature T-cells or NK-cells|T-cell and NK-cell neoplasm|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0010695	elevatedlactate dehydrogenase	NA	elevated lactic acid dehydrogenase;increased LDH;elevated LDH;increase of LDH;Increased lactic acid dehydrogenase	elevatedlactate dehydrogenase|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005193	serum IgG glycosylation measurement	NA		serum IgG glycosylation measurement|serum IgG measurement|antibody measurement|measurement|information entity|experimental factor
EFO:0009826	abnormality of serum enzyme levels	NA		abnormality of serum enzyme levels|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0002035	Rectal prolapse	Protrusion of the rectal mucous membrane through the anus.	Rectum protrudes through anus	Rectal prolapse|Abnormal rectum morphology|Abnormal large intestine morphology|Abnormal intestine morphology|Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004330	coffee consumption	NA	caffeine consumption	coffee consumption|drinking behavior|behavior|biological process|process|experimental factor
MONDO:0007915	systemic lupus erythematosus	An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.	systemic lupus erythematosus, susceptibility to;disseminated lupus erythematosus;systemic lupus erythematosus (disease);SLE;SLE - lupus erythematosus, systemic;systemic lupus erythematosus susceptibility to;lupus erythematosus, systemic;systemic lupus erythematosus	systemic lupus erythematosus|secondary glomerular disease|glomerular disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; systemic lupus erythematosus|lupus erythematosus|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; systemic lupus erythematosus|lupus erythematosus|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; systemic lupus erythematosus|thrombotic microangiopathy|blood coagulation disease|hematologic disease|disease|disposition|material property|experimental factor; systemic lupus erythematosus|thrombotic microangiopathy|blood coagulation disease|hematologic disease|material entity|experimental factor; systemic lupus erythematosus|thrombotic microangiopathy|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; systemic lupus erythematosus|lupus erythematosus|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; systemic lupus erythematosus|secondary glomerular disease|glomerular disease|material entity|experimental factor; systemic lupus erythematosus|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor
EFO:0004562	cryptorchidism	The failure of one or both testes of a male fetus to descend from the abdomen into the scrotum during the late part of pregnancy. If not surgically corrected in early childhood, males may be at increased risk for testicular cancer later in life.	cryptorchidism;undescended testicles;undescended testis;undescended testicle;cryptorchism;undescended testes;cryptorchidism (disease)	cryptorchidism|genetic disorder|material entity|experimental factor; cryptorchidism|genetic disorder|disease|disposition|material property|experimental factor; cryptorchidism|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0008541	response to opioid	NA		response to opioid|response to drug|response to stimulus|biological process|process|experimental factor
MONDO:0024633	hypertensive nephropathy	Kidney damage that results from chronically elevated blood pressure; complications include glomerular damage resulting in proteinuria and hematuria.	hypertensive renal disease;hypertensive nephropathy;HNP1	hypertensive nephropathy|genetic disorder|material entity|experimental factor; hypertensive nephropathy|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; hypertensive nephropathy|genetic disorder|disease|disposition|material property|experimental factor
MONDO:0024431	bilirubin metabolism disease	NA	disorder of bilirubin metabolism	bilirubin metabolism disease|metabolic disease|disease|disposition|material property|experimental factor
EFO:1000710	hidradenitis suppurativa	A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.	acne inversa;pyoderma fistulans significa;ectopic acne;fox den disease;hidradenitis;hidradenitis suppurativa;verneuil disease;Acne inversa, familial;HS	hidradenitis suppurativa|hidradenitis|apocrine sweat gland disease|sweat gland disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; hidradenitis suppurativa|hidradenitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0800027	2-hydroxy-3-methylvalerate measurement	NA		2-hydroxy-3-methylvalerate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0005665	white matter hyperintensity measurement	NA		white matter hyperintensity measurement|brain measurement|measurement|information entity|experimental factor
EFO:0006500	tubular adenocarcinoma	An infiltrating adenocarcinoma in which the malignant cells form tubular structures. Representative examples include the tubular breast carcinoma and the gastric tubular adenocarcinoma.	carcinoma, tubular cell, malignant;tubular adenocarcinoma;tubular carcinoma;tubular adenocarcinoma (morphologic abnormality)	tubular adenocarcinoma|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; tubular adenocarcinoma|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; tubular adenocarcinoma|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
HP:0000132	Menorrhagia	Prolonged and excessive menses at regular intervals in excess of 80 mL or lasting longer than 7 days.	Abnormally heavy bleeding during menstruation;Hypermenorrhea;Abnormally heavy periods	Menorrhagia|Abnormality of the genital system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Menorrhagia|Abnormal bleeding|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005532	angioedema	Swelling involving the deep dermis, subcutaneous, or submucosal tissues, representing localized edema. Angioedema often occurs in the face, lips, tongue, and larynx.	giant urticaria;edema, Quincke's;edema, angioneurotic;giant Urticarias;Quincke edema;Quincke's edema;Urticarias, giant;urticaria, giant;angioedema;Quinckes edema;angioneurotic Edemas;angioedemas;Edemas, angioneurotic	angioedema|skin vascular disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; angioedema|skin vascular disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; angioedema|urticaria|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; angioedema|urticaria|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0004505	telomere length	NA		telomere length|genomic measurement|measurement|information entity|experimental factor
HP:0000618	Blindness	Blindness is the condition of lacking visual perception defined as visual perception below 3/60 and/or a visual field of no greater than 10 degrees in radius around central fixation.	Blindness;Total vision loss	Blindness|Reduced visual acuity|Visual impairment|Abnormality of vision|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0800121	tigloylglycine measurement	NA		tigloylglycine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0021288	X-12100--hydroxytryptophan measurement	NA		X-12100--hydroxytryptophan measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1000668	allergic contact dermatitis	An inflammatory skin condition caused by an immune response to direct contact between the skin and an allergen. It consists of a delayed type of allergic reaction at the affected site with resulting red, swollen, and blistered skin that may itch or leak.	allergic contact dermatitis;allergic form of contact dermatitis	allergic contact dermatitis|atopic eczema|inflammatory skin disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; allergic contact dermatitis|atopic eczema|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; allergic contact dermatitis|atopic eczema|allergic disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; allergic contact dermatitis|contact dermatitis|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; allergic contact dermatitis|contact dermatitis|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; allergic contact dermatitis|atopic eczema|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; allergic contact dermatitis|atopic eczema|genetic disorder|material entity|experimental factor; allergic contact dermatitis|contact dermatitis|allergic disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; allergic contact dermatitis|atopic eczema|genetic disorder|disease|disposition|material property|experimental factor
EFO:0000765	AIDS	A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.	acquired Immune deficiency;Immuno-Deficiency Syndrome, Acquired;Syndrome, Acquired Immuno-Deficiency;acquired immune deficiency syndrome;Acquired Immunodeficiency Syndromes;AIDS (disorder);Immunodeficiency Syndrome, Acquired;AIDS - Acquired immunodeficiency syndrome;Acquired immunodeficiency syndrome;ACQUIRED IMMUNE DEFIC SYNDROME;Acquired Immuno-Deficiency Syndrome;AIDS, acquired immunodeficiency syndrome;acquired immunedeficiency syndrome;ACQUIRED IMMUNODEFIC SYNDROME;AIDS, NOS;Immuno-Deficiency Syndromes, Acquired;acquired immunodeficiency disease;AIDS, ACQUIRED IMMUNODEFICIENCY SYNDROME;Acquired immune deficiency syndrome (AIDS) (disorder);IMMUNODEFIC SYNDROME ACQUIRED;Acquired human immunodeficiency virus infection syndrome NOS;Acquired immune defic. syndr.;acquired human immunodeficiency virus infection syndrome NOS (disorder);ACQUIRED IMMUNO DEFIC SYNDROME;AIDS;Immunodeficiency due to human immunodeficiency virus infection;Syndromes, Acquired Immuno-Deficiency;acquired immunodeficiency syndrome, AIDS;Acquired immune deficiency syndrome, NOS;Immunologic Deficiency Syndrome, Acquired;ACQUIRED IMMUNODEFICIENCY SYNDROME, AIDS;Acquired Immuno Deficiency Syndrome;Acquired immune deficiency syndrome (AIDS);IMMUNOL DEFIC SYNDROME ACQUIRED;Acquired immunodeficiency syndrome, NOS;Syndromes, Acquired Immunodeficiency;acquired immune deficiency;Syndrome, Acquired Immunodeficiency;Immunodeficiency Syndromes, Acquired;Acquired Immuno-Deficiency Syndromes	AIDS|HIV infection|viral sexually transmitted disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; AIDS|HIV infection|viral sexually transmitted disease|sexually transmitted disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; AIDS|HIV infection|Lentivirus Infections|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; AIDS|HIV infection|viral sexually transmitted disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; AIDS|T-cell immunodeficiency|immunodeficiency disease|genetic disorder|disease|disposition|material property|experimental factor; AIDS|HIV infection|Lentivirus Infections|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; AIDS|T-cell immunodeficiency|immunodeficiency disease|immune system disease|disease|disposition|material property|experimental factor; AIDS|reproductive system disease|disease|disposition|material property|experimental factor; AIDS|T-cell immunodeficiency|immunodeficiency disease|genetic disorder|material entity|experimental factor
EFO:0007326	infectious mononucleosis	A condition characterized by an increase in mononuclear white blood cells and swollen lymph nodes, which is usually caused by infection with the Epstein-Barr virus.	mononucleosis;infectious mononucleosis;Monocytic angina;Infectious Mononucleosis;Gammaherpesviral mononucleosis;monocytic angina;glandular fever;Pfeiffer's disease (disorder);Pfeiffer's disease;Mono;Gammaherpesviral mononucleosis (disorder);Filatov's disease	infectious mononucleosis|Epstein-Barr virus infection|Herpesviridae infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; infectious mononucleosis|Epstein-Barr virus infection|Herpesviridae infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0003811	refractory anemia with excess blasts	A myelodysplastic syndrome characterized by the presence of 5-19% myeloblasts in the bone marrow or 2-19% blasts in the peripheral blood. It includes two categories: myelodysplastic syndrome with excess blasts-1 and myelodysplastic syndrome with excess blasts-2.	refractory Anemia with Excess blasts;MDS-EB;myelodysplastic syndrome with Excess blasts;refractory Anemia with an Excess of blasts;myelodysplastic syndrome with excess blasts;RAEB	refractory anemia with excess blasts|myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; refractory anemia with excess blasts|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; refractory anemia with excess blasts|myelodysplastic syndrome|neoplastic syndrome|syndromic disease|material entity|experimental factor; refractory anemia with excess blasts|myelodysplastic syndrome|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; refractory anemia with excess blasts|myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; refractory anemia with excess blasts|myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; refractory anemia with excess blasts|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; refractory anemia with excess blasts|myelodysplastic syndrome|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; refractory anemia with excess blasts|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; refractory anemia with excess blasts|myelodysplastic syndrome|neoplastic syndrome|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; refractory anemia with excess blasts|myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; refractory anemia with excess blasts|myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; refractory anemia with excess blasts|myelodysplastic syndrome|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; refractory anemia with excess blasts|myelodysplastic syndrome|neoplastic syndrome|syndromic disease|disease|disposition|material property|experimental factor
MONDO:0041261	disorder of acid-base balance	NA	disorder of acid-base balance	disorder of acid-base balance|metabolic disease|disease|disposition|material property|experimental factor
EFO:0800679	phenylalanyltryptophan measurement	NA		phenylalanyltryptophan measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0007427	pericarditis	An inflammatory process affecting the pericardium.	pericarditis;pericardium inflammation;inflammation of pericardium;Pericarditis;pericarditis (disease)	pericarditis|pericardium disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; pericarditis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0000203	monoclonal gammopathy	A condition characterized by the abnormal presence of monoclonal immunoglobulins in the blood or urine.	Monoclonal gammopathy of undetermined significance (morphologic abnormality);monoclonal gammopathy;Paraproteinaemia;Monoclonal Gammopathy Of Undetermined Significance (MGUS);Monoclonal gammopathy of uncertain significance;Monoclonal gammopathy of undetermined significance;MGUS - Monoclonal gammopathy of uncertain significance;Monoclonal Gammopathy of Unknown Significance;Paraproteinemia;MGUS;Monoclonal gammopathy of uncertain significance (disorder);Benign Monoclonal Gammopathy	monoclonal gammopathy|hematologic disease|disease|disposition|material property|experimental factor; monoclonal gammopathy|hematologic disease|material entity|experimental factor
HP:0000175	Cleft palate	Cleft palate is a developmental defect of the palate resulting from a failure of fusion of the palatine processes and manifesting as a separation of the roof of the mouth (soft and hard palate).	Cleft roof of mouth;Palatoschisis;Cleft of palate;Cleft palate;Cleft of hard and soft palate;Uranostaphyloschisis;Cleft hard and soft palate	Cleft palate|Oral cleft|Abnormality of the mouth|Abnormality of the face|Abnormality of the head|Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0006812	autoimmune thyroid disease	Inflammatory disease of the thyroid gland due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-cells and thyroid autoantibodies. The clinical signs can range from hypothyroidism to thyrotoxicosis depending on the type of autoimmune thyroiditis.	Thyroiditides, Autoimmune;Autoimmune Thyroiditis;autoimmune thyroiditis;autoimmune thyroid gland inflammation;autoimmune thyroid disease;Autoimmune Thyroiditides	autoimmune thyroid disease|thyroiditis|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor; autoimmune thyroid disease|thyroiditis|inflammatory disease|disease|disposition|material property|experimental factor; autoimmune thyroid disease|autoimmune disorder of endocrine system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; autoimmune thyroid disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; autoimmune thyroid disease|autoimmune disorder of endocrine system|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0800902	X-24699 measurement	NA		X-24699 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009509	limb injury	NA		limb injury|injury|disease|disposition|material property|experimental factor
EFO:0003030	abscess	An inflammatory process characterized by the accumulation of pus within a newly formed tissue cavity which is the result of a bacterial, fungal, or parasitic infection or the presence of a foreign body.	abscess (disease);abscess (disorder);abscess NOS;abscess NOS (disorder);abscess morphology;abscess	abscess|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0004327	electrocardiography	NA	EKG;electrocardiogram	electrocardiography|heart function measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
EFO:0021119	dehydroisoandrosterone sulfate DHEA-S measurement	NA		dehydroisoandrosterone sulfate DHEA-S measurement|metabolite measurement|measurement|information entity|experimental factor
MONDO:0013005	EAST syndrome	SeSAME syndrome is characterized by seizures, sensorineural deafness, ataxia, intellectual deficit, and electrolyte imbalance (hypokalemia, metabolic alkalosis, and hypomagnesemia).	sesame syndrome;EAST syndrome;seizures, sensorineural deafness, ataxia, intellectual disability and electrolyte imbalance;seizures-sensorineural deafness-ataxia-intellectual disability-electrolyte imbalance syndrome;seizures, sensorineural deafness, ataxia, mental retardation and electrolyte imbalance;epilepsy, ataxia, sensorineural deafness and tubulopathy	EAST syndrome|syndromic intellectual disability|syndromic disease|disease|disposition|material property|experimental factor; EAST syndrome|hereditary ataxia|inherited neurodegenerative disorder|genetic disorder|material entity|experimental factor; EAST syndrome|inherited renal tubular disease|renal tubule disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; EAST syndrome|hereditary ataxia|atactic disorder|nervous system disease|disease|disposition|material property|experimental factor; EAST syndrome|syndromic intellectual disability|syndromic disease|material entity|experimental factor; EAST syndrome|hereditary ataxia|inherited neurodegenerative disorder|genetic disorder|disease|disposition|material property|experimental factor; EAST syndrome|hereditary ataxia|inherited neurodegenerative disorder|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; EAST syndrome|inherited renal tubular disease|genetic disorder|disease|disposition|material property|experimental factor; EAST syndrome|syndromic intellectual disability|developmental disorder of mental health|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; EAST syndrome|inherited renal tubular disease|genetic disorder|material entity|experimental factor; EAST syndrome|syndromic intellectual disability|developmental disorder of mental health|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor
HP:0002902	Hyponatremia	An abnormally decreased sodium concentration in the blood.	Low blood sodium levels	Hyponatremia|Abnormal blood sodium concentration|Abnormal blood ion concentration|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009531	aortic valve disease	A disease involving the aortic valve.	disease of aortic valve;aortic valve disorder;disorder of aortic valve;aortic valve disease or disorder;disease or disorder of aortic valve;aortic valve disease	aortic valve disease|aortic disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve disease|heart valve disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve disease|cardiac ventricle disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
HP:0001310	Dysmetria	A type of ataxia characterized by the inability to carry out movements with the correct range and motion across the plane of more than one joint related to incorrect estimation of the distances required for targeted movements.	Lack of coordination of movement	Dysmetria|Ataxia|Abnormal central motor function|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Dysmetria|Abnormality of brain morphology|Morphological central nervous system abnormality|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001938	B-cell non-Hodgkins lymphoma	The most common type of non-Hodgkin lymphoma. It includes the most frequently seen morphologic variants which are: diffuse large B-cell lymphoma, follicular lymphoma, small lymphocytic lymphoma and marginal zone B-cell lymphoma. -- 2003	B-cell non-Hodgkin lymphoma;lymphomas non-Hodgkin's B-cell;B-cell NHL;B-cell non Hodgkin's lymphoma;B-cell lymphoma;B-cell non-Hodgkin's lymphoma;non-Hodgkin's B-cell lymphoma;non-Hodgkin's lymphoma B-cell	B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; B-cell non-Hodgkins lymphoma|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|immune system disease|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; B-cell non-Hodgkins lymphoma|B-cell neoplasm|leukocyte disorder|hematologic disease|material entity|experimental factor; B-cell non-Hodgkins lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0060766	anal polyp	A non-neoplastic or neoplastic polypoid lesion that arises from the anus. Representative examples include the fibroepithelial polyp and squamous papilloma.	polyp of anus;polyp of the anus;anal polyp	anal polyp|gastrointestinal polyp|polyp|cancer or benign tumor|disease|disposition|material property|experimental factor; anal polyp|anus disease|rectal disease|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; anal polyp|polyp of rectum|polyp of large intestine|polyp|cancer or benign tumor|disease|disposition|material property|experimental factor; anal polyp|polyp of rectum|polyp of large intestine|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; anal polyp|gastrointestinal polyp|digestive system disease|disease|disposition|material property|experimental factor; anal polyp|polyp of rectum|rectal disease|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0009130	clostridium difficile infection	NA	clostridium difficile disease;CDI	clostridium difficile infection|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0009846	muscle cramp	NA	Cramp;Cramp(s);Muscle Cramping;Spasm	muscle cramp|sign or symptom|phenotype|quality|material property|experimental factor
HP:0009926	Epiphora	Abnormally increased lacrimation, that is, excessive tearing (watering eye).	Watery eyes;Increased tears;Increased lacrimation;Tearing	Epiphora|Lacrimation abnormality|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0006885	leukoplakia of tongue	NA	tongue leukoplakia	leukoplakia of tongue|Oral leukoplakia|Abnormality of the mouth|Abnormality of the face|Abnormality of the head|Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0004247	peptic ulcer disease	A mucosal erosion that occurs in the esophagus, stomach or duodenum. Symptoms can include abdominal pain, nausea and vomiting, and bleeding.	acute peptic ulcer without hemorrhage and without perforation;acute peptic ulcer with hemorrhage;peptic ulcer;acute peptic ulcer with hemorrhage and perforation	peptic ulcer disease|digestive system disease|disease|disposition|material property|experimental factor; peptic ulcer disease|ulcer disease|injury|disease|disposition|material property|experimental factor
HP:0000408	Progressive sensorineural hearing impairment	A progressive form of sensorineural hearing impairment.	Sensorineural hearing loss, progressive;Hearing loss, sensorineural, bilateral, progressive;Bilateral progressive sensorineural hearing loss;Hearing loss, sensorineural, progressive;Hearing loss, progressive sensorineural;Progressive bilateral sensorineural hearing loss	Progressive sensorineural hearing impairment|Sensorineural hearing impairment|Hearing abnormality|Abnormality of the ear|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Progressive sensorineural hearing impairment|Progressive hearing impairment|Hearing abnormality|Abnormality of the ear|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0800646	thymine measurement	NA		thymine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1001864	uterine prolapse	NA		uterine prolapse|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; uterine prolapse|pelvic organ prolapse|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0009452	hyperaldosteronism	Overproduction of aldosterone by the adrenal glands, which may lead to hypokalemia and/or hypernatremia.	hyperaldosteronism	hyperaldosteronism|adrenal gland hyperfunction|adrenal cortex disorder|adrenal gland disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:1000298	Hydatidiform Mole	A gestational trophoblastic disorder characterized by marked enlargement of the chorionic villi, hyperplasia of the villous trophoblastic cells and hydropic changes.	hydatidiform mole;hydatid mole;molar pregnancy	Hydatidiform Mole|placenta neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Hydatidiform Mole|placenta neoplasm|placenta disease|pregnancy disorder|obstetric disorder|disease|disposition|material property|experimental factor; Hydatidiform Mole|placenta neoplasm|placenta disease|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; Hydatidiform Mole|genetic disorder|material entity|experimental factor; Hydatidiform Mole|placenta neoplasm|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; Hydatidiform Mole|placenta neoplasm|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; Hydatidiform Mole|genetic disorder|disease|disposition|material property|experimental factor; Hydatidiform Mole|trophoblastic neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Hydatidiform Mole|placenta neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0005701	malignant rhabdoid tumour	An aggressive malignant embryonal neoplasm usually occurring during childhood. It is characterized by the presence of large cells with abundant cytoplasm, large eccentric nucleus, and a prominent nucleolus and it is associated with abnormalities of chromosome 22. It can arise from the central nervous system, kidney, and the soft tissues. The prognosis is poor.	rhabdoid tumor;malignant rhabdoid tumour;rhabdoid sarcoma;malignant rhabdoid tumor	malignant rhabdoid tumour|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; malignant rhabdoid tumour|embryonal neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant rhabdoid tumour|soft tissue sarcoma|material entity|experimental factor; malignant rhabdoid tumour|soft tissue sarcoma|sarcoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant rhabdoid tumour|soft tissue sarcoma|malignant soft tissue neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; malignant rhabdoid tumour|soft tissue sarcoma|malignant soft tissue neoplasm|Soft Tissue Neoplasm|connective and soft tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:1000860	cerebral atherosclerosis	Atherosclerosis of the cerebral vasculature.	Cerebral atherosclerosis;cerebral atherosclerosis;Intracranial Arteriosclerosis;Cerebral atherosclerosis (disorder)	cerebral atherosclerosis|atherosclerosis|arteriosclerosis disorder|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; cerebral atherosclerosis|atherosclerosis|arteriosclerosis|arterial occlusive disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:1000663	acquired keratosis	Focal or diffuse thickening of the skin not inherited as a primary genetic disorder. Causes include inflammatory skin disorders, infectious disorders, lymphedema, and medications.	keratoderma, acquired;keratoderma - acquired;acquired keratosis;acquired keratoderma	acquired keratosis|keratosis|keratinization disease|integumentary system disease|disease|disposition|material property|experimental factor; acquired keratosis|keratosis|keratinization disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; acquired keratosis|material entity|experimental factor; acquired keratosis|keratosis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
MONDO:0018916	isolated anorectal malformation	Anorectal malformations (ARM) comprise a wide spectrum of malformations involving the distal anus and rectum as well as the urinary and genital tracts, which can affect boys and girls.	nonsyndromic anorectal malformation	isolated anorectal malformation|anorectal malformation|digestive tract malformation|material entity|experimental factor; isolated anorectal malformation|anorectal malformation|digestive tract malformation|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor
EFO:0800139	5-hydroxyindoleacetate measurement	NA		5-hydroxyindoleacetate measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:15347	acetone	NA	ACETONE;acetone;Acetone;propan-2-one	acetone|lipid|chemical entity|material entity|experimental factor
EFO:0009792	valine measurement	NA		valine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:1001345	Hepatitis, Alcoholic	Acute hepatitis resulting from ingestion of alcohol.	alcoholic Hepatitis;alcoholic hepatitis;acute alcoholic hepatitis;acute alcoholic liver disease;acute alcoholic Hepatitis	Hepatitis, Alcoholic|alcoholic liver disease|alcohol-induced disorders|alcohol-related disorders|substance-related disorder|psychiatric disorder|disease|disposition|material property|experimental factor; Hepatitis, Alcoholic|inflammatory disease|disease|disposition|material property|experimental factor; Hepatitis, Alcoholic|alcoholic liver disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; Hepatitis, Alcoholic|alcoholic liver disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:1001047	mouth disease	A disease involving the mouth.	oral cavity disorder;oral disorder;disease or disorder of mouth;oral cavity disease;mouth disease or disorder;mouth disease;mouth disorder;disease of the mouth;disorder of mouth;oral disease;disease of mouth	mouth disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:1000941	frozen shoulder	A painful inflammatory process leads to a mechanical block in active and passive range of motion (ROM) of the shoulder. Adhesive capsulitis of the shoulder is characterized by functional loss of passive and active shoulder motion. This inflammatory process results in fibroblastic proliferation and extensive scar tissue formation. Fibroblastic proliferation, a late phase of the inflammatory process involved in tissue repair, leads to thickening, fibrosis, and adhesion of the capsule to itself and the humerus.	adhesive capsulitis of shoulder;adhesions-capsulitis,shoulder;adhesive capsulitis;Adhesive capsulitis of shoulder;frozen shoulder;Bursitis	frozen shoulder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; frozen shoulder|connective tissue disease|disease|disposition|material property|experimental factor
EFO:0007429	peritonsillar abscess	An abscess that develops in the space surrounding one or both palatine tonsils.	Peritonsillar abscess;peritonsillar abscess;quinsy;Peritonsillar Abscess;Peritonsillar abscess (disorder);Quinsy	peritonsillar abscess|abscess|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; peritonsillar abscess|disorder of pharynx|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; peritonsillar abscess|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; peritonsillar abscess|disorder of pharynx|respiratory system disease|disease|disposition|material property|experimental factor; peritonsillar abscess|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor
HP:0012388	Acute bronchitis	Inflammation of the large airways of the lung with rapid onset and short course usually associated with cough, mucus production, shortness of breath, wheezing, and chest tightness.		Acute bronchitis|Abnormal lung morphology|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0001361	pulmonary arterial hypertension	Pulmonary arterial hypertension (PAH) is a group of diseases characterized by elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, or induced by drug or toxin (drug-or toxin-induced PAH) or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease).	PHT - Pulmonary hypertension;Ayerza Syndrome;HYPERTENSION PULM;Syndrome, Ayerza;pulmonary hypertension, primary, 1;Syndrome, Ayerza-Arrilaga;pulmonary arterial hypertension;Ayerza-Arrilaga Syndrome;pulmonary hypertension (disorder);PAH;Ayerza Arrilaga Syndrome;Ayerzas Syndrome;PULM HYPERTENSION;pulmonary hypertension;Hypertension, Pulmonary;Pulmonary hypertension, NOS;PPH1;Ayerza's Syndrome	pulmonary arterial hypertension|material entity|experimental factor; pulmonary arterial hypertension|pulmonary hypertension|hypertension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; pulmonary arterial hypertension|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0003901	dysuria	NA		dysuria|sign or symptom|phenotype|quality|material property|experimental factor
CHEBI:24462	gulonic acid	NA		gulonic acid|carbohydrate|chemical entity|material entity|experimental factor
EFO:0003802	refractory anemia	A myelodysplastic syndrome characterized mainly by dysplasia of the erythroid series. Refractory anemia is uncommon. It is primarily a disease of older adults. The median survival exceeds 5 years. (WHO, 2001)	MDS-SLD;refractory anemia;MDS with single lineage dysplasia;myelodysplastic syndrome with single lineage dysplasia;aregenerative anemia;RA	refractory anemia|myelodysplastic syndrome|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; refractory anemia|myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; refractory anemia|myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; refractory anemia|myelodysplastic syndrome|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; refractory anemia|myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; refractory anemia|myelodysplastic syndrome|neoplastic syndrome|syndromic disease|disease|disposition|material property|experimental factor; refractory anemia|myelodysplastic syndrome|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; refractory anemia|myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; refractory anemia|myelodysplastic syndrome|neoplastic syndrome|syndromic disease|material entity|experimental factor; refractory anemia|myelodysplastic syndrome|neoplastic syndrome|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; refractory anemia|myelodysplastic syndrome|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor
EFO:0007543	vulvovaginal candidiasis	Infection of the vulva and vagina with a fungus of the genus CANDIDA. It is a disease associated with HIV infection.	vulvovaginal candidiasis;monilial vulvovaginitis;Candidiasis, Vulvovaginal;Candidal vulvovaginitis NOS (disorder);Candidiasis of vulva and vagina;Candidal vulvovaginitis (disorder);vaginal candidiasis;Monilial vulvovaginitis;candidal: cervix;Vulvovaginal Candidiasis;candidal vulvovaginitis;candidiasis of vulva and vagina;Candidal: [vulvovaginitis NOS] or [cervix];Candidal vulvovaginitis;candidal: [vulvovaginitis NOS] or [cervix]	vulvovaginal candidiasis|cutaneous candidiasis|candidiasis|opportunistic mycosis|fungal infectious disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|cutaneous candidiasis|tinea|cutaneous mycosis|material entity|experimental factor; vulvovaginal candidiasis|infective vaginitis|vaginitis|vaginal disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|cutaneous candidiasis|candidiasis|opportunistic mycosis|material entity|experimental factor; vulvovaginal candidiasis|vulvovaginitis|vulvitis|vulvar disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|vulvovaginitis|vulvitis|inflammatory disease|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|cutaneous candidiasis|tinea|skin infection|skin disorder caused by infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|cutaneous candidiasis|tinea|skin infection|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|cutaneous candidiasis|tinea|skin infection|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|cutaneous candidiasis|tinea|cutaneous mycosis|fungal infectious disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|cutaneous candidiasis|tinea|skin infection|skin disorder caused by infection|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|vulvovaginitis|vaginitis|inflammatory disease|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|infective vaginitis|vaginitis|inflammatory disease|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|vulvovaginitis|vaginitis|vaginal disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; vulvovaginal candidiasis|infective vaginitis|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
MONDO:0020292	congenital anomaly of the great arteries	NA	congenital aorta, aortic arch or pulmonary arteries anomaly	congenital anomaly of the great arteries|genetic vascular anomaly|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; congenital anomaly of the great arteries|genetic vascular anomaly|genetic disorder|disease|disposition|material property|experimental factor; congenital anomaly of the great arteries|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|cardiovascular disease|disease|disposition|material property|experimental factor; congenital anomaly of the great arteries|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; congenital anomaly of the great arteries|genetic vascular anomaly|genetic disorder|material entity|experimental factor; congenital anomaly of the great arteries|congenital heart malformation|genetic disorder|disease|disposition|material property|experimental factor; congenital anomaly of the great arteries|congenital heart malformation|genetic disorder|material entity|experimental factor; congenital anomaly of the great arteries|congenital heart malformation|congenital heart disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; congenital anomaly of the great arteries|genetic vascular anomaly|vascular anomaly|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
MONDO:0002009	major depressive disorder	An episode of depression lasting two or more weeks without an intervening episode of mania.	major depressive disorder and accelerated response to antidepressant drug treatment;recurrent major depression;unipolar depression;single major depressive episode;MDD;major depression;unipolar depression, susceptibility to;seasonal affective disorder, susceptibility to;major depressive disorder;major depressive disorder, response to citalopram therapy in	major depressive disorder|depressive disorder|mood disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; major depressive disorder|depressive disorder|mood disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0001070	folate deficiency	NA	Deficiency of folic acid;Hypovitaminosis, Avitaminosis,Vitamin deficiency (disorder);Acid Deficiency, Folic;Deficiency, Folic Acid;Acid Deficiencies, Folic;Folic Acid Deficiencies;Deficiencies, Folic Acid;Folic acid deficiency;FOLIC ACID DEFIC;Folic acid deficiency (disorder);DEFIC FOLIC ACID;deficiency of folic acid (disorder)	folate deficiency|vitamin deficiency|Abnormality of vitamin metabolism|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0000545	Myopia	An abnormality of refraction characterized by the ability to see objects nearby clearly, while objects in the distance appear blurry.	Near sighted;Close sighted;Nearsightedness;Near sightedness	Myopia|Abnormality of refraction|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007254	enterobiasis	An infection that is caused by the nematode Enterobius vermicularis; it is characterized predominantly by perianal pruritus.	Oxyuris vermicularis infection;Enterobius vermicularis disease or disorder;threadworm infection;enterobiasis;Oxyuriasis;Enterobius vermicularis caused disease or disorder;Oxyuris vermicularis infection (disorder);Enterobius vermicularis infectious disease;Threadworm infection	enterobiasis|Rhabditida infectious disease|Nematoda infectious disease|Helminthiasis|parasitic infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0009613	fibula fracture	NA		fibula fracture|lower extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor; fibula fracture|lower extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0005576	pernicious anemia	Megaloblastic anemia caused by vitamin B-12 deficiency due to impaired absorption. The impaired absorption of vitamin B-12 is secondary to atrophic gastritis and loss of gastric parietal cells.	Addison's anaemia;pernicious anemia;Biermer disease;Addison-Biermer anemia;anemia pernicious;acquired pernicious anemia;Biermer's anemia;juvenile onset pernicious anemia;Addison anaemia;intrinsic factor deficiency;Biermer anemia	pernicious anemia|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; pernicious anemia|blood disease|hematologic disease|disease|disposition|material property|experimental factor; pernicious anemia|megaloblastic anemia|macrocytic anemia|anemia|hematologic disease|material entity|experimental factor; pernicious anemia|megaloblastic anemia|macrocytic anemia|anemia|hematologic disease|disease|disposition|material property|experimental factor; pernicious anemia|nutritional deficiency disease|nutritional disorder|metabolic disease|disease|disposition|material property|experimental factor; pernicious anemia|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; pernicious anemia|blood disease|hematologic disease|material entity|experimental factor; pernicious anemia|inborn errors of metabolism|genetic disorder|material entity|experimental factor
EFO:0005761	lupus nephritis	Glomerulonephritis in the context of systemic lupus erythematosus.	lupus nephritis;lupus glomerulonephritis;SLE nephritis	lupus nephritis|glomerulonephritis|nephritis|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; lupus nephritis|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; lupus nephritis|glomerulonephritis|glomerular disease|material entity|experimental factor; lupus nephritis|glomerulonephritis|glomerular disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; lupus nephritis|glomerulonephritis|nephritis|inflammatory disease|disease|disposition|material property|experimental factor
HP:0025116	Fetal distress	NA	Foetal distress	Fetal distress|Abnormality of prenatal development or birth|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0021618	L-Histidine measurement	NA		L-Histidine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009451	hypoparathyroidism	Hypoparathyroidism is is an endocrine disorder in which the parathyroid glands in the neck do not produce enough parathyroid hormone (PTH). Common signs and symptoms includeabdominal pain, brittle nails, cataracts, dry hair and skin,muscle cramps,tetany, pain in the face, legs, and feet, seizures, tingling sensation,and weakened tooth enamel (in children). It may be caused byinjury to the parathyroid glands (e.g., during surgery). Other causes, include low blood magnesium levels, a side effect of radioactive iodine treatment for hyperthyroidism, metabolic alkalosis, DiGeorge syndrome, and type I polyglandular autoimmune syndrome. The goal of treatment is to restore the calcium and mineral balance in the body.	hypoparathyroidism	hypoparathyroidism|parathyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0004619	factor VII measurement	NA		factor VII measurement|protein measurement|measurement|information entity|experimental factor; factor VII measurement|coagulation factor measurement|measurement|information entity|experimental factor
MONDO:0019139	acquired hemophilia	Acquired hemophilia is a bleeding disorder that interferes with the body's blood clotting process. Signs and symptoms include prolonged bleeding, frequent nosebleeds, bruising throughout the body, solid swellings of congealed blood (hematomas), hematuria, and gastrointestinal or urologic bleeding. Acquired hemophilia occurs when the body's immune system attacks and disables a certain protein that helps the blood clot. About half of the cases are associated with other conditions, such as pregnancy, autoimmune disease, cancer, skin diseases, or allergic reactions to medications.	acquired haemophilia;hemophilia, acquired;acquired hemophilia	acquired hemophilia|hemophilia|coagulation protein disease|blood coagulation disease|hematologic disease|disease|disposition|material property|experimental factor; acquired hemophilia|hemophilia|coagulation protein disease|blood coagulation disease|hematologic disease|material entity|experimental factor; acquired hemophilia|acquired coagulation factor deficiency|coagulation protein disease|blood coagulation disease|hematologic disease|material entity|experimental factor; acquired hemophilia|acquired coagulation factor deficiency|coagulation protein disease|blood coagulation disease|hematologic disease|disease|disposition|material property|experimental factor; acquired hemophilia|hemorrhagic disease|hematologic disease|material entity|experimental factor; acquired hemophilia|hemorrhagic disease|hematologic disease|disease|disposition|material property|experimental factor
EFO:0004242	obsessive-compulsive disorder	A disorder characterized by the presence of persistent and recurrent irrational thoughts (obsessions), resulting in marked anxiety and repetitive excessive behaviors (compulsions) as a way to try to decrease that anxiety.	obsessive compulsive disorder;Anancastic neurosis;obsessive-compulsive disorder;obsessive-compulsive disorder, susceptibility to;OCD	obsessive-compulsive disorder|genetic disorder|material entity|experimental factor; obsessive-compulsive disorder|genetic disorder|disease|disposition|material property|experimental factor; obsessive-compulsive disorder|anxiety disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; obsessive-compulsive disorder|anxiety disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0001672	bronchus cancer	A malignant neoplasm involving the bronchus	cancer of bronchus;bronchus cancer;malignant bronchus neoplasm;malignant neoplasm of bronchus	bronchus cancer|respiratory system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bronchus cancer|bronchial neoplasm|respiratory system neoplasm|respiratory system disease|disease|disposition|material property|experimental factor; bronchus cancer|bronchial neoplasm|respiratory system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; bronchus cancer|respiratory system cancer|respiratory system disease|disease|disposition|material property|experimental factor; bronchus cancer|bronchial neoplasm|bronchial disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
HP:0200026	Ocular pain	NA	Eye pain	Ocular pain|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Ocular pain|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0004126	thyroiditis	Inflammation of the thyroid gland. This category includes Hashimoto thyroiditis, Riedel thyroiditis, acute thyroiditis, subacute thyroiditis, and radiation-induced thyroiditis.	thyroid gland inflammation;thyroiditis (disease);thyroiditis;inflammation of thyroid gland	thyroiditis|inflammatory disease|disease|disposition|material property|experimental factor; thyroiditis|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0004283	goiter	Enlargement of the thyroid gland usually caused by lack of iodine in the diet, hyperthyroidism, or thyroid nodules. Symptoms include difficulty in breathing and swallowing.	goitre;Thyromegaly;goiter;goiter (disease)	goiter|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
MONDO:0001282	fallopian tube endometriosis	Endometriosis that affects the fallopian tube. Symptoms include infertility, pelvic pain, painful menstruation, and painful intercourse.	endometriosis of fallopian tube;fallopian tube endometriosis;fallopian tube endometriosis (disease);endometriosis (disease) of fallopian tube	fallopian tube endometriosis|endometriosis|endometrial disorder|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; fallopian tube endometriosis|fallopian tube disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
HP:0000483	Astigmatism	A type of astigmatism associated with abnormal curvatures on the anterior and/or posterior surface of the cornea.	Abnormal curving of the cornea or lens of the eye;Astigmatism	Astigmatism|Abnormality of refraction|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Astigmatism|Abnormal cornea morphology|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000348	clear cell adenocarcinoma	A malignant neoplasm composed of glandular epithelial clear cells. Various architectural patterns may be seen, including papillary, tubulocystic, and solid.	Wolffian duct neoplasm;mesonephroid clear cell carcinoma;malignant Mesonephroma;Mesonephroid clear cell carcinoma;water-clear cell carcinoma;mesonephroid clear cell adenocarcinoma;water-clear cell adenocarcinoma (morphologic abnormality);clear cell adenocarcinoma;mesonephroma NOS (morphologic abnormality);Mesonephroma, malignant (morphologic abnormality);Mesonephroid clear cell adenocarcinoma;water-clear cell adenocarcinoma;clear cell carcinoma;mesonephroma, malignant (morphologic abnormality);mesonephroma, malignant;Mesonephroma NOS (morphologic abnormality);clear cell adenocarcinoma NOS (morphologic abnormality);clear cell adenocarcinoma (morphologic abnormality);adenocarcinoma, clear cell, malignant;Mesonephroma, malignant	clear cell adenocarcinoma|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; clear cell adenocarcinoma|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; clear cell adenocarcinoma|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
HP:0000020	Urinary incontinence	Loss of the ability to control the urinary bladder leading to involuntary urination.	Bladder incontinence;Loss of bladder control	Urinary incontinence|Constitutional symptom|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Urinary incontinence|Abnormality of the bladder|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
Orphanet:285014	Rare disease with thoracic aortic aneurysm and aortic dissection	NA		
MONDO:0007947	Marfan syndrome	A disorder of the connective tissue. Connective tissue provides strength and flexibility to structures throughout the body such as bones, ligaments, muscles, walls of blood vessels, and heart valves. Marfan syndrome affects most organs and tissues, especially the skeleton, lungs, eyes, heart, and the large blood vessel that distributes blood from the heart to the rest of the body (the aorta). It is caused by mutations in the FBN1 gene, which provides instructions for making a protein called fibrillin-1. Marfan syndrome is inherited in an autosomal dominant pattern. At least 25% of cases are due to a new (de novo) mutation. Treatment is based on the signs and symptoms in each person.	Marfan syndrome;MFS;Marfan's syndrome;MFS1;Marfan syndrome type 1;Marfan syndrome, type 1	Marfan syndrome|overgrowth or tall stature syndrome with skeletal involvement|skeletal dysplasia|genetic disorder|disease|disposition|material property|experimental factor; Marfan syndrome|autosomal dominant disease|autosomal genetic disease|genetic disorder|disease|disposition|material property|experimental factor; Marfan syndrome|syndromic disease|disease|disposition|material property|experimental factor; Marfan syndrome|overgrowth or tall stature syndrome with skeletal involvement|skeletal dysplasia|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; Marfan syndrome|Marfan and Marfan-related disorder|hereditary disorder of connective tissue|connective tissue disease|disease|disposition|material property|experimental factor; Marfan syndrome|Marfan and Marfan-related disorder|hereditary disorder of connective tissue|genetic disorder|material entity|experimental factor; Marfan syndrome|overgrowth or tall stature syndrome with skeletal involvement|skeletal dysplasia|genetic disorder|material entity|experimental factor; Marfan syndrome|autosomal dominant disease|autosomal genetic disease|genetic disorder|material entity|experimental factor; Marfan syndrome|Marfan and Marfan-related disorder|hereditary disorder of connective tissue|genetic disorder|disease|disposition|material property|experimental factor; Marfan syndrome|syndromic disease|material entity|experimental factor
EFO:0005037	aortic root size	NA		aortic root size|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor; aortic root size|aortic measurement|cardiovascular measurement|measurement|information entity|experimental factor
EFO:0009678	paralytic strabismus	NA	paralytic squint;paralytic strabismus;incomitant dissociation	paralytic strabismus|ocular motility disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; paralytic strabismus|ocular motility disease|cranial nerve neuropathy|nervous system disease|disease|disposition|material property|experimental factor; paralytic strabismus|ocular motility disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0010111	acetoacetate measurement	NA		acetoacetate measurement|ketone body measurement|measurement|information entity|experimental factor; acetoacetate measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0009608	stomach disease	A disease involving the stomach.	stomach disease or disorder;disease or disorder of stomach;stomach disease;stomach disorder;gastropathy;disease of stomach;disorder of stomach	stomach disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0009851	muscle atrophy	NA	muscle wasting	muscle atrophy|Atrophy|biological process|process|experimental factor
EFO:0004623	fibrinogen measurement	NA	fibrinogen levels	fibrinogen measurement|coagulation factor measurement|measurement|information entity|experimental factor; fibrinogen measurement|protein measurement|measurement|information entity|experimental factor; fibrinogen measurement|hematological measurement|measurement|information entity|experimental factor
MONDO:0016419	hereditary breast carcinoma	Breast carcinoma that has developed in relatives of patients with history of breast carcinoma.	breast cancer, susceptibility to, autosomal dominant, somatic mutation;familial cancer of the breast;breast cancer, early-onset, susceptibility to, autosomal dominant, somatic mutation;breast cancer, protection against, autosomal dominant, somatic mutation;hereditary breast cancer;breast cancer, lobular, somatic;breast cancer, invasive ductal, autosomal dominant, somatic mutation;breast cancer, somatic;familial breast cancer;familial breast carcinoma;hereditary breast carcinoma;familial cancer of breast;breast cancer, male, susceptibility to, autosomal dominant, somatic mutation;breast cancer susceptibility, autosomal dominant, somatic mutation	hereditary breast carcinoma|breast carcinoma|breast cancer|breast neoplasm|breast disease|disease|disposition|material property|experimental factor; hereditary breast carcinoma|breast carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hereditary breast carcinoma|breast carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hereditary breast carcinoma|breast carcinoma|breast cancer|thoracic cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hereditary breast carcinoma|breast carcinoma|breast cancer|breast neoplasm|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; hereditary breast carcinoma|genetic disorder|disease|disposition|material property|experimental factor; hereditary breast carcinoma|genetic disorder|material entity|experimental factor; hereditary breast carcinoma|breast carcinoma|breast cancer|breast neoplasm|integumentary system disease|disease|disposition|material property|experimental factor; hereditary breast carcinoma|breast carcinoma|breast cancer|thoracic cancer|neoplasm of thorax|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0000959	malignant hypertensive renal disease	NA		malignant hypertensive renal disease|genetic hypertension|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; malignant hypertensive renal disease|hypertensive nephropathy|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; malignant hypertensive renal disease|hypertensive nephropathy|genetic disorder|material entity|experimental factor; malignant hypertensive renal disease|genetic hypertension|hypertension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; malignant hypertensive renal disease|hypertensive nephropathy|genetic disorder|disease|disposition|material property|experimental factor; malignant hypertensive renal disease|genetic hypertension|genetic disorder|material entity|experimental factor; malignant hypertensive renal disease|genetic hypertension|genetic disorder|disease|disposition|material property|experimental factor; malignant hypertensive renal disease|malignant hypertension|hypertension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0003884	chronic kidney disease	Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.	CKD;chronic kidney failure;ESRD;renal failure - chronic;Disease, End-Stage Kidney;chronic renal disease;RENAL DIS END STAGE;Renal Failure, End Stage;Kidney Failure, Chronic;kidney disease, chronic;End-Stage Renal Failure;Kidney Insufficiencies, Chronic;chronic renal insufficiency;End Stage Renal Disease;Chronic Renal Failure;Chronic Renal Insufficiencies;Renal Insufficiencies, Chronic;chronic kidney disease;Renal Disease, End Stage;Renal Insufficiency, Chronic;Chronic Kidney Insufficiency;Renal Disease, End-Stage;End-Stage Renal Disease;Kidney Disease, End-Stage;Chronic Kidney Insufficiencies;END STAGE RENAL DIS;CKD - chronic kidney disease;Kidney Insufficiency, Chronic;End-Stage Kidney Disease;End Stage Kidney Disease;Renal Failure, End-Stage;Disease, End-Stage Renal;END STAGE KIDNEY DIS;Renal Failure, Chronic	chronic kidney disease|chronic disease|disease|disposition|material property|experimental factor; chronic kidney disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
HP:0000238	Hydrocephalus	Hydrocephalus is an active distension of the ventricular system of the brain resulting from inadequate passage of CSF from its point of production within the cerebral ventricles to its point of absorption into the systemic circulation.	Too much cerebrospinal fluid in the brain;Nonsyndromal hydrocephalus;Hydrocephaly	Hydrocephalus|Abnormality of brain morphology|Morphological central nervous system abnormality|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Hydrocephalus|Abnormality of the cerebrospinal fluid|Morphological central nervous system abnormality|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0005117	Elevated diastolic blood pressure	Abnormal increase in diastolic blood pressure.	Elevated diastolic BP	Elevated diastolic blood pressure|Increased blood pressure|Abnormal systemic blood pressure|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0002108	Spontaneous pneumothorax	Pneumothorax occurring without traumatic injury to the chest or lung.	Spontaneous collapsed lung	Spontaneous pneumothorax|Pneumothorax|Abnormal lung morphology|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0008259	familial spontaneous pneumothorax	Familial spontaneous pneumothorax is a rare, genetic pulmonary disease characterized by the uni- or bilateral accumulation of air in the pleural cavity in persons with a positive family history and no underlying lung disease or previous chest trauma. Patients typically present dyspnea associated with acute onset of sharp and steady pleutiric chest pain of variable severity (which resolves within 24h even though pneumothorax is still present). Reflex tachycardia and/or respiratory or circulatory compromise may be observed. Other syndromes (e.g. Birt-Hogg-Dube, Marfan or Ehlers-Danlos syndromes) may be associated.		familial spontaneous pneumothorax|pneumothorax|pleural disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; familial spontaneous pneumothorax|material entity|experimental factor
EFO:0801337	60S ribosomal protein L30 measurement	NA		60S ribosomal protein L30 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004193	basal cell carcinoma	A carcinoma involving the basal cells.	malignant basal cell neoplasm;basal cell cancer;basal cell carcinoma;epithelioma, basal cell	basal cell carcinoma|keratinocyte carcinoma|non-melanoma skin carcinoma|skin carcinoma|epithelial skin neoplasm|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; basal cell carcinoma|keratinocyte carcinoma|non-melanoma skin carcinoma|skin carcinoma|epithelial skin neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; basal cell carcinoma|keratinocyte carcinoma|non-melanoma skin carcinoma|skin carcinoma|skin cancer|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; basal cell carcinoma|keratinocyte carcinoma|non-melanoma skin carcinoma|skin carcinoma|skin cancer|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; basal cell carcinoma|keratinocyte carcinoma|non-melanoma skin carcinoma|skin carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; basal cell carcinoma|keratinocyte carcinoma|non-melanoma skin carcinoma|skin carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; basal cell carcinoma|keratinocyte carcinoma|non-melanoma skin carcinoma|skin carcinoma|skin cancer|integumentary system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; basal cell carcinoma|basal cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; basal cell carcinoma|keratinocyte carcinoma|non-melanoma skin carcinoma|skin carcinoma|skin cancer|integumentary system cancer|integumentary system disease|disease|disposition|material property|experimental factor; basal cell carcinoma|keratinocyte carcinoma|non-melanoma skin carcinoma|skin carcinoma|epithelial skin neoplasm|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
HP:0025246	Trichilemmal cyst	NA	Pilar cyst	Trichilemmal cyst|Abnormality of skin morphology|Abnormality of the skin|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0017778	lamellar ichthyosis	A keratinization disorder characterized by the presence of large scales all over the body without significant erythroderma.	classic lamellar ichthyosis;LI;congenital lamellar ichthyosis	lamellar ichthyosis|secondary ectropion|eyelids malposition disorder|eyelid disease|eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; lamellar ichthyosis|secondary ectropion|eyelids malposition disorder|eyelid disease|eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; lamellar ichthyosis|inherited non-syndromic ichthyosis|inherited ichthyosis|genetic disorder|material entity|experimental factor; lamellar ichthyosis|inherited non-syndromic ichthyosis|inherited ichthyosis|ichthyosis|epidermal disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; lamellar ichthyosis|inherited non-syndromic ichthyosis|inherited ichthyosis|ichthyosis|epidermal disease|material entity|experimental factor; lamellar ichthyosis|secondary ectropion|eyelids malposition disorder|material entity|experimental factor; lamellar ichthyosis|inherited non-syndromic ichthyosis|inherited ichthyosis|genetic disorder|disease|disposition|material property|experimental factor
EFO:0008487	lateral ventricle volume measurement	NA		lateral ventricle volume measurement|brain volume measurement|brain measurement|measurement|information entity|experimental factor; lateral ventricle volume measurement|brain volume measurement|nervous system measurement|measurement|information entity|experimental factor
HP:0030972	Abnormal systemic blood pressure	NA	Abnormal systemic BP	Abnormal systemic blood pressure|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0043579	enteritis	Inflammation of the small intestine.	small intestine inflammation;enteritis of small intestine;inflammation of small intestine;enteritis	enteritis|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; enteritis|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; enteritis|small intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0004244	interstitial lung disease	A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.	interstitial lung disease;lung disease, interstitial;lung diseases, interstitial;ILD	interstitial lung disease|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0007319	hyperprolactinemia	Abnormally high level of prolactin in the blood.	hyperprolactinemia;hyperprolactinemia (disease);Pregnancy-related A-G syndrome (disorder);Chiari-Frommel syndrome;Chiari-Frommel Syndrome;hyperprolactinaemia	hyperprolactinemia|metabolic disease|disease|disposition|material property|experimental factor; hyperprolactinemia|hyperpituitarism|anterior pituitary gland disorder|pituitary gland disease|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; hyperprolactinemia|blood disease|hematologic disease|material entity|experimental factor; hyperprolactinemia|hyperpituitarism|anterior pituitary gland disorder|pituitary gland disease|neuroendocrine disorder|nervous system disease|disease|disposition|material property|experimental factor; hyperprolactinemia|blood disease|hematologic disease|disease|disposition|material property|experimental factor; hyperprolactinemia|hyperpituitarism|anterior pituitary gland disorder|pituitary gland disease|neuroendocrine disorder|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0009576	multiple gestation	NA		multiple gestation|pregnancy|reproductive process|biological process|process|experimental factor
EFO:0006826	trans/trans-18:2 fatty acid measurement	NA		trans/trans-18:2 fatty acid measurement|trans fatty acid measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor; trans/trans-18:2 fatty acid measurement|trans fatty acid measurement|fatty acid measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:1000839	bladder calculus	A concretion in the urinary bladder.	bladder calculus;Urinary Bladder Calculi;bladder stones;vesical calculi;cystoliths;bladder stone	bladder calculus|lower urinary tract calculus|urolithiasis|urinary system disease|disease|disposition|material property|experimental factor; bladder calculus|bladder disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:0010115	glycerol measurement	NA		glycerol measurement|measurement|information entity|experimental factor
EFO:0004208	Vitiligo	Generalized well circumscribed patches of leukoderma that are generally distributed over symmetric body locations and is due to autoimmune destruction of melanocytes.	vitiligo	Vitiligo|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; Vitiligo|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; Vitiligo|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor; Vitiligo|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor
HP:0001123	Visual field defect	NA	Partial loss of field of vision;Visual field defects	Visual field defect|Visual impairment|Abnormality of vision|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0800654	glycine conjugate of C10H12O2 measurement	NA		glycine conjugate of C10H12O2 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0007934	creatinine clearance measurement	NA		creatinine clearance measurement|renal system measurement|measurement|information entity|experimental factor
EFO:1002034	secondary hypertension	High blood pressure caused by an underlying medical condition.	secondary hypertension	secondary hypertension|hypertension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0007442	placenta praevia	Abnormal placentation in which the placenta implants in the lower segment of the uterus (the zone of dilation) and may cover part or all of the opening of the cervix. It is often associated with serious antepartum bleeding and premature labor.	placenta praevia;Placenta Previa;placenta previa	placenta praevia|placenta disease|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; placenta praevia|placenta disease|pregnancy disorder|obstetric disorder|disease|disposition|material property|experimental factor
EFO:0009552	hemorrhoid	Dilated veins in the anal canal.	hemorrhoid;hemorrhoidal disease;Hemorrhoids	hemorrhoid|pelvic varices|varicose disease|vein disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0009562	polyneuropathy	A disease or disorder affecting more than one nerve.	polyneuropathy	polyneuropathy|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; polyneuropathy|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0020020	succinylcarnitine measurement	Quantification of succinylcarnitine levels in a sample.		succinylcarnitine measurement|carnitine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:1000354	Malignant Laryngeal Neoplasm	A primary or metastatic malignant neoplasm involving the larynx. The majority are carcinomas.	malignant neoplasm of larynx;malignant laryngeal neoplasm;malignant larynx tumor;malignant neoplasm of the larynx;malignant laryngeal tumor;malignant larynx neoplasm;larynx cancer;cancer of larynx;malignant tumor of larynx;malignant tumor of the larynx	Malignant Laryngeal Neoplasm|laryngeal neoplasm|respiratory system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Malignant Laryngeal Neoplasm|respiratory system cancer|respiratory system disease|disease|disposition|material property|experimental factor; Malignant Laryngeal Neoplasm|laryngeal neoplasm|respiratory system neoplasm|respiratory system disease|disease|disposition|material property|experimental factor; Malignant Laryngeal Neoplasm|laryngeal neoplasm|laryngeal disease|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; Malignant Laryngeal Neoplasm|respiratory system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0007453	postpartum depression	A type of clinical depression that occurs after childbirth.	Maternity blues (disorder);major depressive episode with peripartum onset;postpartum depression;maternity blues;Depression, Postpartum;postnatal depression;depressive episode with postpartum onset	postpartum depression|depressive disorder|mood disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; postpartum depression|puerperal disorder|obstetric disorder|disease|disposition|material property|experimental factor; postpartum depression|unipolar depression|mood disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; postpartum depression|depressive disorder|mood disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; postpartum depression|unipolar depression|mood disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
MONDO:0004863	purulent endophthalmitis	NA		purulent endophthalmitis|endophthalmitis|eye infectious disorder|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; purulent endophthalmitis|endophthalmitis|eye infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; purulent endophthalmitis|endophthalmitis|eye infectious disorder|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; purulent endophthalmitis|endophthalmitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0000544	infection	NA		infection|pathologic process|biological process|process|experimental factor
EFO:0004462	PR interval	NA	PQ interval	PR interval|electrocardiography|heart function measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
EFO:1000987	intestinal perforation	A rupture in the wall of the small or large intestine due to traumatic or pathologic processes.	intestinal perforation;Perforation of intestine;perforation of intestine;bowel perforation;Intestinal Perforation	intestinal perforation|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0010952	urinary potassium measurement	NA	urine potassium measurement	urinary potassium measurement|urinary metabolite measurement|metabolite measurement|measurement|information entity|experimental factor; urinary potassium measurement|potassium measurement|measurement|information entity|experimental factor
MONDO:0001829	lumbosacral plexus lesion	A nerve plexus disease that involves the lumbosacral nerve plexus.	lumbosacral plexus lesions;nerve plexus disease of lumbosacral nerve plexus;lumbosacral nerve plexus nerve plexus disease	lumbosacral plexus lesion|nerve plexus disease|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; lumbosacral plexus lesion|nerve plexus disease|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0800325	1-(1-enyl-stearoyl)-GPC (P-18:0) measurement	NA		1-(1-enyl-stearoyl)-GPC (P-18:0) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0003767	inflammatory bowel disease	A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.	inflammatory bowel disease;autoimmune bowel disorder;INFLAMM BOWEL DIS;IBD;Inflammatory Bowel Diseases;Bowel Diseases, Inflammatory	inflammatory bowel disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; inflammatory bowel disease|genetic disorder|material entity|experimental factor; inflammatory bowel disease|genetic disorder|disease|disposition|material property|experimental factor; inflammatory bowel disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0009961	Insulinogenic index measurement	NA		Insulinogenic index measurement|insulin measurement|protein measurement|measurement|information entity|experimental factor; Insulinogenic index measurement|insulin measurement|diabetes mellitus biomarker|measurement|information entity|experimental factor; Insulinogenic index measurement|insulin measurement|hormone measurement|measurement|information entity|experimental factor
EFO:0003046	heart transplant rejection	NA		heart transplant rejection|biological process|process|experimental factor
EFO:0009632	amputation	NA		amputation|medical procedure|experimental process|planned process|process|experimental factor
CHEBI:37684	mannose	NA	mannose;manno-hexose	mannose|carbohydrate|chemical entity|material entity|experimental factor
EFO:0000734	vitamin B12 deficiency	A disease characterized by low serum levels of vitamin B12, either inherited or acquired.	hypocobalaminemia;VITAMIN B 12 DEFIC;Cobalamin deficiency (disorder);vitamin b12 deficiency;DEFIC VITAMIN B12;Deficiency, Vitamin B12;Vitamin B12 Deficiencies;Deficiency, Vitamin B 12;Cobalamin deficiency;Deficiency of vitamin B>12<;Deficiencies, Vitamin B12;Vitamin B 12 Deficiency;VITAMIN B12 DEFIC;vitamin B12 deficiency;cobalamin deficiency;Deficiency of vitamin B<sub>12</sub>;Deficiency of vitamin B12;DEFIC VITAMIN B 12;Deficiency of vitamin B>12< (disorder);VITAMIN B A 12 DEFICIENCY	vitamin B12 deficiency|vitamin B deficiency|vitamin deficiency disorder|nutritional deficiency disease|nutritional disorder|metabolic disease|disease|disposition|material property|experimental factor; vitamin B12 deficiency|vitamin deficiency|Abnormality of vitamin metabolism|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007786	menstrual cycle measurement	NA		menstrual cycle measurement|measurement|information entity|experimental factor
EFO:0800407	1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) measurement	NA		1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0010313	Breast hypertrophy	The presence of hypertrophy of the breast.	Gigantomastia;Macromastia;Hypertrophy of the breasts;Large breast;Breast enlargement;Breasts enlarged	Breast hypertrophy|Abnormality of the breast|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007184	bronchopneumonia	Acute inflammation of the walls of the terminal bronchioles that spreads into the peribronchial alveoli and alveolar ducts. It results in the creation of foci of consolidation, which are surrounded by normal parenchyma. It affects one or more lobes, and is frequently bilateral and basal. It is usually caused by bacteria (e.g., Staphylococcus, Streptococcus, Haemophilus influenzae). Signs and symptoms include fever, cough with production of brown-red sputum, dyspnea, and chest pain.	chest infection - unspecified bronchopneumonia;bronchopneumonia;Chest infection - unspecified bronchopneumonia;bronchial pneumonia;lobular pneumonia;chest infection - bronchopneumonia;Bronchopneumonia	bronchopneumonia|pneumonia|pneumonitis|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; bronchopneumonia|pneumonia|pneumonitis|inflammatory disease|disease|disposition|material property|experimental factor; bronchopneumonia|pneumonia|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
HP:0001892	Abnormal bleeding	An abnormal susceptibility to bleeding, often referred to as a bleeding diathesis. A bleeding diathesis may be related to vascular, platelet and coagulation defects.	Hemorrhagic diathesis;Bleeding tendency;Bleeding diathesis	Abnormal bleeding|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004325	blood pressure	NA		blood pressure|vital signs|measurement|information entity|experimental factor
CHEBI:17771	trans-urocanate	NA	(2E)-3-(1H-imidazol-4-yl)prop-2-enoate;trans-urocanate	trans-urocanate|chemical entity|material entity|experimental factor
CHEBI:36659	3-(4-hydroxyphenyl)lactate	NA	3-(4-Hydroxyphenyl)lactate	3-(4-hydroxyphenyl)lactate|chemical entity|material entity|experimental factor
MONDO:0017276	frontotemporal dementia	Frontotemporal dementia (FTD) comprises a group of neurodegenerative disorders, characterized by progressive changes in behavior, executive dysfunction and language impairment, as a result of degeneration of the medial prefrontal and frontoinsular cortices. Four clinical subtypes have been identified: semantic dementia, progressive non-fluent aphasia, behavioral variant FTD and right temporal lobar atrophy.	Wilhemsen-Lynch disease;FTD;frontotemporal lobar degeneration;multiple system tauopathy with presenile dementia;pallidopontonigral degeneration	frontotemporal dementia|inherited neurodegenerative disorder|genetic disorder|disease|disposition|material property|experimental factor; frontotemporal dementia|genetic dementia|dementia|cognitive disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; frontotemporal dementia|genetic dementia|genetic disorder|material entity|experimental factor; frontotemporal dementia|genetic dementia|genetic disorder|disease|disposition|material property|experimental factor; frontotemporal dementia|genetic dementia|dementia|cognitive disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; frontotemporal dementia|inherited neurodegenerative disorder|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; frontotemporal dementia|inherited neurodegenerative disorder|genetic disorder|material entity|experimental factor
EFO:0004362	psychomotor performance	NA	sensory motor performance;perceptual motor performance	psychomotor performance|biological process|process|experimental factor
EFO:0800012	N-acetylaspartate (NAA) measurement	NA		N-acetylaspartate (NAA) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0004348	hematocrit	NA	packed erythrocyte volume;Ht;packed red-cell volume	hematocrit|hematological measurement|measurement|information entity|experimental factor
MONDO:0002691	liver cancer	An epithelial or non-epithelial malignant neoplasm that arises from the liver. Representative examples include hepatocellular carcinoma, intrahepatic cholangiocarcinoma, lymphoma, and sarcoma.	malignant neoplasm of liver, primary;cancer of liver;Ca liver - primary;non-resectable primary hepatic malignant neoplasm;resectable malignant neoplasm of the liver;primary malignant neoplasm of liver;malignant liver neoplasm;primary liver cancer;primary malignant liver neoplasm;malignant tumor of liver;malignant neoplasm of liver, not specified as primary or secondary;malignant hepato-biliary neoplasm;Resectable malignant neoplasm of liver;liver cancer;malignant neoplasm of liver;hepatic neoplasm;hepatic cancer;ca liver - primary	liver cancer|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; liver cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; liver cancer|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; liver cancer|liver and intrahepatic bile duct neoplasm|Hepatobiliary Neoplasm|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; liver cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; liver cancer|liver and intrahepatic bile duct neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; liver cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; liver cancer|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; liver cancer|liver and intrahepatic bile duct neoplasm|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0008392	triiodothyronine measurement	NA	T3 measurement	triiodothyronine measurement|chemical entity|material entity|experimental factor; triiodothyronine measurement|hormone measurement|measurement|information entity|experimental factor; triiodothyronine measurement|amino acid measurement|measurement|information entity|experimental factor
CHEBI:28177	theophylline	NA	1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione;theophylline;Theophylline;THEOPHYLLINE	theophylline|organic heterocyclic compound|chemical entity|material entity|experimental factor
EFO:0800906	X-24762 measurement	NA		X-24762 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800709	X-12127 measurement	NA		X-12127 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1000313	Kidney Cyst	NA		Kidney Cyst|kidney neoplasm|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; Kidney Cyst|kidney neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Kidney Cyst|kidney neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor
MONDO:0004782	diabetes insipidus	A disorder characterized by excretion of large amounts of urine, accompanied by excessive thirst. Causes include deficiency of antidiuretic hormone or failure of the kidneys to respond to antidiuretic hormone. It may also be drug-related.		diabetes insipidus|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:0800699	X-12015 measurement	NA		X-12015 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1001425	Skull Fractures	NA		Skull Fractures|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; Skull Fractures|bone fracture|injury|disease|disposition|material property|experimental factor
EFO:0021007	3-3-hydroxyphenylpropionate measurement	NA		3-3-hydroxyphenylpropionate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0007772	calcaneal bone quantitative ultrasound measurement	NA		calcaneal bone quantitative ultrasound measurement|bone quantitative ultrasound measurement|bone fracture related measurement|bone measurement|measurement|information entity|experimental factor
HP:0000473	Torticollis	Involuntary contractions of the neck musculature resulting in an abnormal posture of or abnormal movements of the head.	Spasmodic torticollis;Wry neck;Loxia;Cervical dystonia	Torticollis|Dystonia|Abnormality of movement|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Torticollis|Dystonia|Behavioral abnormality|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Torticollis|Abnormal skeletal muscle morphology|Abnormality of the musculature|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Torticollis|Abnormal central motor function|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Torticollis|Abnormality of the neck|Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003888	attention deficit hyperactivity disorder	A disorder characterized by a marked pattern of inattention and/or hyperactivity-impulsivity that is inconsistent with developmental level and clearly interferes with functioning in at least two settings (e.g. at home and at school). When present, the symptoms of hyperactivity are most often present before the age of 7 years. There are three recognized presentations or subtypes from most to least common: combined type, inattentive/distractible type, hyperactive/impulsive type.	ATTENTION DEFICIT DIS;Attention Deficit Disorder;Brain Dysfunction, Minimal;Deficit Disorders, Attention;Syndromes, Hyperkinetic;attention deficit-hyperactivity disorder;Minimal Brain Dysfunction;Dysfunction, Minimal Brain;attention deficit-hyperactivity disorder, susceptibility to;Disorder, Attention Deficit;ATTENTION DEFICIT DIS WITH HYPERACTIVITY;Hyperkinetic Syndrome;Attention Deficit Disorders with Hyperactivity;Attention Deficit Hyperactivity Disorders;ADHD;Deficit Disorder, Attention;Attention Deficit Disorders;Disorders, Attention Deficit;ADDH;attention deficit hyperactivity disorder;attention deficit/hyperactivity disorder;Attention Deficit Disorder with Hyperactivity;ATTENTION DEFICIT HYPERACTIVITY DIS	attention deficit hyperactivity disorder|specific developmental disorder|developmental disorder of mental health|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; attention deficit hyperactivity disorder|specific developmental disorder|developmental disorder of mental health|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009315	thrombophilia	A condition characterized by an abnormally high level of thrombi. Causes include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, bone marrow disorders, and antiphospholipid antibody syndrome.	hypercoagulable;Hypercoagulable;Hypercoagulability State;excessive blood clotting;hypercoagulability state;Hypercoagulability;thrombophilia;hypercoagulability;Excessive Blood Clotting	thrombophilia|blood coagulation disease|hematologic disease|material entity|experimental factor; thrombophilia|blood coagulation disease|hematologic disease|disease|disposition|material property|experimental factor
EFO:0001062	cytomegalovirus infection	A herpesvirus infection caused by Cytomegalovirus. Healthy individuals generally do not produce symptoms. However, the infection may be life-threatening in affected immunocompromised patients. The virus may cause retinitis, esophagitis, gastritis, and colitis. Morphologically, it is characterized by the presence of intranuclear inclusion bodies.	cytomegalovirus infection;Infection, Cytomegalovirus;Cytomegalovirus Infections;SALIVARY GLAND VIRUS DIS;Inclusion Disease;[X]Cytomegaloviral disease, unspecified (disorder);INFECT CYTOMEGALOVIRUS;[X]Cytomegaloviral disease, unspecified;CYTOMEGALIC INCLUSION DIS;Inclusion Diseases;Cytomegalic inclusion disease;Disease, Cytomegalic Inclusion;CYTOMEGALOVIRAL DISEASE;HCMV;Disease due to Cytomegalovirus;Cytomegalovirus infection, NOS;Human Herpesvirus 5;Cytomegalic Inclusion Diseases;Cytomegaloviral disease, unspecified (disorder);INCLUSION DIS;Salivary gland virus disease;Cytomegalovirus infectious disease;Cytomagalovirus infection;CYTOMEGALOVIRUS INFECT;Cytomegalovirus infection (disorder);CMV - Cytomegalovirus infection;Cytomegaloviral infection;Cytomegalovirus Infection;HCMV infection;Cytomegaloviral disease, unspecified;Inclusion Diseases, Cytomegalic;CMV infection;Infections, Cytomegalovirus;Inclusion Disease, Cytomegalic;Diseases, Cytomegalic Inclusion	cytomegalovirus infection|Herpesviridae infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; cytomegalovirus infection|Herpesviridae infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0800072	methionine sulfone measurement	NA		methionine sulfone measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0004252	nasopharyngeal neoplasm	A benign or malignant neoplasm affecting the nasopharynx. Representative examples of benign neoplasms include angiofibroma and squamous papilloma. Representative examples of malignant neoplasms include keratinizing squamous cell carcinoma and nonkeratinizing carcinoma.	nasopharynx neoplasm;neoplasm of nasopharynx;nasopharynx tumor;neoplasm of the nasopharynx;nasopharynx neoplasm (disease);nasopharyngeal neoplasm;nasopharyngeal tumor;tumor of the nasopharynx;tumor of nasopharynx;nasopharyngeal neoplasms	nasopharyngeal neoplasm|pharynx neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; nasopharyngeal neoplasm|nasopharyngeal disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; nasopharyngeal neoplasm|nasopharyngeal disorder|disorder of pharynx|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; nasopharyngeal neoplasm|nasopharyngeal disorder|disorder of pharynx|respiratory system disease|disease|disposition|material property|experimental factor; nasopharyngeal neoplasm|head and neck neoplasia|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; nasopharyngeal neoplasm|respiratory system neoplasm|respiratory system disease|disease|disposition|material property|experimental factor; nasopharyngeal neoplasm|respiratory system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; nasopharyngeal neoplasm|head and neck neoplasia|head and neck disorder|disease|disposition|material property|experimental factor
EFO:1000192	Colorectal Gastrointestinal Stromal Tumor	A gastrointestinal stromal tumor that arises from the colon or rectum. The majority of cases have spindle cell morphology. Gastrointestinal stromal tumors of the colon are usually advanced upon detection and tend to have a poor prognosis; gastrointestinal stromal tumors of the rectum usually have an aggressive clinical course.	colorectal gastrointestinal stromal tumor (gist);colorectal gist;colorectal gastrointestinal stromal tumor;colorectal (colon or rectal) gastrointestinal stromal tumor (gist)	Colorectal Gastrointestinal Stromal Tumor|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Colorectal Gastrointestinal Stromal Tumor|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Colorectal Gastrointestinal Stromal Tumor|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0020001	drug resistance	The state of primary insensitivity or greatly reduced sensitivity of a given organism to the action of one or more drugs.	NCIT:C16523	drug resistance|biological process|process|experimental factor
EFO:0009617	knee fracture	NA		knee fracture|lower extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; knee fracture|lower extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor
CHEBI:40279	allopurinol	NA	1H-pyrazolo[3,4-d]pyrimidin-4-ol;Allopurinol	allopurinol|organic heterocyclic compound|chemical entity|material entity|experimental factor
EFO:0002429	polycythemia vera	Polycythemia vera (PV) is an acquired myeloproliferative disorder characterized by an elevated absolute red blood cell mass caused by uncontrolled red blood cell production, frequently associated with uncontrolled white blood cell and platelet production.	polycythaemia rubra vera;acquired primary erythrocytosis;Vaquez disease;polycythemia rubra vera;acquired polycythemia vera;Osler-Vaquez disease;PV;Osler-Vaquez syndrome;proliferative polycythaemia;polycythemia vera;polycythemia vera, somatic	polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; polycythemia vera|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; polycythemia vera|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; polycythemia vera|myeloproliferative disorder|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; polycythemia vera|myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; polycythemia vera|myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|immune system cancer|immune system disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; polycythemia vera|hereditary disorder of connective tissue|genetic disorder|disease|disposition|material property|experimental factor; polycythemia vera|familial polycythemia|genetic disorder|disease|disposition|material property|experimental factor; polycythemia vera|hereditary disorder of connective tissue|genetic disorder|material entity|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|material entity|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|immune system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; polycythemia vera|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; polycythemia vera|familial polycythemia|polycythemia|bone marrow disorder|hematologic disease|material entity|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|chronic disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; polycythemia vera|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; polycythemia vera|hereditary disorder of connective tissue|connective tissue disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; polycythemia vera|familial polycythemia|genetic disorder|material entity|experimental factor; polycythemia vera|familial polycythemia|polycythemia|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; polycythemia vera|myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; polycythemia vera|familial polycythemia|polycythemia|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|musculoskeletal system cancer|musculoskeletal system disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; polycythemia vera|familial polycythemia|polycythemia|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; polycythemia vera|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; polycythemia vera|erythroid neoplasm|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|musculoskeletal system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0019558	discoid lupus erythematosus	A chronic, autoimmune skin condition that manifests with a red, scaling rash, most often found on the face, ears, and scalp; these lesions often lead to permanent scarring and dyspigmentation. Patients may have lesions with or without other symptoms or antibodies suggestive of systemic lupus erythematosus (SLE).	DLE	discoid lupus erythematosus|chronic cutaneous lupus erythematosus|cutaneous lupus erythematosus|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; discoid lupus erythematosus|chronic cutaneous lupus erythematosus|cutaneous lupus erythematosus|lupus erythematosus|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; discoid lupus erythematosus|chronic cutaneous lupus erythematosus|material entity|experimental factor; discoid lupus erythematosus|chronic cutaneous lupus erythematosus|cutaneous lupus erythematosus|lupus erythematosus|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; discoid lupus erythematosus|chronic cutaneous lupus erythematosus|cutaneous lupus erythematosus|lupus erythematosus|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor
EFO:0010814	proinsulin measurement	NA		proinsulin measurement|insulin measurement|protein measurement|measurement|information entity|experimental factor; proinsulin measurement|insulin measurement|diabetes mellitus biomarker|measurement|information entity|experimental factor; proinsulin measurement|insulin measurement|hormone measurement|measurement|information entity|experimental factor
EFO:0003758	autism	Persistent deficits in social interaction and communication and interaction as well as a markedly restricted repertoire of activity and interest as well as repetitive patterns of behavior.	Kanner Syndrome;Kanner's Syndrome;infantile autism;Autism, Early Infantile;Infantile psychosis (disorder);autistic disorder of childhood onset;Infantile autism (disorder);Disorder, Autistic;Infantile Autism, Early;Kanners Syndrome;autism;Autism, Infantile;Kanner's syndrome;Autisms;Infantile Autism;Autistic disorder of childhood onset (disorder);childhood autism;Syndrome, Kanner's;Disorders, Autistic;autism (disease);Early Infantile Autism;Autistic Disorder	autism|autism spectrum disorder|pervasive developmental disorder|developmental disorder of mental health|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; autism|autism spectrum disorder|pervasive developmental disorder|developmental disorder of mental health|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; autism|autism spectrum disorder|pervasive developmental disorder|complex neurodevelopmental disorder|Neurodevelopmental disorder|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:1001015	leukoplakia of penis	A precancerous condition characterized by the presence of abnormal whitish areas on the glans or prepuce of the penis. Risk factors include chronic irritation, inflammation, and infection of the penis, and poor genital hygiene.	penile leukoplakia;Kraurosis of penis;Balanitis Xerotica Obliterans;kraurosis penis;leukoplakia of penis;Leukoplakia of penis (disorder);Leucoplakia of penis;kraurosis of penis;Penile Leukoplakia;leukoplakia of the penis	leukoplakia of penis|penile disorder|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; leukoplakia of penis|leukoplakia|precancerous condition|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0800629	N6-carbamoylthreonyladenosine measurement	NA		N6-carbamoylthreonyladenosine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0007363	meibomian cyst	An eyelid cyst caused by the blockage of a meibomian gland.	chalazion;meibomian gland lipogranuloma;Chalazion	meibomian cyst|internal hordeolum|sebaceous gland disease|skin appendage disorder|integumentary system disease|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|hordeolum|eye infectious disorder|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|hordeolum|blepharitis|eyelid disease|eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|hordeolum|blepharitis|eyelid disease|eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|sebaceous gland disease|disorder of pilosebaceous unit|integumentary system disease|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|hordeolum|skin disease caused by bacterial infection|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|hordeolum|blepharitis|inflammatory disease|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|hordeolum|Staphylococcus aureus infection|staphylococcal skin infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|hordeolum|eye infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|sebaceous gland disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|hordeolum|skin disease caused by bacterial infection|skin disorder caused by infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|hordeolum|skin disease caused by bacterial infection|skin disorder caused by infection|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; meibomian cyst|internal hordeolum|hordeolum|eye infectious disorder|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:1001863	Uterine Inertia	NA	uterine atony	Uterine Inertia|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
HP:0001871	Abnormality of blood and blood-forming tissues	An abnormality of the hematopoietic system.	Haematological abnormality;Abnormality of blood and blood-forming tissues;Abnormality of the hematopoietic system;Abnormality of the haematopoietic system;Hematological abnormality	Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007292	Guillain-Barre syndrome	A spectrum of rare post-infectious neuropathies that usually occur in otherwise healthy patients. GBS is clinically heterogeneous and encompasses acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN), Miller-Fisher syndrome (MFS) and some other regional variants.	Post-infectious polyneuritis (disorder);Guillain-Barre syndrome;Guillain-Barre syndrome (disorder);acute infective polyneuritis NOS (disorder);Guillain-Barre-Strohl syndrome;Postinfectious polyneuritis;Guillain-Barr-Strohl syndrome;Infectious neuronitis (disorder);GBS;acute postinfectious polyneuropathy;Guillain-Barre Syndrome;acute infective polyneuritis;Guillain Barr syndrome;Guillain-Barr syndrome;acute infective polyneuritis (disorder);acute Infective Polyneuritis;Guillain Barre syndrome;acute inf. polyneuritis	Guillain-Barre syndrome|autoimmune disorder of peripheral nervous system|autoimmune disorder of the nervous system|nervous system disease|disease|disposition|material property|experimental factor; Guillain-Barre syndrome|autoimmune disorder of peripheral nervous system|autoimmune disorder of the nervous system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; Guillain-Barre syndrome|syndromic disease|disease|disposition|material property|experimental factor; Guillain-Barre syndrome|syndromic disease|material entity|experimental factor; Guillain-Barre syndrome|autoimmune disorder of peripheral nervous system|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Guillain-Barre syndrome|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor
EFO:0005001	phenylalanine measurement	NA		phenylalanine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:1001478	systemic inflammatory response syndrome	NA	Inflammatory Response Syndrome, Systemic;SIRS;Sepsis Syndrome	systemic inflammatory response syndrome|inflammation|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000220	acute lymphoblastic leukemia	Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.	acute lymphoblastic leukemia (disease);acute lymphoblastic leukemia;leukemia, lymphoblastic, malignant;ALL - acute lymphocytic leukemia;precursor lymphoblastic leukemia;acute lymphocytic leukemia;ALL;lymphoblastic leukemia, acute;acute lymphoblastic leukemia/lymphoma;acute lymphocytic leukaemia;acute lymphoid leukemia;precursor Lymphoblasic leukemia;acute lymphoblastic leukemia (ALL);acute lymphocytic leukemias;acute lymphogenous leukemia;precursor cell lymphoblastic leukemia	acute lymphoblastic leukemia|neoplasm of immature B and T cells|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|neoplasm of immature B and T cells|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|precursor lymphoblastic lymphoma/leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|neoplasm of immature B and T cells|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|precursor lymphoblastic lymphoma/leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|precursor lymphoblastic lymphoma/leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|acute disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|leukemia|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|lymphoid leukemia|leukemia|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; acute lymphoblastic leukemia|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; acute lymphoblastic leukemia|Acute Leukemia|leukemia|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor
EFO:0009681	post term pregnancy	NA	prolonged pregnancy;post-term pregnancy;postterm pregnancy	post term pregnancy|pregnancy disorder|obstetric disorder|disease|disposition|material property|experimental factor
MONDO:0018634	hereditary amyloidosis	Hereditary amyloidosis refers to a group of inherited conditions that make up one of the subtypes of amyloidosis. Hereditary amyloidosisis characterized by the deposit of an abnormal protein called amyloid in multiple organs of the body where it should not be, which causes disruption of organ tissue structure and function. In hereditary amyloidosis, amyloid deposits most often occur in tissues of the heart, kidneys, and nervous system. While symptoms of hereditary amyloidosis may appear in childhood, most individuals do not experience symptoms until adulthood. There are many types of hereditary amyloidosis associated with different gene mutations and abnormal proteins. The most common type of hereditary amyloidosis is transthyretin amyloidosis (ATTR),a condition in which the amyloid deposits are most often made up of the transthyretin protein which is made in the liver. Other examplesof hereditary amyloidosis include, but are not limited to, apolipoprotein AI amyloidosis (A ApoAI), gelsolin amyloidosis (A Gel), lysozyme amyloidosis (A Lys), cystatin C amyloidosis (A Cys), fibrinogen A-chain amyloidosis (A Fib), and apolipoprotein AII amyloidosis (A ApoAII). Most types of hereditary amyloidosis are inherited in an autosomal dominant manner. Treatment is focused on addressing symptoms of organ damage and slowing down the production of amyloid when possible through methods such as liver transplants.	hereditary amyloidosis (disease);amyloidosis, Familial	hereditary amyloidosis|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; hereditary amyloidosis|amyloidosis|acquired metabolic disease|metabolic disease|disease|disposition|material property|experimental factor; hereditary amyloidosis|amyloidosis|acquired metabolic disease|material entity|experimental factor; hereditary amyloidosis|amyloidosis|proteostasis deficiencies|metabolic disease|disease|disposition|material property|experimental factor; hereditary amyloidosis|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; hereditary amyloidosis|inborn errors of metabolism|genetic disorder|material entity|experimental factor
EFO:0005687	fibromyalgia	A chronic disorder of unknown etiology characterized by pain, stiffness, and tenderness in the muscles of neck, shoulders, back, hips, arms, and legs. Other signs and symptoms include headaches, fatigue, sleep disturbances, and painful menstruation.	fibromyalgia;FM;fibromyalgia syndrome	fibromyalgia|idiopathic disease|disease|disposition|material property|experimental factor; fibromyalgia|idiopathic disease|material entity|experimental factor; fibromyalgia|syndromic disease|disease|disposition|material property|experimental factor; fibromyalgia|chronic pain syndrome|neurological pain disorder|nervous system disease|disease|disposition|material property|experimental factor; fibromyalgia|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; fibromyalgia|syndromic disease|material entity|experimental factor
EFO:1001375	Myocardial Ischemia	A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (coronary artery disease), to obstruction by a thrombus (coronary thrombosis), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).	ischemic heart disease;IHD;ischemic disease of myocardium;myocardium ischemic disease;myocardial ischemia	Myocardial Ischemia|coronary artery disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Myocardial Ischemia|ischemic disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Myocardial Ischemia|myocardial disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; Myocardial Ischemia|coronary artery disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:1000013	Prinzmetal's angina	A syndrome typically consisting of angina (cardiac chest pain) at rest that occurs in cycles. It is caused by vasospasm, a narrowing of the coronary arteries caused by contraction of the smooth muscle tissue in the vessel walls rather than directly by atherosclerosis (buildup of fatty plaque and hardening of the arteries). For a portion of patients Prinzmetal's angina may be a manifestation of vasospastic disorder and is associated with migraine, Raynaud's phenomenon or aspirin-induced asthma.	Prinzmetal's angina;coronary artery spasm;variant angina;variant angina pectoris;angina inversa;Prinzmetal's variant angina;coronary vessel spasms;Prinzmetal angina;coronary vessel spasm;coronary artery spasms	Prinzmetal's angina|Coronary Vasospasm|coronary artery disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Prinzmetal's angina|Coronary Vasospasm|coronary artery disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
CHEBI:38545	rosuvastatin	NA	(3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid	rosuvastatin|organic heterocyclic compound|chemical entity|material entity|experimental factor
EFO:0006943	blood pressure change measurement	NA		blood pressure change measurement|measurement|information entity|experimental factor
EFO:0001955	heart component	NA		heart component|heart|circulatory system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|circulatory system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|cardiovascular system|circulatory system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|trunk|body proper|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|trunk|body proper|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|cardiovascular system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|cardiovascular system|circulatory system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|cardiovascular system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|trunk|body proper|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|trunk|body proper|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|trunk|body proper|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|cardiovascular system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|trunk|body proper|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|circulatory system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|trunk|body proper|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|cardiovascular system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|cardiovascular system|circulatory system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|heart|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; heart component|cardiovascular system|circulatory system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|circulatory system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|thoracic segment of trunk|trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; heart component|heart|trunk|body proper|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor
EFO:0007617	pure tone hearing measurement	NA	pure tone audiometry	pure tone hearing measurement|hearing measurement|measurement|information entity|experimental factor
HP:0012042	Aspirin-induced asthma	A type of asthma in which aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygen-ase 1 (COX-1) exacerbate bronchoconstriction.	Aspirin-induced asthma	Aspirin-induced asthma|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Aspirin-induced asthma|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0003776	coronary artery bypass	NA	Aortocoronary Bypass;Bypass, Aortocoronary;Artery Bypasses, Coronary;Artery Bypass, Coronary;Bypasses, Coronary Artery;CABG;BYPASS SURG CORONARY ARTERY;Bypasses, Aortocoronary;CORONARY ARTERY BYPASS SURG;Bypass, Coronary Artery;Coronary Artery Bypasses;Bypass Surgery, Coronary Artery;Coronary Artery Bypass Surgery;Coronary Artery Bypass Grafting;Aortocoronary Bypasses	coronary artery bypass|medical procedure|experimental process|planned process|process|experimental factor
HP:0002571	Achalasia	A disorder of esophageal motility characterized by the inability of the lower esophageal sphincter to relax during swallowing and by inadequate or lacking peristalsis in the lower half of the body of the esophagus.	Achalasia of the esophagus;Achalasia of the oesophagus	Achalasia|Abnormal esophagus physiology|Functional abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Achalasia|Abnormal peristalsis|Gastrointestinal dysmotility|Abnormal gastrointestinal motility|Functional abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004518	creatinine measurement	NA	serum creatinine levels;serum creatinine measurement;creatinine levels	creatinine measurement|renal system measurement|measurement|information entity|experimental factor; creatinine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0008584	Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction	NA		Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction|myocardial infarction|myocardial disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:1000783	diabetic neuropathy	A chronic, pathological complication associated with diabetes mellitus, where nerve damages are incurred due to diabetic microvascular injury involving small blood vessels that supply these nerves, resulting in peripheral and/or autonomic nerve dysfunction.	diabetic neuropathies;Diabetic Amyotrophy;Amyotrophies, Diabetic;Diabetic Autonomic Neuropathies;Diabetic Mononeuropathies;Diabetic Autonomic Neuropathy;Diabetic Asymmetric Polyneuropathies;Diabetic Mononeuropathy;Asymmetric Polyneuropathy, Diabetic;Amyotrophy, Diabetic;Diabetic Asymmetric Polyneuropathy;Diabetic Mononeuropathy Simplices;Painful Diabetic Neuropathies;diabetic neuropathy;Diabetic Mononeuropathy Simplex;Painful Diabetic Neuropathy;Diabetic Amyotrophies	diabetic neuropathy|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; diabetic neuropathy|autonomic nervous system disease|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; diabetic neuropathy|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; diabetic neuropathy|autonomic nervous system disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0009558	mononeuropathy	Disease or trauma involving a single peripheral nerve in isolation, or out of proportion to evidence of diffuse peripheral nerve dysfunction. Mononeuropathy multiplex refers to a condition characterized by multiple isolated nerve injuries. Mononeuropathies may result from a wide variety of causes, including ischemia; traumatic injury; compression; connective tissue diseases; cumulative trauma disorders; and other conditions.	mononeuropathy	mononeuropathy|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; mononeuropathy|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor
CHEBI:30660	thyroxine	NA	thyroxine	thyroxine|phenols|chemical entity|material entity|experimental factor; thyroxine|amino acid|acid|chemical entity|material entity|experimental factor
MONDO:0019297	lymphedema	Excess fluid collection in tissues, causing swelling. It is the result of obstruction of lymphatic vessels or lymph nodes.	lymphatic edema;lymphoedema;lymphatic edema (morphologic abnormality)	lymphedema|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor
EFO:0000401	diabetic nephropathy	Progressive kidney disorder caused by vascular damage to the glomerular capillaries, in patients with diabetes mellitus. It is usually manifested with nephritic syndrome and glomerulosclerosis.	Kimmelstiel-Wilson Disease;Diabetes-nephrosis syndrome;Renal disorder associated with diabetes mellitus;diabetic kidney disease;Nodular Glomerulosclerosis;Nephrotic syndrome due to diabetes mellitus;Kimmelstiel - Wilson disease;Syndrome, Kimmelstiel-Wilson;Diabetic Kidney Diseases;Diabetic Glomerulosclerosis;Kimmelstiel Wilson Disease;Nephrotic syndrome in diabetes mellitus (disorder);DMII RENAL UNCNTRLD;Kimmelstiel-Wilson Syndrome;Nephropathies, Diabetic;Diabetes with renal manifestations;Diabetic renal disease;diabetic nephropathy;Kidney Diseases, Diabetic;Glomerulosclerosis, Diabetic;DKD;Nephrotic syndrome in diabetes mellitus;Diabetic Nephropathies;Diabetes with renal manifestations (disorder);Glomerulosclerosis, Nodular;Kidney Disease, Diabetic;Nephropathy, Diabetic;DMII RENL NT ST UNCNTRLD;Intracapillary Glomerulosclerosis;Kimmelstiel Wilson Syndrome;Diabetic renal disease (disorder);Diabetes-nephrosis syndrome (disorder);Diabetic Kidney Disease	diabetic nephropathy|metabolic disease|disease|disposition|material property|experimental factor; diabetic nephropathy|chronic kidney disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; diabetic nephropathy|chronic kidney disease|chronic disease|disease|disposition|material property|experimental factor
CHEBI:6801	metformin	NA	N,N-dimethyltriimidodicarbonic diamide	metformin|chemical entity|material entity|experimental factor
EFO:0009304	percent glycated albumin	NA		percent glycated albumin|glycated albumin measurement|measurement|information entity|experimental factor
CHEBI:24996	lactate	NA	2-hydroxypropanoate;lactate	lactate|chemical entity|material entity|experimental factor
EFO:0003949	eye color	NA	iris color;Colors, Eye;Color, Eye;Eye Colors	eye color|phenotype|quality|material property|experimental factor
EFO:0001074	morbid obesity	An excess of body weight, normally defined as an individual with a body mass index greater than 35 or a body weight greater than one hundred percent of ideal body weight.	severe obesity;Obesity, Morbid;Morbid obesity (disorder);Severe obesity;Obesities, Morbid;Morbid Obesities;morbid obesity	morbid obesity|obesity|overnutrition|nutritional disorder|metabolic disease|disease|disposition|material property|experimental factor
MONDO:0001823	sick sinus syndrome	A constellation of signs and symptoms which may include syncope, fatigue, dizziness, and alternating periods of bradycardia and atrial tachycardia, which is caused by sinoatrial node dysfunction.	sinus node infection;SSS	sick sinus syndrome|sinoatrial node disorder|conduction system disorder|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; sick sinus syndrome|syndromic disease|material entity|experimental factor; sick sinus syndrome|syndromic disease|disease|disposition|material property|experimental factor; sick sinus syndrome|sinoatrial node disorder|conduction system disorder|myocardial disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; sick sinus syndrome|sinoatrial node disorder|heart conduction disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0008519	primary hyperparathyroidism	Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones.	primary hyperparathyroidism (disease);primary hyperparathyroidism	primary hyperparathyroidism|hyperparathyroidism|parathyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0008506	hyperparathyroidism	Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes.	hyperparathyroidism	hyperparathyroidism|parathyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0004920	progression free survival	NA	time before disease progression	progression free survival|disease free survival|event free survival time|survival time|clinical temporal measurement|temporal measurement|measurement|information entity|experimental factor
HP:0002883	Hyperventilation	Hyperventilation refers to an increased pulmonary ventilation rate that is faster than necessary for the exchange of gases. Hyperventilation can result from increased frequency of breathing, an increased tidal volume, or both, and leads to an excess intake of oxygen and the blowing off of carbon dioxide.	Rapid breathing	Hyperventilation|Abnormal pattern of respiration|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0002033	cecum cancer	A malignant neoplasm involving the caecum	caecum cancer;malignant cecum neoplasm;malignant neoplasm of caecum;malignant tumor of cecum;malignant tumor of the cecum;malignant neoplasm of the cecum;malignant neoplasm of cecum;malignant cecum tumor;cancer of caecum;malignant caecum neoplasm	cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cecum cancer|cecal neoplasm|cecal disorder|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; cecum cancer|cecal neoplasm|colonic neoplasm|colorectal neoplasm|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|intestinal neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colorectal cancer|intestinal cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; cecum cancer|cecal neoplasm|colonic neoplasm|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colorectal cancer|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; cecum cancer|malignant colon neoplasm|colonic neoplasm|colorectal neoplasm|intestinal neoplasm|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0008524	small cell carcinoma	A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble "oat cells" under the microscope. Small cell carcinoma most often affects the lungs. Clinically, this is often a rapidly growing cancer that spreads to distant sites early.	small cell car. (extrapulmonary);small cell cancer;oat cell carcinoma;small cell neuroendocrine carcinoma;small cell NEC;small cell carcinoma;small cell carcinoma (extrapulmonary);oat cell cancer	small cell carcinoma|neuroendocrine carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; small cell carcinoma|neuroendocrine carcinoma|neuroendocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; small cell carcinoma|neuroendocrine carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; small cell carcinoma|neuroendocrine carcinoma|neuroendocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; small cell carcinoma|neuroendocrine carcinoma|malignant endocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor; small cell carcinoma|neuroendocrine carcinoma|malignant endocrine neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; small cell carcinoma|neuroendocrine carcinoma|malignant endocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0801005	propyl 4-hydroxybenzoate sulfate measurement	NA		propyl 4-hydroxybenzoate sulfate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0021523	examination for neoplasm	NA	neoplasm screening test	examination for neoplasm|medical procedure|experimental process|planned process|process|experimental factor
MONDO:0021251	endometrium neoplasm	A neoplasm (disease) that involves the endometrium.	neoplasm of the endometrium;endometrial tumor;tumor of the endometrium;endometrium tumor;neoplasm of endometrium;tumor of endometrium;endometrial neoplasm;endometrium neoplasm (disease)	endometrium neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; endometrium neoplasm|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; endometrium neoplasm|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; endometrium neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; endometrium neoplasm|endometrial disorder|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0007532	uterine corpus cancer	A malignant neoplasm involving the body of uterus.	uterine corpus cancer;cancer of the corpus uteri;malignant body of uterus neoplasm;corpus uteri cancer;malignant neoplasm of body of uterus;body of uterus cancer;endometrial cancer;cancer of body of uterus;uterine (including endometrial) cancer	uterine corpus cancer|corpus uteri neoplasm|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; uterine corpus cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; uterine corpus cancer|corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; uterine corpus cancer|corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; uterine corpus cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; uterine corpus cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; uterine corpus cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; uterine corpus cancer|uterine cancer|uterine neoplasm|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; uterine corpus cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; uterine corpus cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; uterine corpus cancer|corpus uteri neoplasm|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; uterine corpus cancer|uterine cancer|uterine neoplasm|female reproductive system neoplasm|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; uterine corpus cancer|uterine cancer|Genital neoplasm, female|female reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; uterine corpus cancer|uterine cancer|Genital neoplasm, female|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor
EFO:1001347	Herpes Labialis	NA		Herpes Labialis|Herpesviridae infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Herpes Labialis|Herpesviridae infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0800137	2-aminoadipate measurement	NA		2-aminoadipate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800792	X-18888 measurement	NA		X-18888 measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0003394	Muscle spasm	Sudden and involuntary contractions of one or more muscles.	Muscle cramps	Muscle spasm|Abnormal muscle physiology|Abnormality of the musculature|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0800060	beta-citrylglutamate measurement	NA		beta-citrylglutamate measurement|metabolite measurement|measurement|information entity|experimental factor
MONDO:0022394	cervical intraepithelial neoplasia	NA		cervical intraepithelial neoplasia|material entity|experimental factor; cervical intraepithelial neoplasia|dysplasia of cervix|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0800018	N-acetyltryptophan measurement	NA		N-acetyltryptophan measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0000216	acinar cell carcinoma	A carcinoma that arises from epithelial cells of the acinar cell	acinar cell adenocarcinoma;acinar cell carcinoma;acinic cell adenocarcinoma;acinic cell carcinoma;acinar cell carcinoma (morphologic abnormality);carcinoma, acinar cell, malignant;acinar adenocarcinoma;carcinoma of acinar cell;acinar carcinoma	acinar cell carcinoma|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acinar cell carcinoma|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; acinar cell carcinoma|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0004976	amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscular paralysis reflecting degeneration of motor neurons in the primary motor cortex, corticospinal tracts, brainstem and spinal cord.	Lou Gehrig disease;amyotrophic lateral sclerosis;Charcot disease;motor neuron disease, bulbar;ALS;Lou Gehrig's disease	amyotrophic lateral sclerosis|material entity|experimental factor; amyotrophic lateral sclerosis|motor neuron disease|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; amyotrophic lateral sclerosis|motor neuron disease|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; amyotrophic lateral sclerosis|anterior horn disorder|spinal cord disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0008514	neurofibromatosis	A hereditary neoplastic syndrome in which tumors grow in the nervous system. There are typically 3 main types recognized, but other forms with uncertain etiology exist.	Recklinghausen's neurofibromatosis;neurofibromatosis;neurofibromatosis syndrome;acoustic neurofibromatosis;type IV neurofibromatosis of riccardi;peripheral Neurofibromatosis;central Neurofibromatosis;von Reklinghausen disease	neurofibromatosis|hereditary neoplastic syndrome|genetic disorder|material entity|experimental factor; neurofibromatosis|autosomal dominant disease|autosomal genetic disease|genetic disorder|disease|disposition|material property|experimental factor; neurofibromatosis|autosomal dominant disease|autosomal genetic disease|genetic disorder|material entity|experimental factor; neurofibromatosis|neurocutaneous syndrome|nervous system disease|disease|disposition|material property|experimental factor; neurofibromatosis|inherited nervous system cancer-predisposing syndrome|material entity|experimental factor; neurofibromatosis|inherited nervous system cancer-predisposing syndrome|nervous system disease|disease|disposition|material property|experimental factor; neurofibromatosis|hereditary neoplastic syndrome|genetic disorder|disease|disposition|material property|experimental factor; neurofibromatosis|hereditary neoplastic syndrome|neoplastic syndrome|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; neurofibromatosis|hereditary neoplastic syndrome|neoplastic syndrome|syndromic disease|disease|disposition|material property|experimental factor; neurofibromatosis|hereditary neoplastic syndrome|neoplastic syndrome|syndromic disease|material entity|experimental factor
HP:0001657	Prolonged QT interval	Increased time between the start of the Q wave and the end of the T wave as measured by the electrocardiogram (EKG).	Long QT syndrome;Prolong qt interval on ekg	Prolonged QT interval|Abnormal EKG|Abnormality of cardiovascular system electrophysiology|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0002721	postmenopausal	NA	NA	postmenopausal|adult|developmental stage|process|experimental factor
EFO:1000694	erythema multiforme	Erythema multiforme (EM) refers to a group ofhypersensitivity disorders characterized by symmetric red, patchy lesions, primarily on the arms and legs. The cause is unknown, but EM frequently occurs in association with herpes simplex virus, suggesting an immunologic process initiated by the virus. In half of the cases, the triggering agents appear to be medications, including anticonvulsants, sulfonamides, nonsteroidal anti-inflammatory drugs, and other antibiotics. In addition, some cases appear to be associated with infectious organisms such as Mycoplasma pneumoniae and many viral agents. Erythema multiforme is the mildest of three skin disorders that are often discussed in relation to each other. It is generally the mildest of the three. More severe is Stevens-Johnson syndrome. The most severe of the three is toxic epidermal necrolysis (TEN).	erythema multiforme	erythema multiforme|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0800805	X-21310 measurement	NA		X-21310 measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0011106	Hypovolemia	An decrease in the amount of intravascular fluid, particularly in the volume of the circulating blood.	Depleted blood volume	Hypovolemia|Abnormality of blood circulation|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0801034	sulfate of piperine metabolite C16H19NO3 (2) measurement	NA		sulfate of piperine metabolite C16H19NO3 (2) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009582	sprain	NA		sprain|injury|disease|disposition|material property|experimental factor
HP:0003549	Abnormality of connective tissue	Any abnormality of the soft tissues, including both connective tissue (tendons, ligaments, fascia, fibrous tissues, and fat).		Abnormality of connective tissue|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004579	serum IgE measurement	NA	IgE levels	serum IgE measurement|antibody measurement|measurement|information entity|experimental factor
EFO:0800635	2'-O-methylcytidine measurement	NA		2'-O-methylcytidine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0600011	Parkinson's disease symptom measurement	NA		Parkinson's disease symptom measurement|measurement|information entity|experimental factor
HP:0004338	Abnormal circulating aromatic amino acid concentration	Any deviation from the normal concentration of a aromatic amino acid in the blood circulation.	Abnormality of aromatic amino acid family metabolism	Abnormal circulating aromatic amino acid concentration|Abnormal circulating carboxylic acid concentration|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009690	urinary system disease	A disease involving the renal system.	urinary tract disease;urological diseases;diseases, urological;disease, urologic;urological disorders;diseases, urologic;urological disease;renal system disease or disorder;urinary system disorder;disease of renal system;disorder of the urinary system;disease, urological;renal system disease;urinary tract diseases;urinary system disease;urinary tract disorder;urologic disorder;disorder of renal system;urologic disease;disease or disorder of renal system;diseases, urinary tract;disorder of urinary system;urinary disease;disease, urinary tract;urological disorder;non-neoplastic urinary tract disease	urinary system disease|disease|disposition|material property|experimental factor
EFO:0004243	carcinoid tumor	A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis. The tumor may show a variety of patterns, such as solid, trabecular, and acinar. Electron microscopy shows small secretory granules. Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity. Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen. Such cases may have an aggressive clinical course. Gastrointestinal tract and lung are common sites of involvement.	neuroendocrine neoplasm G1;carcinoid tumor (disease);carcinoid tumor;neuroendocrine tumor G1;NET G1;carcinoid	carcinoid tumor|neuroendocrine neoplasm|endocrine neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; carcinoid tumor|neuroendocrine neoplasm|endocrine neoplasm|endocrine system disease|disease|disposition|material property|experimental factor
CHEBI:26986	threonine	NA	threonine	threonine|amino acid|acid|chemical entity|material entity|experimental factor
EFO:0009610	cervical spondylosis	NA	spondylosis, cervical	cervical spondylosis|genetic disorder|disease|disposition|material property|experimental factor; cervical spondylosis|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; cervical spondylosis|genetic disorder|material entity|experimental factor
EFO:0800085	5-hydroxyindole sulfate measurement	NA		5-hydroxyindole sulfate measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0012718	Morphological abnormality of the gastrointestinal tract	Abnormal structure of the gastrointestinal tract.	Morphological anomaly of the digestive system;Morphological abnormality of the GI tract;Abnormal shape of the digestive system	Morphological abnormality of the gastrointestinal tract|Abnormality of the gastrointestinal tract|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007264	ethmoid sinusitis	An acute or chronic inflammatory process affecting the mucous membrane of the ethmoid sinus.	ethmoidal sinusitis;Ethmoid Sinusitis;sinusitis of ethmoid bone;ethmoid bone sinusitis;ethmoid sinusitis;ethmoiditis	ethmoid sinusitis|sinusitis|paranasal sinus disease|head and neck disorder|disease|disposition|material property|experimental factor; ethmoid sinusitis|disorder of facial skeleton|skull disorder|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ethmoid sinusitis|sinusitis|inflammatory disease|disease|disposition|material property|experimental factor; ethmoid sinusitis|sinusitis|paranasal sinus disease|nasal disorder|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; ethmoid sinusitis|sinusitis|paranasal sinus disease|skull disorder|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; ethmoid sinusitis|sinusitis|paranasal sinus disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0800962	cinnamoylglycine measurement	NA		cinnamoylglycine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0007012	NSAID use measurement	NA	non-steroid anti-inflammatory drug use measurement	NSAID use measurement|drug use measurement|measurement|information entity|experimental factor
EFO:0003047	hepatitis C virus infection	A viral infection caused by the hepatitis C virus.	viral hepatitis C;Hepatitis C (disorder);hepatitis type C;NANBH;hepatitis C;Viral hepatitis C;Hepatitis non-A non-B (disorder);Hepatitis C virus hepatitis;hepatitis C infection;Viral hepatitis C (disorder);hepatitis C virus infection;Hepatitis C virus caused hepatitis;HCV infection;acute hepatitis C with hepatic coma;hepatitis Nona nonB;non-A, non-B Hepatitis;hepatitis nonA nonB	hepatitis C virus infection|viral human hepatitis infection|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; hepatitis C virus infection|viral human hepatitis infection|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; hepatitis C virus infection|viral human hepatitis infection|digestive system infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; hepatitis C virus infection|viral human hepatitis infection|inflammatory disease|disease|disposition|material property|experimental factor; hepatitis C virus infection|viral human hepatitis infection|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; hepatitis C virus infection|Flaviviridae infectious disease|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; hepatitis C virus infection|viral human hepatitis infection|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; hepatitis C virus infection|Flaviviridae infectious disease|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0008328	chronotype measurement	NA		chronotype measurement|sleep measurement|measurement|information entity|experimental factor
EFO:0800636	2'-O-methyluridine measurement	NA		2'-O-methyluridine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0005052	nervous system measurement	NA		nervous system measurement|measurement|information entity|experimental factor
MONDO:0015517	common variable immunodeficiency	Common variable immunodeficiency (CVID) comprises a heterogeneous group of diseases characterized by a significant hypogammaglobulinemia of unknown cause, failure to produce specific antibodies after immunizations and susceptibility to bacterial infections, predominantly caused by encapsulated bacteria.	common variable agammaglobulinemia;primary hypogammaglobulinemia;secondary hypogammaglobulinemia;CVID;idiopathic immunoglobulin deficiency;primary antibody deficiency;sporadic hypogammaglobulinemia	common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|B cell deficiency|inborn error of immunity|immune deficiency disease|immune system disease|disease|disposition|material property|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|B cell deficiency|inborn error of immunity|immune deficiency disease|genetic disorder|disease|disposition|material property|experimental factor; common variable immunodeficiency|hereditary neoplastic syndrome|neoplastic syndrome|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|B cell deficiency|immunodeficiency disease|genetic disorder|disease|disposition|material property|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|B cell deficiency|leukocyte disorder|immune system disease|disease|disposition|material property|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|B cell deficiency|immunodeficiency disease|genetic disorder|material entity|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|immunodeficiency predominantly affecting antibody production|primary immunodeficiency due to a defect in adaptive immunity|inborn error of immunity|immune deficiency disease|immune system disease|disease|disposition|material property|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|B cell deficiency|leukocyte disorder|hematologic disease|material entity|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|B cell deficiency|immunodeficiency disease|immune system disease|disease|disposition|material property|experimental factor; common variable immunodeficiency|hereditary neoplastic syndrome|neoplastic syndrome|syndromic disease|material entity|experimental factor; common variable immunodeficiency|hereditary neoplastic syndrome|neoplastic syndrome|syndromic disease|disease|disposition|material property|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|syndromic disease|material entity|experimental factor; common variable immunodeficiency|hereditary neoplastic syndrome|genetic disorder|material entity|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|immunodeficiency predominantly affecting antibody production|primary immunodeficiency due to a defect in adaptive immunity|inborn error of immunity|immune deficiency disease|genetic disorder|material entity|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|immunodeficiency predominantly affecting antibody production|primary immunodeficiency due to a defect in adaptive immunity|inborn error of immunity|immune deficiency disease|genetic disorder|disease|disposition|material property|experimental factor; common variable immunodeficiency|hereditary neoplastic syndrome|genetic disorder|disease|disposition|material property|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|B cell deficiency|inborn error of immunity|immune deficiency disease|genetic disorder|material entity|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|agammaglobulinemia|B cell deficiency|leukocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; common variable immunodeficiency|syndromic agammaglobulinemia|syndromic disease|disease|disposition|material property|experimental factor
EFO:0010690	renal dialysis	NA	kidneydialysis;artificial dialysis of kidney	renal dialysis|medical procedure|experimental process|planned process|process|experimental factor
MONDO:0004641	skin carcinoma in situ	A in situ carcinoma that involves the zone of skin.	zone of skin carcinoma in situ;skin cancer stage 0;carcinoma of the skin stage 0;stage 0 zone of skin carcinoma;skin carcinoma stage 0;cutaneous carcinoma in situ;skin carcinoma in situ;stage 0 skin cancer;carcinoma in situ of skin;stage 0 skin cancer aJCC v6;carcinoma in situ of zone of skin;carcinoma in situ of the skin;stage 0 skin cancer aJCC v7;stage 0 nonmelanoma skin carcinoma in situ;carcinoma of skin stage 0;zone of skin in situ carcinoma;stage 0 skin carcinoma;nonmelanoma carcinoma in situ	skin carcinoma in situ|in situ carcinoma|high grade malignant neoplasm|material entity|experimental factor; skin carcinoma in situ|in situ carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; skin carcinoma in situ|skin carcinoma|epithelial skin neoplasm|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; skin carcinoma in situ|skin carcinoma|epithelial skin neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; skin carcinoma in situ|skin carcinoma|skin cancer|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; skin carcinoma in situ|in situ carcinoma|high grade malignant neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; skin carcinoma in situ|in situ carcinoma|precancerous condition|cancer or benign tumor|disease|disposition|material property|experimental factor; skin carcinoma in situ|skin carcinoma|skin cancer|integumentary system cancer|integumentary system disease|disease|disposition|material property|experimental factor; skin carcinoma in situ|skin carcinoma|epithelial skin neoplasm|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; skin carcinoma in situ|skin carcinoma|skin cancer|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; skin carcinoma in situ|skin carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; skin carcinoma in situ|in situ carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; skin carcinoma in situ|skin carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; skin carcinoma in situ|skin carcinoma|skin cancer|integumentary system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0020981	dependence on enabling machines and devices	NA		dependence on enabling machines and devices|medical procedure|experimental process|planned process|process|experimental factor
EFO:0009293	percutaneous kidney biopsy	NA	percutaneous renal biopsy	percutaneous kidney biopsy|biopsy|collecting specimen from organism|specimen collection process|experimental process|planned process|process|experimental factor
EFO:0005708	renal cell adenocarcinoma	A carcinoma arising from the renal parenchyma. There is a strong correlation between cigarette smoking and the development of renal cell carcinoma. The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass. A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes. Radical nephrectomy is the standard intervention procedure. Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.	kidney adenocarcinoma;renal cell adenocarcinoma;renal cell carcinoma;renal cell carcinoma, stage unspecified;renal cell cancer;RCC;adenocarcinoma of kidney;adenocarcinoma of the kidney;carcinoma, renal cell, malignant	renal cell adenocarcinoma|renal cell carcinoma|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|renal carcinoma|kidney cancer|Malignant Urinary System Neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|renal carcinoma|kidney cancer|kidney neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|material entity|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|renal carcinoma|kidney cancer|Malignant Urinary System Neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|renal carcinoma|kidney cancer|kidney neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|renal carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|renal carcinoma|kidney cancer|kidney neoplasm|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|renal carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; renal cell adenocarcinoma|renal cell carcinoma|renal carcinoma|kidney cancer|Malignant Urinary System Neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0001715	volume	NA	NA	volume|size|morphology|quality|material property|experimental factor
MONDO:0013131	polycystic kidney disease 2	Autosomal dominant polycystic kidney disease caused by a mutation in PKD2.	Autosomal dominant polycystic kidney disease type 2;polycystic kidney disease, adult, type II;PKD2 autosomal dominant polycystic kidney disease;autosomal dominant polycystic kidney disease caused by mutation in PKD2;PKD2;polycystic kidney disease type 2;polycystic kidney disease 2;APKD2	polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|Polycystic Kidney Disease|familial cystic renal disease|genetic disorder|material entity|experimental factor; polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|male infertility|infertility|reproductive system disease|disease|disposition|material property|experimental factor; polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|autosomal dominant disease|autosomal genetic disease|genetic disorder|disease|disposition|material property|experimental factor; polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|Polycystic Kidney Disease|familial cystic renal disease|Cystic Kidney Disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|Rare genetic renal disease|genetic disorder|material entity|experimental factor; polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|Rare genetic renal disease|genetic disorder|disease|disposition|material property|experimental factor; polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|autosomal dominant disease|autosomal genetic disease|genetic disorder|material entity|experimental factor; polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|male infertility|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|Rare genetic renal disease|urinary system disease|disease|disposition|material property|experimental factor; polycystic kidney disease 2|Autosomal dominant polycystic kidney disease|Polycystic Kidney Disease|familial cystic renal disease|genetic disorder|disease|disposition|material property|experimental factor
EFO:1001505	cystic liver disease	NA	cystic disease of the liver	cystic liver disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; cystic liver disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0000660	polycystic ovary syndrome	A disorder that manifests as multiple cysts on the ovaries. It results in hormonal imbalances and leads to irregular and abnormal menstrual periods, excess growth of hair, acne eruptions and obesity.	Ovaries, Sclerocystic;Stein-Leventhal synd.;Ovary Syndrome, Polycystic;polycystic ovary;Stein-Leventhal syndrome;Ovarian Syndromes, Polycystic;polycystic ovary syndrome;Polycystic ovarian disease;Syndrome, Stein-Leventhal;polycystic ovaries;PCOD - Polycystic ovarian disease;Ovary, Sclerocystic;Sclerocystic Ovary;Sclerocystic Ovaries;Sclerocystic Ovarian Degeneration;polycystic ovarian disease;Polycystic ovaries (disorder);Polycystic ovaries;Cystic disease of ovaries;Polycystic ovarian syndrome;Ovarian Syndrome, Polycystic;PCO - Polycystic ovaries;multicystic ovaries;PCOS - Polycystic ovarian syndrome;Stein-Leventhal Syndrome;Syndrome, Polycystic Ovary;Multicystic ovaries;Sclerocystic Ovary Syndrome;Stein Leventhal Syndrome;Ovarian Degeneration, Sclerocystic;PCOS	polycystic ovary syndrome|ovarian disease|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; polycystic ovary syndrome|ovarian disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; polycystic ovary syndrome|genetic disorder|material entity|experimental factor; polycystic ovary syndrome|syndromic disease|disease|disposition|material property|experimental factor; polycystic ovary syndrome|syndromic disease|material entity|experimental factor; polycystic ovary syndrome|ovarian disease|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; polycystic ovary syndrome|genetic disorder|disease|disposition|material property|experimental factor
CHEBI:62932	mycophenolate	NA	(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate;mycophenolate	mycophenolate|chemical entity|material entity|experimental factor
EFO:1002039	renal hypertension	Hypertension caused by the kidney's hormonal response to narrowing or occlusion of the renal arteries.	renal hypertension	renal hypertension|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; renal hypertension|secondary hypertension|hypertension|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0009642	follow-up	NA	follow up	follow-up|medical procedure|experimental process|planned process|process|experimental factor
EFO:0008458	tacrolimus measurement	NA	tacrolimus hydrate measurement	tacrolimus measurement|tacrolimus hydrate|chemical entity|material entity|experimental factor; tacrolimus measurement|measurement|information entity|experimental factor
CHEBI:2948	azathioprine	NA	6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine	azathioprine|thiopurine|organic heterocyclic compound|chemical entity|material entity|experimental factor
EFO:0010134	kidney transplant	NA	NA	kidney transplant|medical procedure|experimental process|planned process|process|experimental factor
EFO:0003103	urinary tract infection	NA	urinary tract infection;TRACT, INFECTION OF URINARY;urinary tract infection (disease);INFECTION, URINARY TRACT	urinary tract infection|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
MONDO:0002281	macrocytic anemia	Anemia that is characterized by increased red blood cell volume.	macrocytic anemia (disease);macrocytic Anemia;anemia macrocytic;D22S676;macrocytic anaemia of unspecified cause;D22S750;macrocytic anemia;macrocytic anaemia	macrocytic anemia|anemia|hematologic disease|material entity|experimental factor; macrocytic anemia|anemia|hematologic disease|disease|disposition|material property|experimental factor
CHEBI:47426	furosemide	NA	4-chloro-2-{[(furan-2-yl)methyl]amino}-5-sulfamoylbenzoic acid;Furosemide	furosemide|organic heterocyclic compound|chemical entity|material entity|experimental factor
CHEBI:4031	cyclosporin A	NA	30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Cyclosporin A;cyclosporin A	cyclosporin A|chemical entity|material entity|experimental factor
CHEBI:8378	prednisolone	NA	11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione	prednisolone|steroid hormone|steroid|lipid|chemical entity|material entity|experimental factor
EFO:0007697	left superior temporal gyrus grey matter volume measurement	NA		left superior temporal gyrus grey matter volume measurement|grey matter volume measurement|brain volume measurement|nervous system measurement|measurement|information entity|experimental factor; left superior temporal gyrus grey matter volume measurement|grey matter volume measurement|brain volume measurement|brain measurement|measurement|information entity|experimental factor; left superior temporal gyrus grey matter volume measurement|grey matter volume measurement|mental or behavioural disorder biomarker|measurement|information entity|experimental factor
EFO:0009472	tympanic membrane perforation	NA		tympanic membrane perforation|Abnormality of the ear|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0004190	open-angle glaucoma	Chronic outflow obstruction of the eye's drainage canals that can lead to increased internal eye pressure and optic nerve damage.	wide-angle glaucoma;primary open angle glaucoma;open angle glaucoma;glaucoma simplex;glaucoma, primary open angle;glaucoma, open-angle;POAG;pigmentary glaucoma;open-angle glaucoma;glaucoma (primary open-angle)	open-angle glaucoma|glaucoma|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; open-angle glaucoma|glaucoma|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor
EFO:0008320	white matter volume measurement	NA		white matter volume measurement|brain volume measurement|nervous system measurement|measurement|information entity|experimental factor; white matter volume measurement|brain volume measurement|brain measurement|measurement|information entity|experimental factor
EFO:0007157	aspergillosis	Aspergillosis is an infection, growth, or allergic response caused by the Aspergillus fungus. There are several different kinds of aspergillosis. One kind is allergic bronchopulmonary aspergillosis (also called ABPA), a condition where the fungus causes allergic respiratory symptoms similar to asthma, such as wheezing and coughing, but does not actually invade and destroy tissue. Another kind of aspergillosis is invasive aspergillosis. This infection usually affects people with weakened immune systems due to cancer, AIDS, leukemia, organ transplantation, chemotherapy, or other conditions or events that reduce the number of normal white blood cells. In this condition, the fungus invades and damages tissues in the body. Invasive aspergillosis most commonly affects the lungs, but can also cause infection in many other organs and can spread throughout the body (commonly affecting the kidneys and brain). Aspergilloma, a growth (fungus ball) that develops in an area of previous lung disease such as tuberculosis or lung abscess, is a third kind of aspergillosis. This type of aspergillosis is composed of a tangled mass of fungus fibers, blood clots, and white blood cells. The fungus ball gradually enlarges, destroying lung tissue in the process, but usually does not spread to other areas.	infection due to Aspergillus;Aspergillosis;Infection due to Aspergillus;aspergillosis	aspergillosis|opportunistic mycosis|material entity|experimental factor; aspergillosis|opportunistic mycosis|fungal infectious disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0009488	spinal cord disease	A disease involving the spinal cord.	spinal cord disease;disease of spinal cord;disease of the spinal cord;disease or disorder of spinal cord;spinal cord disease or disorder;spinal cord disorder;disorder of spinal cord	spinal cord disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0007148	aortic valve insufficiency	Dysfunction of the aortic valve characterized by incomplete valve closure.	rheumatic aortic regurgitation;rheumatic aortic valve regurgitation;Rheumatic aortic valve regurgitation;Rheumatic aortic regurgitation;rheumatic aortic valve insufficiency;aortic regurgitation;aortic incompetence;aortic insufficiency;Aortic Valve Insufficiency;rheumatic aortic insufficiency;aortic valve insufficiency;Rheumatic aortic insufficiency	aortic valve insufficiency|aortic valve disease|aortic disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve insufficiency|aortic valve disease|cardiac ventricle disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve insufficiency|aortic valve disease|heart valve disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; aortic valve insufficiency|vascular insufficiency disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
HP:0002353	EEG abnormality	Abnormality observed by electroencephalogram (EEG), which is used to record of the brain's spontaneous electrical activity from multiple electrodes placed on the scalp.	EEG abnormalities;Abnormal EEG;Electroencephalogram abnormal;Electroencephalogram abnormalities;Abnormal electroencephalogram	EEG abnormality|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007215	composite lymphoma	Coexistence of Hodgkin and non-Hodgkin lymphoma in the same anatomic site.	composite lymphoma;composite Hodgkin and non-Hodgkin lymphoma	composite lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; composite lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; composite lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; composite lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; composite lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; composite lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; composite lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; composite lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; composite lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; composite lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; composite lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0021662	Phenyllactate (PLA) measurement	NA		Phenyllactate (PLA) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0020023	N-acetyltaurine measurement	Quantification of N-acetyltaurine levels in a sample.	NAcT measurement	N-acetyltaurine measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:16682	N-acetyl-beta-alanine	NA	3-acetamidopropanoic acid;N-Acetyl-beta-alanine	N-acetyl-beta-alanine|chemical entity|material entity|experimental factor
EFO:0003099	Cushing syndrome	Cushing's syndrome (CS) encompasses a group of hormonal disorders caused by prolonged and high exposure levels to glucocorticoids that can be of either endogenous (adrenal cortex production) or exogenous (iatrogenic) origin.	Cushing's syndrome NOS;suprarenogenic syndrome;Cushing's syndrome;cortisol Excess;Cushing syndrome;pituitary basophilism;Cushing's syndrome NOS (disorder);Suprarenogenic syndrome;hyperadrenocorticism;hypercorticism	Cushing syndrome|adrenal gland disease|endocrine system disease|disease|disposition|material property|experimental factor; Cushing syndrome|syndromic disease|material entity|experimental factor; Cushing syndrome|syndromic disease|disease|disposition|material property|experimental factor
EFO:0004304	blood sedimentation	NA	erythrocyte sedimentation;erythrocyte sedimentation rate	blood sedimentation|inflammatory biomarker measurement|measurement|information entity|experimental factor; blood sedimentation|hematological measurement|measurement|information entity|experimental factor
EFO:0800136	S-1-pyrroline-5-carboxylate measurement	NA		S-1-pyrroline-5-carboxylate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800100	N6,N6-dimethyllysine measurement	NA		N6,N6-dimethyllysine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800705	X-12112 measurement	NA		X-12112 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800061	N6-methyllysine measurement	NA		N6-methyllysine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0007196	Cauda equina syndrome	Cauda equina syndrome refers to a group of symptoms that occur when some of the nerves in the cauda equina (the bundle of nerves that spread out from the bottom of the spinal cord) become compressed and/or damaged. Signs and symptoms of this condition include pain, numbness, or tingling in the lower back and/or legs; ' foot drop '; problems with bowel and/or bladder control; and sexual dysfunction. Cauda equina syndrome may be caused by a herniated disk, tumor, infection, fracture, or spinal stenosis. Treatment usually targets the underlying cause of the condition and often includes surgery to remove the material that is pressing on the nerves. Physical therapy, occupational therapy, and/or other services may be required if symptoms persist following surgery.	cauda equina syndrome;Polyradiculopathy;syndromic disease of cauda equina;cauda equina syndromic disease	Cauda equina syndrome|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; Cauda equina syndrome|syndromic disease|material entity|experimental factor; Cauda equina syndrome|syndromic disease|disease|disposition|material property|experimental factor
EFO:0009757	idiopathic type 1 diabetes	NA	type 1B	idiopathic type 1 diabetes|type 1 diabetes mellitus|diabetes mellitus|endocrine pancreas disorder|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor; idiopathic type 1 diabetes|type 1 diabetes mellitus|autoimmune disorder of gastrointestinal tract|digestive system disease|disease|disposition|material property|experimental factor; idiopathic type 1 diabetes|type 1 diabetes mellitus|autoimmune disorder of endocrine system|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; idiopathic type 1 diabetes|type 1 diabetes mellitus|diabetes mellitus|glucose metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; idiopathic type 1 diabetes|type 1 diabetes mellitus|autoimmune disorder of endocrine system|endocrine system disease|disease|disposition|material property|experimental factor; idiopathic type 1 diabetes|type 1 diabetes mellitus|autoimmune disorder of gastrointestinal tract|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; idiopathic type 1 diabetes|type 1 diabetes mellitus|diabetes mellitus|endocrine pancreas disorder|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor
MONDO:0007669	renal cysts and diabetes syndrome	Renal cysts and diabetes syndrome (RCAD) is a rare form of maturity-onset diabetes of the young (MODY) characterized clinically by heterogeneous cystic renal disease and early-onset familial non-autoimmune diabetes. Pancreatic atrophy, liver dysfunction and genital tract anomalies are also features of the syndrome.	hypoplastic type glomerulocystic kidney disease;MODY5;renal dysfunction-early-onset diabetes syndrome;HNF1B-related renal cysts and diabetes syndrome;RCAD;hepatocyte nuclear Factor 1-beta-associated monogenic diabetes;maturity onset diabetes of the Young, type 5;CAKUT with diabetes;HNF1B-MODY;RCAD syndrome;renal cysts-maturity-onset diabetes of the young syndrome;atypical FJHN;atypical familial juvenile hyperuricemic nephropathy;familial hypoplastic glomerulocystic kidney;congenital anomalies of the kidney and urinary tract with diabetes;renal cysts and diabetes syndrome	renal cysts and diabetes syndrome|maturity-onset diabetes of the young|diabetes mellitus|glucose metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|inborn disorder of purine or pyrimidine metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|inborn disorder of purine or pyrimidine metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|pyruvate metabolism disorder|disorder of organic acid metabolism|metabolic disease|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|inborn carbohydrate metabolic disorder|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|pyruvate metabolism disorder|inborn disorder of energy metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|pyruvate metabolism disorder|inborn disorder of amino acid and other organic acid metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|pyruvate metabolism disorder|inborn disorder of amino acid and other organic acid metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|syndromic disease|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|syndromic disease|material entity|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|diabetes mellitus|endocrine pancreas disorder|pancreas disease|endocrine system disease|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|inborn disorder of purine or pyrimidine metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|inborn carbohydrate metabolic disorder|inborn errors of metabolism|genetic disorder|material entity|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|inborn carbohydrate metabolic disorder|carbohydrate metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|pyruvate metabolism disorder|inborn disorder of energy metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|diabetes mellitus|endocrine pancreas disorder|pancreas disease|digestive system disease|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|pyruvate metabolism disorder|inborn disorder of amino acid and other organic acid metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|inborn carbohydrate metabolic disorder|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; renal cysts and diabetes syndrome|maturity-onset diabetes of the young|disorder of glycolysis|pyruvate metabolism disorder|inborn disorder of energy metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor
CHEBI:82931	4-vinylphenol sulfate	NA	4-ethenylphenyl hydrogen sulfate	4-vinylphenol sulfate|chemical entity|material entity|experimental factor
MONDO:0002036	penile disorder	A non-neoplastic or neoplastic disorder that affects the penis. Representative examples of non-neoplastic disorders include phimosis, balanitis, and hypospadias. Representative examples of neoplastic disorders include hemangioma, penile intraepithelial neoplasia, and penile carcinoma.	disease or disorder of penis;disease of penis;disorder of penis;penis disease;penile disease;penile disorder;penis disease or disorder	penile disorder|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0801045	3-(methylthio)acetaminophen sulfate measurement	NA		3-(methylthio)acetaminophen sulfate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0008518	polymyalgia rheumatica	A syndrome characterized by pain, stiffness, and tenderness of the proximal muscle groups including the shoulder, pelvic girdle and the neck. There is no muscle atrophy and muscle biopsies do not reveal pathologic changes. Additional signs and symptoms include low grade fever, fatigue and depression.	polymyalgia rheumatica;rhizomelic pseudopolyarthritis	polymyalgia rheumatica|syndromic disease|material entity|experimental factor; polymyalgia rheumatica|myopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; polymyalgia rheumatica|syndromic disease|disease|disposition|material property|experimental factor; polymyalgia rheumatica|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; polymyalgia rheumatica|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor
EFO:1001219	trigeminal neuralgia	Trigeminal neuralgia is a nerve disorder that causes a stabbing or electric-shock-like pain in parts of the face. The pain lasts a few seconds to a few minutes, and usually on only one side of the face. It can also cause muscle spasms in the face the same time as the pain. The pain may result from a blood vessel pressing against the trigeminal nerve (the nerve that carries pain, feeling, and other sensations from the brain to the skin of theface), as a complication of multiple sclerosis, or due to compression of the nerve by a tumor or cyst. In some cases, the cause is unknown. Treatment options include medicines, surgery, and complementary approaches.	Trigeminal neuralgia;trigeminal neuralgia;neuralgia of trigeminal nerve;Trigeminal neuralgia (disorder);Trigeminal neuralgia NOS (disorder);trifocal neuralgia;trigeminal nerve neuralgia;Trifacial neuralgia;Trigeminal Neuralgia;trifacial neuralgia;Trigeminal neuralgia [no drugs here] (disorder)	trigeminal neuralgia|cranial neuralgia|neuralgia|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; trigeminal neuralgia|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; trigeminal neuralgia|cranial neuralgia|neuralgia|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; trigeminal neuralgia|cranial neuralgia|acquired peripheral neuropathy|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; trigeminal neuralgia|trigeminal nerve disease|cranial nerve neuropathy|nervous system disease|disease|disposition|material property|experimental factor; trigeminal neuralgia|cranial neuralgia|acquired peripheral neuropathy|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; trigeminal neuralgia|trigeminal nerve disease|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; trigeminal neuralgia|cranial neuralgia|cranial nerve neuropathy|nervous system disease|disease|disposition|material property|experimental factor; trigeminal neuralgia|cranial neuralgia|neuralgia|neurological pain disorder|nervous system disease|disease|disposition|material property|experimental factor; trigeminal neuralgia|cranial neuralgia|acquired peripheral neuropathy|material entity|experimental factor
EFO:0002614	insulin resistance	NA	Drug resistance to insulin (disorder);IR	insulin resistance|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1000714	impetigo	NA		impetigo|Pyoderma|Inflammatory abnormality of the skin|Abnormality of the skin|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor; impetigo|Pyoderma|Recurrent infections|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; impetigo|Pyoderma|Inflammatory abnormality of the skin|Increased inflammatory response|Abnormal inflammatory response|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0010453	adenosine measurement	NA		adenosine measurement|nucleoside measurement|measurement|information entity|experimental factor
HP:0001250	Seizure	A seizure is an intermittent abnormality of nervous system physiology characterised by a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain.	Seizures;Epileptic seizure	Seizure|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0020950	apolipoprotein C measurement	NA		apolipoprotein C measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
CHEBI:27732	caffeine	NA	1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione;Caffeine;CAFFEINE;caffeine	caffeine|organic heterocyclic compound|chemical entity|material entity|experimental factor
EFO:1001497	cardiac conduction defect	NA	SCD;sudden cardiac death;nonspecific cardiac conduction defect;cardiac conduction defect, nonspecific	cardiac conduction defect|cardiac arrhythmia|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0010291	cerebellar cortex volume measurement	NA	cerebellum cortex volume measurement	cerebellar cortex volume measurement|cerebellar volume measurement|brain volume measurement|brain measurement|measurement|information entity|experimental factor; cerebellar cortex volume measurement|cerebellar volume measurement|brain volume measurement|nervous system measurement|measurement|information entity|experimental factor
HP:0001395	Hepatic fibrosis	The presence of excessive fibrous connective tissue in the liver. Fibrosis is a reparative or reactive process.	Liver fibrosis	Hepatic fibrosis|Abnormality of the liver|Abnormality of the abdominal organs|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
Orphanet:331244	Other immunodeficiency syndrome with predominantly antibody defects	NA		
HP:0031685	Abnormal stool composition	NA	Abnormal faeces composition;Abnormal feces composition	Abnormal stool composition|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Abnormal stool composition|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0009373	edema	NA	Fluid retention;Oedema;Dropsy;Water retention;Hydrops	edema|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
HP:0001822	Hallux valgus	Lateral deviation of the great toe (i.e., in the direction of the little toe).	Lateral deviation of great toe;Lateral deviation of halluces;Bunion	Hallux valgus|Abnormality of toe|Abnormal digit morphology|Abnormal skeletal morphology|Abnormality of the skeletal system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Hallux valgus|Abnormality of toe|Abnormal digit morphology|Abnormality of limbs|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Hallux valgus|Abnormality of toe|Abnormal foot morphology|Abnormality of the lower limb|Abnormality of limbs|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:23965	estradiol	NA	estra-1,3,5(10)-triene-3,17-diol	estradiol|phenols|chemical entity|material entity|experimental factor; estradiol|steroid|lipid|chemical entity|material entity|experimental factor
HP:0000540	Hypermetropia	An abnormality of refraction characterized by the ability to see objects in the distance clearly, while objects nearby appear blurry.	Farsightedness;Hyperopia;Long-sightedness	Hypermetropia|Abnormality of refraction|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0800384	glycochenodeoxycholate 3-sulfate measurement	NA		glycochenodeoxycholate 3-sulfate measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:16958	beta-alanine	NA	beta-alanine;beta-Alanine;BETA-ALANINE;3-aminopropanoic acid	beta-alanine|amino acid|acid|chemical entity|material entity|experimental factor
MONDO:0021678	gram-negative bacterial infections	Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.		gram-negative bacterial infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0004279	suntan	NA		suntan|skin pigmentation|phenotype|quality|material property|experimental factor
MONDO:0000153	transposition of the great arteries	A congenital cardiac defect in which two heart vessels are reversed (transposed).	transposition of the great vessels;complete transposition;TGA;TGV;transposition of great vessels;great vessels transposition	transposition of the great arteries|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|genetic disorder|disease|disposition|material property|experimental factor; transposition of the great arteries|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|genetic disorder|material entity|experimental factor; transposition of the great arteries|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; transposition of the great arteries|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|congenital heart disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; transposition of the great arteries|transposition of the great arteries and conotruncal cardiac anomaly|congenital heart malformation|congenital heart disease|congenital anomaly of cardiovascular system|cardiovascular disease|disease|disposition|material property|experimental factor
MONDO:0020831	congenital vertebral-cardiac-renal anomalies syndrome	NA	VCRL;vertebral, cardiac, renal, and limb defects syndrome	congenital vertebral-cardiac-renal anomalies syndrome|multiple congenital anomalies/dysmorphic syndrome without intellectual disability|multiple congenital anomalies/dysmorphic syndrome|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; congenital vertebral-cardiac-renal anomalies syndrome|autosomal recessive disease|autosomal genetic disease|genetic disorder|material entity|experimental factor; congenital vertebral-cardiac-renal anomalies syndrome|multiple congenital anomalies/dysmorphic syndrome without intellectual disability|multiple congenital anomalies/dysmorphic syndrome|material entity|experimental factor; congenital vertebral-cardiac-renal anomalies syndrome|autosomal recessive disease|autosomal genetic disease|genetic disorder|disease|disposition|material property|experimental factor; congenital vertebral-cardiac-renal anomalies syndrome|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
CHEBI:22653	asparagine	NA	asparagine	asparagine|amino acid|acid|chemical entity|material entity|experimental factor
EFO:0021650	Methionine sulfoxide measurement	NA		Methionine sulfoxide measurement|metabolite measurement|measurement|information entity|experimental factor
CHEBI:27897	tryptophan	NA	tryptophan;Tryptophan	tryptophan|amino acid|acid|chemical entity|material entity|experimental factor; tryptophan|organic heterocyclic compound|chemical entity|material entity|experimental factor
EFO:0800715	X-12410 measurement	NA		X-12410 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800749	X-15461 measurement	NA		X-15461 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0021522	urinary sodium measurement	NA	sodium in urine	urinary sodium measurement|urinary metabolite measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0009537	cervical disc degenerative disorder	Any degenerative disorder affecting one or more vertebral discs of the cervical spine.	cervical Disc Degeneration;cervical Disc degenerative disorder;intervertebral disc degenerative disorder of cervical region of vertebral column;cervical Disc degenerative disease;degeneration of cervical intervertebral disc;cervical region of vertebral column intervertebral disc degenerative disorder;cervical disc degenerative disorder	cervical disc degenerative disorder|head and neck disorder|disease|disposition|material property|experimental factor; cervical disc degenerative disorder|lumbar disc degeneration|genetic disorder|material entity|experimental factor; cervical disc degenerative disorder|lumbar disc degeneration|vertebral joint disease|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; cervical disc degenerative disorder|lumbar disc degeneration|vertebral joint disease|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; cervical disc degenerative disorder|lumbar disc degeneration|genetic disorder|disease|disposition|material property|experimental factor
CHEBI:23614	deoxycholate	NA	deoxycholate;3alpha,12alpha-dihydroxy-5beta-cholan-24-oate	deoxycholate|chemical entity|material entity|experimental factor
CHEBI:30839	orotate	NA	orotate;2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate	orotate|chemical entity|material entity|experimental factor
EFO:0009671	hereditary ataxia	An instance of an atactic disorder that is caused by an inherited genomic modification in an individual.	rare hereditary ataxia;hereditary ataxia	hereditary ataxia|atactic disorder|nervous system disease|disease|disposition|material property|experimental factor; hereditary ataxia|inherited neurodegenerative disorder|genetic disorder|disease|disposition|material property|experimental factor; hereditary ataxia|inherited neurodegenerative disorder|genetic disorder|material entity|experimental factor; hereditary ataxia|inherited neurodegenerative disorder|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0800983	3-acetylphenol sulfate measurement	NA		3-acetylphenol sulfate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0002430	primary myelofibrosis	Myelofibrosis with myeloid metaplasia is a myeloproliferative disease with annual incidence of approximately 1 case per 100,000 individuals and age at diagnosis around 60 (an increased prevalence is noted in Ashkenazi Jews). Clinical manifestations depend on the type of blood cell affected and may include anemia, pallor, splenomegaly, hypermetabolic state, petechiae, ecchymosis, bleeding, lymphadenopathy, hepatomegaly, portal hypertension.	idiopathic myelofibrosis;myelosclerosis;AMM;chronic idiopathic myelofibrosis;myelofibrosis with myeloid metaplasia;primary myelofibrosis;megakaryocytic myelosclerosis;myelosclerosis with myeloid metaplasia;bone marrow fibrosis;Agnogenic myeloid metaplasia;myelofibrosis with myeloid metaplasia, somatic;aleukemic myelosis;myelofibrosis, somatic;idiopathic bone marrow fibrosis;osteomyelofibrosis;CIMF	primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|immune system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; primary myelofibrosis|inherited aplastic anemia|genetic disorder|material entity|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; primary myelofibrosis|hereditary disorder of connective tissue|connective tissue disease|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|hematologic disease|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; primary myelofibrosis|inherited aplastic anemia|aplastic anemia|anemia|hematologic disease|disease|disposition|material property|experimental factor; primary myelofibrosis|inherited aplastic anemia|genetic disorder|disease|disposition|material property|experimental factor; primary myelofibrosis|inherited aplastic anemia|aplastic anemia|anemia|hematologic disease|material entity|experimental factor; primary myelofibrosis|myeloproliferative disorder|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary myelofibrosis|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|immune system cancer|immune system disease|disease|disposition|material property|experimental factor; primary myelofibrosis|myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; primary myelofibrosis|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; primary myelofibrosis|myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|musculoskeletal system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|hematologic disease|material entity|experimental factor; primary myelofibrosis|hereditary disorder of connective tissue|genetic disorder|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|immune system disease|disease|disposition|material property|experimental factor; primary myelofibrosis|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; primary myelofibrosis|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; primary myelofibrosis|hereditary disorder of connective tissue|genetic disorder|material entity|experimental factor; primary myelofibrosis|fibrosis|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|musculoskeletal system cancer|musculoskeletal system disease|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|bone marrow neoplasm|bone marrow disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; primary myelofibrosis|myeloproliferative disorder|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|myeloid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|bone marrow cancer|Malignant Bone Neoplasm|bone neoplasm|material entity|experimental factor; primary myelofibrosis|myeloproliferative disorder|myeloid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; primary myelofibrosis|chronic myeloproliferative disorder|chronic disease|disease|disposition|material property|experimental factor
GO:0042493	response to drug	NA	drug resistance;drug susceptibility/resistance	response to drug|response to stimulus|biological process|process|experimental factor
EFO:0005420	grey matter volume measurement	NA		grey matter volume measurement|brain volume measurement|brain measurement|measurement|information entity|experimental factor; grey matter volume measurement|brain volume measurement|nervous system measurement|measurement|information entity|experimental factor; grey matter volume measurement|mental or behavioural disorder biomarker|measurement|information entity|experimental factor
EFO:0800602	3-hydroxy-3-methylglutarate measurement	NA		3-hydroxy-3-methylglutarate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800380	adipoylcarnitine (C6-DC) measurement	NA		adipoylcarnitine (C6-DC) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1001811	Monteggia's fracture	NA	Monteggia's fracture of ulna	Monteggia's fracture|ulna fracture|upper extremity fracture|bone fracture|injury|disease|disposition|material property|experimental factor; Monteggia's fracture|ulna fracture|upper extremity fracture|bone fracture|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0021241	X-11470 measurement	NA		X-11470 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0005092	entorhinal cortical volume	NA		entorhinal cortical volume|brain volume measurement|nervous system measurement|measurement|information entity|experimental factor; entorhinal cortical volume|brain volume measurement|brain measurement|measurement|information entity|experimental factor
EFO:1001055	myxedema	A condition characterized by severe hypothyroidism that is caused by autoimmune thyroid gland disorders, surgical reduction of thyroid tissue, radiation exposure, and viral infections. Signs and symptoms include generalized fatigue, lethargy, increased body weight, pale, edematous and thickened skin, low blood pressure, constipation and cold intolerance.	myxedema;myxoedema;Myxedema;Myxedema (disorder);MYXEDEMA;Myxoedema	myxedema|hypothyroidism|thyroid disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0000759	lipoma	A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue.	lipoma;lipomatous neoplasm;lipomatosis, familial multiple;lipomatous neoplasm (morphologic abnormality);lipomatous tumor;benign tumor of adipose tissue;lipoma, benign	lipoma|benign lipomatous neoplasm|tumor of adipose tissue|connective tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; lipoma|benign lipomatous neoplasm|benign connective and soft tissue neoplasm|connective and soft tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lipoma|benign lipomatous neoplasm|tumor of adipose tissue|connective tissue neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lipoma|benign lipomatous neoplasm|benign connective and soft tissue neoplasm|musculoskeletal system benign neoplasm|musculoskeletal system disease|disease|disposition|material property|experimental factor; lipoma|benign lipomatous neoplasm|tumor of adipose tissue|mesenchymal cell neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; lipoma|benign lipomatous neoplasm|benign connective and soft tissue neoplasm|connective tissue disease|disease|disposition|material property|experimental factor; lipoma|benign lipomatous neoplasm|benign connective and soft tissue neoplasm|musculoskeletal system benign neoplasm|benign neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
CHEBI:17368	hypoxanthine	NA	hypoxanthine;Hypoxanthine;1,7-dihydro-6H-purin-6-one;HYPOXANTHINE	hypoxanthine|organic heterocyclic compound|chemical entity|material entity|experimental factor
EFO:0003906	heart valve prosthesis	NA	Implantation, Heart Valve Prosthesis;Prostheses, Cardiac Valve;Valve Prostheses, Heart;Prostheses, Heart Valve;Valve Prosthesis, Heart;Cardiac Valve Prostheses;Valve Prostheses, Cardiac;Prosthesis, Cardiac Valve;Valve Prosthesis, Cardiac;Cardiac Valve Prosthesis;Heart Valve Prosthesis Implantation;Prosthesis, Heart Valve;Heart Valve Prostheses	heart valve prosthesis|medical procedure|experimental process|planned process|process|experimental factor
EFO:0003032	anaplastic large cell lymphoma	Anaplastic large cell lymphoma (ALCL) is a rare and aggressive peripheral T-cell non-Hodgkin lymphoma, belonging to the group of CD30-positive lymphoproliferative disorders, which affects lymph nodes and extranodal sites. It is comprised of two sub-types, based on the expression of a protein called anaplastic lymphoma kinase (ALK): ALK positive and ALK negative ALCL.	anaplastic large cell lymphoma;CD30 positive anaplastic large cell lymphoma;ALCL;Ki-1 positive anaplastic large cell lymphoma;sACL;primary systemic ALCL;Ki-1 lymphoma;CD30 Positive anaplastic large cell lymphoma;Ki-1+ ALCL;Ki-1+ anaplastic large cell lymphoma	anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|neoplasm of mature T-cells or NK-cells|T-cell and NK-cell neoplasm|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|neoplasm of mature T-cells or NK-cells|T-cell and NK-cell neoplasm|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|neoplasm of mature T-cells or NK-cells|T-cell and NK-cell neoplasm|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; anaplastic large cell lymphoma|mature T-cell and NK-cell non-Hodgkin lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
HP:0011142	Age-related nuclear cataract	A type of age-related cataract that primarily affects the nucleus of the lens.		Age-related nuclear cataract|Age-related cataract|Abnormal lens morphology|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0000519	Developmental cataract	A cataract that occurs congenitally as the result of a developmental defect, in contrast to the majority of cataracts that occur in adulthood as the result of degenerative changes of the lens.	Cataract, congenital;Congenital cataracts, bilateral;Clouding of the lens of the eye at birth;Congenital cataracts;Bilateral congenital cataracts;Congenital cataract	Developmental cataract|Ocular anterior segment dysgenesis|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Developmental cataract|Abnormal lens morphology|Abnormality of the eye|Phenotypic abnormality|phenotype|quality|material property|experimental factor
HP:0001760	Abnormal foot morphology	An abnormality of the skeleton of foot.	Abnormality of the foot;Foot deformity;Abnormal feet structure;Foot deformities;Abnormality of the feet	Abnormal foot morphology|Abnormality of the lower limb|Abnormality of limbs|Phenotypic abnormality|phenotype|quality|material property|experimental factor
Orphanet:1479	Atrial septal defect - atrioventricular conduction defects	NA		
EFO:1001486	primary biliary cirrhosis	Primary biliary cholangitis (PBC) is a chronic and slowly progressive cholestatic liver disease of autoimmune etiology characterized by injury of the intrahepatic bile ducts that may eventually lead to liver failure.	primary biliary cirrhosis;cholestatic cirrhosis;PBC;biliary liver cirrhosis;primary biliary cholangitis;chronic non-suppurative destructive cholangitis;primary Bilary cirrhosis (PBC);chronic nonsuppurative destructive cholangitis;Hanot syndrome	primary biliary cirrhosis|cirrhosis, familial|genetic disorder|disease|disposition|material property|experimental factor; primary biliary cirrhosis|cirrhosis, familial|telomere syndrome|premature aging syndrome|material entity|experimental factor; primary biliary cirrhosis|genetic biliary tract disease|genetic disorder|disease|disposition|material property|experimental factor; primary biliary cirrhosis|genetic biliary tract disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; primary biliary cirrhosis|cirrhosis, familial|cirrhosis of liver|fibrosis|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary biliary cirrhosis|biliary liver cirrhosis|cirrhosis of liver|fibrosis|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; primary biliary cirrhosis|cirrhosis, familial|telomere syndrome|premature aging syndrome|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; primary biliary cirrhosis|biliary liver cirrhosis|cirrhosis of liver|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; primary biliary cirrhosis|genetic biliary tract disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; primary biliary cirrhosis|cirrhosis, familial|genetic disorder|material entity|experimental factor; primary biliary cirrhosis|genetic biliary tract disease|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; primary biliary cirrhosis|cirrhosis, familial|cirrhosis of liver|liver disease|endocrine system disease|disease|disposition|material property|experimental factor; primary biliary cirrhosis|cirrhosis, familial|cirrhosis of liver|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; primary biliary cirrhosis|genetic biliary tract disease|genetic disorder|material entity|experimental factor; primary biliary cirrhosis|biliary liver cirrhosis|cirrhosis of liver|liver disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0800839	X-22162 measurement	NA		X-22162 measurement|metabolite measurement|measurement|information entity|experimental factor
Orphanet:220448	Macrothrombocytopenia with mitral valve insufficiency	NA		
EFO:0010674	cardioverter defibrillator	NA	automated implantable cardioverter-defibrillator;automated implantable cardiac defibrillator;in situ cardioverter-defibrillator;cardiac defibrillator in situ;in-situ cardioverter-defibrillator;implantable cardioverter-defibrillator;cardioverter-defibrillator;in-situ cardiac defibrillator;in situ cardiac defibrillator	cardioverter defibrillator|medical procedure|experimental process|planned process|process|experimental factor
HP:0004751	Paroxysmal ventricular tachycardia	NA	Episodes of ventricular tachycardia	Paroxysmal ventricular tachycardia|Tachycardia|Ventricular arrhythmia|Abnormality of cardiovascular system electrophysiology|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
CHEBI:10033	warfarin	NA	rac-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one	warfarin|chemical entity|material entity|experimental factor
HP:0006699	Premature atrial contractions	NA	Atrial premature complex;Premature supraventricular beats;Ectopic supraventricular rhythms;PACs;Atrial ectopic beats	Premature atrial contractions|Abnormality of cardiovascular system electrophysiology|Abnormal cardiovascular system physiology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0005527	ejection fraction measurement	NA		ejection fraction measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
EFO:0009276	ventricular ectopy	NA	ventricular ectopic beats;VPB;premature ventricular beats;VPCs;ventricular ectopics;extrasystole;premature ventricular contractions;premature ventricular complex;PVC;PVCs	ventricular ectopy|premature cardiac contractions|cardiac arrhythmia|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0010813	fasting C-peptide measurement	NA	NA	fasting C-peptide measurement|C-peptide measurement|insulin secretion measurement|insulin measurement|diabetes mellitus biomarker|measurement|information entity|experimental factor; fasting C-peptide measurement|C-peptide measurement|cancer biomarker measurement|measurement|information entity|experimental factor; fasting C-peptide measurement|C-peptide measurement|insulin secretion measurement|insulin measurement|hormone measurement|measurement|information entity|experimental factor; fasting C-peptide measurement|C-peptide measurement|insulin secretion measurement|insulin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800889	X-24494 measurement	NA		X-24494 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800474	glycochenodeoxycholate glucuronide (1) measurement	NA		glycochenodeoxycholate glucuronide (1) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800552	cortolone glucuronide (1) measurement	NA		cortolone glucuronide (1) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800163	alpha-CEHC glucuronide measurement	NA		alpha-CEHC glucuronide measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0008004	resting metabolic rate measurement	NA	RMR measurement	resting metabolic rate measurement|metabolic rate measurement|measurement|information entity|experimental factor
EFO:0010641	3-ureidopropionate measurement	NA	N-carbamoyl-beta-alaninate measurement	3-ureidopropionate measurement|metabolite measurement|measurement|information entity|experimental factor
MONDO:0021739	prurigo	A name applied to several itchy skin eruptions of unknown cause. The characteristic course is the formation of a dome-shaped papule with a small transient vesicle on top, followed by crusting over or lichenification. (From Dorland, 27th ed)	prurigo;pruritic rash	prurigo|exanthem|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0007205	Chlamydia trachomatis infectious disease	An infection that is caused by Chlamydia trachomatis.	Chlamydia Infections;chlamydial disease;Chlamydia trachomatis disease or disorder;chlamydia trachomatis infectious disease;Chlamydia trachomatis caused disease or disorder;Chlamydial Infection;Chlamydia trachomatis infectious disease;Chlamydial infection	Chlamydia trachomatis infectious disease|Chlamydophila infectious disease|Chlamydiaceae Infections|gram-negative bacterial infections|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Chlamydia trachomatis infectious disease|commensal bacterial infectious disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Chlamydia trachomatis infectious disease|Chlamydophila infectious disease|bacterial sexually transmitted disease|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; Chlamydia trachomatis infectious disease|Chlamydophila infectious disease|bacterial sexually transmitted disease|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Chlamydia trachomatis infectious disease|Chlamydophila infectious disease|bacterial sexually transmitted disease|sexually transmitted disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; Chlamydia trachomatis infectious disease|Chlamydophila infectious disease|bacterial sexually transmitted disease|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor
HP:0000407	Sensorineural hearing impairment	A type of hearing impairment in one or both ears related to an abnormal functionality of the cochlear nerve.	Sensorineural hearing loss;Sensorineural deafness;Hearing loss, sensorineural	Sensorineural hearing impairment|Hearing abnormality|Abnormality of the ear|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0801053	5-hydroxymethyl-2-furoylcarnitine measurement	NA		5-hydroxymethyl-2-furoylcarnitine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800998	4-vinylguaiacol sulfate measurement	NA		4-vinylguaiacol sulfate measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0002907	Microscopic hematuria	Microscopic hematuria detected by dipstick or microscopic examination of the urine.	Occult hematuria;Microhematuria;Small amount of blood in urine	Microscopic hematuria|Hematuria|Abnormal urine cytology|Abnormality of urine homeostasis|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Microscopic hematuria|Hematuria|Abnormal renal physiology|Abnormality of the kidney|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Microscopic hematuria|Hematuria|Abnormal renal physiology|Abnormality of the urinary system physiology|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Microscopic hematuria|Hematuria|Abnormal urine cytology|Abnormality of urine homeostasis|Abnormality of the urinary system physiology|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:1001158	retinopathy of prematurity	A bilateral retinopathy characterized by neovascularization, scarring, retinal detachment, and eventually blindness. It may be mild or severe. It occurs in babies born prematurely. Causes include oxygen toxicity and hypoxia.	Retinopathy of prematurity (disorder);ROP;retrolental fibroplasia;Retrolental Fibroplasia;Retinopathy of prematurity;Retrolental fibroplasia;retinopathy of prematurity;Retinopathy of Prematurity;Terry syndrome;Retrolental fibroplasia (disorder);premature retinopathy	retinopathy of prematurity|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; retinopathy of prematurity|material entity|experimental factor; retinopathy of prematurity|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; retinopathy of prematurity|retinopathy|nervous system disease|disease|disposition|material property|experimental factor
EFO:0800362	etiocholanolone glucuronide measurement	NA		etiocholanolone glucuronide measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800104	1-carboxyethylleucine measurement	NA		1-carboxyethylleucine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0005672	acute coronary syndrome	Signs and symptoms related to acute ischemia of the myocardium secondary to coronary artery disease. The clinical presentation covers a spectrum of heart diseases from unstable angina to myocardial infarction.	acute coronary syndrome	acute coronary syndrome|syndromic disease|material entity|experimental factor; acute coronary syndrome|Myocardial Ischemia|myocardial disorder|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; acute coronary syndrome|syndromic disease|disease|disposition|material property|experimental factor; acute coronary syndrome|Myocardial Ischemia|ischemic disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; acute coronary syndrome|acute disease|disease|disposition|material property|experimental factor; acute coronary syndrome|Myocardial Ischemia|coronary artery disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; acute coronary syndrome|Myocardial Ischemia|coronary artery disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0021103	caprylate 8:0 measurement	NA		caprylate 8:0 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800714	X-12306 measurement	NA		X-12306 measurement|metabolite measurement|measurement|information entity|experimental factor
HP:0000707	Abnormality of the nervous system	An abnormality of the nervous system.	Neurological abnormality;Abnormality of the nervous system;Neurologic abnormalities	Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0801340	activating signal cointegrator 1 complex subunit 1 measurement	NA		activating signal cointegrator 1 complex subunit 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802257	adenylyltransferase and sulfurtransferase MOCS3 measurement	NA		adenylyltransferase and sulfurtransferase MOCS3 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008011	a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement	NA	ADAMTS-13 measurement	a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008014	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 measurement	NA		ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0015609	advanced sleep phase syndrome	A very rare circadian rhythm sleep disorder characterized by very early sleep onset and offset possibly resulting in emotional and physical disruptions.	familial advanced sleep-phase syndrome;FASPS	advanced sleep phase syndrome|genetic disorder|disease|disposition|material property|experimental factor; advanced sleep phase syndrome|circadian rhythm sleep disorder|sleep-wake disorder|Sleep Disorder|mental or behavioural disorder|psychiatric disorder|disease|disposition|material property|experimental factor; advanced sleep phase syndrome|genetic disorder|material entity|experimental factor; advanced sleep phase syndrome|circadian rhythm sleep disorder|sleep-wake disorder|Sleep Disorder|mental or behavioural disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor
EFO:0008015	afamin measurement	NA		afamin measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0007318	Alagille syndrome	Alagille (AGS) syndrome is variably characterized by chronic cholestasis due to paucity of intrahepatic bile ducts, peripheral pulmonary artery stenosis, vertebrae segmentation anomalies, characteristic facies, posterior embryotoxon/anterior segment abnormalities, pigmentary retinopathy, and dysplastic kidneys.	syndromic bile duct paucity;Alagille-Watson syndrome;Alagille syndrome;Arteriohepatic dysplasia	Alagille syndrome|syndromic disease|disease|disposition|material property|experimental factor; Alagille syndrome|syndromic visceral malformation|visceral malformation of the liver, biliary tract, pancreas or spleen|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; Alagille syndrome|multiple congenital anomalies/dysmorphic syndrome without intellectual disability|multiple congenital anomalies/dysmorphic syndrome|material entity|experimental factor; Alagille syndrome|syndromic disease|material entity|experimental factor; Alagille syndrome|syndromic visceral malformation|visceral malformation of the liver, biliary tract, pancreas or spleen|material entity|experimental factor; Alagille syndrome|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; Alagille syndrome|genetic biliary tract disease|genetic disorder|material entity|experimental factor; Alagille syndrome|genetic biliary tract disease|biliary tract disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; Alagille syndrome|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; Alagille syndrome|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; Alagille syndrome|multiple congenital anomalies/dysmorphic syndrome without intellectual disability|multiple congenital anomalies/dysmorphic syndrome|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; Alagille syndrome|genetic biliary tract disease|genetic disorder|disease|disposition|material property|experimental factor; Alagille syndrome|genetic biliary tract disease|liver disease|hepatobiliary disease|digestive system disease|disease|disposition|material property|experimental factor; Alagille syndrome|genetic biliary tract disease|liver disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0801364	aldose reductase measurement	NA		aldose reductase measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008018	alpha-1-antichymotrypsin complex measurement	NA		alpha-1-antichymotrypsin complex measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008327	alpha-1-antitrypsin measurement	NA		alpha-1-antitrypsin measurement|measurement|information entity|experimental factor
EFO:0008020	alpha-2-HS-glycoprotein measurement	NA	fetuin-A protein measurement	alpha-2-HS-glycoprotein measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008021	alpha-2-macroglobulin receptor-associated protein measurement	NA		alpha-2-macroglobulin receptor-associated protein measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801371	alpha-amylase 1 measurement	NA		alpha-amylase 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020139	alpha-L-iduronidase measurement	NA		alpha-L-iduronidase measurement|protein measurement|measurement|information entity|experimental factor
FMA:3866	proximal portion of anterior interventricular branch of left coronary artery	NA	Proximal portion of anterior descending branch of left coronary artery	proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|cardiovascular system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|trunk|body proper|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|circulatory system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|trunk|body proper|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|circulatory system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|circulatory system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|trunk|body proper|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|circulatory system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|circulatory system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|trunk|body proper|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|trunk|body proper|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|trunk|body proper|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|cardiovascular system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|cardiovascular system|circulatory system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|artery|blood vessel|vessel|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|cardiovascular system|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|cardiovascular system|circulatory system|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|trunk|body proper|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|cardiovascular system|circulatory system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|trunk|body proper|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|trunk|body proper|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|anatomical system|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|trunk|body proper|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|trunk|body proper|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|trunk|body proper|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|trunk|body proper|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|trunk|body proper|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|trunk|body proper|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|trunk|body proper|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|trunk|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|trunk|body proper|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|trunk|body proper|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|cardiovascular system|circulatory system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|cardiovascular system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|trunk|body proper|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|trunk|body proper|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|anatomical system|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|trunk|body proper|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|trunk|body proper|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|artery|blood vessel|vessel|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|circulatory system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|trunk|body proper|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|trunk|body proper|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|thoracic segment of trunk|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart|thoracic segment of trunk|trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|trunk|multicellular organism|anatomical structure|anatomical entity|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|thoracic segment of trunk|trunk|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|circulatory system|anatomical system|multicellular organism|anatomical structure|anatomy basic component|organism part|material entity|experimental factor; proximal portion of anterior interventricular branch of left coronary artery|coronary artery|heart component|heart|circulatory system|anatomical system|anatomical structure|anatomy basic component|organism part|material entity|experimental factor
EFO:0021117	androsterone sulfate measurement	NA		androsterone sulfate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0008022	angiogenin measurement	NA		angiogenin measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020148	angiopoietin-related protein 3 measurement	NA		angiopoietin-related protein 3 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008024	angiostatin measurement	NA		angiostatin measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004463	angiotensin converting enzyme activity measurement	NA	ACE activity measurement;Angiotensin-converting enzyme activity	angiotensin converting enzyme activity measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801384	AP-4 complex accessory subunit tepsin measurement	NA		AP-4 complex accessory subunit tepsin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021854	apolipoprotein L1 measurement	NA		apolipoprotein L1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004980	appendicular lean mass	NA		appendicular lean mass|bone fracture related measurement|bone measurement|measurement|information entity|experimental factor; appendicular lean mass|anthropometric measurement|measurement|information entity|experimental factor
EFO:0020990	arginine measurement	NA		arginine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:0005856	arthritis	An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.	arthritides;arthritis;inflammation of skeletal joint;arthritic joint disease;skeletal joint inflammation	arthritis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; arthritis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; arthritis|inflammatory disease|disease|disposition|material property|experimental factor; arthritis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; arthritis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor
EFO:0020163	arylsulfatase A measurement	NA		arylsulfatase A measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800169	ascorbic acid 2-sulfate measurement	NA		ascorbic acid 2-sulfate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0801397	asporin measurement	NA		asporin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0009783	carotid atherosclerosis	NA	CAROTID ATHEROSCLEROTIC DIS;Carotid Atheroscleroses;Atherosclerotic Diseases, Carotid;Carotid Atherosclerotic Disease;Carotid Atherosclerotic Diseases;carotid atherosclerotic disease;ATHEROSCLEROTIC DIS CAROTID;Atherosclerotic Disease, Carotid	carotid atherosclerosis|carotid artery disease|cerebrovascular disorder|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; carotid atherosclerosis|atherosclerosis|arteriosclerosis|arterial occlusive disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; carotid atherosclerosis|carotid artery disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; carotid atherosclerosis|carotid artery disease|cerebrovascular disorder|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; carotid atherosclerosis|carotid artery disease|cerebrovascular disorder|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; carotid atherosclerosis|atherosclerosis|arteriosclerosis disorder|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0801398	ATP-dependent RNA helicase DHX8 measurement	NA		ATP-dependent RNA helicase DHX8 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801399	augurin measurement	NA		augurin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020169	aurora kinase B measurement	NA		aurora kinase B measurement|protein measurement|measurement|information entity|experimental factor
EFO:0005140	autoimmune disease	NA	autoimmunity	autoimmune disease|immune system disease|disease|disposition|material property|experimental factor
EFO:0020174	baculoviral IAP repeat-containing protein 5 measurement	NA		baculoviral IAP repeat-containing protein 5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008032	basal cell adhesion molecule measurement	NA		basal cell adhesion molecule measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007995	basophil percentage of granulocytes	NA		basophil percentage of granulocytes|basophil count|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor; basophil percentage of granulocytes|basophil count|inflammatory biomarker measurement|measurement|information entity|experimental factor
EFO:0801403	B-cell lymphoma/leukemia 10 measurement	NA		B-cell lymphoma/leukemia 10 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800427	behenoyl dihydrosphingomyelin (d18:0/22:0) measurement	NA		behenoyl dihydrosphingomyelin (d18:0/22:0) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0801416	beta-defensin 104 measurement	NA		beta-defensin 104 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008034	beta-endorphin measurement	NA		beta-endorphin measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801425	bile salt-activated lipase measurement	NA		bile salt-activated lipase measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004908	testosterone measurement	NA	testosterone levels;testosterone level	testosterone measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; testosterone measurement|sex hormone measurement|hormone measurement|measurement|information entity|experimental factor
EFO:0003924	hair color	NA	Hair Colors;Colors, Hair;Color, Hair	hair color|hair morphology|phenotype|quality|material property|experimental factor
EFO:0005629	small bowel Crohn's disease	An Crohn disease involving a pathogenic inflammatory response in the small intestine.	small bowel Crohn disease;small bowel Crohn's disease	small bowel Crohn's disease|Crohn's disease|inflammatory bowel disease|genetic disorder|disease|disposition|material property|experimental factor; small bowel Crohn's disease|enteritis|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; small bowel Crohn's disease|Crohn's disease|inflammatory bowel disease|genetic disorder|material entity|experimental factor; small bowel Crohn's disease|enteritis|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; small bowel Crohn's disease|enteritis|small intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; small bowel Crohn's disease|Crohn's disease|inflammatory bowel disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; small bowel Crohn's disease|Crohn's disease|inflammatory bowel disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor
EFO:0801429	BPI fold-containing family B member 1 measurement	NA		BPI fold-containing family B member 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020193	brevican core protein measurement	NA		brevican core protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0009661	bronchitis	An acute or chronic inflammatory process affecting the bronchi.	bronchitis;CI - chest infection;inflammation of bronchus;bronchial infection;bronchus inflammation	bronchitis|tracheobronchitis|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; bronchitis|bronchial disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; bronchitis|tracheobronchitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0802341	butyrophilin-like protein 9 measurement	NA		butyrophilin-like protein 9 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008060	cadherin-5 measurement	NA		cadherin-5 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801440	cadherin-related family member 5 measurement	NA		cadherin-related family member 5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020215	calcineurin subunit B type 1 measurement	NA		calcineurin subunit B type 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008063	calcium/calmodulin-dependent protein kinase type 1D measurement	NA		calcium/calmodulin-dependent protein kinase type 1D measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008062	calcium/calmodulin-dependent protein kinase type 1 measurement	NA		calcium/calmodulin-dependent protein kinase type 1 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801445	calpain-2 catalytic subunit measurement	NA		calpain-2 catalytic subunit measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020227	carbonic anhydrase 1 measurement	NA		carbonic anhydrase 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008068	carbonic anhydrase 6 measurement	NA		carbonic anhydrase 6 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0009719	artificial cardiac pacemaker	NA	artificial pacemaker;pacemaker	artificial cardiac pacemaker|medical procedure|experimental process|planned process|process|experimental factor
EFO:0010469	carnitine measurement	NA		carnitine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:0020243	cathepsin H measurement	NA		cathepsin H measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008074	cathepsin Z measurement	NA		cathepsin Z measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021905	CCAAT/enhancer-binding protein beta measurement	NA		CCAAT/enhancer-binding protein beta measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802351	C-X-C motif chemokine 14 measurement	NA		C-X-C motif chemokine 14 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008043	C-C motif chemokine 15 measurement	NA		C-C motif chemokine 15 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008046	C-C motif chemokine 18 measurement	NA	pulmonary and activation-regulated chemokine (PARC) measurement	C-C motif chemokine 18 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008041	C-C motif chemokine 1 measurement	NA		C-C motif chemokine 1 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020196	C-C motif chemokine 22 measurement	NA		C-C motif chemokine 22 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008049	C-C motif chemokine 23 measurement	NA		C-C motif chemokine 23 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008054	C-C motif chemokine 7 measurement	NA		C-C motif chemokine 7 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021866	cD177 antigen measurement	NA		cD177 antigen measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008238	myeloid cell surface antigen CD33 measurement	NA		myeloid cell surface antigen CD33 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004790	CD40 ligand measurement	NA	CD154 ligand measurement	CD40 ligand measurement|inflammatory biomarker measurement|measurement|information entity|experimental factor
EFO:0020248	CD5 antigen-like measurement	NA		CD5 antigen-like measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020250	CD97 antigen measurement	NA		CD97 antigen measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801461	cell growth regulator with EF hand domain protein 1 measurement	NA		cell growth regulator with EF hand domain protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801463	cellular retinoic acid-binding protein 1 measurement	NA		cellular retinoic acid-binding protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0022006	cellular tumor antigen p53 measurement	NA		cellular tumor antigen p53 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801466	cerebellin-1 measurement	NA		cerebellin-1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007707	cerebral amyloid deposition measurement	NA		cerebral amyloid deposition measurement|Alzheimer's disease biomarker measurement|mental or behavioural disorder biomarker|measurement|information entity|experimental factor; cerebral amyloid deposition measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004670	beta-amyloid 1-42 measurement	NA	amyloid-beta 1-42 measurement;CSF AB1-42 levels;CSF A1-42 levels	beta-amyloid 1-42 measurement|Alzheimer's disease biomarker measurement|mental or behavioural disorder biomarker|measurement|information entity|experimental factor; beta-amyloid 1-42 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004760	t-tau measurement	NA		t-tau measurement|Alzheimer's disease biomarker measurement|mental or behavioural disorder biomarker|measurement|information entity|experimental factor; t-tau measurement|protein measurement|measurement|information entity|experimental factor
EFO:0005139	serum ceruloplasmin measurement	NA	serum ceruloplasmin levels	serum ceruloplasmin measurement|renal system measurement|measurement|information entity|experimental factor; serum ceruloplasmin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008084	chitotriosidase-1 measurement	NA		chitotriosidase-1 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020258	chromobox protein homolog 5 measurement	NA		chromobox protein homolog 5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0006505	chronic bronchitis	A type of chronic obstructive pulmonary disease characterized by chronic inflammation in the bronchial tree that results in edema, mucus production, obstruction, and reduced airflow to and from the lung alveoli. The most common cause is tobacco smoking. Signs and symptoms include coughing with excessive mucus production, and shortness of breath.	bronchitis, chronic;chronic bronchitis	chronic bronchitis|bronchitis|bronchial disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; chronic bronchitis|chronic obstructive pulmonary disease|chronic lung disease|chronic disease|disease|disposition|material property|experimental factor; chronic bronchitis|chronic obstructive pulmonary disease|tracheal disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor; chronic bronchitis|chronic obstructive pulmonary disease|tracheal disorder|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; chronic bronchitis|bronchitis|tracheobronchitis|inflammatory disease|disease|disposition|material property|experimental factor; chronic bronchitis|chronic obstructive pulmonary disease|chronic lung disease|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; chronic bronchitis|bronchitis|tracheobronchitis|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0801477	chymotrypsinogen B measurement	NA		chymotrypsinogen B measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020261	ciliary neurotrophic factor receptor subunit alpha measurement	NA		ciliary neurotrophic factor receptor subunit alpha measurement|protein measurement|measurement|information entity|experimental factor
EFO:0003953	circumcision	NA	Circumcisions, Male;Male Circumcisions;male circumcision;Circumcision, Male	circumcision|medical procedure|experimental process|planned process|process|experimental factor
EFO:0008085	Ck-beta-8-1 measurement	NA		Ck-beta-8-1 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008086	CMRF35-like molecule 6 measurement	NA		CMRF35-like molecule 6 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020266	coagulation factor XA measurement	NA		coagulation factor XA measurement|protein measurement|measurement|information entity|experimental factor
NCBITaxon:13442	Coffea	NA	coffee	Coffea|Viridiplantae|Eukaryota|organism|material entity|experimental factor
EFO:0020267	cofilin-1 measurement	NA		cofilin-1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007710	cognitive decline measurement	NA		cognitive decline measurement|cognitive impairment measurement|measurement|information entity|experimental factor
EFO:0020268	coiled-coil domain-containing protein 80 measurement	NA		coiled-coil domain-containing protein 80 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0003872	colitis	Inflammation of the colon.	colitis;Colitides;colitis (disease);colon inflammation;inflammation of colon	colitis|colonic disorder|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; colitis|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; colitis|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; colitis|inflammatory bowel disease|genetic disorder|material entity|experimental factor; colitis|inflammatory bowel disease|genetic disorder|disease|disposition|material property|experimental factor; colitis|inflammatory bowel disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; colitis|inflammatory bowel disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor
EFO:0801491	collectin-10 measurement	NA		collectin-10 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008088	collectin-11 measurement	NA		collectin-11 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020272	collectin-12 measurement	NA		collectin-12 measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0013661	combined malonic and methylmalonic acidemia	Combined malonic and methylmalonic acidemia is a rare inborn error of metabolism characterized by elevation of malonic acid (MA) and methylmalonic acid (MMA) in body fluids, with higher levels of MMA than MA. CMAMMA presents in childhood with metabolic acidosis, developmental delay, dystonia and failure to thrive or in adulthood with seizures, memory loss and cognitive decline.	CMAMMA;combined malonic and methylmalonic aciduria;combined malonic and methylmalonic acidemia	combined malonic and methylmalonic acidemia|methylmalonic acidemia|inborn organic aciduria|inborn disorder of amino acid metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor; combined malonic and methylmalonic acidemia|classic organic aciduria|inborn organic aciduria|inborn disorder of amino acid metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; combined malonic and methylmalonic acidemia|classic organic aciduria|inborn organic aciduria|inborn disorder of amino acid metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; combined malonic and methylmalonic acidemia|methylmalonic acidemia|inborn organic aciduria|inborn disorder of amino acid metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; combined malonic and methylmalonic acidemia|methylmalonic acidemia|inborn organic aciduria|inborn disorder of amino acid metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; combined malonic and methylmalonic acidemia|classic organic aciduria|inborn organic aciduria|inborn disorder of amino acid metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor
EFO:0801492	complement C1q subcomponent subunit C measurement	NA		complement C1q subcomponent subunit C measurement|complement C1q subcomponent measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801494	complement C1q tumor necrosis factor-related protein 5 measurement	NA		complement C1q tumor necrosis factor-related protein 5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801495	complement C1r subcomponent-like protein measurement	NA		complement C1r subcomponent-like protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008091	complement C1s subcomponent measurement	NA		complement C1s subcomponent measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004984	complement C4 measurement	NA	complement C4 levels	complement C4 measurement|autoimmune disease biomarker|measurement|information entity|experimental factor; complement C4 measurement|glycoprotein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020281	complement component C6 measurement	NA		complement component C6 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008093	complement component C7 measurement	NA		complement component C7 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020282	complement component C9 measurement	NA		complement component C9 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0600091	complement factor H-related protein 4 measurement	NA	CFHL4 protein measurement;FHR-4 protein measurement;FHR4 protein measurement	complement factor H-related protein 4 measurement|complement factor H-related proteins measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008098	complement factor H-related protein 5 measurement	NA		complement factor H-related protein 5 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0019403	congenital dyserythropoietic anemia	Congenital dyserythropoietic anemia (CDA) is a heterogenous group of hematological disorders of late erythropoiesis and red cell abnormalities that lead to anemia. Five types of CDA are defined: CDA I, CDA II, CDA III, CDA IV and thrombocytopenia with CDA.	congenital dyshaematopoietic anaemia;CDA;anemia, congenital dyserythropoietic	congenital dyserythropoietic anemia|familial hemolytic anemia|genetic disorder|disease|disposition|material property|experimental factor; congenital dyserythropoietic anemia|constitutional dyserythropoietic anemia|anemia|hematologic disease|material entity|experimental factor; congenital dyserythropoietic anemia|familial hemolytic anemia|normocytic anemia|anemia|hematologic disease|disease|disposition|material property|experimental factor; congenital dyserythropoietic anemia|familial hemolytic anemia|normocytic anemia|anemia|hematologic disease|material entity|experimental factor; congenital dyserythropoietic anemia|familial hemolytic anemia|genetic disorder|material entity|experimental factor; congenital dyserythropoietic anemia|constitutional dyserythropoietic anemia|anemia|hematologic disease|disease|disposition|material property|experimental factor
EFO:0008102	copine-1 measurement	NA		copine-1 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0021661	coronary atherosclerosis	Atherosclerosis of the coronary vasculature.	coronary artery arteriosclerosis (disease);coronary atherosclerosis;arteriosclerosis disorder of coronary artery;coronary artery arteriosclerosis disorder	coronary atherosclerosis|coronary artery disease|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; coronary atherosclerosis|atherosclerosis|arteriosclerosis disorder|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; coronary atherosclerosis|coronary artery disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; coronary atherosclerosis|atherosclerosis|arteriosclerosis|arterial occlusive disease|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0801502	CREB-binding protein measurement	NA		CREB-binding protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0005622	Crohn's colitis	Crohn's disease affecting the colon.	Crohn's colitis;Crohn colitis	Crohn's colitis|large intestine disorder|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Crohn's colitis|Crohn's disease|inflammatory bowel disease|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; Crohn's colitis|Crohn's disease|inflammatory bowel disease|genetic disorder|disease|disposition|material property|experimental factor; Crohn's colitis|Crohn's disease|inflammatory bowel disease|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; Crohn's colitis|Crohn's disease|inflammatory bowel disease|genetic disorder|material entity|experimental factor
EFO:0802347	C-type lectin domain family 4 member D measurement	NA		C-type lectin domain family 4 member D measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020204	C-type mannose receptor 2 measurement	NA		C-type mannose receptor 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008056	C-X-C motif chemokine 10 measurement	NA	Interferon gamma-induced protein 10 measurement;IP-10 measurement;IP10 measurement	C-X-C motif chemokine 10 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008057	C-X-C motif chemokine 11 measurement	NA		C-X-C motif chemokine 11 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020296	cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement	NA		cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement|protein measurement|measurement|information entity|experimental factor
EFO:0010474	cystathionine measurement	NA		cystathionine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:0008104	cystatin-F measurement	NA		cystatin-F measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801511	cysteine-rich secretory protein 2 measurement	NA		cysteine-rich secretory protein 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801512	cysteine-rich secretory protein LCCL domain-containing 2 measurement	NA		cysteine-rich secretory protein LCCL domain-containing 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021870	cysteine-rich with EGF-like domain protein 1 measurement	NA		cysteine-rich with EGF-like domain protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800049	cysteinylglycine disulfide measurement	NA		cysteinylglycine disulfide measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0020303	cytochrome p450 3a4 measurement	NA		cytochrome p450 3a4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004507	D dimer measurement	NA	plasma D-dimer levels;fibrin D-dimer levels;D-dimer levels	D dimer measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor; D dimer measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800598	decadienedioic acid (C10:2-DC) measurement	NA		decadienedioic acid (C10:2-DC) measurement|metabolite measurement|measurement|information entity|experimental factor
MONDO:0002562	demyelinating disease	A broad group of disorders that affect the myelin sheaths that cover the neurons. Myelin sheathes cover neuronal axons in the central and peripheral nervous system and function to increase travelling impulse speeds. Disruption of this sheath impairs neuronal transmission and can result in disorders such as multiple sclerosis and Guillain-Barre syndrome, among others.	demyelinating disorder	demyelinating disease|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; demyelinating disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor
EFO:0802463	desmin measurement	NA		desmin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020321	desmoglein-1 measurement	NA		desmoglein-1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801525	diacylglycerol kinase beta measurement	NA		diacylglycerol kinase beta measurement|protein measurement|measurement|information entity|experimental factor
EFO:0003962	pulsed doppler echocardiography	NA	Echocardiography, Pulsed Doppler;PULSED ECHOCARDIOGR DOPPLER;DOPPLER ECHOCARDIOGR PULSED;Echocardiography, Doppler Pulsed;Doppler Pulsed Echocardiography;ECHOCARDIOGR PULSED DOPPLER;DOPPLER PULSED ECHOCARDIOGR;Pulsed Echocardiography, Doppler;Doppler Echocardiography, Pulsed;Echocardiography, Doppler, Pulsed;PULSED DOPPLER ECHOCARDIOGR;ECHOCARDIOGR DOPPLER PULSED	pulsed doppler echocardiography|heart function measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
EFO:0003951	percutaneous transluminal coronary angioplasty	NA	Balloon Angioplasties, Coronary;Transluminal Coronary Balloon Dilation;Balloon Dilation, Coronary Artery;Angioplasty, Balloon, Coronary;Angioplasty, Coronary Balloon;Balloon Angioplasty, Coronary;Coronary Balloon Angioplasties;Coronary Balloon Angioplasty;Angioplasties, Coronary Balloon;Coronary Angioplasty, Transluminal Balloon;Angioplasty, Transluminal, Percutaneous Coronary	percutaneous transluminal coronary angioplasty|medical procedure|experimental process|planned process|process|experimental factor
EFO:0802465	diamine acetyltransferase 2 measurement	NA		diamine acetyltransferase 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020326	dipeptidyl peptidase 2 measurement	NA		dipeptidyl peptidase 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020329	disintegrin and metalloproteinase domain-containing protein 9 measurement	NA		disintegrin and metalloproteinase domain-containing protein 9 measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0037871	amino acid metabolism disease	A disease that has its basis in the disruption of cellular amino acid metabolic process.	disorder of amino acid metabolism;disorder of cellular amino acid metabolic process;cellular amino acid metabolic process disease;amino acid metabolism disorder	amino acid metabolism disease|disorder of organic acid metabolism|metabolic disease|disease|disposition|material property|experimental factor
MONDO:0002279	iron metabolism disease	Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization.	disorder of iron metabolism;iron disorder	iron metabolism disease|mineral metabolism disease|metabolic disease|disease|disposition|material property|experimental factor
EFO:0802484	DNA-binding protein SATB2 measurement	NA		DNA-binding protein SATB2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802485	DNA-directed DNA/RNA polymerase mu measurement	NA		DNA-directed DNA/RNA polymerase mu measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801535	DNA-directed RNA polymerases I and III subunit RPAC1 measurement	NA		DNA-directed RNA polymerases I and III subunit RPAC1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801541	DnaJ homolog subfamily C member 17 measurement	NA		DnaJ homolog subfamily C member 17 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020330	DNA repair protein rad51 homolog 1 measurement	NA		DNA repair protein rad51 homolog 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020876	docosahexaenoic acid change measurement	NA		docosahexaenoic acid change measurement|docosahexaenoic acid measurement|fatty acid measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
MONDO:0013282	alpha 1-antitrypsin deficiency	Alpha-1-antitrypsin deficiency is a hereditary disease that develops in adulthood and is characterized by chronic liver disorders (cirrhosis), respiratory disorders (emphysema), and rarely panniculitis.	deficiency in Alpa-1-proteinase inhibitor;emphysema-cirrhosis, due to AAT deficiency;emphysema due to AAT deficiency;A-1ATD;A1AD;alpha 1-antitrypsin deficiency;AAT deficiency;hemorrhagic diathesis due to antithrombin pittsburgh	alpha 1-antitrypsin deficiency|plasma protein metabolism disease|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; alpha 1-antitrypsin deficiency|plasma protein metabolism disease|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; alpha 1-antitrypsin deficiency|respiratory system disease|disease|disposition|material property|experimental factor; alpha 1-antitrypsin deficiency|syndromic disease|material entity|experimental factor; alpha 1-antitrypsin deficiency|plasma protein metabolism disease|inborn errors of metabolism|genetic disorder|material entity|experimental factor; alpha 1-antitrypsin deficiency|syndromic disease|disease|disposition|material property|experimental factor; alpha 1-antitrypsin deficiency|nephropathy secondary to a storage or other metabolic disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; alpha 1-antitrypsin deficiency|nephropathy secondary to a storage or other metabolic disease|material entity|experimental factor
EFO:0801544	dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement	NA		dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008112	dual specificity mitogen-activated protein kinase kinase 2 measurement	NA		dual specificity mitogen-activated protein kinase kinase 2 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020338	dynactin subunit 2 measurement	NA		dynactin subunit 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:1001869	dysentery	Acute inflammation of the intestine associated with infectious diarrhea of various etiologies, generally acquired by eating contaminated food containing toxins, biological derived from bacteria or other microorganisms. Dysentery is characterized initially by watery feces then by bloody mucoid stools. It is often associated with abdominal pain; fever; and dehydration.	infectious diarrheal diseases;dysenteric diarrhea;dysentery;diarrheal disease, infectious;infectious diarrhea;infective diarrhea;infectious diarrheal disease	dysentery|intestinal infectious disease|digestive system infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; dysentery|intestinal infectious disease|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; dysentery|inflammatory diarrhea|gastroenteritis|intestinal disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; dysentery|acute diarrhea|diarrheal disease|digestive system disease|disease|disposition|material property|experimental factor; dysentery|intestinal infectious disease|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; dysentery|inflammatory diarrhea|diarrheal disease|digestive system disease|disease|disposition|material property|experimental factor; dysentery|inflammatory diarrhea|gastroenteritis|inflammatory disease|disease|disposition|material property|experimental factor; dysentery|acute diarrhea|acute disease|disease|disposition|material property|experimental factor
EFO:0801554	E3 ubiquitin-protein ligase NEURL1 measurement	NA		E3 ubiquitin-protein ligase NEURL1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801555	E3 ubiquitin-protein ligase RNF128 measurement	NA		E3 ubiquitin-protein ligase RNF128 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802511	E3 ubiquitin-protein ligase RNF149 measurement	NA		E3 ubiquitin-protein ligase RNF149 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020342	ectonucleoside triphosphate diphosphohydrolase 1 measurement	NA		ectonucleoside triphosphate diphosphohydrolase 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008115	ectonucleoside triphosphate diphosphohydrolase 5 measurement	NA		ectonucleoside triphosphate diphosphohydrolase 5 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0011015	educational attainment	NA	academic attainment	educational attainment|measurement|information entity|experimental factor
EFO:1001493	cardiac embolism	NA	cardioembolism	cardiac embolism|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; cardiac embolism|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0008119	endoplasmic reticulum aminopeptidase 1 measurement	NA		endoplasmic reticulum aminopeptidase 1 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801566	endoplasmic reticulum aminopeptidase 2 measurement	NA		endoplasmic reticulum aminopeptidase 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020347	endostatin measurement	NA		endostatin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008120	endothelial cell-selective adhesion molecule measurement	NA		endothelial cell-selective adhesion molecule measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008121	endothelin-converting enzyme 1 measurement	NA		endothelin-converting enzyme 1 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007996	eosinophil percentage of granulocytes	NA		eosinophil percentage of granulocytes|eosinophil count|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0021120	epiandrosterone sulfate measurement	NA		epiandrosterone sulfate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0801576	epididymal-specific lipocalin-10 measurement	NA		epididymal-specific lipocalin-10 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801580	ER membrane protein complex subunit 4 measurement	NA		ER membrane protein complex subunit 4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004575	e-selectin measurement	NA	eukocyte-endothelial cell adhesion molecule 2 measurement;soluble e-selectin levels;endothelial-leukocyte adhesion molecule 1measurement;CD62 antigen-like family member E measurement;E-selectin levels	e-selectin measurement|cancer biomarker measurement|measurement|information entity|experimental factor; e-selectin measurement|protein measurement|measurement|information entity|experimental factor; e-selectin measurement|adhesion molecule measurement|measurement|information entity|experimental factor; e-selectin measurement|inflammatory biomarker measurement|measurement|information entity|experimental factor
EFO:0004697	estradiol measurement	NA	oestrogen level;oestrogen levels;estradiol levels	estradiol measurement|estrogen measurement|sex hormone measurement|hormone measurement|measurement|information entity|experimental factor
MONDO:0014801	even-plus syndrome	NA	epiphysial-vertebral-ear dysplasia-nose-plus associated findings syndrome;EVPLS;even-plus syndrome	even-plus syndrome|syndromic anorectal malformation|syndromic disease|disease|disposition|material property|experimental factor; even-plus syndrome|spondyloepiphyseal dysplasia|osteochondrodysplasia|bone development disease|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; even-plus syndrome|spondyloepiphyseal dysplasia|skeletal dysplasia|genetic disorder|disease|disposition|material property|experimental factor; even-plus syndrome|syndromic anorectal malformation|anorectal malformation|digestive tract malformation|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; even-plus syndrome|syndromic anorectal malformation|anorectal malformation|digestive tract malformation|material entity|experimental factor; even-plus syndrome|spondyloepiphyseal dysplasia|osteochondrodysplasia|bone development disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; even-plus syndrome|multiple congenital anomalies/dysmorphic syndrome without intellectual disability|multiple congenital anomalies/dysmorphic syndrome|material entity|experimental factor; even-plus syndrome|spondyloepiphyseal dysplasia|skeletal dysplasia|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; even-plus syndrome|syndromic anorectal malformation|syndromic disease|material entity|experimental factor; even-plus syndrome|spondyloepiphyseal dysplasia|skeletal dysplasia|genetic disorder|material entity|experimental factor; even-plus syndrome|multiple congenital anomalies/dysmorphic syndrome without intellectual disability|multiple congenital anomalies/dysmorphic syndrome|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor
EFO:0022018	extracellular superoxide dismutase [Cu-Zn] measurement	NA		extracellular superoxide dismutase [Cu-Zn] measurement|protein measurement|measurement|information entity|experimental factor
Orphanet:227535	Hereditary breast cancer	NA		
MONDO:0100189	apolipoprotein A-I deficiency	A rare lipoprotein metabolism disorder characterized biochemically by complete absence of apolipoprotein AI and extremely low plasma high density lipoprotein (HDL) cholesterol, and clinically by corneal opacities and xanthomas complicated with premature coronary heart disease (CHD).	familial apoA-I deficiency;familial hypoalphalipoproteinemia;ApoA-I deficiency	apolipoprotein A-I deficiency|hypoalphalipoproteinemia|material entity|experimental factor; apolipoprotein A-I deficiency|hypoalphalipoproteinemia|metabolic disease|disease|disposition|material property|experimental factor
EFO:0008592	high density lipoprotein particle size measurement	NA	HDL particle size measurement	high density lipoprotein particle size measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; high density lipoprotein particle size measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; high density lipoprotein particle size measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0008128	fetuin-B measurement	NA		fetuin-B measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020392	ficolin-3 measurement	NA		ficolin-3 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020395	fractalkine measurement	NA		fractalkine measurement|protein measurement|measurement|information entity|experimental factor
EFO:0003963	freckles	NA	Freckle;freckling;Melanosis;Melasmas;Melasma;Melanoses;Melanism;Chloasmas;Chloasma	freckles|skin pigmentation|phenotype|quality|material property|experimental factor
EFO:0801612	galanin-like peptide measurement	NA		galanin-like peptide measurement|protein measurement|measurement|information entity|experimental factor
EFO:0010241	galectin-3-binding protein measurement	NA	mac-2-binding protein measurement;tumor-asociated antigen 90K measurement;90K protein measurement	galectin-3-binding protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008137	galectin-3 measurement	NA		galectin-3 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0009285	gamma-glutamyl transpeptidase deficiency	Gamma-glutamyl transpeptidase deficiency is characterized by increased glutathione concentration in the plasma and urine.	glutathionuria;rare inborn error of glutathione hydrolase activity;inborn error of glutathione hydrolase activity;glutathioninuria;inborn glutathione hydrolase activity disorder	gamma-glutamyl transpeptidase deficiency|inherited glutathione metabolism disease|disorder of peptide and amine metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; gamma-glutamyl transpeptidase deficiency|inherited glutathione metabolism disease|inborn disorder of the gamma-glutamyl cycle|inborn disorder of amino acid and other organic acid metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor; gamma-glutamyl transpeptidase deficiency|inherited glutathione metabolism disease|inborn disorder of the gamma-glutamyl cycle|inborn disorder of amino acid and other organic acid metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; gamma-glutamyl transpeptidase deficiency|inherited glutathione metabolism disease|sulfur metabolism disease|mineral metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; gamma-glutamyl transpeptidase deficiency|inherited glutathione metabolism disease|disorder of peptide and amine metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; gamma-glutamyl transpeptidase deficiency|inherited glutathione metabolism disease|inborn disorder of the gamma-glutamyl cycle|inborn disorder of amino acid and other organic acid metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; gamma-glutamyl transpeptidase deficiency|inherited glutathione metabolism disease|disorder of peptide and amine metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor
EFO:0021144	gamma-glutamyltyrosine measurement	NA		gamma-glutamyltyrosine measurement|metabolite measurement|measurement|information entity|experimental factor
MONDO:0001056	gastric cancer	A primary or metastatic malignant neoplasm involving the stomach.	gastric cancer;malignant neoplasm of lesser curve of stomach;malignant tumor of stomach;malignant tumor of greater curve of stomach;gastric cancer risk after h. pylori infection;malignant neoplasm of stomach;gastric cancer, somatic;malignant stomach neoplasm;stomach cancer;Ca lesser curvature - stomach;malignant gastric tumor;malignant tumor of body of stomach;malignant tumor of lesser curve of stomach;malignant tumor of the stomach;malignant neoplasm of the stomach;cancer of stomach;malignant gastric neoplasm	gastric cancer|stomach neoplasm|stomach disease|gastrointestinal disease|digestive system disease|disease|disposition|material property|experimental factor; gastric cancer|digestive system cancer|digestive system disease|disease|disposition|material property|experimental factor; gastric cancer|stomach neoplasm|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; gastric cancer|digestive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; gastric cancer|digestive system cancer|digestive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0801619	GDH/6PGL endoplasmic bifunctional protein measurement	NA		GDH/6PGL endoplasmic bifunctional protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801621	GDP-fucose protein O-fucosyltransferase 1 measurement	NA		GDP-fucose protein O-fucosyltransferase 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801064	gluconate measurement	NA		gluconate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0801629	glucoside xylosyltransferase 1 measurement	NA		glucoside xylosyltransferase 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020885	glutamine change measurement	NA		glutamine change measurement|glutamine measurement|amino acid measurement|measurement|information entity|experimental factor
EFO:0802570	glutaminyl-peptide cyclotransferase measurement	NA		glutaminyl-peptide cyclotransferase measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801637	glutathione S-transferase A4 measurement	NA		glutathione S-transferase A4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801640	glycerol-3-phosphate dehydrogenase 1-like protein measurement	NA		glycerol-3-phosphate dehydrogenase 1-like protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801643	glycolipid transfer protein domain-containing protein 2 measurement	NA		glycolipid transfer protein domain-containing protein 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801649	glypican-1 measurement	NA		glypican-1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008141	granulins measurement	NA		granulins measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008142	granulocyte colony-stimulating factor measurement	NA		granulocyte colony-stimulating factor measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008144	granulysin measurement	NA		granulysin measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801656	gremlin-2 measurement	NA		gremlin-2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801659	growth factor receptor-bound protein 7 measurement	NA		growth factor receptor-bound protein 7 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008146	growth-regulated alpha protein measurement	NA		growth-regulated alpha protein measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802588	guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 measurement	NA		guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801662	guanylate-binding protein 6 measurement	NA		guanylate-binding protein 6 measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0006507	hereditary hemochromatosis	An inherited metabolic disorder characterized by iron accumulation in the tissues.	diabetes bronze;iron storage disorder;hemochromatosis, hereditary	hereditary hemochromatosis|inborn metal metabolism disorder|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; hereditary hemochromatosis|disorder of iron metabolism and transport|disorder of mineral absorption and transport|disorder of metabolite absorption and transport|inborn errors of metabolism|genetic disorder|material entity|experimental factor; hereditary hemochromatosis|disorder of iron metabolism and transport|disorder of mineral absorption and transport|disorder of metabolite absorption and transport|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; hereditary hemochromatosis|inborn metal metabolism disorder|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; hereditary hemochromatosis|hemosiderosis|iron metabolism disease|mineral metabolism disease|metabolic disease|disease|disposition|material property|experimental factor; hereditary hemochromatosis|disorder of iron metabolism and transport|disorder of mineral absorption and transport|disorder of metabolite absorption and transport|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; hereditary hemochromatosis|inborn metal metabolism disorder|inborn errors of metabolism|genetic disorder|material entity|experimental factor
MONDO:0002249	thrombocytosis disease	A disease characterized by higher than normal platelet counts in the peripheral blood.	Platelet count increased;elevated Platelet count;Thrombocythaemia	thrombocytosis disease|blood platelet disease|hematologic disease|disease|disposition|material property|experimental factor; thrombocytosis disease|blood platelet disease|hematologic disease|material entity|experimental factor
HP:0010720	Abnormal hair pattern	An abnormality of the distribution of hair growth.	Abnormal distribution of hair;Abnormal hair pattern	Abnormal hair pattern|Abnormality of the integument|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0007629	hemoglobin A1 measurement	NA	HbA1 levels;HbA levels;hemoglobin A measurement;hemoglobin A1 levels	hemoglobin A1 measurement|hemoglobin measurement|protein measurement|measurement|information entity|experimental factor; hemoglobin A1 measurement|hemoglobin measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0008149	hemopexin measurement	NA		hemopexin measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008150	heparin cofactor 2 measurement	NA		heparin cofactor 2 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008151	hepatitis A virus cellular receptor 2 measurement	NA		hepatitis A virus cellular receptor 2 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008152	hepatocyte growth factor activator measurement	NA		hepatocyte growth factor activator measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008154	hepatocyte growth factor-like protein measurement	NA	macrophage-stimulating protein (MSP) measurement	hepatocyte growth factor-like protein measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801672	hepatocyte nuclear factor 4-alpha measurement	NA		hepatocyte nuclear factor 4-alpha measurement|protein measurement|measurement|information entity|experimental factor
HP:0002240	Hepatomegaly	Abnormally increased size of the liver.	Enlarged liver	Hepatomegaly|Abnormal abdomen morphology|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Hepatomegaly|Abnormality of the liver|Abnormality of the abdominal organs|Abnormality of the digestive system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0019118	inherited retinal dystrophy	An instance of retinal degeneration that is caused by an inherited modification of the individual's genome.	inherited retinal dystrophy;hereditary retinal degeneration;retinal dystrophy;familial retinal dystrophy;genetic retinal dystrophy;hereditary retinal dystrophy	inherited retinal dystrophy|inherited vitreous-retinal disease|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; inherited retinal dystrophy|retinal degeneration|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; inherited retinal dystrophy|vision disorder|perceptual disorders|nervous system disease|disease|disposition|material property|experimental factor; inherited retinal dystrophy|inherited vitreous-retinal disease|vitreous body disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; inherited retinal dystrophy|inherited vitreous-retinal disease|genetic disorder|material entity|experimental factor; inherited retinal dystrophy|inherited vitreous-retinal disease|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; inherited retinal dystrophy|retinal degeneration|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; inherited retinal dystrophy|retinal degeneration|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; inherited retinal dystrophy|inherited vitreous-retinal disease|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; inherited retinal dystrophy|inherited vitreous-retinal disease|vitreous body disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; inherited retinal dystrophy|vision disorder|disorder of visual system|disease|disposition|material property|experimental factor; inherited retinal dystrophy|inherited vitreous-retinal disease|genetic disorder|disease|disposition|material property|experimental factor
MONDO:0019956	encephalitis	An acute inflammatory process affecting the brain parenchyma. Causes include viral infections and less frequently bacterial infections, toxins, and immune-mediated processes.		encephalitis|brain inflammatory disease|brain disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; encephalitis|acute disease|disease|disposition|material property|experimental factor; encephalitis|brain inflammatory disease|encephalomyelitis|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; encephalitis|brain inflammatory disease|encephalomyelitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0020443	heterogeneous nuclear ribonucleoprotein q measurement	NA		heterogeneous nuclear ribonucleoprotein q measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802598	high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor measurement	NA		high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004612	high density lipoprotein cholesterol measurement	NA	HDL measurement	high density lipoprotein cholesterol measurement|lipoprotein measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor; high density lipoprotein cholesterol measurement|lipoprotein measurement|protein measurement|measurement|information entity|experimental factor; high density lipoprotein cholesterol measurement|lipid measurement|lipid or lipoprotein measurement|measurement|information entity|experimental factor
EFO:0008039	BMI-adjusted hip circumference	NA		BMI-adjusted hip circumference|hip circumference|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor; BMI-adjusted hip circumference|hip circumference|bone measurement|measurement|information entity|experimental factor
EFO:0020452	histone acetyltransferase type b catalytic subunit measurement	NA		histone acetyltransferase type b catalytic subunit measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021164	homostachydrine measurement	NA		homostachydrine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0008156	human Chorionic Gonadotropin measurement	NA		human Chorionic Gonadotropin measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
HP:0000044	Hypogonadotropic hypogonadism	Hypogonadotropic hypogonadism is characterized by reduced function of the gonads (testes in males or ovaries in females) and results from the absence of the gonadal stimulating pituitary hormones: follicle stimulating hormone (FSH) and luteinizing hormone (LH).	Hypogonadotrophic hypogonadism;Low gonadotropins (secondary hypogonadism)	Hypogonadotropic hypogonadism|Abnormality of the endocrine system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Hypogonadotropic hypogonadism|Abnormality of the genital system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0018555	hypogonadotropic hypogonadism	Abnormal ovarian or testicular function due to insufficient hormonal stimulation from the hypothalamic-pituitary axis.	hypogonadotropic hypogonadism;low gonadotropins (secondary hypogonadism);Normosmic idiopathic hypogonadotropic hypogonadism;nIHH;hypogonadism, hypogonadotropic;normosmic congenital hypogonadotropic hypogonadism;secondary hypogonadism;gonadotropic deficiency;central hypogonadism;hypogonadotropic hypogonadism with or without anosmia	hypogonadotropic hypogonadism|genetic disorder|material entity|experimental factor; hypogonadotropic hypogonadism|hypogonadism|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; hypogonadotropic hypogonadism|hypogonadism|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; hypogonadotropic hypogonadism|genetic disorder|disease|disposition|material property|experimental factor
MONDO:0019269	ichthyosis	Disorders of cornification that are characterized by visible scaling and/or hyperkeratosis of most or all of the skin. Inherited ichthyoses, defined as the generalized form of Mendelian disorders of cornification, affect most or all of the skin. This etiologically and phenotypically heterogenous group of conditions is caused by mutations in various different genes important for keratinocyte differentiation and epidermal barrier function. Acquired forms of ichthyosis can be observed with certain autoimmune, inflammatory, metabolic, endocrine, or infectious diseases or with malignancies.	fish scale disease;fish skin disease;DOC;disorder of cornification;ichthyoses;ichthyosis;ichthyosis (disease)	ichthyosis|epidermal disease|material entity|experimental factor; ichthyosis|epidermal disease|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0007160	autoimmune thrombocytopenic purpura	An autoimmune disorder in which the number of circulating platelets is reduced due to their antibody-mediated destruction. ITP is a diagnosis of exclusion and is heterogeneous in origin.	idiopathic thrombocytopenic purpura;Purpura, Thrombocytopenic, Idiopathic;thrombocytopenic purpura, autoimmune;autoimmune thrombocytopenic purpura;primary thrombocytopenic purpura;immune thrombocytopenia;Autoimmune thrombocytopenic purpura;Immune thrombocytopenic purpura (disorder);idiopathic thrombocytopenia purpura;ITP;idiopathic thrombocytopenia	autoimmune thrombocytopenic purpura|thrombocytopenic purpura|blood platelet disease|hematologic disease|material entity|experimental factor; autoimmune thrombocytopenic purpura|autoimmune thrombocytopenia|blood platelet disease|hematologic disease|disease|disposition|material property|experimental factor; autoimmune thrombocytopenic purpura|autoimmune thrombocytopenia|blood platelet disease|hematologic disease|material entity|experimental factor; autoimmune thrombocytopenic purpura|thrombocytopenic purpura|thrombotic microangiopathy|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; autoimmune thrombocytopenic purpura|thrombocytopenic purpura|purpura|hemorrhagic disease|hematologic disease|material entity|experimental factor; autoimmune thrombocytopenic purpura|primary thrombocytopenia|autoimmune disorder of blood|hematologic disease|disease|disposition|material property|experimental factor; autoimmune thrombocytopenic purpura|thrombocytopenic purpura|purpura|hemorrhagic disease|hematologic disease|disease|disposition|material property|experimental factor; autoimmune thrombocytopenic purpura|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; autoimmune thrombocytopenic purpura|primary thrombocytopenia|autoimmune disorder of blood|hematologic disease|material entity|experimental factor; autoimmune thrombocytopenic purpura|thrombocytopenic purpura|thrombotic microangiopathy|blood coagulation disease|hematologic disease|material entity|experimental factor; autoimmune thrombocytopenic purpura|autoimmune thrombocytopenia|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; autoimmune thrombocytopenic purpura|thrombocytopenic purpura|thrombotic microangiopathy|blood coagulation disease|hematologic disease|disease|disposition|material property|experimental factor; autoimmune thrombocytopenic purpura|primary thrombocytopenia|autoimmune disorder of blood|type II hypersensitivity reaction disease|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; autoimmune thrombocytopenic purpura|thrombocytopenic purpura|blood platelet disease|hematologic disease|disease|disposition|material property|experimental factor; autoimmune thrombocytopenic purpura|thrombocytopenic purpura|immune system disease|disease|disposition|material property|experimental factor
MONDO:0021094	immunodeficiency disease	Disease in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.	immunodeficiency;immuno-deficiency;immunodeficiency disorder	immunodeficiency disease|immune system disease|disease|disposition|material property|experimental factor; immunodeficiency disease|genetic disorder|disease|disposition|material property|experimental factor; immunodeficiency disease|genetic disorder|material entity|experimental factor
EFO:0004912	serum IgA measurement	NA	serum immunoglobulin A measurement;IgA levels	serum IgA measurement|antibody measurement|measurement|information entity|experimental factor
EFO:0004993	serum IgM measurement	NA	IgM levels	serum IgM measurement|measurement|information entity|experimental factor
EFO:0801690	immunoglobulin superfamily DCC subclass member 4 measurement	NA		immunoglobulin superfamily DCC subclass member 4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801694	inactive peptidyl-prolyl cis-trans isomerase FKBP6 measurement	NA		inactive peptidyl-prolyl cis-trans isomerase FKBP6 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800043	indole-3-carboxylate measurement	NA		indole-3-carboxylate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0021015	indoleacetate measurement	NA		indoleacetate measurement|metabolite measurement|measurement|information entity|experimental factor
GO:0006954	inflammatory response	NA	inflammation	inflammatory response|response to stimulus|biological process|process|experimental factor
EFO:0009903	inflammatory disease	A disease involving a pathogenic inflammatory response in the anatomical structure.	anatomical structure inflammation;inflammatory disorder;inflammation of anatomical structure;inflammatory disease	inflammatory disease|disease|disposition|material property|experimental factor
EFO:0005226	swine influenza	An acute viral respiratory infection caused by a strain of influenza virus which is endemic in swine (pigs). Rarely reported in humans prior to 2009, the disease is caused by a mutated strain of swine influenza A (H1N1) virus. It is highly contagious and spreads mainly through coughing and sneezing. Signs and symptoms include fever, chills, coughing, sore throat headache, muscle ache, and generalized weakness. Antiviral medications are most effective in the first two days of the illness.	H1N1 Virus infection;H1N1 Influenza;SIV;swine flu;Swine influenza virus caused influenza;H1N1 flu;Influenza A (H1N1) Virus infection;Swine influenza virus influenza;swine influenza;Influenza A (H1N1)	swine influenza|influenza|respiratory system disease|disease|disposition|material property|experimental factor; swine influenza|influenza|viral respiratory tract infection|respiratory tract infectious disorder|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; swine influenza|influenza|viral respiratory tract infection|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; swine influenza|influenza|primary viral infectious disease|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; swine influenza|influenza|viral respiratory tract infection|viral disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; swine influenza|influenza|primary viral infectious disease|viral disease|viral disease or post-viral disorder|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor
EFO:0801698	inositol monophosphatase 3 measurement	NA		inositol monophosphatase 3 measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0015129	chronic primary adrenal insufficiency	A chronic disorder of the adrenal cortex resulting in the inadequate production of glucocorticoid and mineralocorticoid hormones.	Addison's disease;primary hypoadrenalism;Addison disease;classic Addison's disease;primary adrenocortical insufficiency;chronic adrenocorticoid insufficiency;autoimmune Addison disease;primary adrenal insufficiency, chronic;Addison disease, chronic adrenal insufficiency;hypoadrenocorticism, familial;primary Addison's disease;CPAI;autoimmune adrenalitis	chronic primary adrenal insufficiency|adrenocortical insufficiency|adrenal cortex disorder|adrenal gland disease|endocrine system disease|disease|disposition|material property|experimental factor; chronic primary adrenal insufficiency|primary adrenal insufficiency|adrenal gland disease|endocrine system disease|disease|disposition|material property|experimental factor
EFO:0801700	insulin growth factor-like family member 3 measurement	NA		insulin growth factor-like family member 3 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004626	IGFBP-3 measurement	NA	Insulin-Like Growth Factor Binding Protein 3 levels	IGFBP-3 measurement|protein measurement|measurement|information entity|experimental factor; IGFBP-3 measurement|cancer biomarker measurement|measurement|information entity|experimental factor
EFO:0802637	integrin alpha-5 measurement	NA		integrin alpha-5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020481	inter-alpha-trypsin inhibitor heavy chain h4 measurement	NA		inter-alpha-trypsin inhibitor heavy chain h4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801706	inter-alpha-trypsin inhibitor heavy chain H5 measurement	NA		inter-alpha-trypsin inhibitor heavy chain H5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008164	intercellular adhesion molecule 5 measurement	NA		intercellular adhesion molecule 5 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021850	interferon alpha/beta receptor 1 measurement	NA		interferon alpha/beta receptor 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021890	interleukin-10 receptor subunit alpha measurement	NA		interleukin-10 receptor subunit alpha measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801718	interleukin-17 receptor A measurement	NA		interleukin-17 receptor A measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801711	interleukin-1 receptor accessory protein measurement	NA		interleukin-1 receptor accessory protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801712	interleukin-1 receptor antagonist protein measurement	NA		interleukin-1 receptor antagonist protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801713	interleukin-1 receptor-like 1 measurement	NA		interleukin-1 receptor-like 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801714	interleukin-1 receptor-like 2 measurement	NA		interleukin-1 receptor-like 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021842	interleukin-1 receptor type 2 measurement	NA		interleukin-1 receptor type 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020500	interleukin-22 receptor subunit alpha-2 measurement	NA		interleukin-22 receptor subunit alpha-2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021851	interleukin-36 alpha measurement	NA		interleukin-36 alpha measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801730	interleukin-5 receptor subunit alpha measurement	NA		interleukin-5 receptor subunit alpha measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801731	interleukin-6 receptor subunit alpha measurement	NA		interleukin-6 receptor subunit alpha measurement|protein measurement|measurement|information entity|experimental factor
EFO:1000997	iritis	Inflammation of the iris.	iritis (disease);inflammation of iris;Iritis;iris inflammation;iritis	iritis|uveitis|uveal disorder|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; iritis|iris disorder|uveal disorder|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; iritis|uveitis|uveal disorder|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; iritis|uveitis|inflammatory disease|disease|disposition|material property|experimental factor; iritis|iris disorder|uveal disorder|eye disease|disorder of visual system|disease|disposition|material property|experimental factor
EFO:0010573	kallikrein-11 measurement	NA		kallikrein-11 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008194	kallikrein-12 measurement	NA		kallikrein-12 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020513	kallikrein-14 measurement	NA		kallikrein-14 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801739	kallikrein-6 measurement	NA		kallikrein-6 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008196	kallistatin measurement	NA		kallistatin measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801749	kremen protein 1 measurement	NA		kremen protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801751	kv channel-interacting protein 1 measurement	NA		kv channel-interacting protein 1 measurement|protein measurement|measurement|information entity|experimental factor
NCBITaxon:1624	Lactobacillus salivarius	NA	Lactobacillus salivarus	Lactobacillus salivarius|Bacteria|organism|material entity|experimental factor
NCBITaxon:1358	Lactococcus lactis	NA	Bacterium lacti;Lactococcus lactis (Lohnis) Schleifer et al. 1986;Streptococcus lactis	Lactococcus lactis|Bacteria|organism|material entity|experimental factor
EFO:0020526	lactotransferrin measurement	NA		lactotransferrin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020529	layilin measurement	NA		layilin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004995	lean body mass	NA		lean body mass|anthropometric measurement|measurement|information entity|experimental factor
EFO:0020530	legumain measurement	NA		legumain measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004635	leptin receptor measurement	NA	leptin receptor levels;soluble leptin receptor levels	leptin receptor measurement|protein measurement|measurement|information entity|experimental factor; leptin receptor measurement|hormone measurement|measurement|information entity|experimental factor
EFO:0802689	leucine-rich repeat and fibronectin type III domain-containing protein 1 measurement	NA		leucine-rich repeat and fibronectin type III domain-containing protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802690	leucine-rich repeat and fibronectin type-III domain-containing protein 2 measurement	NA		leucine-rich repeat and fibronectin type-III domain-containing protein 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801763	leucine-rich repeat-containing protein 74A measurement	NA		leucine-rich repeat-containing protein 74A measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802697	leucine-rich repeat transmembrane neuronal protein 4 measurement	NA		leucine-rich repeat transmembrane neuronal protein 4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021861	leucine-rich repeat transmembrane protein FLRT3 measurement	NA		leucine-rich repeat transmembrane protein FLRT3 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801767	leukocyte immunoglobulin-like receptor subfamily A member 6 measurement	NA		leukocyte immunoglobulin-like receptor subfamily A member 6 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008208	leukocyte immunoglobulin-like receptor subfamily B member 1 measurement	NA		leukocyte immunoglobulin-like receptor subfamily B member 1 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021894	lipopolysaccharide-binding protein measurement	NA		lipopolysaccharide-binding protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021969	low affinity immunoglobulin gamma Fc region receptor II-a measurement	NA		low affinity immunoglobulin gamma Fc region receptor II-a measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021970	low affinity immunoglobulin gamma Fc region receptor II-b measurement	NA		low affinity immunoglobulin gamma Fc region receptor II-b measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008213	low molecular weight phosphotyrosine protein phosphatase measurement	NA		low molecular weight phosphotyrosine protein phosphatase measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020543	lymphotoxin alpha2:beta1 measurement	NA		lymphotoxin alpha2:beta1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008215	lysosomal protective protein measurement	NA		lysosomal protective protein measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801777	lysosomal Pro-X carboxypeptidase measurement	NA		lysosomal Pro-X carboxypeptidase measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008216	lysozyme C measurement	NA		lysozyme C measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020549	macrophage-capping protein measurement	NA		macrophage-capping protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020547	macrophage colony-stimulating factor 1 receptor measurement	NA		macrophage colony-stimulating factor 1 receptor measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008222	macrophage scavenger receptor types I and II measurement	NA		macrophage scavenger receptor types I and II measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0006851	malignant	NA		malignant|clinical modifier|quality|material property|experimental factor
EFO:1000363	Malignant Urinary System Neoplasm	A primary or metastatic malignant tumor involving the urinary system. Common tumor types include carcinomas, lymphomas, and sarcomas.	malignant urinary system neoplasm;cancer of renal system;malignant neoplasm of renal system;renal system cancer;malignant urinary tract neoplasm;malignant renal system neoplasm;urinary system cancer	Malignant Urinary System Neoplasm|urinary system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Malignant Urinary System Neoplasm|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Malignant Urinary System Neoplasm|urinary system neoplasm|urinary system disease|disease|disposition|material property|experimental factor
EFO:0008224	mannose-binding protein C measurement	NA		mannose-binding protein C measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020553	MAP kinase-activated protein kinase 5 measurement	NA		MAP kinase-activated protein kinase 5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802730	marginal zone B- and B1-cell-specific protein measurement	NA		marginal zone B- and B1-cell-specific protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801787	mast cell-expressed membrane protein 1 measurement	NA		mast cell-expressed membrane protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:1001366	mastodynia	NA	mastalgia;breast pain;mammalgia	mastodynia|pain|sign or symptom|phenotype|quality|material property|experimental factor
EFO:0008227	matrilysin measurement	NA		matrilysin measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0006340	mean arterial pressure	NA	MAP	mean arterial pressure|blood pressure|vital signs|measurement|information entity|experimental factor
EFO:0801791	mediator of RNA polymerase II transcription subunit 4 measurement	NA		mediator of RNA polymerase II transcription subunit 4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0009939	Antimigraine preparation use measurement	NA		Antimigraine preparation use measurement|drug use measurement|measurement|information entity|experimental factor
EFO:0009925	Antithrombotic agent use measurement	NA		Antithrombotic agent use measurement|drug use measurement|measurement|information entity|experimental factor
EFO:0009930	Calcium channel blocker use measurement	NA		Calcium channel blocker use measurement|drug use measurement|measurement|information entity|experimental factor
EFO:0009923	Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement	NA		Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement|drug use measurement|measurement|information entity|experimental factor
EFO:0009924	Drugs used in diabetes use measurement	NA		Drugs used in diabetes use measurement|drug use measurement|measurement|information entity|experimental factor
EFO:0009932	HMG CoA reductase inhibitor use measurement	NA		HMG CoA reductase inhibitor use measurement|drug use measurement|measurement|information entity|experimental factor
EFO:0009926	Vasodilators used in cardiac diseases use measurement	NA		Vasodilators used in cardiac diseases use measurement|drug use measurement|measurement|information entity|experimental factor
EFO:0008229	melanoma-derived growth regulatory protein measurement	NA		melanoma-derived growth regulatory protein measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801796	membrane-associated progesterone receptor component 2 measurement	NA		membrane-associated progesterone receptor component 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008233	MHC class I polypeptide-related sequence A measurement	NA		MHC class I polypeptide-related sequence A measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008234	MHC class I polypeptide-related sequence B measurement	NA		MHC class I polypeptide-related sequence B measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
HP:0012594	Moderate albuminuria	The presence of moderately increased concentrations of albumin in the urine, defined as and albumin-creatinine ratio (ACR) of 30 to 299 mg/gm (3.4 to 34 mg/mmol).	Microalbuminuria;High urine albumin levels	Moderate albuminuria|albuminuria|Proteinuria|Abnormality of urine homeostasis|Abnormality of metabolism/homeostasis|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Moderate albuminuria|albuminuria|Proteinuria|Abnormality of urine homeostasis|Abnormality of the urinary system physiology|Abnormality of the urinary system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
MONDO:0016828	autosomal recessive sideroblastic anemia	Congenital autosomal recessive sideroblastic anemia (ARSA) is a non-syndromic, microcytic/hypochromic sideroblastic anemia, present from early infancy and characterized by severe microcytic anemia, which is not pyridoxine responsive, and increased serum ferritin.	ARSA;sideroblastic anemia, autosomal recessive	autosomal recessive sideroblastic anemia|inherited sideroblastic anemia|sideroblastic anemia|anemia|hematologic disease|disease|disposition|material property|experimental factor; autosomal recessive sideroblastic anemia|inherited sideroblastic anemia|genetic disorder|disease|disposition|material property|experimental factor; autosomal recessive sideroblastic anemia|inherited sideroblastic anemia|genetic disorder|material entity|experimental factor; autosomal recessive sideroblastic anemia|autosomal recessive disease|autosomal genetic disease|genetic disorder|disease|disposition|material property|experimental factor; autosomal recessive sideroblastic anemia|autosomal recessive disease|autosomal genetic disease|genetic disorder|material entity|experimental factor; autosomal recessive sideroblastic anemia|inherited sideroblastic anemia|sideroblastic anemia|anemia|hematologic disease|material entity|experimental factor
MONDO:0001245	microcytic anemia	Anemia in which the red blood cell volume is decreased.		microcytic anemia|anemia|hematologic disease|material entity|experimental factor; microcytic anemia|anemia|hematologic disease|disease|disposition|material property|experimental factor
EFO:0801801	microfibrillar-associated protein 2 measurement	NA		microfibrillar-associated protein 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020571	midkine measurement	NA		midkine measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007372	mitral valve stenosis	Narrowing of the left atrioventricular mitral orifice.	mitral stenosis;mitral valve stenosis;Mitral Valve Stenosis;Mitral stenosis	mitral valve stenosis|mitral valve disease|heart valve disease|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0003782	motor neuron disease	A disease involving the motor neuron.	Sclerosis, Lateral;MOTOR NEURON DIS;Lower Motor Neuron Disease;ANTERIOR HORN CELL DIS;motor neuron disease or disorder;MOTOR SYSTEM DIS;Motor Neuron Disease, Lower;MOTOR NEURON DIS UPPER;FAMILIAL MOTOR NEURON DIS;Neuron Disease, Motor;LOWER MOTOR NEURON DIS;disease of motor neuron;MOTOR NEURON DIS FAMILIAL;UPPER MOTOR NEURON DIS;motor neuron disorder;Lateral Sclerosis;motor neuron disease;MOTOR NEURON DIS SECOND;Motor System Diseases;Anterior Horn Cell Disease;Secondary Motor Neuron Disease;Motor Neuron Disease, Upper;MOTOR NEURON DIS LOWER;Familial Motor Neuron Disease;Scleroses, Primary Lateral;Motor System Disease;Neuron Diseases, Motor;Scleroses, Lateral;disorder of motor neuron;Lateral Scleroses;SECOND MOTOR NEURON DIS;Motor Neuron Diseases;anterior horn cell disease;Motor Neuron Disease, Secondary;Motor Neuron Disease, Familial;disease or disorder of motor neuron;Upper Motor Neuron Disease	motor neuron disease|neurodegenerative disease|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; motor neuron disease|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor
EFO:0010609	mucin16 measurement	NA		mucin16 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020584	muellerian-inhibiting factor measurement	NA		muellerian-inhibiting factor measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801809	multimerin-2 measurement	NA		multimerin-2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004747	protein measurement	NA	protein levels	protein measurement|measurement|information entity|experimental factor
EFO:0020585	myeloblastin measurement	NA		myeloblastin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007988	myeloid white cell count	NA	myeloid leukocyte count	myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0011039	myeloperoxidase (MPO)-DNA complex measurement	NA	MPO-DNA complex	myeloperoxidase (MPO)-DNA complex measurement|protein measurement|measurement|information entity|experimental factor; myeloperoxidase (MPO)-DNA complex measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0802773	myotubularin-related protein 1 measurement	NA		myotubularin-related protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800628	N4-acetylcytidine measurement	NA		N4-acetylcytidine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800151	N-acetylglucosaminylasparagine measurement	NA		N-acetylglucosaminylasparagine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0020022	N-acetylneuraminate measurement	Quantification of N-acetylneuraminate levels in a sample.	Neu5Ac measurement;NANA measurement	N-acetylneuraminate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800127	N-acetylputrescine measurement	NA		N-acetylputrescine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800038	N-acetylserine measurement	NA		N-acetylserine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0008240	N-acylethanolamine-hydrolyzing acid amidase measurement	NA		N-acylethanolamine-hydrolyzing acid amidase measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008241	NAD-dependent protein deacetylase sirtuin-2 measurement	NA		NAD-dependent protein deacetylase sirtuin-2 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803307	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 measurement	NA		NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008243	natural cytotoxicity triggering receptor 3 measurement	NA		natural cytotoxicity triggering receptor 3 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020591	netrin receptor UNC5D measurement	NA		netrin receptor UNC5D measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0009324	Hartnup disease	Hartnup disease is a rare metabolic disorder belonging to the neutral aminoacidurias and characterized by abnormal renal and gastrointestinal transport of neutral amino acids (tryptophan, alanine, asparagine, glutamine, histidine, isoleucine, leucine, phenylalanine, serine, threonine, tyrosine and valine).	aminoaciduria, Hartnup type;Hartnup disorder;neutral 1 amino acid transport defect;neutral amino acid transport defect;Hartnup disease;deficiency of tryptophan oxygenase	Hartnup disease|inborn disorder of amino acid transport|inborn disorder of amino acid metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor; Hartnup disease|inborn disorder of amino acid transport|inborn disorder of amino acid metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; Hartnup disease|inborn disorder of amino acid transport|inborn disorder of amino acid metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor
EFO:0008247	neutral ceramidase measurement	NA		neutral ceramidase measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007994	neutrophil percentage of granulocytes	NA		neutrophil percentage of granulocytes|neutrophil count|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:1001380	Niemann-Pick disease	A group of inherited, severe metabolic disorders in which sphingomyelin accumulates in lysosomes in cells. The lysosomes normally transport material through and out of the cell.	Sphingomyelinase Deficiency Disease;lipoid histiocytosis (classical phosphatide);lipoid histiocytosis;Niemann-Pick disease with cholesterol esterification block;sphingomyelin/cholesterol lipidosis;NIEMANN-PICK DISEASE WITH CHOLESTEROL ESTERIFICATION BLOCK;sphingomyelin lipidosis;Niemann-Pick disease;Niemann-Pick disease, subacute juvenile form;sphingomyelinase deficiency disease;NIEMANN-PICK DISEASE, SUBACUTE JUVENILE FORM;SPHINGOMYELIN LIPIDOSIS	Niemann-Pick disease|sphingolipidosis|lysosomal lipid storage disorder|inherited lipid metabolism disorder|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; Niemann-Pick disease|autosomal recessive disease|autosomal genetic disease|genetic disorder|material entity|experimental factor; Niemann-Pick disease|autosomal recessive disease|autosomal genetic disease|genetic disorder|disease|disposition|material property|experimental factor; Niemann-Pick disease|Lipid storage disease|Lysosomal disease|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; Niemann-Pick disease|sphingolipidosis|lysosomal lipid storage disorder|lysosomal storage disease|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; Niemann-Pick disease|sphingolipidosis|lysosomal lipid storage disorder|lysosomal storage disease|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; Niemann-Pick disease|Lipid storage disease|Lysosomal disease|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; Niemann-Pick disease|sphingolipidosis|lysosomal lipid storage disorder|inherited lipid metabolism disorder|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; Niemann-Pick disease|sphingolipidosis|lysosomal lipid storage disorder|lysosomal storage disease|inborn errors of metabolism|genetic disorder|material entity|experimental factor; Niemann-Pick disease|Lipid storage disease|Lysosomal disease|inborn errors of metabolism|genetic disorder|material entity|experimental factor; Niemann-Pick disease|non-Langerhans cell histiocytosis|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor; Niemann-Pick disease|sphingolipidosis|lysosomal lipid storage disorder|inherited lipid metabolism disorder|inborn errors of metabolism|genetic disorder|material entity|experimental factor
EFO:0021995	noggin measurement	NA		noggin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800381	nonanoylcarnitine (C9) measurement	NA		nonanoylcarnitine (C9) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0021872	non-histone chromosomal protein HMG-14 measurement	NA		non-histone chromosomal protein HMG-14 measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0018997	Noonan syndrome	Noonan Syndrome (NS) is characterised by short stature, typical facial dysmorphism and congenital heart defects.	Noonan syndrome;Turner's phenotype, karyotype normal;Noonan's syndrome	Noonan syndrome|Noonan syndrome and Noonan-related syndrome|familial hypertrophic cardiomyopathy|hypertrophic cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; Noonan syndrome|Noonan syndrome and Noonan-related syndrome|familial hypertrophic cardiomyopathy|familial cardiomyopathy|cardiomyopathy|material entity|experimental factor; Noonan syndrome|Noonan syndrome and Noonan-related syndrome|rasopathy|genetic disorder|material entity|experimental factor; Noonan syndrome|malposition of external canthus|canthal anomaly|material entity|experimental factor; Noonan syndrome|syndromic lymphedema|lymphedema|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor; Noonan syndrome|Noonan syndrome and Noonan-related syndrome|rasopathy|genetic disorder|disease|disposition|material property|experimental factor; Noonan syndrome|Noonan syndrome and Noonan-related syndrome|familial hypertrophic cardiomyopathy|familial cardiomyopathy|genetic disorder|disease|disposition|material property|experimental factor; Noonan syndrome|eyelids malposition disorder|eyelid disease|eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; Noonan syndrome|lymphatic malformation|genetic vascular anomaly|genetic disorder|material entity|experimental factor; Noonan syndrome|syndromic lymphedema|syndromic disease|disease|disposition|material property|experimental factor; Noonan syndrome|lymphatic malformation|primary lymphedema|simple vascular malformation|vascular anomaly|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Noonan syndrome|multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome|multiple congenital anomalies/dysmorphic syndrome|material entity|experimental factor; Noonan syndrome|lymphatic malformation|primary lymphedema|lymphedema|lymphatic system disease|lymphoid system disorder|immune system disease|disease|disposition|material property|experimental factor; Noonan syndrome|multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome|multiple congenital anomalies/dysmorphic syndrome|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; Noonan syndrome|lymphatic malformation|genetic vascular anomaly|vascular anomaly|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; Noonan syndrome|Noonan syndrome and Noonan-related syndrome|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; Noonan syndrome|Noonan syndrome and Noonan-related syndrome|familial hypertrophic cardiomyopathy|familial cardiomyopathy|genetic disorder|material entity|experimental factor; Noonan syndrome|eyelids malposition disorder|material entity|experimental factor; Noonan syndrome|lymphatic malformation|genetic vascular anomaly|genetic disorder|disease|disposition|material property|experimental factor; Noonan syndrome|Noonan syndrome and Noonan-related syndrome|familial hypertrophic cardiomyopathy|familial cardiomyopathy|cardiomyopathy|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; Noonan syndrome|eyelids malposition disorder|eyelid disease|eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; Noonan syndrome|Noonan syndrome and Noonan-related syndrome|familial hypertrophic cardiomyopathy|familial cardiomyopathy|cardiomyopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; Noonan syndrome|lymphatic malformation|genetic vascular anomaly|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; Noonan syndrome|syndromic lymphedema|syndromic disease|material entity|experimental factor; Noonan syndrome|Noonan syndrome and Noonan-related syndrome|familial hypertrophic cardiomyopathy|hypertrophic cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|heart disease|cardiovascular disease|disease|disposition|material property|experimental factor; Noonan syndrome|malposition of external canthus|canthal anomaly|eyelid disease|eye adnexa disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; Noonan syndrome|malposition of external canthus|canthal anomaly|eyelid disease|eye adnexa disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; Noonan syndrome|Noonan syndrome and Noonan-related syndrome|familial hypertrophic cardiomyopathy|hypertrophic cardiomyopathy|intrinsic cardiomyopathy|cardiomyopathy|material entity|experimental factor
EFO:0802827	o-acetyl-ADP-ribose deacetylase MACROD1 measurement	NA		o-acetyl-ADP-ribose deacetylase MACROD1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008252	OCIA domain-containing protein 1 measurement	NA		OCIA domain-containing protein 1 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0018910	oculocutaneous albinism	Oculocutaneous albinism (OCA) describes a group of inherited disorders of melanin biosynthesis characterized by a generalized reduction in pigmentation of hair, skin and eyes and variable ocular findings including nystagmus, reduced visual acuity and photophobia. Variants include OCA1A (the most severe form), OCA1B, OCA1-minimal pigment (OCA1-MP), OCA1-temperature sensitive (OCA1-TS), OCA2, OCA3, OCA4, OCA5, OCA6 and OCA7.	OCA;non-syndromic oculocutaneous albinism;nonsyndromic oculocutaneous albinism	oculocutaneous albinism|disorder of melanin metabolism|inborn disorder of amino acid and other organic acid metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; oculocutaneous albinism|oculocutaneous or ocular albinism|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; oculocutaneous albinism|oculocutaneous or ocular albinism|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; oculocutaneous albinism|oculocutaneous or ocular albinism|albinism|inborn disorder of amino acid metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; oculocutaneous albinism|disorder of melanin metabolism|inborn disorder of amino acid and other organic acid metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor; oculocutaneous albinism|oculocutaneous or ocular albinism|albinism|inborn disorder of amino acid metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; oculocutaneous albinism|hypopigmentation of the skin|skin pigmentation disorder|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; oculocutaneous albinism|oculocutaneous or ocular albinism|albinism|inborn disorder of amino acid metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor; oculocutaneous albinism|disorder of melanin metabolism|inborn disorder of amino acid and other organic acid metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor
EFO:0003200	oncostatin M	NA		oncostatin M|interleukin|cytokine|protein|chemical entity|material entity|experimental factor; oncostatin M|interleukin|cytokine|protein|biological macromolecule|material entity|experimental factor
EFO:0009802	number of operations, self-reported	NA		number of operations, self-reported|self-reported trait|quality|material property|experimental factor
EFO:0009776	ornithine measurement	NA		ornithine measurement|amino acid measurement|measurement|information entity|experimental factor
HP:0002788	Recurrent upper respiratory tract infections	An increased susceptibility to upper respiratory tract infections as manifested by a history of recurrent upper respiratory tract infections (running ears - otitis, sinusitis, pharyngitis, tonsillitis).	Frequent upper respiratory infections;Recurrent upper respiratory infections;Recurrent URI;Recurrent colds;Recurrent upper respiratory infection;Upper respiratory tract infections;Recurrent upper respiratory and lower respiratory infections;Upper respiratory tract infections, recurrent;Frequent upper respiratory tract infections	Recurrent upper respiratory tract infections|Abnormality of the nose|Abnormality of the face|Abnormality of the head|Abnormality of head or neck|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Recurrent upper respiratory tract infections|Recurrent respiratory infections|Recurrent infections|Abnormality of the immune system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; Recurrent upper respiratory tract infections|Recurrent respiratory infections|Abnormal lung morphology|Abnormality of the respiratory system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0000768	idiopathic pulmonary fibrosis	Idiopathic pulmonary fibrosis (IPF) is a nonneoplastic pulmonary disease that is characterized by the formation of scar tissue within the lungs in the absence of any known cause.	fibrocystic pulmonary dysplasia;idiopathic pulmonary fibrosis, familial;cryptogenic fibrosing alveolitis;idiopathic pulmonary fibrosis;usual interstitial pneumonia;CFA;UIP	idiopathic pulmonary fibrosis|pulmonary fibrosis|interstitial lung disease|lung disease|lower respiratory tract disease|respiratory system disease|disease|disposition|material property|experimental factor; idiopathic pulmonary fibrosis|pulmonary fibrosis|fibrosis|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:1000249	Extramammary Paget Disease	A malignant neoplasm in which there is infiltration of the skin by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (Paget cells). It may affect the anus, penis, scrotum, and vulva.	extramammary Paget disease;Paget's disease of skin;Extramammary Paget's disease;cutaneous Paget's disease;Paget's skin disease;Paget's disease of the skin;Paget disease Extramammary	Extramammary Paget Disease|Paget disease|adenocarcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Extramammary Paget Disease|Paget disease|adenocarcinoma|glandular cell neoplasm|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Extramammary Paget Disease|Paget disease|adenocarcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
MONDO:0010720	partial androgen insensitivity syndrome	Partial androgen insensitivity syndrome (PAIS) is a disorder of sex development (DSD) distinct from complete AIS (CAIS) characterized by the presence of abnormal genital development in a 46,XY individual with normal testis development and partial responsiveness to age-appropriate levels of androgens.	pseudohermaphroditism, incomplete male, type I;Reifenstein syndrome, partial;androgen insensitivity, partial;partial androgen resistance syndrome;PAIS;pais;familial incomplete Male pseudohermaphroditism, type 1;Reifenstein syndrome;androgen insensitivity, partial, with or without breast cancer;androgen insensitivity, partial, with or without breast cancer, X-linked recessive	partial androgen insensitivity syndrome|androgen insensitivity syndrome|male infertility|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; partial androgen insensitivity syndrome|androgen insensitivity syndrome|developmental anomaly of metabolic origin|metabolic disease|disease|disposition|material property|experimental factor; partial androgen insensitivity syndrome|androgen insensitivity syndrome|46,XY disorder of sex development of endocrine origin|46,XY disorder of sex development|disorder of sexual differentiation|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; partial androgen insensitivity syndrome|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; partial androgen insensitivity syndrome|inborn errors of metabolism|genetic disorder|material entity|experimental factor; partial androgen insensitivity syndrome|androgen insensitivity syndrome|male infertility|infertility|reproductive system disease|disease|disposition|material property|experimental factor; partial androgen insensitivity syndrome|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; partial androgen insensitivity syndrome|androgen insensitivity syndrome|material entity|experimental factor; partial androgen insensitivity syndrome|androgen insensitivity syndrome|46,XY disorder of sex development of endocrine origin|46,XY disorder of sex development|disorder of sexual differentiation|gonadal disorder|endocrine system disease|disease|disposition|material property|experimental factor; partial androgen insensitivity syndrome|androgen insensitivity syndrome|46,XY disorder of sex development of endocrine origin|46,XY disorder of sex development|disorder of sexual differentiation|gonadal disorder|reproductive system disease|disease|disposition|material property|experimental factor; partial androgen insensitivity syndrome|androgen insensitivity syndrome|developmental anomaly of metabolic origin|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor
EFO:0020624	peptidoglycan recognition protein 1 measurement	NA		peptidoglycan recognition protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801871	peptidyl-glycine alpha-amidating monooxygenase measurement	NA		peptidyl-glycine alpha-amidating monooxygenase measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801877	peptidyl-prolyl cis-trans isomerase-like 2 measurement	NA		peptidyl-prolyl cis-trans isomerase-like 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020628	periostin measurement	NA		periostin measurement|protein measurement|measurement|information entity|experimental factor
EFO:1000552	Subcutaneous Panniculitis-Like T-Cell Lymphoma	Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare cytotoxic cutaneous lymphoma that has been recognized as a distinct subset of peripheral T-cell lymphomas originating and presenting primarily in the subcutaneous fat tissue.	SPTCL;subcutaneous panniculitis-like T-cell lymphoma, Alpha/Beta type;subcutaneous panniculitis-like T-cell lymphoma;subcutaneous panniculitis-like T-cell lymphoma (Alpha/Beta type);subcutaneous panniculitic T-cell lymphoma	Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|inherited skin tumor|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|immune system cancer|immune system disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|leukocyte disorder|hematologic disease|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|inherited skin tumor|genetic disorder|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|leukocyte disorder|hematologic disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|inherited skin tumor|genetic disorder|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|inherited skin tumor|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|skin cancer|skin neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|skin cancer|skin neoplasm|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|skin cancer|integumentary system cancer|integumentary system disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|leukocyte disorder|immune system disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|Genetic skin tumor|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|Genetic skin tumor|Rare genetic tumor|genetic disorder|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|Genetic skin tumor|Rare genetic tumor|genetic disorder|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|immune system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|genetic disorder|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|Rare genetic tumor|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|material entity|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|T-cell non-Hodgkin lymphoma|non-Hodgkins lymphoma|lymphoma|lymphoid neoplasm|hematopoietic and lymphoid cell neoplasm|hematopoietic and lymphoid system neoplasm|hematologic disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|lymphoid hemopathy|tumor of hematopoietic and lymphoid tissues|hematopoietic and lymphoid system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|primary organ-specific lymphoma|lymphoma|Genetic tumor of hematopoietic and lymphoid tissues|hematologic disease|disease|disposition|material property|experimental factor; Subcutaneous Panniculitis-Like T-Cell Lymphoma|indolent primary cutaneous T-cell lymphoma|primary cutaneous T-cell lymphoma|primary cutaneous lymphoma|skin cancer|integumentary system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0803302	PH and SEC7 domain-containing protein 1 measurement	NA		PH and SEC7 domain-containing protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803295	PH and SEC7 domain-containing protein 2 measurement	NA		PH and SEC7 domain-containing protein 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802863	phosphatidylinositol transfer protein beta isoform measurement	NA		phosphatidylinositol transfer protein beta isoform measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802866	phospholipase D3 measurement	NA		phospholipase D3 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008261	plasma protease C1 inhibitor measurement	NA		plasma protease C1 inhibitor measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008265	platelet-derived growth factor receptor beta measurement	NA		platelet-derived growth factor receptor beta measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008262	platelet glycoprotein 4 measurement	NA		platelet glycoprotein 4 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801891	pleckstrin homology domain-containing family A member 7 measurement	NA		pleckstrin homology domain-containing family A member 7 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008266	plexin-C1 measurement	NA		plexin-C1 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0003063	polymyositis	Polymyositis (PM) is a rare idiopathic inflammatory myopathy characterized by symmetric proximal muscle weakness and elevated muscle enzymes.	PM;polymyositis;Polymyositis, Idiopathic;multiple myositis;Polymyositis Ossificans;Polymyositis (disorder);Myositis, Multiple	polymyositis|acquired idiopathic inflammatory myopathy|idiopathic disease|disease|disposition|material property|experimental factor; polymyositis|acquired idiopathic inflammatory myopathy|idiopathic inflammatory myopathy|myositis|inflammatory disease|disease|disposition|material property|experimental factor; polymyositis|acquired idiopathic inflammatory myopathy|idiopathic inflammatory myopathy|myositis|immune system disease|disease|disposition|material property|experimental factor; polymyositis|hypersensitivity reaction disease|immune system disease|disease|disposition|material property|experimental factor; polymyositis|acquired idiopathic inflammatory myopathy|acquired skeletal muscle disease|skeletal muscle disorder|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; polymyositis|acquired peripheral neuropathy|material entity|experimental factor; polymyositis|acquired idiopathic inflammatory myopathy|acquired skeletal muscle disease|material entity|experimental factor; polymyositis|acquired idiopathic inflammatory myopathy|idiopathic inflammatory myopathy|myositis|myopathy|muscle tissue disorder|muscular disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; polymyositis|acquired peripheral neuropathy|peripheral neuropathy|neuromuscular disease|neuropathy|nervous system disease|disease|disposition|material property|experimental factor; polymyositis|acquired idiopathic inflammatory myopathy|idiopathic disease|material entity|experimental factor; polymyositis|secondary glomerular disease|glomerular disease|material entity|experimental factor; polymyositis|acquired peripheral neuropathy|peripheral neuropathy|peripheral nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; polymyositis|secondary glomerular disease|glomerular disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:0000662	polyp	A usually exophytic mass attached to the underlying tissue by a broad base or a thin stalk. Polyps can be neoplastic or non-neoplastic. Neoplastic polyps usually represent proliferations of the epithelium, and are commonly seen in the gastrointestinal tract. Polyps of the gastrointestinal tract are often called adenomas, are associated with dysplasia, and may eventually transform into carcinomas. Non-neoplastic polyps may be inflammatory, degenerative, or the result of malformations.	polyp;polyp (morphologic abnormality);polyps	polyp|cancer or benign tumor|disease|disposition|material property|experimental factor
EFO:0009673	laryngeal disease	A non-neoplastic or neoplastic disorder that affects the larynx. Representative examples include laryngitis, vocal cord polyp, squamous papilloma, and carcinoma.	larynx disease or disorder;larynx disease;disorder of larynx;laryngeal disorder;laryngeal disease;disorder of the larynx;disease or disorder of larynx;disease of larynx	laryngeal disease|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0802888	potassium voltage-gated channel subfamily A member 10 measurement	NA		potassium voltage-gated channel subfamily A member 10 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801902	potassium voltage-gated channel subfamily E regulatory beta subunit 5 measurement	NA		potassium voltage-gated channel subfamily E regulatory beta subunit 5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801904	PR domain zinc finger protein 1 measurement	NA		PR domain zinc finger protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802894	pre-mRNA-processing factor 6 measurement	NA		pre-mRNA-processing factor 6 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801910	prenylcysteine oxidase-like measurement	NA		prenylcysteine oxidase-like measurement|protein measurement|measurement|information entity|experimental factor
EFO:0010726	total joint arthroplasty	NA	joint replacement;total joint replacement surgery;joint replacement surgery;TJA	total joint arthroplasty|medical procedure|experimental process|planned process|process|experimental factor
EFO:0801913	probable ATP-dependent RNA helicase DDX58 measurement	NA		probable ATP-dependent RNA helicase DDX58 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801914	probable carboxypeptidase X1 measurement	NA		probable carboxypeptidase X1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801922	procollagen galactosyltransferase 1 measurement	NA		procollagen galactosyltransferase 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801929	prolow-density lipoprotein receptor-related protein 1 measurement	NA		prolow-density lipoprotein receptor-related protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800210	propionylcarnitine (C3) measurement	NA		propionylcarnitine (C3) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0008270	proprotein convertase subtilisin/kexin type 7 measurement	NA		proprotein convertase subtilisin/kexin type 7 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0023122	familial prostate carcinoma	Prostate carcinoma that has developed in relatives of patients with a history of prostate carcinoma.	hereditary prostate carcinoma;prostate cancer, susceptibility to, autosomal dominant, somatic mutation;prostate cancer, familial, susceptibility to, autosomal dominant, somatic mutation;familial prostate cancer;hereditary prostate cancer;prostate cancer, autosomal dominant, somatic mutation;prostate cancer, somatic	familial prostate carcinoma|genetic disorder|disease|disposition|material property|experimental factor; familial prostate carcinoma|prostate carcinoma|prostate cancer|male reproductive organ cancer|male reproductive system neoplasm|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; familial prostate carcinoma|prostate carcinoma|carcinoma|epithelial neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; familial prostate carcinoma|genetic disorder|material entity|experimental factor; familial prostate carcinoma|prostate carcinoma|prostate cancer|male reproductive organ cancer|reproductive system cancer|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; familial prostate carcinoma|prostate carcinoma|prostate cancer|prostate neoplasm|prostate disease|male reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; familial prostate carcinoma|prostate carcinoma|prostate cancer|prostate neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; familial prostate carcinoma|prostate carcinoma|prostate cancer|male reproductive organ cancer|reproductive system cancer|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; familial prostate carcinoma|prostate carcinoma|prostate cancer|male reproductive organ cancer|male reproductive system neoplasm|reproductive system neoplasm|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; familial prostate carcinoma|prostate carcinoma|prostate cancer|prostate neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; familial prostate carcinoma|prostate carcinoma|prostate cancer|male reproductive organ cancer|male reproductive system neoplasm|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor; familial prostate carcinoma|prostate carcinoma|carcinoma|cancer|neoplasm|neoplastic disease or syndrome|cancer or benign tumor|disease|disposition|material property|experimental factor; familial prostate carcinoma|prostate carcinoma|prostate cancer|male reproductive organ cancer|reproductive system cancer|reproductive system neoplasm|reproductive system disease|disease|disposition|material property|experimental factor
EFO:0801937	protein CREG1 measurement	NA		protein CREG1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801939	protein DEPP measurement	NA		protein DEPP measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020669	protein disulfide-isomerase measurement	NA		protein disulfide-isomerase measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021857	protein FAM3B measurement	NA		protein FAM3B measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021869	protein FAM3D measurement	NA		protein FAM3D measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801962	protein sel-1 homolog 2 measurement	NA		protein sel-1 homolog 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802969	protein YIPF6 measurement	NA		protein YIPF6 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021849	protein Z-dependent protease inhibitor measurement	NA		protein Z-dependent protease inhibitor measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020692	prothrombin measurement	NA		prothrombin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801972	protocadherin alpha-4 measurement	NA		protocadherin alpha-4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802972	protocadherin beta-1 measurement	NA		protocadherin beta-1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:1001141	pyelonephritis	An inflammatory process affecting the kidney. The cause is most often bacterial, but may also be fungal in nature. Signs and symptoms may include fever, chills, flank pain, painful and frequent urination, cloudy or bloody urine, and confusion.	kidney infection;Pyelonephritis;pyelonephritis	pyelonephritis|bacterial urinary tract infection|urinary tract infection|bacterial disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; pyelonephritis|pyelitis|nephritis|inflammatory disease|disease|disposition|material property|experimental factor; pyelonephritis|uterine inflammatory disease|uterine disorder|female reproductive system disease|reproductive system disease|disease|disposition|material property|experimental factor; pyelonephritis|pyelitis|nephritis|kidney disease|urinary system disease|disease|disposition|material property|experimental factor
EFO:0801984	rab9 effector protein with kelch motifs measurement	NA		rab9 effector protein with kelch motifs measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802989	rap guanine nucleotide exchange factor 5 measurement	NA		rap guanine nucleotide exchange factor 5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801989	ras-related protein Rab-26 measurement	NA		ras-related protein Rab-26 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007460	reactive arthritis	Reactive arthritis (ReA) is an autoimmune disorder belonging to the group of seronegative spondyloarthropathies and is characterized by the classic triad of arthritis, urethritis and conjunctivitis.	postdysenteric arthropathy;Reactive arthritis;Reiter disease;arthritis urethritica;Reiter's disease;Fiessinger-Leroy-Reiter syndrome;post-bacterial arthropathy;reactive arthritis;Reiter's syndrome;Post-bacterial arthropathy;venereal arthritis;polyarthritis enterica;Fiessinger-Leroy disease;Arthritis, Reactive;Reiter syndrome;Fiessinger Leroy Reiter syndrome	reactive arthritis|arthritis|bone inflammation disease|bone disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; reactive arthritis|arthritis|rheumatic disease|connective tissue disease|disease|disposition|material property|experimental factor; reactive arthritis|autoimmune disease|immune system disease|disease|disposition|material property|experimental factor; reactive arthritis|material entity|experimental factor; reactive arthritis|arthritis|joint disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; reactive arthritis|arthritis|inflammatory disease|disease|disposition|material property|experimental factor; reactive arthritis|arthritis|rheumatic disease|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor
EFO:0021921	regenerating islet-derived protein 4 measurement	NA		regenerating islet-derived protein 4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801997	regulator of G-protein signaling 8 measurement	NA		regulator of G-protein signaling 8 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0010616	renin measurement	NA		renin measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004351	resting heart rate	NA		resting heart rate|heart rate|vital signs|measurement|information entity|experimental factor; resting heart rate|heart rate|heart function measurement|cardiovascular disease biomarker measurement|cardiovascular measurement|measurement|information entity|experimental factor
MONDO:0019200	retinitis pigmentosa	Retinitis pigmentosa (RP) is an inherited retinal dystrophy leading to progressive loss of the photoreceptors and retinal pigment epithelium and resulting in blindness usually after several decades.	retinitis pigmentosa	retinitis pigmentosa|inherited retinal dystrophy|vision disorder|disorder of visual system|disease|disposition|material property|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|inherited vitreous-retinal disease|genetic disorder|material entity|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|inherited vitreous-retinal disease|vitreous body disease|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; retinitis pigmentosa|inborn disorder of amino acid transport|inborn disorder of amino acid metabolism|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|inherited vitreous-retinal disease|genetic disorder|disease|disposition|material property|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|inherited vitreous-retinal disease|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|inherited vitreous-retinal disease|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|retinal degeneration|retinopathy|eye disease|disease of orbital region|head and neck disorder|disease|disposition|material property|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|retinal degeneration|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|inherited vitreous-retinal disease|vitreous body disease|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; retinitis pigmentosa|inborn disorder of amino acid transport|inborn disorder of amino acid metabolism|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|vision disorder|perceptual disorders|nervous system disease|disease|disposition|material property|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|inherited vitreous-retinal disease|retinopathy|nervous system disease|disease|disposition|material property|experimental factor; retinitis pigmentosa|inherited retinal dystrophy|retinal degeneration|retinopathy|eye disease|disorder of visual system|disease|disposition|material property|experimental factor; retinitis pigmentosa|inborn disorder of amino acid transport|inborn disorder of amino acid metabolism|inborn errors of metabolism|genetic disorder|material entity|experimental factor
EFO:0802004	retinoic acid receptor responder protein 1 measurement	NA		retinoic acid receptor responder protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802007	retinol dehydrogenase 16 measurement	NA		retinol dehydrogenase 16 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802008	retroviral-like aspartic protease 1 measurement	NA		retroviral-like aspartic protease 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008521	rhinitis	An inflammation of the mucous membrane lining the nose, usually associated with nasal discharge.	rhinitis;inflammation of nasal cavity mucosa;nasal cavity mucosa inflammation	rhinitis|nasal cavity disorder|nasal disorder|otorhinolaryngologic disease|disease|disposition|material property|experimental factor; rhinitis|inflammatory disease|disease|disposition|material property|experimental factor; rhinitis|nasal cavity disorder|upper respiratory tract disorder|respiratory system disease|disease|disposition|material property|experimental factor
EFO:0802017	ribonuclease 4 measurement	NA		ribonuclease 4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803025	ribosome biogenesis protein TSR3 homolog measurement	NA		ribosome biogenesis protein TSR3 homolog measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803298	ribosyldihydronicotinamide dehydrogenase [quinone] measurement	NA		ribosyldihydronicotinamide dehydrogenase [quinone] measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007510	tinea	A skin infection caused by a fungus.	Tinea infectious disease;Microsporic tinea, NOS;ringworm;Tinea;Dermatophytosis-tinea/ringworm;Tinea disease or disorder;Tinea caused disease or disorder;Tinea infection;tinea infection	tinea|skin infection|dermatitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; tinea|skin infection|skin disorder caused by infection|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; tinea|cutaneous mycosis|fungal infectious disease|infectious disease|infectious disease or post-infectious disorder|disease|disposition|material property|experimental factor; tinea|skin infection|skin disorder caused by infection|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; tinea|cutaneous mycosis|material entity|experimental factor; tinea|skin infection|dermatitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0802030	RNA-binding protein 24 measurement	NA		RNA-binding protein 24 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802028	RNA polymerase II elongation factor ELL measurement	NA		RNA polymerase II elongation factor ELL measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803044	scavenger receptor class A member 3 measurement	NA		scavenger receptor class A member 3 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020717	scavenger receptor cysteine-rich type 1 protein m130 measurement	NA		scavenger receptor cysteine-rich type 1 protein m130 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020718	secreted frizzled-related protein 1 measurement	NA		secreted frizzled-related protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802039	secreted frizzled-related protein 2 measurement	NA		secreted frizzled-related protein 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008277	Secreted frizzled-related protein 3 measurement	NA		Secreted frizzled-related protein 3 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0009868	sedation	NA		sedation|medical procedure|experimental process|planned process|process|experimental factor
EFO:0008279	semaphorin-3E measurement	NA		semaphorin-3E measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021864	semaphorin-5A measurement	NA		semaphorin-5A measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802054	serine protease inhibitor Kazal-type 2 measurement	NA		serine protease inhibitor Kazal-type 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021965	serine/threonine-protein kinase Chk1 measurement	NA		serine/threonine-protein kinase Chk1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0009269	ADAMTS13 measurement	NA	disintegrin and metalloproteinase with thrombospondin motifs 13 measurement	ADAMTS13 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802194	uncharacterized protein C6orf226 measurement	NA		uncharacterized protein C6orf226 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0009414	CCL17 measurement	NA	CC motif chemokine 17 measurement;thymus and activation regulated chemokine measurement;TARC measurement	CCL17 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0009416	CCL21 measurement	NA	CC motif chemokine 21 measurement	CCL21 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0009417	CCL23 measurement	NA	CC motif chemokine 23 measurement;MPIF1 measurement;myeloid progenitor inhibitory factor 1 measurement	CCL23 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0010772	CD244 measurement	NA		CD244 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007634	major depressive episode	NA		major depressive episode|Behavioral abnormality|Abnormal nervous system physiology|Abnormality of the nervous system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0802064	sialic acid-binding Ig-like lectin 10 measurement	NA		sialic acid-binding Ig-like lectin 10 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008284	sialic acid-binding Ig-like lectin 14 measurement	NA		sialic acid-binding Ig-like lectin 14 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020739	sialic acid-binding ig-like lectin 7 measurement	NA		sialic acid-binding ig-like lectin 7 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020740	sialoadhesin measurement	NA		sialoadhesin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008287	SLAM family member 7 measurement	NA		SLAM family member 7 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803081	small conductance calcium-activated potassium channel protein 1 measurement	NA		small conductance calcium-activated potassium channel protein 1 measurement|protein measurement|measurement|information entity|experimental factor
HP:0001518	Small for gestational age	Smaller than normal size according to sex and gestational age related norms, defined as a weight below the 10th percentile for the gestational age.	Small for gestational age;Birth weight less than 10th percentile;Low birth weight	Small for gestational age|Decreased body weight|Abnormality of body weight|Growth abnormality|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0803041	s-methyl-5'-thioadenosine phosphorylase measurement	NA		s-methyl-5'-thioadenosine phosphorylase measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803095	sorting nexin-8 measurement	NA		sorting nexin-8 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802082	sperm-associated antigen 11A measurement	NA		sperm-associated antigen 11A measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020750	sphingosine kinase 1 measurement	NA		sphingosine kinase 1 measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0003937	spondylitis	The inflammation of a vertebra.	inflammation of vertebra;vertebra inflammation	spondylitis|vertebral disorder|vertebral column disorder|skeletal system disease|musculoskeletal system disease|disease|disposition|material property|experimental factor; spondylitis|inflammatory disease|disease|disposition|material property|experimental factor
EFO:0007118	sitting height ratio	NA		sitting height ratio|body ratio measurement|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
EFO:0008292	stem Cell Growth Factor beta measurement	NA		stem Cell Growth Factor beta measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004276	Stevens-Johnson syndrome	Stevens-Johnson syndrome is a limited form of toxic epidermal necrolysis characterized by destruction and detachment of the skin epithelium and mucous membranes involving less than 10% of the body surface area.	Dermatostomatitis, Stevens Johnson type;Stevens Johnson syndrome;Stevens-Johnson syndrome	Stevens-Johnson syndrome|syndromic disease|material entity|experimental factor; Stevens-Johnson syndrome|toxic epidermal necrolysis|severe cutaneous adverse reaction|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; Stevens-Johnson syndrome|toxic epidermal necrolysis|toxic dermatosis|material entity|experimental factor; Stevens-Johnson syndrome|syndromic disease|disease|disposition|material property|experimental factor; Stevens-Johnson syndrome|toxic epidermal necrolysis|toxic dermatosis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor
EFO:0803105	stromal cell-derived factor 2-like protein 1 measurement	NA		stromal cell-derived factor 2-like protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802093	stromal interaction molecule 1 measurement	NA		stromal interaction molecule 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0010621	stromelysin2 measurement	NA		stromelysin2 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:1000746	panniculitis	Inflammation of the subcutaneous adipose tissue.	inflammation of subcutaneous adipose tissue;panniculitis;subcutaneous adipose tissue inflammation;Subcutaneous adipose tissue;Subcutaneous tissue;subcutis	panniculitis|inflammatory disease|disease|disposition|material property|experimental factor; panniculitis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; panniculitis|connective tissue disease|disease|disposition|material property|experimental factor
MONDO:0004938	substance dependence	The psychological or physiological need to take a substance in order to experience its effects or to avoid the effects of its absence.	dependence	substance dependence|substance-related disorder|psychiatric disorder|disease|disposition|material property|experimental factor
EFO:0802098	sulfatase-modifying factor 1 measurement	NA		sulfatase-modifying factor 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0009388	sum of basophil and neutrophil counts	NA		sum of basophil and neutrophil counts|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0009389	sum of eosinophil and basophil counts	NA		sum of eosinophil and basophil counts|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0009390	sum of neutrophil and eosinophil counts	NA		sum of neutrophil and eosinophil counts|granulocyte count|myeloid white cell count|leukocyte count|complete blood cell count|hematological measurement|measurement|information entity|experimental factor
EFO:0802103	SUN domain-containing protein 5 measurement	NA		SUN domain-containing protein 5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:1001209	temporal arteritis	Giant cell arteritis (GCA) is a large vessel vasculitis predominantly involving the arteries originating from the aortic arch and especially the extracranial branches of the carotid arteries.	inflammation of temporal artery;Giant cell arteritis (disorder);Temporal arteritis (disorder);Horton disease;Giant cell arteritis NOS (disorder);temporal artery inflammation;Horton's disease;Giant Cell Arteritis;giant cell arteritis;temporal arteritis;Giant cell arteritis;Giant cell Arteritis	temporal arteritis|central nervous system vasculitis|neurovascular disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; temporal arteritis|central nervous system vasculitis|central nervous system disease|nervous system disease|disease|disposition|material property|experimental factor; temporal arteritis|secondary glomerular disease|glomerular disease|material entity|experimental factor; temporal arteritis|central nervous system vasculitis|vasculitis|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; temporal arteritis|granulomatous angiitis|Arteritis|vasculitis|inflammatory disease|disease|disposition|material property|experimental factor; temporal arteritis|predominantly large-vessel vasculitis|vasculitis|material entity|experimental factor; temporal arteritis|predominantly large-vessel vasculitis|vasculitis|inflammatory disease|disease|disposition|material property|experimental factor; temporal arteritis|central nervous system vasculitis|neurovascular disorder|nervous system disease|disease|disposition|material property|experimental factor; temporal arteritis|central nervous system vasculitis|vasculitis|material entity|experimental factor; temporal arteritis|granulomatous angiitis|Arteritis|vasculitis|material entity|experimental factor; temporal arteritis|granulomatous angiitis|Arteritis|vasculitis|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; temporal arteritis|secondary glomerular disease|glomerular disease|kidney disease|urinary system disease|disease|disposition|material property|experimental factor; temporal arteritis|central nervous system vasculitis|vasculitis|inflammatory disease|disease|disposition|material property|experimental factor; temporal arteritis|granulomatous angiitis|Arteritis|arterial disorder|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor; temporal arteritis|predominantly large-vessel vasculitis|vasculitis|vascular disease|cardiovascular disease|disease|disposition|material property|experimental factor
EFO:0803114	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related measurement	NA		SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802118	tapasin measurement	NA		tapasin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020763	tartrate-resistant acid phosphatase type 5 measurement	NA		tartrate-resistant acid phosphatase type 5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800584	taurochenodeoxycholic acid 3-sulfate measurement	NA		taurochenodeoxycholic acid 3-sulfate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0802114	T-cell surface glycoprotein CD3 epsilon chain measurement	NA		T-cell surface glycoprotein CD3 epsilon chain measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803135	t-cell surface glycoprotein CD8 beta chain measurement	NA		t-cell surface glycoprotein CD8 beta chain measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802121	tenascin-X measurement	NA		tenascin-X measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800582	tetrahydrocortisol sulfate (1) measurement	NA		tetrahydrocortisol sulfate (1) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0004020	transgenic	NA	TG	transgenic|genetic modification|process|experimental factor
EFO:0008298	thioredoxin domain-containing protein 12 measurement	NA		thioredoxin domain-containing protein 12 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802128	thioredoxin domain-containing protein 5 measurement	NA		thioredoxin domain-containing protein 5 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803149	thioredoxin-interacting protein measurement	NA		thioredoxin-interacting protein measurement|protein measurement|measurement|information entity|experimental factor
HP:0001907	Thromboembolism	The formation of a blood clot inside a blood vessel that subsequently travels through the blood stream from the site where it formed to another location in the body, generally leading to vascular occlusion at the distant site.	Blood clot in blood vessel;Thromboembolic disease;Thromboembolic events	Thromboembolism|Abnormal thrombosis|Abnormality of blood and blood-forming tissues|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0803159	toll-like receptor 1 measurement	NA		toll-like receptor 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802136	TOM1-like protein 1 measurement	NA		TOM1-like protein 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020778	transcription factor IIIb 90 kda subunit measurement	NA		transcription factor IIIb 90 kda subunit measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008303	transmembrane glycoprotein NMB measurement	NA		transmembrane glycoprotein NMB measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802149	transmembrane protease serine 11D measurement	NA		transmembrane protease serine 11D measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802152	transmembrane protein 132C measurement	NA		transmembrane protein 132C measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803190	transmembrane protein 9 measurement	NA		transmembrane protein 9 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0010151	soluble triggering receptor expressed on myeloid cells 2 measurement	NA	sTREM2 measurement	soluble triggering receptor expressed on myeloid cells 2 measurement|Alzheimer's disease biomarker measurement|mental or behavioural disorder biomarker|measurement|information entity|experimental factor; soluble triggering receptor expressed on myeloid cells 2 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020787	tropomyosin beta chain measurement	NA		tropomyosin beta chain measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008306	tryptase beta-2 measurement	NA		tryptase beta-2 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803197	tubulointerstitial nephritis antigen-like measurement	NA		tubulointerstitial nephritis antigen-like measurement|protein measurement|measurement|information entity|experimental factor
EFO:0003271	tumor necrosis factor-alpha	NA	TNF-alpha; tumor necrosis factor	tumor necrosis factor-alpha|cytokine|protein|biological macromolecule|material entity|experimental factor; tumor necrosis factor-alpha|cytokine|protein|chemical entity|material entity|experimental factor
EFO:0020795	tumor necrosis factor ligand superfamily member 18 measurement	NA		tumor necrosis factor ligand superfamily member 18 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020801	tumor necrosis factor receptor superfamily member 11B measurement	NA		tumor necrosis factor receptor superfamily member 11B measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008309	tumor necrosis factor receptor superfamily member 19L measurement	NA		tumor necrosis factor receptor superfamily member 19L measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020813	tumor necrosis factor receptor superfamily member 3 measurement	NA		tumor necrosis factor receptor superfamily member 3 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0010610	tumor necrosis factor receptor superfamily member 6 measurement	NA	FAS ligand (FASLG) receptor measurement	tumor necrosis factor receptor superfamily member 6 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008310	tumor necrosis factor receptor superfamily member EDAR measurement	NA		tumor necrosis factor receptor superfamily member EDAR measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020891	tyrosine change measurement	NA		tyrosine change measurement|tyrosine measurement|measurement|information entity|experimental factor
EFO:0020831	tyrosine-protein kinase transmembrane receptor ROR1 measurement	NA		tyrosine-protein kinase transmembrane receptor ROR1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0020833	tyrosine-protein kinase ZAP-70 measurement	NA		tyrosine-protein kinase ZAP-70 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802173	tyrosine-protein phosphatase non-receptor type 7 measurement	NA		tyrosine-protein phosphatase non-receptor type 7 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802175	tyrosine-protein phosphatase non-receptor type substrate 1 measurement	NA		tyrosine-protein phosphatase non-receptor type substrate 1 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803211	U6 snRNA phosphodiesterase measurement	NA		U6 snRNA phosphodiesterase measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802178	ubiquitin carboxyl-terminal hydrolase 21 measurement	NA		ubiquitin carboxyl-terminal hydrolase 21 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021881	ubiquitin carboxyl-terminal hydrolase 25 measurement	NA		ubiquitin carboxyl-terminal hydrolase 25 measurement|protein measurement|measurement|information entity|experimental factor
MONDO:0043839	ulcer disease	A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.	ulcerative;ulceration;ulcers;ulcer	ulcer disease|injury|disease|disposition|material property|experimental factor
EFO:0802193	uncharacterized protein C3orf18 measurement	NA		uncharacterized protein C3orf18 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803233	unconventional myosin-VI measurement	NA		unconventional myosin-VI measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008304	trefoil factor 3 measurement	NA		trefoil factor 3 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0010803	urokinase-type plasminogen activator measurement	NA	uPA	urokinase-type plasminogen activator measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802204	uroplakin-3b-like protein measurement	NA		uroplakin-3b-like protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803242	urotensin-2 receptor measurement	NA		urotensin-2 receptor measurement|protein measurement|measurement|information entity|experimental factor
EFO:0010727	vacuum aspiration	NA	suction aspiration;aspiration	vacuum aspiration|collecting specimen from organism|specimen collection process|experimental process|planned process|process|experimental factor
EFO:0802210	valine--tRNA ligase measurement	NA		valine--tRNA ligase measurement|protein measurement|measurement|information entity|experimental factor
EFO:0801056	vanillic acid glycine measurement	NA		vanillic acid glycine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:1001923	varicose ulcer	NA	Venous Hypertension Ulcers;Venous Stasis Ulcers;Stasis Ulcer;Venous Ulcer	varicose ulcer|Varicose veins|Abnormal venous morphology|Abnormality of cardiovascular system morphology|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor; varicose ulcer|Varicose veins|Abnormal venous morphology|Abnormality of the vasculature|Abnormality of the cardiovascular system|Phenotypic abnormality|phenotype|quality|material property|experimental factor
EFO:0020848	vascular endothelial growth factor C measurement	NA		vascular endothelial growth factor C measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008314	vascular endothelial growth factor receptor 2 measurement	NA		vascular endothelial growth factor receptor 2 measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0022012	vesicular integral-membrane protein VIP36 measurement	NA		vesicular integral-membrane protein VIP36 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0008318	vitamin K-dependent protein C measurement	NA		vitamin K-dependent protein C measurement|blood protein measurement|protein measurement|measurement|information entity|experimental factor
EFO:0802217	vitrin measurement	NA		vitrin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0021843	vitronectin measurement	NA		vitronectin measurement|protein measurement|measurement|information entity|experimental factor
EFO:0004629	von Willebrand factor measurement	NA	vWF;von Willebrand factor levels	von Willebrand factor measurement|protein measurement|measurement|information entity|experimental factor; von Willebrand factor measurement|coagulation factor measurement|measurement|information entity|experimental factor; von Willebrand factor measurement|hematological measurement|measurement|information entity|experimental factor
EFO:0803247	v-set and transmembrane domain-containing protein 4 measurement	NA		v-set and transmembrane domain-containing protein 4 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0007789	BMI-adjusted waist circumference	NA		BMI-adjusted waist circumference|waist circumference|body weights and measures|anthropometric measurement|measurement|information entity|experimental factor
EFO:0021228	X-11381 measurement	NA		X-11381 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0021237	X-11444 measurement	NA		X-11444 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800720	X-12707 measurement	NA		X-12707 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800742	X-13729 measurement	NA		X-13729 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800818	X-21471 measurement	NA		X-21471 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800879	X-24418 measurement	NA		X-24418 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800898	X-24588 measurement	NA		X-24588 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800904	X-24736 measurement	NA		X-24736 measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800910	X-24947 measurement	NA		X-24947 measurement|metabolite measurement|measurement|information entity|experimental factor
MONDO:0019600	xeroderma pigmentosum	Xeroderma pigmentosum (XP) is a rare genodermatosis characterized by extreme sensitivity to ultraviolet (UV)-induced changes in the skin and eyes, and multiple skin cancers. It is subdivided into 8 complementation groups, according to the affected gene: classical XP (XPA to XPG) and XP variant (XPV).	xeroderma of Kaposi;XP;Kaposi disease;pigmented epitheliomatosis;Kaposi dermatosis;xeroderma pigmentosum syndrome;angioma pigmentosum atrophicum;atrophoderma pigmentosum;melanosis lenticularis progressiva	xeroderma pigmentosum|hereditary photodermatosis|skin disease|integumentary system disease|disease|disposition|material property|experimental factor; xeroderma pigmentosum|developmental anomaly of metabolic origin|metabolic disease|disease|disposition|material property|experimental factor; xeroderma pigmentosum|developmental anomaly of metabolic origin|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; xeroderma pigmentosum|progeroid syndrome|premature aging syndrome|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; xeroderma pigmentosum|DNA repair deficiency|inborn errors of metabolism|metabolic disease|disease|disposition|material property|experimental factor; xeroderma pigmentosum|hereditary photodermatosis|genetic disorder|material entity|experimental factor; xeroderma pigmentosum|progeroid syndrome|premature aging syndrome|material entity|experimental factor; xeroderma pigmentosum|hereditary photodermatosis|genetic disorder|disease|disposition|material property|experimental factor; xeroderma pigmentosum|progeroid syndrome|developmental defect during embryogenesis|disorder of development or morphogenesis|disease|disposition|material property|experimental factor; xeroderma pigmentosum|DNA repair deficiency|inborn errors of metabolism|genetic disorder|disease|disposition|material property|experimental factor; xeroderma pigmentosum|DNA repair deficiency|inborn errors of metabolism|genetic disorder|material entity|experimental factor
EFO:0802227	zinc finger protein 276 measurement	NA		zinc finger protein 276 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0803287	zinc transporter 3 measurement	NA		zinc transporter 3 measurement|protein measurement|measurement|information entity|experimental factor
EFO:0800184	1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement	NA		1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0010980	3-aminoisobutyrate measurement	NA		3-aminoisobutyrate measurement|urinary metabolite measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800379	3beta-hydroxy-5-cholestenoate measurement	NA		3beta-hydroxy-5-cholestenoate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800566	3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement	NA		3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0021003	4-acetamidobutanoate measurement	NA		4-acetamidobutanoate measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800002	5-hydroxylysine measurement	NA		5-hydroxylysine measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0020013	5-methyluridine (ribothymidine) measurement	Quantification of 5-methyluridine levels in a sample.		5-methyluridine (ribothymidine) measurement|uridine diphosphate measurement|phosphate measurement|measurement|information entity|experimental factor; 5-methyluridine (ribothymidine) measurement|uridine diphosphate measurement|nucleotide measurement|measurement|information entity|experimental factor
EFO:0010988	5-oxoproline measurement	NA		5-oxoproline measurement|urinary metabolite measurement|metabolite measurement|measurement|information entity|experimental factor
EFO:0800573	11beta-hydroxyandrosterone glucuronide measurement	NA		11beta-hydroxyandrosterone glucuronide measurement|metabolite measurement|measurement|information entity|experimental factor
